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Genomics has gathered broad public attention since Lamarck put forward his top-
down hypothesis of ‘motivated change’ in 1809 in his famous book “Philosophie 
Zoologique” and even more so since Darwin published his famous bottom-up theory of 
natural selection in “The Origin of Species” in 1859. The public awareness culminated 
in the much anticipated race to decipher the sequence of the human genome in 2002. 
Over all those years, it has become apparent that genomic DNA is compacted into 
chromatin with a dedicated 3D higher-order organization and dynamics, and that 
on each structural level epigenetic modifications exist. The book “Chromatin and 
Epigenetics “ addresses current issues in the fields of epigenetics and chromatin 
ranging from more theoretical overviews in the first four chapters to much more 
detailed methodologies and insights into diagnostics and treatments in the following 
chapters. The chapters illustrate in their depth and breadth that genetic information is 
stored on all structural and dynamical levels within the nucleus with corresponding 
modifications of functional relevance. Thus, only an integrative systems approach 
allows to understand, treat, and manipulate the holistic interplay of genotype and 
phenotype creating functional genomes. The book chapters therefore contribute to 
this general perspective, not only opening opportunities for a true universal view on 
genetic information but also being key for a general understanding of genomes, their 
function, as well as life and evolution in general.
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Department (RIMLS), Nijmegen, The Netherlands, which is a joint venture 
with the Medical Faculty of the Radboud University. For the past seven years 
he has focused on human blood monocytes, and the cell types they can dif-
ferentiate into such as macrophages, dendritic cells, and osteoclasts as an ex-
perimental research system. He is interested in the systems-wide integration 
of nuclear receptor action in health and disease. Through the COST-funded 
Gene Regulation Ensemble Effort for the Knowledge Commons (GREEKC) 
he became a member of the Gene Ontology Consortium. There he partici-
pates in setting the stage for computer-readable gene annotation for the 21st 
century, with a focus on ‘breaking through the DNA wall’ so as to enable 
automated reasoning through cellular signal transduction all the way to the 
trans-acting sequence-specific DNA binding transcription factors and their 
co-factors that act in concert on cis-acting chromosomal DNA sequences 
to permit cell type- and environmentally-conditioned gene transcription 
regulation. This includes the concepts of epigenetic memory embodied by 
post-replicational DNA modifications such as DNA methylation, nucleo-
some-borne epigenetic information in the form of histone post-translational 
modifications, nucleosome remodelling, and the positioning of nucleosomes 
along the length of chromosomes. Also chromatin domain boundaries have 
been a focus of his recent research. Over the years, his research has been 
funded by EMBL, Human Frontiers Science Program (HFSP), the Dutch 
Research Organisation NWO, the European Science Foundation (ESF), and 
indirectly by the European Research Council (ERC) with Hendrik G. Stun-
nenberg and Stefano Ceri.
Born in the Rhein-Neckar region Mannheim/Heidelberg, 
Germany, Dr. Knoch studied Physics, Mathematics, and 
Biology at the University of Heidelberg. In 1998, he gradu-
ated in (bio-)physics with “Three-Dimensional Organiza-
tion of Chromosomes domains in Simulation and Exper-
iment”, followed by his dissertation “Approaching the 
Three-Dimensional Organization of the Human Genome“ 
both at the German Cancer Research Center (DKFZ), Heidelberg, in 2002. 
In 2002/2004 Dr. Knoch founded his group Biophysical Genomics located at 
the Kirchhoff Institute for Physics, University of Heidelberg, and until today 
at the Cell Biology Department, Erasmus Medical Center, Rotterdam, The 
Netherlands. His work is focusing on the determination and understanding 
of genome organization from the DNA sequence level to the entire nucle-
ar morphology. Therefore, approaches from theoretical physics have been 
combined with molecular biology in highly interdisciplinary projects ranging 
from advanced DNA sequence analyses, parallel high-performance comput-
er modelling of genomic architectures, and new image analysis methods, to 
advanced fluorescence in situ hybridization and high-resolution chromatin 
conformation interaction genome mapping. Major achievements have been: 
an artefact-free in vivo labelling method of nuclear chromatin, the first 
system-biological genome browser (GLOBE 3D Genome Browser), the set-
up of one of the largest desktop computing grids, and last but not least the 
final determination of the general structural organization of higher mam-
malian genomes leading to a consistent systems genomics view of genomes 
from genotype to phenotype. All this has resulted in patents, publications, 
the foundation/coordination of international interdisciplinary cooperative 
networks, and consortia. He also (co-)founded many initiatives improving 
institutional/university study and management performance including the 
science outreach to the public and industry. Besides, he also conducts envi-
ronmental and human ecology research, has achieved law-changing contri-
butions in the human-rights sector, is an increasingly recognized artist in the 
fine arts, and last but not least has founded and is running two companies in 
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X Contents Preface
Since Charles Darwin put forward his famous bottom-up theory of natural selection
in “The Origin of Species” in 1859, genetics and nowadays genomics increasingly
gained world-wide attention [1]. The frequently debated cartoons depicting the
descent of man from apes mark the transition from ancient mystical beliefs to a sci-
entifically falsifiable modern theory of the origin of life and mankind. Jean-Baptiste
Lamarck had already put forward a top-down hypothesis in 1809 in his famous book
“Philosophie Zoologique” symbolized by the elongating giraffe-neck longing for
leaves at tree-tops [2]. It achieved public attention due to the ‘motivated change’
paradigm that remains simple to grasp, actually to this day. The discovery of the
DNA double helix and the four base code culminated in the publicly much antici-
pated race to decipher the sequence of the human genome in 2002 by the public
Human Genome Project and the private initiative of Craig Venter. Now everything
would be known about humans, their lives from birth to death as well as all species,
the origin of life and its future - so resounded the promise of some and the happy
belief of many.
But are 3 billion A, T, G, C bases and the ensuing code for ~20,000 proteins really
sufficient explanation for the holy grail of human life, as would be suggested by
monozygotic twin physiologic and physiognomic identity? Or is the real situation
much more complex, potentially involving a multitude of interactions of the geno-
type ranging from its own internal physicochemical foundation, via the phenotype
it is creating, up to the entire ecosystem, which is itself made up of many genomes? 
There is little doubt that a purely reductionistic approach cannot explore the full 
extent of the interaction-networks of genomes. While reductionism can formally
identify biological variables that are rate-limiting under the experimental condi-
tions that are tested, there may always be biological signals that are not observed 
because they were not solicited during the experiment.
Since the initial investigations in the late 18th century much progress has been
made, achieving a picture of the notoriously hard-to-access eukaryotic cell nucleus
and the chromatin it contains [3]. This revealed a layered organization of the physi-
cal genome comprising DNA, nucleosomes, chromatin quasi-fibres, chromatin
loops, loop aggregates/rosettes, as well as chromosome arms, entire chromosomes, 
and their position within the cell nucleus as outlined in Chapter 4 of this book.
Intriguingly, it also has become apparent relatively early already that there are heri-
table phenotype changes that do not involve alterations in the nucleotide sequence. 
This led to the concept of epigenetic coding initially introduced by Conrad Hall 
Waddington in 1942 [4] to explain why almost every cell of an organism harbours
the same DNA but does not express the same parts of the genetic information, 
enabling cell fate determination and cell lineage differentiation to yield all the cells
of an organism, as explained in Chapter 1.
This book addresses current issues in the fields of epigenetics and chromatin rang-
ing from more theoretical overviews in the first four chapters to much more detailed
methodologies and insights into diagnostics and treatments in the other chapters.
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loops, loop aggregates/rosettes, as well as chromosome arms, entire chromosomes, 
and their position within the cell nucleus as outlined in Chapter 4 of this book.
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table phenotype changes that do not involve alterations in the nucleotide sequence. 
This led to the concept of epigenetic coding initially introduced by Conrad Hall 
Waddington in 1942 [4] to explain why almost every cell of an organism harbours 
the same DNA but does not express the same parts of the genetic information, 
enabling cell fate determination and cell lineage differentiation to yield all the cells 
of an organism, as explained in Chapter 1.
This book addresses current issues in the fields of epigenetics and chromatin rang-
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In the elaborate Chapter 1 “Logic of Epigenetics and Investigation of Potential Gene 
Regions”, an overview is presented on epigenetic coding and the regulation of 
genes as well as what kind of modifications appear and how this can be understood 
within a broader scope. Chapter 2 “Recognition of Nucleosomes by Chromatin Factors: 
Lessons from Data-Driven Docking-Based Structures of Nucleosome-Protein Complexes” 
focuses on the intricate molecular interactions and thus how epigenetics actually 
works, i.e. the involved proteins and their structure. In Chapter 3 “Chromatin 
Dynamics Upon DNA Damage”, fingers are laid deep into the chromatin dynamics 
after DNA damage and its repair, thus showing how a genome reacts to the inevi-
table reality of life and consequent DNA damaging events. Finally, this first part 
of the book is rounded-off by Chapter 4 “A Consistent Systems Mechanics Model of 
the 3D Architecture and Dynamics of Genomes”, in which for the first time a broad 
systems genomics model based on the complete determination of genomic layers is 
presented leading to new perspectives on genome evolution and general complex 
systems development in nature.
As far as much more detailed methodologies and insights are concerned, in Chapter 5 
“Apicomplexan and Histone Variants: What’s new?”, the clinically relevant histone 
variants in Plasmodium spp. and Toxoplasma gondii are investigated in depth. 
Furthermore, in the far-reaching Chapter 6 “Epigenetic Modulation of Circadian 
Rhythms: Bmal1 Gene Regulation”, regulation of complex metabolic effects and phe-
notypic modulations are considered within a disease-relevant context. In Chapter 7 
“Epigenome Editing”, we dive deeply into an overview of modern epigenome editing 
systems locally and in genome-wide contexts, of which the CRISPR-Cas9 system has 
gained prominent public attention. This leads immediately to Chapter 8 “Resetting 
Cell Fate by Epigenetic Reprogramming”, which details phenomenally the setting of 
epigenetic patterns during differentiation and different reprogramming strategies 
that can be applied. In Chapter 9 “Cytosine Modifications and Distinct Functions of 
TET1 on Tumorigenesis”, very practical aspects of epigenetics during tumorigenesis 
are investigated. Other important clinical aspects are considered in Chapter 10 “Role 
of COX-2 Promoter Methylation and Helicobacter pylori Infection in Impaired Gastric 
Ulcer Healing”, where a treatment of epigenetic inhibition is shown. In the broad 
Chapter 11 “Epigenetic Regulation of Hepatitis B Virus Replication”, the importance 
of epigenetics for the regulation of the Hepatitis B virus is described, thus shedding 
light on how epigenetic control of transcription can be used for therapeutic strate-
gies. The book ends with a great double: In Chapter 12 “Part 1: The PIWI-piRNA 
Pathway is an Immune-Like Surveillance Process that Controls Genome Integrity by 
Silencing Transposable Elements”, we get an in-depth introduction into the pivotal 
roles of the PIWI pathway focusing on origin, properties, and functions in the 
germ line and somatic tissues. This is followed by Chapter 13 “Part 2: Deregulated 
Expressions of PIWI Proteins and piRNAs as New Candidate Biomarkers and Potential 
Therapeutic Tools in Cancer”, where we dive into how such epigenetic-based research 
as in the case of PIWI can lead to biomarkers which could be used as potential 
therapeutic tools in the perhaps emotionally most feared disease, namely cancer.
Consequently, the general development of genomics, which these chapters on 
epigenetics and chromatin illustrate in both their depth as well as broadness, shows 
clearly that genetic information is stored on all structural and dynamical levels 
within the nucleus with corresponding modifications. Only an integrative systems 
approach allows to understand and manipulate the consequently holistic interplay 
of geno- and phenotype creating functional genomes. All this opens the door to a 
concrete grasp of life as well as in more general terms complex systems as a whole. 
Hence, genomics and the entire biology are driven into the future by broad complex 
physical and mathematical methodologies and approaches. This not only opens 
III
opportunities for a true universal view of genetic information, but also is the key for
a general understanding of genomes, their function, as well as life and evolution in
general. Furthermore, these insights pave the path for diagnostics and disease treat-
ment, for future genome manipulation and engineering efforts, and ultimately also
for de novo created life forms. This will leave much room for new ample opportuni-
ties and we are sure that the most interesting times are yet to come.
Thus, in practical terms and in the formulation of T.A.K., to ultimately approach
Sustainable Development Goals as health/disease, and death, i.e. to achieve “eter-
nal” as well as artificial intelligence and life, demands the following: i) R&D must
work inter-/trans-disciplinarily in an open innovative network! Here, THE keys are
new virtual paper tools representing and seamlessly visualizing, integrating, and 
manipulating the complexity of systems wholeness (Figure 1, 2; Movie 1). Beyond, 
as foundation, ii) broad humanistic education (the baroquian Bildung ideal) must be
achieved with inter-/trans-disciplinary curricula of ALL sciences, arts, and profes-
sional crafts to efficiently exploit the opportunities of systems complexity. Learning 
for its own sake beyond mere training on the job must be the final mantra. Lastly, 
of ultimate importance, iii) society as a whole must epitomize an overall integra-
tive thinking and operation, i.e. living an internalized Human Ecology autopoietic
systems perspective [10]. Hence, ALL this must be represented in a humanistic
systems vision of terrestrial, interplanetary, and artificial intelligence/life, being for
everybody ad hoc graspable in a playful “Glass Bead Game” [11] manner, both for
the detailed daily practice as well as for a general “enlightened” understanding of
existence.
Figure 1.
Visions make the world go round: The simulation of an entire human genome with all chromosomes (different 
colours; [5]) depicting a chromatin quasi-fibre folding into stable loop aggregates/rosettes (Multi-Loop 
Subcompartment Model) has opened huge opportunities for an immediate intuitive understanding of the 
dynamic genome organization and function not only as, i.e. concerned spatial stable proximities, accessibilities, 
and replicability are concerned, but also in respect to the bigger genotype-phenotype evolutionary systems 
genomics entanglement.
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Figure 1. 
Visions make the world go round: The simulation of an entire human genome with all chromosomes (different 
colours; [5]) depicting a chromatin quasi-fibre folding into stable loop aggregates/rosettes (Multi-Loop 
Subcompartment Model) has opened huge opportunities for an immediate intuitive understanding of the 
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Figure 2, Movie 1. 
Practical systemic virtual paper tools make seeing is believing accessible: The GLOBE 3D Genome Platform [6] 
creates a virtual desktop environment for genomics combining i) visual data representation, ii) data access/
management, and iii) data analysis/creation. This allows, i.e. to combine 3D genome simulations (background 
left [5]) with complex DNA similarity and syndrome analysis of a linear ideogram chromosome representation 
(foreground) in respect to actual data (microscopy/FISH of two chromosome loci: PWLS/AS region (A-C; [5, 7]), 
chromosome arms (D; courtesy S. Dietzel), subchromosomal domains (E; courtesy D. Zink) [5], IgH region (F, G; 
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Abstract
In living organisms, all molecular structures are formed, and all events are carried out 
by specific DNA sequences referred to as ‛genes’. However, these genes need to be 
governed and controlled to function properly. In this way, they can participate in bio-
logical processes at the optimal time. Genes are actively controlled by other genes and 
specific proteins called ‛transcription factors’. In addition, there is another mechanism 
that determines gene expression, which can be transmitted from generation to genera-
tion and from cell to cell. This mechanism is referred to as the ‛epigenetic code’. The 
DNA sequence does not undergo any changes during the formation of this code, but the 
relevant part of DNA fragment becomes no longer meaningful. While histone modifica-
tions control expression of DNA in chromosome structure, methylation modifications at 
the gene level are quite effective in controlling expressions the cytosine-end methylation 
seen in mammalian genome often occurs in the nucleotide pairs which are also called 
the CpG dinucleotides. The most common epigenetic modifications are the changes in 
histone proteins and DNA methylation, and the most widely studied and the most well-
established epigenetic mechanism is the latter.
Keywords: epigenetic, methylation, mitochondria, methylation-specific PCR, analysis
1. Introduction
Epigenetic changes in living organisms can basically be grouped under two headings. One 
is protein acetylation, which is an epigenetic modification at the protein level. The other is 
DNA methylation, an epigenetic modification that occurs at the DNA level. In living species, 
all macro-molecular structures are determined by nucleotide sequences in the genome, and 
there is a different mechanism that can be transferred to cell from cell, which has inherent 
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ability to determine gene expression. It is called epigenetic code. During creation of this code, 
DNA sequence does not undergo any change. The genetic and epigenetic alterations men-
tioned above result in the activation of oncogenes or the inactivation of tumour suppressor 
genes. Methylation may occur in any living organism from bacteria to complex species such 
as humans. The most common type of methylation is the methylation of gene promoters. This 
is followed by exon methylation, intron methylation and exon-intron methylations, which 
may be observed quite frequently.
Methylation-specific PCR (MSP) and methylation-sensitive restriction fragment length poly-
morphism (MS-RFLP) are the two most widely utilized methods in DNA methylation studies. 
Also, modified DNA sequencing with bisulphite treatment, known as bisulphite sequencing, 
may also be employed to investigate the conformation of the region of interest. These 3 are 
considerably successful methods. With the advances in technology and reduced costs, methyla-
tion-specific DNA sequencing has become a frequently used method to investigate the methyl-
ated regions identified by means of these methods. Whether a methylation region affects the 
expression of the gene of interest is another aspect to take into account as some genes may not 
yield any products although they are not methylated. In that case, one should consider that the 
gene in question may be activated by other mechanisms. With a better understanding of such 
histone and DNA modifications, they now attract attention as therapeutic targets in cancer and 
various diseases. They have started to create new alternatives especially in cancer treatments. 
Various computer programs have begun to be developed for methylation analysis. This section 
discusses all of the aforementioned conditions separately.
1.1. Histone modifications
The most basic unit of the structure called chromatin is nucleosomes. A nucleosome is a unit of 
146 bp stretch of DNA over H2A, H2B, H3 and H4 central histone proteins and binding of H1 
protein to the structure as a lock. In addition, these constructs provide necessary packaging for 
the DNA molecule, which is quite large, to fit in a small area (Figure 1).
Covalent changes in amino acids are found in tail parts of central histone proteins form the 
epigenetic code. As a result of these changes, chromosome structure constitutes expression con-
trol constructs in DNA by acquiring heterochromatin (expressionally inactive) or by forming 
regions euchromatin (expressionally active regions). Histone modifications can be classified as 
acetylation, methylation and phosphorylation. The modifications are mostly visible and revers-
ible at the amino (NH3-) and carboxyl (COO-) ends of central histone proteins. Each of these 
Figure 1. Core histone and nucleosome structure.
Chromatin and Epigenetics2
changes to square may cause differentiation by altering histone function. For example, it can 
be seen that one, two and three bases of methyl group are added in methylation of arginine [1]. 
Histone changes are carried out by various enzymes. These include histone acetyl transferases 
(HATs), histone deacetylases (HDACs) and histone methyl transferases. The equilibrium in 
activity of these enzymes and their associated proteins is important when they can perform 
functions of normal cells. These equilibrium distortions can cause problems that can occur from 
loss of cell function to cancer formation.
1.2. DNA modifications—methylations
The underlying transcriptional silencing mechanism of DNA methylation is based on the 
overmethylation of cytosine in CpG-rich islands in the promoter region of a gene. This mech-
anism cooperates with histone deacetylation to suppress the chromatin structure. GC-rich 
DNA sequences in the human genome are often found in the promoter region and exon 1 of 
about 50% of all genes [2]. DNA methylation is the main underlying mechanism that regu-
lates gene expression in mammalian cells, as it happens to be one of the major mechanisms for 
the silencing of genes involved in cell cycle as well as cell growth and death [3].
The most widely studied and the most well-established epigenetic mechanism is DNA meth-
ylation. It is an enzymatic change where cytosines are converted to 5′-methylcytosine. The 
cytosine-end methylation seen in mammalian genome often occurs at the 5’-CpG-3′ dinucleo-
tides, which are also called CpG dinucleotides [4].
Methylation occurs by means of DNA methyltransferase (DNMT) enzymes. The DNMT family 
consists of four members, namely DNMT1, DNMT2, DNMT3A and DNMT3B. These enzymes 
are stratified into two groups: those that protect the methylated region and the ones that add 
new methyl groups. About 70% of all CpG dinucleotides of the human genome are methylated 
[5]. The remaining are the CpG-rich promoter regions of about 200 base pairs or are the first 
exons of genes. These regions are also called CpG islands and are found in 60% of all genes [6]. 
CpG methylation is programmed during the early embryonic period and preserved in later 
periods. CpG methylation is highly important with regard to normal functions of a given cell, 
as it affects the regulation of gene expression. For example, DNA methylation plays an impor-
tant role in gene silencing of the inactive X chromosome as well as the regulation of age-related 
or tissue-specific gene expression [7].
Although the structural changes that occur in DNA are usually termed as mutations, not every 
alteration is actually a mutation. A mutation refers to any change at base level such as purine-
to-pyrimidine (G-A) or pyrimidine-to-pyrimidine (C-T) changes; single or multiple altera-
tions; insertions, deletions and even single nucleotide polymorphisms (SNP). Yet, SNPs differ 
from mutations due to their structure. When methylation is compared with other changes in 
DNA, the methylation process may be considered as another type of mutation, with a change 
in the structure of the base resulting from a chemical change in DNA. However, mutations are 
rare changes compared to methylation, and they may or may not be repaired by DNA repair 
mechanisms [8]. They can be inherited from any ancestor or parent, and they may also occur 
as germline changes. On the other hand, SNPs can be called DNA alterations, which are more 
common in the population and which manifest themselves as susceptibility to disease, rather 
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be seen that one, two and three bases of methyl group are added in methylation of arginine [1]. 
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activity of these enzymes and their associated proteins is important when they can perform 
functions of normal cells. These equilibrium distortions can cause problems that can occur from 
loss of cell function to cancer formation.
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overmethylation of cytosine in CpG-rich islands in the promoter region of a gene. This mech-
anism cooperates with histone deacetylation to suppress the chromatin structure. GC-rich 
DNA sequences in the human genome are often found in the promoter region and exon 1 of 
about 50% of all genes [2]. DNA methylation is the main underlying mechanism that regu-
lates gene expression in mammalian cells, as it happens to be one of the major mechanisms for 
the silencing of genes involved in cell cycle as well as cell growth and death [3].
The most widely studied and the most well-established epigenetic mechanism is DNA meth-
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tides, which are also called CpG dinucleotides [4].
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as germline changes. On the other hand, SNPs can be called DNA alterations, which are more 
common in the population and which manifest themselves as susceptibility to disease, rather 
Logic of Epigenetics and Investigation of Potential Gene Regions
http://dx.doi.org/10.5772/intechopen.81739
3
than resulting in a direct disease phenotype. At this point, methylation is not considered as a 
mutation, despite the fact that it prevents cytosine behaviour by adding a methyl group from 
CpG dinucleotides to cytosine [9, 10].
The most appropriate means of this option are the CpG sequences within the DNA, which 
are bound to their conjugates through an enzymatic process in a stronger manner compared 
to the A-T pairs. This is because ApTs are bound to their complementary pairs in the cor-
responding chain by means of two hydrogen bonds, while CpGs are bound with three. 
Such binding characteristics are expected to provide stability to CpGs compared to ApTs. 
This may explain the greater frequency of methylation in CpGs rather than ApTs in the 
organism.
Methylation usually occurs through the addition of a methyl group to CpG sequence or to 
the C base in these CpG islands. Although such a change normally appears as a mutation, 
it is understood that, unlike mutations, this change is a highly functional mechanism in 
terms of cellular development and quite common across living organisms from bacteria 
to highly complex multicellular species. In this way, the organism can adapt to environ-
mental changes by changing the activation of the desired genes in response to external 
influences when necessary, thereby maintaining vitality and survival. During a methyla-
tion reaction, 5-methylcytosine is formed with the addition of a methyl group to the fifth 
carbon of the cytosine in CpG base pairs by the DNA methyltransferase enzyme (Figure 1). 
Potentially, any CpG base pair or island may undergo methylation. In addition, the fourth 
nitrogen of cytosine and sixth nitrogen of adenine, which are usually not found in multi-
cellular organisms, may also be methylated in addition to the 5-methylcytosine formation 
in bacteria [11].
Genomic imprinting is another example of DNA methylation that is involved in single-allele 
gene expression. Approximately 80 loci are suppressed in this way. The tissue-specific and con-
dition-specific expressions of these genes occur through the regulation of methylation [12]. At 
the end of 1970s, a decrease in methylcytosine numbers was observed in the genome of tumour 
cells [13]. This was referred to as hypomethylation of DNA and was demonstrated in benign 
and malignant tumours [14]. Hypomethylation of DNA may also activate oncogenes. Studies 
have shown hypomethylation in SI00A4, a metastasis-associated gene in colorectal cancers and 
the genes, cyclin-D2 and maspin, in gastric carcinomas [14, 15]. Hypomethylation may cause 
loss of imprinting (LOI), thereby promoting cell proliferation. One of the best examples of this 
process is the loss of imprinting in the IGF2/H19 region, which is seen in about 40% of colorectal 
cancers [1].
2. Bacterial epigenetic mechanisms
Modulation of chromosome organisation is one of the host defence mechanisms against bac-
terial attacks in eukaryotes. The host cell can often resist bacteria through these highly special 
and successful defence mechanisms. However, bacteria also have mechanisms that are devel-
oped against this system. Some bacteria may contain eukaryote-like proteins and eukaryotic 
histone translation proteins, which target the chromosomal machinery. In this way, they can 
activate appropriate enzymes in the host [16].
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Several bacteria contain an N4-methylcytosine base whose function has not been fully charac-
terised. There are studies indicating that these N4C modifications affect global gene expres-
sion in Helicobacter pylori, an example of carcinogenic bacteria [17].
Methylation in bacteria is different from eukaryotes in that it is seen in the fourth carbon of the 
cytosine as well as methylated adenine (N6-methyladenine) in addition to the fourth carbon 
of cytosine. DNA methylation occurs in bacteria by methyl binding to cytosine C-5 or N-4 and 
N6-adenine on the DNA methyltransferase enzyme side. N6-methyladenine is found only in 
bacteria and in less complex eukaryotes, and not in vertebrates [11]. Interestingly, bacteria also 
contain a restriction modification system that digests DNA methylase to provide protection 
against foreign DNA. These consist of the restriction enzyme systems called DcM, which rec-
ognises the 5-C cytosine, and Dam, which recognises methylated adenine. Of these, the Dam 
family is the most well-known protein group. The functional domain of Dam is a DNA MTase 
with an alpha molecule consisting of a polypeptide of 10 amino acids [18].
Similar to eukaryotes, bacteria also have rRNA methylation. The most important aspect of this 
methylation is that it creates targets for bacterial infections that can cause infection in humans. 
While promoter methylation is associated with negative expression, this may not always be the 
case for exon methylation. Still, sometimes exon methylation shows no effect on gene expres-
sion. Investigation on genetic mechanisms affecting cardiomyocyte differentiation includes 
some studies, which show that intragenic methylations create cellular memory through this 
mechanism, particularly in pluripotent cells [11].
3. Mitochondrial methylation
In all eukaryotic cells, mitochondrion is the most important organelle for cellular energy and 
the only organelle containing genomic material apart from the nucleus. Owing to its unique 
and small genome, this organelle exerts certain proteins and RNAs needed for respiratory 
reactions and cell growth. Together with the nucleus, it is one of the two genetic systems 
found in the cell. Mitochondrial DNA (mtDNA) has a circular structure and is located inside 
mitochondrial matrix, bound to the internal membrane. The mtDNA consists of 16,569 base 
pairs in a loop form, containing a heavy chain (H) and a light chain. This chain structure con-
tains 2 rRNA molecules, 22 tRNA molecules, and 13 genes necessary for oxidative phosphory-
lation and electron transport (Figure 2). A healthy mitochondrion exerts adequate functions 
by means of certain proteins that are present in the mechanism of oxidative phosphorylation. 
This genome is about 16.5 kb in humans, and 13 proteins and rRNAs are synthesised from the 
mitochondrial genome in mammals [19, 20]. Therefore, the slightest change in mitochondrial 
genome can potentially affect the life of the cell, and thus the organism [21].
As is the case with mutations, methylation is a mechanism that alters the way the genes work 
together with the diet, drugs and oxidative stress. Methylation profile of human mtDNA starts 
from the intrauterine period. With the aid of foetal thyroid hormones, mtDNA copy number 
and mtDNA methylation are regulated by a thyroid-dependent pathway [23]. In addition, 
mtDNA is also affected by airway pollutants. The elemental carbon present in benzene and 
exhaust gas in traffic may influence the number of mtDNA copies by means of ribosomal 
RNA methylation [24].
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Despite the understanding of these methylation changes in mitochondrial genome, the func-
tion of methylated mtDNA has not been fully understood; however, Monique et al. have 
revealed a different situation. Contrary to what is expected with the methylation of CpGs and 
GpCs in mtDNA, they have demonstrated that methylation of CpG base pairs had no effect 
on expression while methylated GpCs were associated with decreased expression [25].
Furthermore, since the mitochondria in humans are entirely of maternal origin, life style of 
the mother may also have effects at mitochondrion level. Habitual behaviour of the mother, 
her diet and excessive consumption of fats and sugars trigger obesity, which may affect epi-
genetics, including that of mitochondria in subsequent generations. A study conducted in 
mice revealed increased methylation leading to alterations in gene expression and suppres-
sion, particularly in the respiratory tract of the offspring of mice that were fed high-fat diets 
[26]. Furthermore, because the structure of mitochondrion is highly similar to that of bacteria, 
some genetic factors and structures may also be the same.
4. Detection of the methylation region
Any DNA region containing a CpG sequence may potentially undergo methylation. For this 
reason, any gene may be subjected to methylation; however, methylation most commonly 
occurs in the promoter region of genes. That is quite reasonable given the fact that the pro-
moter region is the recognition site for RNA polymerases and therefore of critical importance 
Figure 2. Gene structure of mitochondrial genome [22].
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Figure 3. QUMA Web-based program interface.
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for gene expression. Although more rarely, methylation may also be observed in exon 1 and 
other exons of certain genes. One of the ways of finding out whether a gene or DNA region 
may undergo methylation is to investigate that region with sequence analysis programs spe-
cifically developed for this task. There are paid programs by companies such as Fermentas 
(Methyl Primer Express® Software v1.0) serving this purpose as well as Web-based free 
access programs such as ‘MethPrimer’ developed by Li LC and Dahiya R. (available at http://
www.urogene.org/methprimer/) [27]. There is also a Web-based program ‘DiseaseMeth’ 
(available at http://202.97.205.78/diseasemeth/Analyze.html#form3), which offers researchers 
who is interested in using a study of which disease or cancer is associated with a desired gene 
methylation. Another Web-based program is SMS (Sequence Manipulation Suite; available 
at http://www.bioinformatics.org/sms2/) [28]. One of many useful programs at this address 
is program which shows CpG islands in a desired DNA region. Another program is a Web-
based program QUMA (Quantification tool for Methylation Analysis; available at http://quma.
cdb.riken.jp/) (Figure 3) [29]. These programs allow methylation region mapping, designing 
methylation-specific primers, determining bisulphite sequencing primers, identification of 
CpG islands and determination of DNA sequences that are altered or newly formed due to 
bisulphite modifications.
In order to do this, the initial step should be obtaining the FASTA sequence of the sequence in 
question. The Ensembl genome browser 92, available at https://www.ensembl.org/, is a very 
Figure 4. Survivin gene sequence on Ensembl genome browser 92.
Chromatin and Epigenetics8
Figure 5. Enter the sequence into Methyl Primer Express. The selection is made for bisulphite sequestration or MSP.
Figure 6. The possible gene region resulting from the analysis.
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good resource that can be utilised for this step. Ensembl is a database that allows access to DNA 
sequences in formats such as BLAST and BLAT for comparative genomic studies, evolution 
studies, sequence variants and transcriptional variants across vertebrate genomes. The relevant 
DNA sequence obtained from such a database is added to the methylation primer program, the 
sites of interest are labelled, and the program is run (Figures 4–8).
Figure 7. Methyl and unmethyl primer sequences and product length for the gene region of interest.
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5. Methylation-specific PCR (MSP)
MSP is an established and the most commonly utilised method to determine the presence or 
absence of methylation in a gene region of interest as well as the extent of methylation, if any 
[30, 31].
In this method, DNA is initially subjected to total bisulphite treatment. In this way, all of the 
unmethylated cytosines in the DNA sequence are transformed into thymine. However, the 
methylated cytosines remain unchanged (Figure 5). This results in a motif change in the meth-
ylated region. Subsequently, spectrophotometric DNA quantification is conducted with DNA 
samples. For this, measurements are made at wavelengths of 260/280 nm and multiplied by the 
Figure 8. Upper row: original sequence. Lower row: bisulphite modified sequence. (For display, assume all CpG sites are 
methylated) ++, CpG sites; ::::, non-CpG ‘C’ converted to ‘T’; M>>>>>>, left methylated-specific primer; M<<<<<<, right 
methylated-specific primer; U>>>>>>, left unmethylated-specific primer; U<<<<<<, right unmethylated-specific primer.
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dilution factor to determine the amount of DNA as nanogram per microlitre; and according to 
these amounts, MS-PCR is performed taking care to include equal amounts of DNA samples in 
the PCR. In this type of PCR, the PCR is conducted in two separate tubes for each sample. While 
the primer specific for the methylated region is added into one tube, the other tube contains the 
primer for the unmethylated region, and PCR is performed as 35–40 cycles. PCR samples are 
then analysed by visualisation with ethidium bromide agarose gel imaging systems.
5.1. Sample reaction: (for the prestin gene promoter region in guinea pigs)
Methylation-specific polymerase chain reaction: DNA purity was measured at wavelengths of 
260 and 280 nm on spectrophotometry, and DNA quantification was performed using the DNA 
(μg/mL) = A260 × Dilution Factor × 50 (coefficient) formula at 260 nm UV. Subsequently, 10 μL 
of DNA was taken from each sample and bisulphite modification was carried out for DNA 
with Millipore CpGenome modification kit according to the manufacturer’s instructions. This 
modification converts the cytosines of the unmethylated region to thymines. For the region 
thought to be altered in this manner, CpG sequences in exon 1 of the prestin gene were detected 
using the MethPrimer V1.1 beta program [30]. MSP was conducted according to the following 
protocols to investigate methylation utilising the PCR primers for exon 1 of the prestin gene 
stated below, and PCR conditions for the methylated and unmethylated regions are as follows:
Methylated region (M: methylated):
M-Forward: ATGTTGAAGAAAATGAAATTTTCGT,
M-Reverse: ACTTATCCCCGATAAAATCCG,
PCR product: 164 base pairs (bp).
Unmethylated region (UnM: unmethylated):
UnM-Forward: TTTATTTTTAGAAGGTTGTGG,
UnM-Reverse: AAACTACCAAACAAAAAACAACATC,
PCR product: 163 bp.
PCR conditions:
PCR buffer 1×, MgCl: 2 2.5 mM, DMSO: 5% (v/v), dNTP: 12.5 mM, Primer Forward: 10 pmol, 
Primer Reverse: 10 pmol, Taq Polymerase: 1 U (5 U/μL), Template DNA: 100 ng and dH2O 
were used to obtain a total of 50 μL, and PCR thermal cycling procedure was as follows:
This investigation allows determining whether the region of interest is methylated and quantify-
ing methylation by measuring the band intensity with any gel analysis system. If desired, results 
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may also be obtained while real-time PCR is performed with SYBR-green or Taqman or similar 
fluorescent probes (the probe must be designed according to the bisulphite DNA sequence).
5.2. Evaluation of agarose gel imaging
The resulting primers were stained with ethidium bromide on 2% agarose gel, and agarose 
gel findings were evaluated by examination under ultraviolet light (Figures 7–10).
Example run:
5.3. MS RFLP
Another method used to detect any DNA methylation is the methylation-specific restriction 
fragment length polymorphism (MS-RFLP) method, which produces methylation-specific 
digestion. This method employs restriction enzymes obtained from bacteria, which recognise 
5’ C ↓ C G G 3’
3’ G G C ↑ C 5’
Figure 9. Results of polymerase chain reaction in all study groups at the time point of second week for prestin (K1–K3: 
Group 1; K3–K6: Group 2; T1–T6: Group 3). Complete methylation is seen in sample 6T, while heterozygous methylation 
is observed in other samples [32].
Figure 10. Imaging of MSP and un-MSP PCRs of survivin exon 1. Well 1: marker, 100 bp marker; well 2: positive control; 
3–4, 5–6, 7–8, 9–10, 11–12, while unmethylated PCR results are found to be at the same (+) intensity in MSP and un-MSP 
sample wells of the same cases, the following methylated PCR results were not observed except the control DNA (+), and 
all samples were accepted as unmethylated. Well 13 is the negative control of the reaction (Figure 10).
Logic of Epigenetics and Investigation of Potential Gene Regions
http://dx.doi.org/10.5772/intechopen.81739
13
dilution factor to determine the amount of DNA as nanogram per microlitre; and according to 
these amounts, MS-PCR is performed taking care to include equal amounts of DNA samples in 
the PCR. In this type of PCR, the PCR is conducted in two separate tubes for each sample. While 
the primer specific for the methylated region is added into one tube, the other tube contains the 
primer for the unmethylated region, and PCR is performed as 35–40 cycles. PCR samples are 
then analysed by visualisation with ethidium bromide agarose gel imaging systems.
5.1. Sample reaction: (for the prestin gene promoter region in guinea pigs)
Methylation-specific polymerase chain reaction: DNA purity was measured at wavelengths of 
260 and 280 nm on spectrophotometry, and DNA quantification was performed using the DNA 
(μg/mL) = A260 × Dilution Factor × 50 (coefficient) formula at 260 nm UV. Subsequently, 10 μL 
of DNA was taken from each sample and bisulphite modification was carried out for DNA 
with Millipore CpGenome modification kit according to the manufacturer’s instructions. This 
modification converts the cytosines of the unmethylated region to thymines. For the region 
thought to be altered in this manner, CpG sequences in exon 1 of the prestin gene were detected 
using the MethPrimer V1.1 beta program [30]. MSP was conducted according to the following 
protocols to investigate methylation utilising the PCR primers for exon 1 of the prestin gene 
stated below, and PCR conditions for the methylated and unmethylated regions are as follows:
Methylated region (M: methylated):
M-Forward: ATGTTGAAGAAAATGAAATTTTCGT,
M-Reverse: ACTTATCCCCGATAAAATCCG,
PCR product: 164 base pairs (bp).
Unmethylated region (UnM: unmethylated):
UnM-Forward: TTTATTTTTAGAAGGTTGTGG,
UnM-Reverse: AAACTACCAAACAAAAAACAACATC,
PCR product: 163 bp.
PCR conditions:
PCR buffer 1×, MgCl: 2 2.5 mM, DMSO: 5% (v/v), dNTP: 12.5 mM, Primer Forward: 10 pmol, 
Primer Reverse: 10 pmol, Taq Polymerase: 1 U (5 U/μL), Template DNA: 100 ng and dH2O 
were used to obtain a total of 50 μL, and PCR thermal cycling procedure was as follows:
This investigation allows determining whether the region of interest is methylated and quantify-
ing methylation by measuring the band intensity with any gel analysis system. If desired, results 
Chromatin and Epigenetics12
may also be obtained while real-time PCR is performed with SYBR-green or Taqman or similar 
fluorescent probes (the probe must be designed according to the bisulphite DNA sequence).
5.2. Evaluation of agarose gel imaging
The resulting primers were stained with ethidium bromide on 2% agarose gel, and agarose 
gel findings were evaluated by examination under ultraviolet light (Figures 7–10).
Example run:
5.3. MS RFLP
Another method used to detect any DNA methylation is the methylation-specific restriction 
fragment length polymorphism (MS-RFLP) method, which produces methylation-specific 
digestion. This method employs restriction enzymes obtained from bacteria, which recognise 
5’ C ↓ C G G 3’
3’ G G C ↑ C 5’
Figure 9. Results of polymerase chain reaction in all study groups at the time point of second week for prestin (K1–K3: 
Group 1; K3–K6: Group 2; T1–T6: Group 3). Complete methylation is seen in sample 6T, while heterozygous methylation 
is observed in other samples [32].
Figure 10. Imaging of MSP and un-MSP PCRs of survivin exon 1. Well 1: marker, 100 bp marker; well 2: positive control; 
3–4, 5–6, 7–8, 9–10, 11–12, while unmethylated PCR results are found to be at the same (+) intensity in MSP and un-MSP 
sample wells of the same cases, the following methylated PCR results were not observed except the control DNA (+), and 
all samples were accepted as unmethylated. Well 13 is the negative control of the reaction (Figure 10).
Logic of Epigenetics and Investigation of Potential Gene Regions
http://dx.doi.org/10.5772/intechopen.81739
13
and cut only specific methylated regions. The most commonly used restriction enzymes for 
this purpose are HpaII and MspI.
This process digests the methylated CpG (if present) in the DNA region of interest. If that 
region is not methylated, digestion occurs via HpaII, an isomer of MspI. Concurrent use of 
these two enzymes provides insight on the methylation status of the region in question.
6. COBRA (combined bisulphite restriction analysis)
COBRA is a method developed by combined use of bisulphite modification and RFLP meth-
ods. In this combined method, DNA is first differentiated in the methylation-dependent DNA 
sequence with sodium bisulphite. As mentioned earlier, in practice, methylase cytosines are not 
affected, while unmethylated cytosines are converted into uracil. PCR is performed with prim-
ers designed specifically for these new DNA sequences obtained by bisulphite method. Unlike 
MS-PCR, primers used in this PCR step should not contain CpG sequences. After this step, diges-
tion step of restriction comes. At this step, PCR products are treated with two restriction enzymes 
with TaqI (TCGA) and BstUI (CGCG). These enzymes form a methylation profile by cutting off 
DNA fragments to properties of whether residues of cytosine are methylated or not (Figure 11).
Methylated regions in DNA fragments digested BstUI and unmethylated homologue of the 
same region digested TaqI enzyme. These new fragments, which are formed according to 
methylation state, can be calculated as percentages of methylation rate for region investigated 
according to patterns and density of band formed by conducting the polyacrylamide gel elec-
trophoresis. It should be noted here that band densities should be determined by a photo 
Figure 11. Calculation of band intensity in survivin exon 1 with ‘Gel Quant Express’.
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image analysis program (e.g., Figure 12). Once these values have been obtained, percentage 
of methylation can be calculated by substituting the following formula [33, 34] (Figure 13).
6.1. Advantages
It is simple, cheap and fast. DNA methylation levels can be shown without needing for any 
extra bisulphite sequencing.
Due to its high specificity, it is very successful even in DNA material, which is obtained from 
paraffin blocks.
It is quite quantitative compared to methylation-specific PCR, which is a qualitative method.
In MS-PCR, only locus-specific methylation information can be obtained, whereas in this 
method, entire region within locus is examined.
6.2. Disadvantages
This method is limited by existing restriction regions in region being investigated.
In addition, incomplete digestions of restriction enzymes can have misleading results for the 
amount of methylation.
Due to cell-type heterogeneity in different cell complexes, methylated CG sequence may be 
transformed into other sequences, such as CA or CT, leading to a change in restriction sites.
Considering all these advantages and disadvantages, the COBRA method emerges as an 
effective method for determining a highly effective level of methylation.
Figure 12. The image of COBRA method and calculation step.
Figure 13. Mathematical calculation of percentage methylation rates in COBRA method.
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DNA fragments to properties of whether residues of cytosine are methylated or not (Figure 11).
Methylated regions in DNA fragments digested BstUI and unmethylated homologue of the 
same region digested TaqI enzyme. These new fragments, which are formed according to 
methylation state, can be calculated as percentages of methylation rate for region investigated 
according to patterns and density of band formed by conducting the polyacrylamide gel elec-
trophoresis. It should be noted here that band densities should be determined by a photo 
Figure 11. Calculation of band intensity in survivin exon 1 with ‘Gel Quant Express’.
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image analysis program (e.g., Figure 12). Once these values have been obtained, percentage 
of methylation can be calculated by substituting the following formula [33, 34] (Figure 13).
6.1. Advantages
It is simple, cheap and fast. DNA methylation levels can be shown without needing for any 
extra bisulphite sequencing.
Due to its high specificity, it is very successful even in DNA material, which is obtained from 
paraffin blocks.
It is quite quantitative compared to methylation-specific PCR, which is a qualitative method.
In MS-PCR, only locus-specific methylation information can be obtained, whereas in this 
method, entire region within locus is examined.
6.2. Disadvantages
This method is limited by existing restriction regions in region being investigated.
In addition, incomplete digestions of restriction enzymes can have misleading results for the 
amount of methylation.
Due to cell-type heterogeneity in different cell complexes, methylated CG sequence may be 
transformed into other sequences, such as CA or CT, leading to a change in restriction sites.
Considering all these advantages and disadvantages, the COBRA method emerges as an 
effective method for determining a highly effective level of methylation.
Figure 12. The image of COBRA method and calculation step.
Figure 13. Mathematical calculation of percentage methylation rates in COBRA method.




Many studies after the first discovery of epigenetic changes have shown that epigenetic modi-
fications are quite important in natural flow of life and that many genes are mechanisms used 
for expression and inactivation when needed.
Furthermore, as these mechanisms are understood better, they have been associated with many 
pathological conditions, from cancer to mental retardations such as fragile X and Prader-Willi 
Angelman, to chromosomal instability. In this regard, such diseases have emerged in new 
therapeutic targets. Chemical agents such as 5-azacytidine and 5-aza-2′-deoxycytidine, which 
inhibit methylation by binding to and inhibiting DNMT enzyme, are now being tested in phase 
II-III studies [35–38]. Furthermore, use of oligonucleotides that bind to promoter regions at 
specific gene level and perform gene inhibition is seen as approaches that may contribute to 
cancer treatments [39–41].
In addition, histone acetyltransferase inhibitors, which inhibit formation of epigenetic modifi-
cations at histone level, have emerged as novel cancer treatment agents. For example, H3-H4 
of a soy protein Lunasin has been found to exhibit anticancer properties in mammals by sup-
pressing histone acetylation. Wenyi et al. have shown that YEAST domain, an acetyl lysine-
binding module, is effective in the development of cancer, and this domain appears to be the 
target for anticancer therapies. It seems that such approaches in the future will start to give 
more successful results [42].
In light of the information presented above, one may conclude that methylation is a highly 
important genomic mechanism for the cell from unicellular organisms to multicellular organ-
isms. This mechanism is seen in bacteria, mitochondria and all eukaryotic cells in proportion 
to the complexity and development level of the organism. The identification of methylated 
regions is as important as the methylation process itself, as this may allow identifying several 
potential novel targets related to subject matters such as the development mechanism of dis-
eases, certain roles in cancer development and bacterial resistance.
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Abstract
The function of chromatin ultimately depends on the many chromatin-associated proteins 
and protein complexes that regulate all DNA-templated processes such as transcription, 
repair and replication. As the molecular docking platform for these proteins, the nucleo-
some is the essential gatekeeper to the genome. As such, the nucleosome-binding activity 
of a myriad of proteins is essential for a healthy cell. Here, we review the molecular 
basis of nucleosome-protein interactions and classify the different binding modes avail-
able. The structural data needed for such studies not only come from traditional sources 
such as X-Ray crystallography but also increasingly from other sources. In particular, we 
highlight how partial interaction data, derived from for example NMR or mutagenesis, 
are used in data-driven docking to drive the modeling of the complex into an atomistic 
structure. This approach has opened up detailed insights for several nucleosome-protein 
complexes that were intractable or recalcitrant to traditional methods. These structures 
guide the formation of new hypotheses and advance our understanding of chromatin 
function at the molecular level.
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The packaging of DNA into chromatin represents one of the most fundamental layers of the 
biology of the cell. It provides the required structural compaction of DNA to fit in the nucleus 
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and plays crucial roles in controlling cell fate and protecting genome integrity. The funda-
mental unit of chromatin is the nucleosome in which 147 base pairs (bp) of DNA are wrapped 
around an octameric protein complex composed of two copies of histone proteins H2A, H2B, 
H3 and H4 [1–3]. Nucleosomes are arranged as beads-on-a-string forming 10 nanometer (nm) 
wide fiber that subsequently condense into higher order structures [4]. Nucleosomes as the 
basis of chromatin are responsible for its dynamics. Chromatin state and changes in DNA 
accessibility are determined at the nucleosome level. These changes are mediated through 
interactions of histone proteins and nucleosomal DNA alike with a wide range of protein 
complexes that control the structure of chromatin. They interpret, write and erase post- 
translational modifications or act as ATP-dependent nucleosome remodelers. This allows 
changes in the functional state of chromatin and regulation of DNA-templated processes. 
While promoting a large variety of effects on chromatin structure, nucleosome-interacting 
proteins share the molecular basis of recognizing and binding the nucleosome. Understanding 
the basis of chromatin dynamics therefore demands understanding the molecular basis of 
nucleosome-protein interactions.
In particular, insights into the molecular mechanistic basis of how histone-modifying enzymes 
install or remove post-translational modifications (writers and erasers, respectively) and 
how these modifications are recognized by effector proteins (readers) are of immense inter-
est, especially in drug development. Deregulation of these proteins is strongly connected to 
pathological outcome, including cardiovascular diseases, neurological disorders, metabolic 
disorders and cancer [5]. So-called epigenetic drugs that target the nucleosome interaction 
of these chromatin factors offer new therapeutic potential [6–9]. A selection of epigenetic 
drugs including those currently undergoing clinical trial is described in detail elsewhere 
[10]. Advancement in their development requires insights into the underlying molecular 
mechanism of nucleosome recognition, enabling control over subsequent modification of the 
chromatin state.
In the following, we will review the molecular basis of nucleosome-protein interactions, 
focusing on the different binding epitopes presented by the nucleosome. After an over-
view of the nucleosome-protein structures determined by crystallography or cryo-electron 
microscopy (cryo-EM), we highlight several studies in which experimental data from nuclear 
magnetic resonance spectroscopy (NMR), cross-link-based mass spectrometry (XL-MS) or 
mutational analysis were used to build atomistic structural models of nucleosome complexes. 
Throughout, we emphasize the role of these data-driven models in deepening our under-
standing of nucleosome recognition.
2. Nucleosome-binding epitopes
Consisting of DNA and histone proteins, the nucleosome offers a selection of distinct interac-
tion surfaces for binding of effector proteins with high levels of specificity (Figure 1).
Histone proteins possess a globular tertiary structure with exposed, disordered N-terminal 
tails. Histone tails are known to carry a wide range of covalent, post-translational side chain 
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modifications (PTMs) such as, mono-, di- and trimethylation (Lys, Arg); acetylation (Lys); 
phosphorylation (Ser, Thr) and ubiquitination (Lys) [11, 12]. This cosmos of modifications 
maintains a dynamic nature through the reversibility of the covalent modifications. Modified 
Figure 1. A schematic depiction of different modes of nucleosome recognition. Reported types of epitopes are histone 
tails including PTMs (A), the H2A-H2B acidic patch (B), the canonical histone surface (C), specific surface motifs formed 
by histone variants (D) or nucleosomal DNA (E). A manifold of synergetic combinations of binding epitopes are known, 
such as histone mark and DNA (F), acidic patch and DNA (G) or all three epitopes (H).
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histones are recognized by so-called reader protein domains specific for the respective modifi-
cation (Figure 1A). Interestingly, nucleosome-interacting proteins can possess more than one 
reader domain which allows cross talk between different post-translational modifications. 
Examples of PTM reader domains are Chromo, Tudor, PHD and MBT domains for methyl-
ated lysine residues, bromodomains for acetylated lysine residues and 14–3-3 proteins for 
phosphorylated serine [11, 13] (Table 1). The most recent addition to the list is YEATS domains 
that recognize crotonylated lysine [14–16]. Reader domains often have structurally conserved 
motifs that are able to complex a specific modification. The “Royal Family” of reader domains 
is in this respect a particularly instructive example. This superfamily includes the Chromo, 
MBT, PWWP and plant Agenet domains that bind methylated lysine (Tudor, Chromo, MBT, 
PWWP, plant Agenet) or arginine (Tudor) residues. Most domains of this family contain a 
barrel-shaped structure formed by 3–5 antiparallel β-strands that holds a cluster of aromatic 
residues that form the so-called aromatic cage [17]. The aromatic cage presents an electron-
rich yet hydrophobic surface that is ideally suited to bind methylated lysines through cation-π 
interactions [18]. The structural features and similarities, as well as their substrate specificity, 
have been subject to literature reviews [19–21].
Reader domains can, in addition to the post translational modification, show specificity for a 
defined amino acid sequence motif around the epigenetic mark that supports complex forma-
tion. For example, the WD40 domain of the EED (embryonic ectoderm development) protein 
selectively reads out trimethylated lysine in a A-R-K-S sequence motif (as for H3K27me3) but 
not in a R-T-K-Q motif (as for H3K4me3) [37].
(sub)Domain Modification Protein Function
Royal family
Tudor Kme1, Kme2, Kme3, 
Rme2
53BP1 DNA damage response [24]
TDRD3 Transcription activation [25]
MBT Kme1, Kme2 L3MBTL1 Transcriptional repression [26, 27]
PWWP Kme3 PSIP1 Transcriptional co-activation, DNA repair  
[28, 29]
Chromo Kme, Kme2, Kme3 CHD1 Chromatin remodeling [30, 31]
HP1 Heterochromatin [32]
MRG15 Splicing [33]
Plant Agenet Kme, Kme2, Kme3 FMRP DNA damage response [34]
Bromodomain
KAc BRD2/3 Transcriptional regulation [35]
14-3-3
Sph 14–3-3ζ Transcriptional activation [36]
aSee Refs. [21–23] for more in-depth discussion.
Table 1. Overview of selected reader domains for post-translational modificationsa.
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Next to histone tails, the nucleosome also possesses intrinsic docking platforms on its histone 
surface. The most prominent of these is composed of histones H2A and H2B. While the his-
tone octamer is overall highly positively charged, there is a patch on the H2A-H2B dimer sur-
face formed by acidic residues with negative surface charge. This structural feature is named 
the acidic patch and engages in a manifold of interactions with specific binding domains 
(Figure 1), including the tail of histone H4 of adjacent nucleosomes that promotes chromatin 
compaction. A common feature observed for acidic patch-interacting proteins is a positively 
charged arginine residue that interacts with a triad of acidic residues on H2A (Glu61, Asp90, 
Glu92). This is referred to as the arginine anchor [38]. It is often supported by surrounding 
positively charged residues interacting with acidic H2A/H2B interface residues.
Other parts of the histone core surface may also mediate protein-nucleosome interactions 
(Figure 1C). First, a solvent exposed cleft between H4 and H2B was shown to be involved in 
binding interactions with Sir3 or 53BP1 [39, 40]. Interestingly, these proteins bind simultane-
ously to both the H4-H2B cleft and the acidic patch using one nucleosome-binding domain for 
each epitope. Second, incorporation of non-canonical histones in nucleosomes introduces spe-
cific interaction surfaces that allow histone variant-specific nucleosome binding (Figure 1D). 
An example hereof are CENP-N and CENP-C that recognize the incorporated histone H3 
variant CENP-A [41, 42].
Finally, the nucleosomal DNA is a major protein interaction site. First, it forms the binding 
site of linker histone H1 [43–45] (see also Section 4.9). Second, it is often involved in additional 
synergistic interactions to nucleosome-binding domains (Figure 1E). Finally, recent studies 
have identified transcription factor proteins that primarily bind to nucleosomal DNA. These 
so-called pioneer factors bind their DNA target sites while embedded in the nucleosome 
[46–48]. The structural details of these are however still lacking.
Throughout the advances in studies on nucleosome binding, it has become clear that binding 
of effector proteins in many cases involves interactions of nucleosome-binding domains to 
multiple nucleosome epitopes (Figure 1G, H). However, due to their size and complexity 
as well as the stability and dynamics of complex formation, the nucleosome is a challenging 
system for structural biology.
3. Crystal clear: lessons from crystallography and single particles
A key role in the research of protein interactions are high-resolution three-dimensional struc-
tures of the complexes, typically obtained by crystallography and, increasingly, cryo-electron 
microscopy. These structures enable the identification of binding sites and intermolecular 
interactions, offering a guided approach to design binding-deficient mutants or competitive 
binders. The history of nucleosome structural biology peaked with the publication of the high-
resolution crystal structure of the nucleosome in 1997 [3]. Luger et al. achieved crystallization of 
the nucleosome together with a palindromic version of human α-satellite DNA [49]. This mile-
stone study provided the foundation to also study the structures of nucleosomes together with 
chromatin factors in complexes. Table 2 lists the structures of nucleosome-protein complexes 
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solved to date by crystallography and cryo-electron microscopy [39, 50–58]. The most recent 
addition to this ever-growing list is the spectacular structures of the complex between the 
INO80 chromatin remodeler and the nucleosome [59, 60]. Below, we discuss a few cardinal 
studies to highlight the different nucleosomal binding modes of effector proteins.
3.1. The first crystal structure of a nucleosome complex (LANA)
The first high-resolution structure of a nucleosome-protein complex was the crystal structure 
of a peptide model of Kaposi’s sarcoma-associated herpesvirus LANA N-terminal region 
bound to the nucleosome [61]. The binding site identified in this study was the acidic patch. 
The atomistic resolution allowed to identify intermolecular side chain interactions including 
the arginine anchor bound to the acidic triad. Ever since, the LANA-nucleosome has become 
a golden standard for comparisons with other acidic patch interactions [50, 55]. Importantly, 
LANA is used to investigate the acidic patch binding ability of other proteins by competitive 
binding [62–64]. Interestingly, this exact epitope happened to be the binding interface also for 
the first full protein domain that was crystalized in its nucleosome-bound state.
Name PDB-id Role Year Technique Reference Resolution [Å]
Proteins
RCC1 3MVD Ran recruitment 2010 X-Ray [50] 2.9






X-Ray [39, 51–53] 3.0 – 3.3
CENP-C 4X23 H3 variant binding 2013 X-Ray [54] 3.5
Ring1B 4R8P E3 ligase 2014 X-Ray [55] 3.3
53BP1 5KGF Reader 2016 EM [40] 4.5
SAGA/DUB 4ZUX Eraser 2016 X-Ray [56] 3.8
Set8 5HQ2 Writer 2016 X-Ray [57] 4.5
Chd1 5O9G Remodeler 2017 X-Ray [74] 4.8
Snf2 5X0X, 5X0Y Remodeler 2017 EM [71] 4.0
CENP-N 6BUZ, 6C0W H3 variant binder 2017, 2018 EM [72, 73] 3.9/4.0
H1 4QLC, 5NL0 Linker histone 2015, 2017 X-Ray [45, 75] 3.5
INO80 6FML, 6ETX Remodeling complex 2018, 2018 EM [59, 60] 4.4/4.8
Peptides
LANA 1ZLA, 5GTC Viral protein 2006, 2017 X-Ray [61, 76] 2.9/2.7
IE1 5E5A Viral protein 2016 X-Ray [77] 2.8
GAG 5MLU Synthetic acetylation 
system
2017 X-Ray [78] 2.8
Table 2. Structures of nucleosome-protein or nucleosome-peptide complexes deposited in the RCSB protein databank 
PDB.
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3.2. The first crystal structure of a nucleosome-bound protein domain (RCC1)
The first structure of a protein bound to the nucleosome was the RCC1-nucleosome complex 
published by the Tan lab in 2010. RCC1 (regulator of chromosome condensation) is essential 
during mitosis by recruiting Ran GTPase, which plays a role in nucleus reorganization, to 
the nucleosome [65, 66]. A comparison with LANA highlighted the crucial and conserved 
interaction of arginine residues with the acidic patch triad [50]. Strikingly, RCC1 binds to 
the acidic patch using the canonical arginine anchor, here contained in a loop, and also binds 
the nucleosomal DNA through its N-terminal tail. Such synergetic interactions have been 
observed later in many other nucleosome-binding proteins [50, 55, 67–70]. This study was the 
first to show such complexity of nucleosomes as interaction platforms. It also highlights the 
importance of properly defining the boundaries of binding domains to capture all binding 
epitopes in order to reveal possible synergetic interactions and fully understand complex 
formation and subsequent effects on chromatin structure.
3.3. Specificity of effector protein orientation in nucleosome complex formation 
(PRC1)
Besides determining the binding mode, synergetic interactions can also provide the struc-
tural basis for specificity of effector protein activity. This was shown in the crystal structure, 
also from the Tan lab, of the polycomb repressive complex 1 (PRC1) that ubiquitinates H2A 
K119 in a highly specific manner [55]. On its surface, the nucleosome displays various lysine 
residues that can be ubiquitinated by the respective writer proteins. However, the down-
stream response wildly differs depending on the position of the ubiquitinated lysine. Thus, 
target specificity is of high importance for ubiquitin writer proteins. In case of PRC1, this is 
based on two distinct binding processes. For one, there is the interaction between acidic patch 
and the arginine anchor of the Ring1B/Bmi1 subunit. In addition, the E2 subunit UbcH5c 
engages the nucleosomal DNA. Combined, both contributions are responsible for exact posi-
tioning of the catalytic center of the ubiquitin carrying E2 to the target H2A K119 (Figure 2B).
Besides LANA, RCC1 and PRC1, other crystal structures of nucleosome complexes offered 
further insights into nucleosome recognition. In particular, the structure of the nucleosome 
complex of the SAGA DUB deubiquitination module showed a non-canonical acidic patch 
binding. Morgan et al. found that the SAGA nucleosome-binding DUB module possesses 
three equally crucial arginine residues distributed over an α-helix [56] (Figure 2A). This per-
haps points towards yet other acidic patch interaction modes.
Recently, also cryo-EM-derived structures of nucleosome-protein complexes have been pub-
lished. The first structure, solved in 2016, yielded the structure of the complex with 53BP1, a 
reader protein for post-translational histone modifications [40]. Subsequently, the structures 
of Snf2 and CENP-N were solved and published [71–73].
Since the first crystal structure two decades ago, the list of nucleosome complexes deposited 
in the RCSB PDB protein databank is continuously growing. Still, the 12 high-resolution struc-
tures solved to date only encompass a fraction of all nucleosome-protein interactions. This 
discrepancy highlights the need for alternative techniques in chromatin structural biology.
Recognition of Nucleosomes by Chromatin Factors: Lessons from Data-Driven Docking-Based…
http://dx.doi.org/10.5772/intechopen.81016
27
solved to date by crystallography and cryo-electron microscopy [39, 50–58]. The most recent 
addition to this ever-growing list is the spectacular structures of the complex between the 
INO80 chromatin remodeler and the nucleosome [59, 60]. Below, we discuss a few cardinal 
studies to highlight the different nucleosomal binding modes of effector proteins.
3.1. The first crystal structure of a nucleosome complex (LANA)
The first high-resolution structure of a nucleosome-protein complex was the crystal structure 
of a peptide model of Kaposi’s sarcoma-associated herpesvirus LANA N-terminal region 
bound to the nucleosome [61]. The binding site identified in this study was the acidic patch. 
The atomistic resolution allowed to identify intermolecular side chain interactions including 
the arginine anchor bound to the acidic triad. Ever since, the LANA-nucleosome has become 
a golden standard for comparisons with other acidic patch interactions [50, 55]. Importantly, 
LANA is used to investigate the acidic patch binding ability of other proteins by competitive 
binding [62–64]. Interestingly, this exact epitope happened to be the binding interface also for 
the first full protein domain that was crystalized in its nucleosome-bound state.
Name PDB-id Role Year Technique Reference Resolution [Å]
Proteins
RCC1 3MVD Ran recruitment 2010 X-Ray [50] 2.9






X-Ray [39, 51–53] 3.0 – 3.3
CENP-C 4X23 H3 variant binding 2013 X-Ray [54] 3.5
Ring1B 4R8P E3 ligase 2014 X-Ray [55] 3.3
53BP1 5KGF Reader 2016 EM [40] 4.5
SAGA/DUB 4ZUX Eraser 2016 X-Ray [56] 3.8
Set8 5HQ2 Writer 2016 X-Ray [57] 4.5
Chd1 5O9G Remodeler 2017 X-Ray [74] 4.8
Snf2 5X0X, 5X0Y Remodeler 2017 EM [71] 4.0
CENP-N 6BUZ, 6C0W H3 variant binder 2017, 2018 EM [72, 73] 3.9/4.0
H1 4QLC, 5NL0 Linker histone 2015, 2017 X-Ray [45, 75] 3.5
INO80 6FML, 6ETX Remodeling complex 2018, 2018 EM [59, 60] 4.4/4.8
Peptides
LANA 1ZLA, 5GTC Viral protein 2006, 2017 X-Ray [61, 76] 2.9/2.7
IE1 5E5A Viral protein 2016 X-Ray [77] 2.8
GAG 5MLU Synthetic acetylation 
system
2017 X-Ray [78] 2.8
Table 2. Structures of nucleosome-protein or nucleosome-peptide complexes deposited in the RCSB protein databank 
PDB.
Chromatin and Epigenetics26
3.2. The first crystal structure of a nucleosome-bound protein domain (RCC1)
The first structure of a protein bound to the nucleosome was the RCC1-nucleosome complex 
published by the Tan lab in 2010. RCC1 (regulator of chromosome condensation) is essential 
during mitosis by recruiting Ran GTPase, which plays a role in nucleus reorganization, to 
the nucleosome [65, 66]. A comparison with LANA highlighted the crucial and conserved 
interaction of arginine residues with the acidic patch triad [50]. Strikingly, RCC1 binds to 
the acidic patch using the canonical arginine anchor, here contained in a loop, and also binds 
the nucleosomal DNA through its N-terminal tail. Such synergetic interactions have been 
observed later in many other nucleosome-binding proteins [50, 55, 67–70]. This study was the 
first to show such complexity of nucleosomes as interaction platforms. It also highlights the 
importance of properly defining the boundaries of binding domains to capture all binding 
epitopes in order to reveal possible synergetic interactions and fully understand complex 
formation and subsequent effects on chromatin structure.
3.3. Specificity of effector protein orientation in nucleosome complex formation 
(PRC1)
Besides determining the binding mode, synergetic interactions can also provide the struc-
tural basis for specificity of effector protein activity. This was shown in the crystal structure, 
also from the Tan lab, of the polycomb repressive complex 1 (PRC1) that ubiquitinates H2A 
K119 in a highly specific manner [55]. On its surface, the nucleosome displays various lysine 
residues that can be ubiquitinated by the respective writer proteins. However, the down-
stream response wildly differs depending on the position of the ubiquitinated lysine. Thus, 
target specificity is of high importance for ubiquitin writer proteins. In case of PRC1, this is 
based on two distinct binding processes. For one, there is the interaction between acidic patch 
and the arginine anchor of the Ring1B/Bmi1 subunit. In addition, the E2 subunit UbcH5c 
engages the nucleosomal DNA. Combined, both contributions are responsible for exact posi-
tioning of the catalytic center of the ubiquitin carrying E2 to the target H2A K119 (Figure 2B).
Besides LANA, RCC1 and PRC1, other crystal structures of nucleosome complexes offered 
further insights into nucleosome recognition. In particular, the structure of the nucleosome 
complex of the SAGA DUB deubiquitination module showed a non-canonical acidic patch 
binding. Morgan et al. found that the SAGA nucleosome-binding DUB module possesses 
three equally crucial arginine residues distributed over an α-helix [56] (Figure 2A). This per-
haps points towards yet other acidic patch interaction modes.
Recently, also cryo-EM-derived structures of nucleosome-protein complexes have been pub-
lished. The first structure, solved in 2016, yielded the structure of the complex with 53BP1, a 
reader protein for post-translational histone modifications [40]. Subsequently, the structures 
of Snf2 and CENP-N were solved and published [71–73].
Since the first crystal structure two decades ago, the list of nucleosome complexes deposited 
in the RCSB PDB protein databank is continuously growing. Still, the 12 high-resolution struc-
tures solved to date only encompass a fraction of all nucleosome-protein interactions. This 
discrepancy highlights the need for alternative techniques in chromatin structural biology.
Recognition of Nucleosomes by Chromatin Factors: Lessons from Data-Driven Docking-Based…
http://dx.doi.org/10.5772/intechopen.81016
27
Figure 2. A detailed depiction of the acidic patch region and the triad of H2A that complexes the canonical arginine 
anchor. (A) LANA was the first peptide model of a binding domain to be crystalized (green, pdb: 1zla). (B) The first 
crystalized protein domain was RCC1 (pink, pdb: 3mvd). (C) They all share the acidic patch as a common binding 
epitope for the arginine anchor residue, as is also the case for the PRC1 complex with its acidic patch binding RING 
domain (cyan, 4r8p). (D) Interestingly, acidic patch binding is not necessarily limited to one single arginine anchor 
residue. As for the nucleosome-bound structure of the deubiquitinase complex SAGA-DUB (yellow, pdb: 4zux), three 
arginine residues are essential part of the acidic patch binding, of which none occupies the position in the center of the 
acidic triad. Combination of nucleosomal DNA and acidic patch binding is shown in the structure of RCC1 and PRC1. 
(E) PRC1 (cyan, pdb: 4r8p) that besides the acidic patch also engages DNA with its UbcH5c subunit. (F) The same holds 
true for RCC1 (pink, pdb: 3mvd) that contacts to DNA with the unstructured tail region.
Chromatin and Epigenetics28
4. Data-driven modeling
An attractive alternative to traditional structure determination methods is the modeling of 
structures of complexes based on some sort of experimental information on the interaction 
[79, 80]. In such data-driven modeling of a complex structure, the two interaction partners are 
docked together, guided by the experimental data, and respecting their biophysical proper-
ties. The exact binding interface and relative orientation of the binding partners are typically 
refined over several steps. Prerequisite for this approach is the availability of the 3D structures 
of the interacting partners. Several molecular docking programs allow the incorporation and 
use of experimental data and so increase the accuracy of resulting structures [81]. Hence, data 
from diverse biophysical techniques are translated into restraints guiding the docking pro-
cess [82–84]. The type of information includes interaction interface, distances or shape of the 
complex and its subunits. Techniques that can provide these information are listed in Table 3.
Interestingly, all three classes of information can be provided by NMR spectroscopy. It is 
possible to gather data on intermolecular distances and shape by paramagnetic relaxation 
enhancement (PRE) and the nuclear Overhauser effect (NOE) as well as information on bind-
ing interfaces and binding affinity through chemical shift perturbation (CSP). The use of these 
NMR methods in docking studies is reviewed in detail elsewhere [79]. An overview of publi-
cations that used data-driven docking to investigate nucleosome-protein complexes is listed 
in Table 4.
4.1. Bringing data-driven modeling to nucleosome complexes (LSD1-CoREST)
A pioneer study for data-driven modeling of a nucleosome complex was successfully applied 
for the lysine-specific demethylase 1 and CoREST complex [86]. Both proteins cooperate in the 
demethylation of mono- and dimethylated H3K4. While it was possible to solve the crystal 
structure of LSD1-CoREST, their nucleosome-bound state remains elusive. Yang et al. gained 
insight into the molecular basis of LSD1-CoREST interaction by identifying point mutations 
that interfere with the LSD1-CoREST ability to demethylate a methylated peptide model of 
the histone H3 tail. Since it was previously shown that LSD1 recognizes a specific stretch 
of the H3 tail [94], it was possible to employ modeling to identify intermolecular interac-
tions between the peptide and both the LSD1 active site and the LSD1-CoREST interface 
(Figure 3B). Lastly, NMR titration experiments of the CoREST SANT2 domain with DNA 
revealed a DNA-binding interface on SANT2. These pieces of interaction data were used to 
Interaction interface Distances Shape
Mutagenesis XL-MS Cryo-EM
H/D exchange Forster resonance energy transfer (FRET) Small angle X-ray or neutron scattering (SAXS/
SANS)
Electron paramagnetic resonance (EPR) Ion-mobility mass spectrometry (IM-MS)
Table 3. Biochemical and biophysical techniques for structural analysis of protein complexes.
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ing interfaces and binding affinity through chemical shift perturbation (CSP). The use of these 
NMR methods in docking studies is reviewed in detail elsewhere [79]. An overview of publi-
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structure of LSD1-CoREST, their nucleosome-bound state remains elusive. Yang et al. gained 
insight into the molecular basis of LSD1-CoREST interaction by identifying point mutations 
that interfere with the LSD1-CoREST ability to demethylate a methylated peptide model of 
the histone H3 tail. Since it was previously shown that LSD1 recognizes a specific stretch 
of the H3 tail [94], it was possible to employ modeling to identify intermolecular interac-
tions between the peptide and both the LSD1 active site and the LSD1-CoREST interface 
(Figure 3B). Lastly, NMR titration experiments of the CoREST SANT2 domain with DNA 
revealed a DNA-binding interface on SANT2. These pieces of interaction data were used to 
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SANS)
Electron paramagnetic resonance (EPR) Ion-mobility mass spectrometry (IM-MS)
Table 3. Biochemical and biophysical techniques for structural analysis of protein complexes.
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guide a docking approach resulting in a complete structural model of the LSD1-CoREST-
nucleosome complex (Figure 3A). With the lack of experimental data on the nucleosome 
interaction, this is a prime example of combining crystal structures, mutagenesis and NMR 
data to overcome limitations of the separate techniques.
Protein Role Data source Reference
PSIP1-PWWP Trimethyl lysine reader H3K36 NMR [67, 68, 85]
CoREST/LSD1 Demethylase Crystallography/NMR [86]
Rad6-Bre1 Ubiquitin ligase XL-MS [70]
LANA Viral protein ssNMR [87]
NSD1 Methyltransferase H3K36 Mutagenesis [88]
RNF169 Ubiquitin reader NMR, SAXS [69, 89]
H1 Linker histone NMR [43, 90]
ISW2 Chromatin remodeler XL-MS [91]
Rad18 DNA repair factor NMR [89]
RCC1 Ran-recruitment Crystallography [62]
PHF1 Tudor Trimethyl lysine reader H3K36 Crystallography/NMR [92]
HMGN2 Chromatin decompaction NMR [93]
Table 4. Structural models of nucleosome-protein complexes based on biophysical data.
Figure 3. (A) Structural model of LSD1-CoREST bound to the nucleosome. The DNA binding of the SANT2 domain 
was elucidated by NMR spectroscopy. A previously identified binding motif in the H3 tail sequence was docked onto 
the interface of amine oxidase (AOD) and SWIRM domain revealing a second binding epitope. (B) The resulting model 
of the model peptide binding to AOD-SWIRM is shown as a close-up, highlighting how the tail is positioned on the 
interface of both domains. Figure generated using the author-provided PDB file [86].
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4.2. NMR-based structural biology of nucleosome-protein complexes
Over recent years, several studies have demonstrated that state-of-the-art solution NMR 
can offer high-resolution and site-specific characterization of the structures and dynamics 
of nucleosome-protein complexes. NMR has the particular advantage of its sensitivity to 
dynamics and the ease with which interactions can be studied, allowing detailed insights 
into molecular recognition processes. NMR allows studies when systems are dynamic, or 
(partially) disordered, while this typically hampers high-resolution structure determination 
by crystallography and cryo-EM.
The molecular size of nucleosomes, and even more so of complexes with effector proteins, 
poses a challenge to traditional NMR methods. However, this challenge can be overcome 
through the use of methodologies designed for high-molecular weight systems. This method, 
methyl group-based transverse-relaxation-optimized spectroscopy (methyl-TROSY), relies 
on the highly sensitive observation of NMR signals of protein methyl groups [95]. Here, a 
specific isotope-labeling scheme is used, which typically results in observation of isoleucine, 
leucine, valine (ILV) methyl groups. The methyl-TROSY NMR spectra can subsequently be 
used to delineate binding sites of effector proteins on the nucleosome surface and vice versa 
[68, 69, 93, 96]. Extracting more detailed structural information is possible through the use of 
so-called spin-labels that can generate long-range distance restraints between the interaction 
partners [97, 98]. Whichever way used, NMR-based interaction data are of unique value in the 
modeling of nucleosome-protein complexes.
4.3. Expanding data sources for nucleosome complex models to NMR (HMGN2)
Kato et al. were the first to use the methyl-TROSY approach for the study of nucleosome-
protein interactions [93]. Importantly, they reported the NMR signal assignments of the 
ILV-methyl groups for all histones in the nucleosomes. These assignments are essential in 
determining protein-binding sites on the nucleosome surface. The approach was demon-
strated using high mobility group nucleosomal protein 2 (HMGN2), which regulates a variety 
of chromatin functions. HMGN2 was found to bind both the acidic patch and nucleosomal 
DNA. Based on these NMR data, supported by mutagenesis, it was possible to determine a 
structural model of the complex (Figure 4A). HMGN2 binds to the nucleosome as a staple, 
using two main interaction sites. On one side, HMGN2 is anchored to the acidic patch using 
a canonical arginine anchor in the N-terminal region of the binding domain, while the lysine-
rich motif in its C-terminal region binds to nucleosomal DNA (Figure 4B). This binding mode 
provided a structural basis for the antagonistic function of HMGN2 towards linker histone 
H1 for nucleosome binding.
4.4. Latest applications of NMR to investigate structures of nucleosome 
complexes (RNF169 & Rad18)
Two recent studies relied on methyl-TROSY NMR-derived binding data to elucidate the 
recognition of ubiquitinated nucleosomes. Both focused on the interaction between ubiqui-
tylated H2A K13/15 and the DNA repair factor RNF169. The work of Kitevski-LeBlanc et al. 
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guide a docking approach resulting in a complete structural model of the LSD1-CoREST-
nucleosome complex (Figure 3A). With the lack of experimental data on the nucleosome 
interaction, this is a prime example of combining crystal structures, mutagenesis and NMR 
data to overcome limitations of the separate techniques.
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Rad18 DNA repair factor NMR [89]
RCC1 Ran-recruitment Crystallography [62]
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HMGN2 Chromatin decompaction NMR [93]
Table 4. Structural models of nucleosome-protein complexes based on biophysical data.
Figure 3. (A) Structural model of LSD1-CoREST bound to the nucleosome. The DNA binding of the SANT2 domain 
was elucidated by NMR spectroscopy. A previously identified binding motif in the H3 tail sequence was docked onto 
the interface of amine oxidase (AOD) and SWIRM domain revealing a second binding epitope. (B) The resulting model 
of the model peptide binding to AOD-SWIRM is shown as a close-up, highlighting how the tail is positioned on the 
interface of both domains. Figure generated using the author-provided PDB file [86].
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tylated H2A K13/15 and the DNA repair factor RNF169. The work of Kitevski-LeBlanc et al. 
Recognition of Nucleosomes by Chromatin Factors: Lessons from Data-Driven Docking-Based…
http://dx.doi.org/10.5772/intechopen.81016
31
established the molecular basis of this interaction. The α-helical MIU2 (motif interacting with 
ubiquitin) domain binds to a hydrophobic patch on the K13/15-conjugated ubiquitin while a 
disordered region anchors RNF169 on the nucleosome by binding to the acidic patch. They 
subsequently reconstructed a model structure that presents both epitopes in their nucleosome-
bound state (Figure 5A). The work of Hu et al. combined traditional NOESY-based structure 
determination at the level of histone-dimers with interaction studies at the nucleosome level 
and complemented these with SAXS data into a final model [89]. The authors also extended 
their findings to an NMR-based structural model for the complex with DNA repair factor 
Rad18. Both RNF169 and Rad18 are known to interfere with the binding of 53BP1 to nucleo-
somes ubiquitinated at H2A K13/15. These NMR-based structural models have allowed to 
hypothesize on the molecular mechanism for this interference.
4.5. Importance of the nucleosomal context in epigenetic read-out (PSIP1-PWWP & 
PHF1-Tudor)
The complexity of nucleosome recognition by reader proteins is well illustrated by the 
NMR-based studies on the recognition of H3K36me-nucleosomes by the PWWP domain of 
PSIP1(Ledgf). NMR studies of this reader interaction found that the PWWP domain has bind-
ing affinity orders of magnitude lower for a H3K36me peptide compared to H3K36me3 in 
a nucleosomal context. Interestingly, a similar observation was made for the Tudor domain 
of the H3K36me reader PHF1 [85]. Here, an isolated peptide model of the H3 tail showed 
decreased affinity as well. Due to the proximity of H3K36 to nucleosomal DNA, a role of DNA 
binding was hypothesized for both proteins. NMR studies showed for PSIP1 and PHF1 alike 
Figure 4. (A) Structural model of HMGN2 (red) bound to the nucleosome. The binding occurs along the nucleosome 
surface and is driven by interactions with the acidic patch and nucleosomal DNA, resulting in HMGN2 competing 
with H1 for nucleosome binding. (B) Close view on the acidic patch binding N-terminal HMGN2 region depicting the 
canonical arginine anchor R26 surrounded by the Glu 91, Asp 89, Glu 60 acidic triad motif of H2A. Figure generated 
using the author-provided PDB file [93].
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a binding site for nucleosomal DNA, resulting in a simultaneous binding mechanism of both 
trimethyl lysine and nucleosomal DNA.
For PHF1-Tudor, a crystal structure bound to a trimethylated H3 tail peptide was already 
available to use. The additional importance of the nucleosomal context and synergetic bind-
ing mechanism can be understood from the corresponding nucleosome-bound structure 
(Figure 6A). In case of PSIP1-PWWP, the domain structure was solved by NMR and, together 
with NMR titration data, used to determine a structural model of nucleosome-bound pro-
tein (Figure 6B) [67, 68, 85]. The structural models of both highlighted the importance of the 
nucleosomal context in H3K36me3 recognition, emphasizing that complex formation criti-
cally depends on two synergetic binding processes. Firstly, the aromatic residues that form 
the aromatic cage bind to trimethylated lysine H3K36me3. This recognition of the PTM is cru-
cial for the binding, but the readers reach their full binding affinity only when their positive 
surface residues interact with the nucleosomal DNA. This makes both studies outstanding 
examples of synergetic interplay of epitopes in nucleosome-binding proteins (Figure 6C, D).
The insights derived from these structural models were used to design experiments to vali-
date the structural model and may offer possible tools for further research approaches. In case 
of PSIP1-PWWP, the structural model sparked current efforts in the design of nucleosome-
mimicking peptides to modulate the PSIP1-chromatin interaction.
4.6. LANA goes solid state
The studies mentioned above illustrate the potential of data-driven modeling of nucleosome-
protein complexes based on state-of the-art solution NMR. Recent advances in solid-state 
Figure 5. (A) Structural model of nucleosome-bound RNF169 (red) and ubiquitin (green). (B, top) The proposed main 
acidic patch anchoring residue R700 (conserved position throughout the docking solutions) is shown in the conserved 
arginine anchor position between the acidic triads (Glu 60, Asp 89, Glu 91). (B, bottom) Side chain interactions between 
RNF169 MIU2 (red) and ubiquitin (green). Figure generated using the author-provided PDB file [69].
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established the molecular basis of this interaction. The α-helical MIU2 (motif interacting with 
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bound state (Figure 5A). The work of Hu et al. combined traditional NOESY-based structure 
determination at the level of histone-dimers with interaction studies at the nucleosome level 
and complemented these with SAXS data into a final model [89]. The authors also extended 
their findings to an NMR-based structural model for the complex with DNA repair factor 
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a binding site for nucleosomal DNA, resulting in a simultaneous binding mechanism of both 
trimethyl lysine and nucleosomal DNA.
For PHF1-Tudor, a crystal structure bound to a trimethylated H3 tail peptide was already 
available to use. The additional importance of the nucleosomal context and synergetic bind-
ing mechanism can be understood from the corresponding nucleosome-bound structure 
(Figure 6A). In case of PSIP1-PWWP, the domain structure was solved by NMR and, together 
with NMR titration data, used to determine a structural model of nucleosome-bound pro-
tein (Figure 6B) [67, 68, 85]. The structural models of both highlighted the importance of the 
nucleosomal context in H3K36me3 recognition, emphasizing that complex formation criti-
cally depends on two synergetic binding processes. Firstly, the aromatic residues that form 
the aromatic cage bind to trimethylated lysine H3K36me3. This recognition of the PTM is cru-
cial for the binding, but the readers reach their full binding affinity only when their positive 
surface residues interact with the nucleosomal DNA. This makes both studies outstanding 
examples of synergetic interplay of epitopes in nucleosome-binding proteins (Figure 6C, D).
The insights derived from these structural models were used to design experiments to vali-
date the structural model and may offer possible tools for further research approaches. In case 
of PSIP1-PWWP, the structural model sparked current efforts in the design of nucleosome-
mimicking peptides to modulate the PSIP1-chromatin interaction.
4.6. LANA goes solid state
The studies mentioned above illustrate the potential of data-driven modeling of nucleosome-
protein complexes based on state-of the-art solution NMR. Recent advances in solid-state 
Figure 5. (A) Structural model of nucleosome-bound RNF169 (red) and ubiquitin (green). (B, top) The proposed main 
acidic patch anchoring residue R700 (conserved position throughout the docking solutions) is shown in the conserved 
arginine anchor position between the acidic triads (Glu 60, Asp 89, Glu 91). (B, bottom) Side chain interactions between 
RNF169 MIU2 (red) and ubiquitin (green). Figure generated using the author-provided PDB file [69].
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NMR (ssNMR) have enabled the detailed investigation of large, soluble biomolecular com-
plexes. Very recently, our lab capitalized on these advances and tailored them for application 
to nucleosome-protein complexes [87]. Unlike the methyl-TROSY methods, this approach 
allows observation of all residues, in principle allowing for a more complete mapping of 
binding interfaces. In this approach, NMR spectra are recorded on sediments, generated by 
ultracentrifugation, of nucleosomes or their complexes. After assignments of NMR signals of 
histone H2A in the unbound nucleosome, spectra were recorded on the nucleosome complex 
with the LANA peptide, analogous to the LANA crystal structure (Figure 7A) [61, 87]. Based 
on the chemical shift changes, the binding site of LANA could be mapped to the acidic patch 
Figure 6. Structural model of nucleosome-bound PHF1 (red; A) and PSIP1-PWWP (green; B). The electrostatic potential 
of nucleosomal DNA and the surface of PHF1 (C) and PWWP (D), respectively, act in combination with H3K36me3 
recognition by the aromatic cage motif (trimethyl lysine side chain shown as sticks). Figure generated using the author-
provided PDB file [85].
Chromatin and Epigenetics34
and a structural model generated. The large agreement between the crystal structure and 
ssNMR-derived structural model (Figure 7B) illustrates the power of this approach. In our 
view, ssNMR, just as the solution NMR approach, is an attractive alternative for structure 
determination for nucleosome-protein complexes. While its application awaits to be extended 
to larger nucleosome-binding domains, we anticipate that it will be a valuable addition to the 
tool kit in chromatin structural biology.
4.7. Modeling nucleosome-bound Rad6-Bre1 based on cross-linking MS
Next to NMR, cross-linking mass spectrometry has found increasing application as a data 
source on nucleosome-protein interactions. With cross-linking, intermolecular contacts 
between the proteins of interest are captured and converted to covalent connections. These 
connections are introduced by small molecule linkers, specific for the fusion of well-defined 
side chains or less specific as radical-forming photo cross-linkers. Furthermore, cross-linkers 
possess a spacer between their terminal functional groups to define the range of cross-linking 
ability [99, 100]. Both characteristics can be tuned for the study of a specific system, resulting 
in a manifold of reported linker molecules. After cross-linking, the protein complex undergoes 
trypsin digestion resulting in peptide fragments of the complex. Here, covalently cross-linked 
fragments stay connected. An analysis of these fragments by liquid chromatography mass 
spectrometry (LC-MS) enables identification of the sequence positions. The cross-links can 
thus be converted to distance restraints between two residues, with the distance depending 
on the length of the cross-linker. These restraints can be used to guide structural modelling 
of the complex [80]. In one of the earliest examples for nucleosome complexes, XL-MS was 
used to map the binding sites of the various nucleosome-binding domains of the chromatin 
Figure 7. (A) Structural model for nucleosome-bound LANA peptide. ssNMR data derived from NMR titration 
experiments were used to direct the docking simulation. (B) Alignment of the ssNMR-derived model for LANA (red) 
and the crystal structure (green, pdb: 1zla) shows remarkable accuracy of the docking-derived solution. For both, the 
canonical arginine anchor is depicted as sticks in the typical central position between the acidic triad of H2A (yellow).
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NMR (ssNMR) have enabled the detailed investigation of large, soluble biomolecular com-
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allows observation of all residues, in principle allowing for a more complete mapping of 
binding interfaces. In this approach, NMR spectra are recorded on sediments, generated by 
ultracentrifugation, of nucleosomes or their complexes. After assignments of NMR signals of 
histone H2A in the unbound nucleosome, spectra were recorded on the nucleosome complex 
with the LANA peptide, analogous to the LANA crystal structure (Figure 7A) [61, 87]. Based 
on the chemical shift changes, the binding site of LANA could be mapped to the acidic patch 
Figure 6. Structural model of nucleosome-bound PHF1 (red; A) and PSIP1-PWWP (green; B). The electrostatic potential 
of nucleosomal DNA and the surface of PHF1 (C) and PWWP (D), respectively, act in combination with H3K36me3 
recognition by the aromatic cage motif (trimethyl lysine side chain shown as sticks). Figure generated using the author-
provided PDB file [85].
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and a structural model generated. The large agreement between the crystal structure and 
ssNMR-derived structural model (Figure 7B) illustrates the power of this approach. In our 
view, ssNMR, just as the solution NMR approach, is an attractive alternative for structure 
determination for nucleosome-protein complexes. While its application awaits to be extended 
to larger nucleosome-binding domains, we anticipate that it will be a valuable addition to the 
tool kit in chromatin structural biology.
4.7. Modeling nucleosome-bound Rad6-Bre1 based on cross-linking MS
Next to NMR, cross-linking mass spectrometry has found increasing application as a data 
source on nucleosome-protein interactions. With cross-linking, intermolecular contacts 
between the proteins of interest are captured and converted to covalent connections. These 
connections are introduced by small molecule linkers, specific for the fusion of well-defined 
side chains or less specific as radical-forming photo cross-linkers. Furthermore, cross-linkers 
possess a spacer between their terminal functional groups to define the range of cross-linking 
ability [99, 100]. Both characteristics can be tuned for the study of a specific system, resulting 
in a manifold of reported linker molecules. After cross-linking, the protein complex undergoes 
trypsin digestion resulting in peptide fragments of the complex. Here, covalently cross-linked 
fragments stay connected. An analysis of these fragments by liquid chromatography mass 
spectrometry (LC-MS) enables identification of the sequence positions. The cross-links can 
thus be converted to distance restraints between two residues, with the distance depending 
on the length of the cross-linker. These restraints can be used to guide structural modelling 
of the complex [80]. In one of the earliest examples for nucleosome complexes, XL-MS was 
used to map the binding sites of the various nucleosome-binding domains of the chromatin 
Figure 7. (A) Structural model for nucleosome-bound LANA peptide. ssNMR data derived from NMR titration 
experiments were used to direct the docking simulation. (B) Alignment of the ssNMR-derived model for LANA (red) 
and the crystal structure (green, pdb: 1zla) shows remarkable accuracy of the docking-derived solution. For both, the 
canonical arginine anchor is depicted as sticks in the typical central position between the acidic triad of H2A (yellow).
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remodeling complex ISW2 onto the nucleosome surface [91]. These data were subsequently 
used to build a structural model of the ISW2-nucleosome complex. A recent case of cross-
linking-based modeling in nucleosome research is the E2/E3 ubiquitin ligase complex Rad6-
Bre1 (Figure 8A). Bre1 is known to act as a homodimer in a complex with Rad6 to specifically 
ubiquitinate H2B K123 [101, 102]. However, the molecular mechanism of specific ubiquiti-
nation remained unknown without any nucleosome-bound complex structure available. 
Gallego et al. addressed exactly this problem by using XL-MS data to identify the binding 
interface between the Bre1 RING domain and the nucleosome. Next to nucleosomal DNA 
binding, they observed binding of the homodimer to the acidic patch (Figure 8B), which was 
verified by LANA-induced inhibition of Bre1 RING nucleosome binding. As a first step in the 
modeling, the authors modeled the Rad6-Bre1 complex structures based on homology with 
known E2/E3 RING ligases. Importantly, the resulting model was supported by the observed 
cross-links. The Rad6-Bre1 model could then be docked onto the nucleosome guided by the 
observed cross-links. This provided the structural basis for the specificity of Bre1 towards 
H2B K123 ubiquitination [70].
4.8. Adding new perspective on binding modes
Data-driven structural models complement high-resolution structures in many ways. An 
interesting example is the RCC1-nucleosome interaction, which serves as binding platform 
for subsequent binding of Ran, a protein relevant during mitosis (see Section 3.2). Biochemical 
data have shown that Ran activity is increased in the nucleosome-bound complex. The crys-
tal structure suggests no nucleosome-Ran interactions upon modeling Ran to the RCC1 
Figure 8. (A) Structural model of homodimeric Bre1 (red) bound to the nucleosome together with the E2 ligase Rad6 
(blue) with attached ubiquitin (green). The study was conducted by identifying the interactions between positive Bre1 
RING residues and the acidic patch. The docking was further facilitated due to the known target lysine residue. (B) Close 
view on Bre1 bound to both the acidic patch and nucleosomal DNA. The homodimeric nature allows the engagement of 
both epitopes in simultaneous binding. Figure generated using the author-provided PDB file [70].
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Ran-binding interface. Before the crystal structure of nucleosome-bound RCC1 was solved, 
a data-driven model was reported, which does feature Ran-nucleosome interactions. [62]. 
The authors suggest that, upon Ran binding, the nucleosomal DNA contacts with RCC1 
N-terminal tail observed in the crystal are broken in favor of Ran-nucleosome interactions as 
observed in model. Even though additional studies have to elucidate the exact mechanism of 
RCC1-Ran nucleosome binding, the use of crystal structure and data-driven model in combi-
nation outlines a possible mechanism to further investigate.
4.9. Debating H1
Another cardinal topic is the nucleosome-bound state of linker histone H1. To date, the struc-
ture of the chromatosome, consisting of the four canonical histones and 166bp of DNA in a 
complex with linker histones, is strongly debated. In this case as well, there are contradictions 
between structural models and a nucleosome-bound crystal structure of the chromatosome. 
The crystal structure reported by Zhou et al. displays the globular domain of linker histone 
H5 (chicken H5) with truncated tails in an on-dyad binding mode encountering both entering 
and leaving ends of linker DNA [75]. As for linker histone H1 (X. laevis H1.0b, human H1.5), a 
similar on-dyad binding mode was reported by cryo-EM and crystallography independently 
from absence or presence of H1 tails [45]. In fact, while not vital for linker histone position-
ing, the H1 C-terminal domain engages in binding of one of both linker DNAs preferably, 
introducing asymmetry into the nucleosome-bound complex.
In contrast to the proposed on-dyad complex, computational studies on linker histone bind-
ing suggest an alternative, off-dyad binding geometry of the complex in which the linker 
histone shows interactions with but one strand of linker DNA [103]. This binding mode was 
shown experimentally in the case of the globular domain of linker histone H1 (D. melano-
gaster). Here, NMR-based distance information, obtained through paramagnetic relaxation 
enhancement (PRE), was used to derive the nucleosome-binding mode of H1, showing an 
asymmetric, off-dyad binding [43]. Interestingly, it was shown by PRE as well that the muta-
tion of a set of five crucial amino acids in H5 to its equivalents in H1 is sufficient to change the 
binding mode of H5 from on-dyad (crystal) to off-dyad [90]. This points out the importance 
of linker histone subtype sequence and the interacting residues in determining the binding 
mode towards the nucleosome [44].
5. Conclusions
Chromatin structural biology is an equally important as demanding field. This is not only 
clear from the tremendous efforts necessary for the first nucleosome structure but also from 
the limited number of structures for nucleosome-protein complexes. While crystallography 
and cryo-EM resulted in various high-resolution structures, not every interaction is acces-
sible this way due to either of many experimental limitations, such as the need for crystalliza-
tion, the fleeting nature of some complexes or the pervasive role of highly dynamic protein 
regions. Here, an increasing number of studies shift towards a combined approach utilizing 
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remodeling complex ISW2 onto the nucleosome surface [91]. These data were subsequently 
used to build a structural model of the ISW2-nucleosome complex. A recent case of cross-
linking-based modeling in nucleosome research is the E2/E3 ubiquitin ligase complex Rad6-
Bre1 (Figure 8A). Bre1 is known to act as a homodimer in a complex with Rad6 to specifically 
ubiquitinate H2B K123 [101, 102]. However, the molecular mechanism of specific ubiquiti-
nation remained unknown without any nucleosome-bound complex structure available. 
Gallego et al. addressed exactly this problem by using XL-MS data to identify the binding 
interface between the Bre1 RING domain and the nucleosome. Next to nucleosomal DNA 
binding, they observed binding of the homodimer to the acidic patch (Figure 8B), which was 
verified by LANA-induced inhibition of Bre1 RING nucleosome binding. As a first step in the 
modeling, the authors modeled the Rad6-Bre1 complex structures based on homology with 
known E2/E3 RING ligases. Importantly, the resulting model was supported by the observed 
cross-links. The Rad6-Bre1 model could then be docked onto the nucleosome guided by the 
observed cross-links. This provided the structural basis for the specificity of Bre1 towards 
H2B K123 ubiquitination [70].
4.8. Adding new perspective on binding modes
Data-driven structural models complement high-resolution structures in many ways. An 
interesting example is the RCC1-nucleosome interaction, which serves as binding platform 
for subsequent binding of Ran, a protein relevant during mitosis (see Section 3.2). Biochemical 
data have shown that Ran activity is increased in the nucleosome-bound complex. The crys-
tal structure suggests no nucleosome-Ran interactions upon modeling Ran to the RCC1 
Figure 8. (A) Structural model of homodimeric Bre1 (red) bound to the nucleosome together with the E2 ligase Rad6 
(blue) with attached ubiquitin (green). The study was conducted by identifying the interactions between positive Bre1 
RING residues and the acidic patch. The docking was further facilitated due to the known target lysine residue. (B) Close 
view on Bre1 bound to both the acidic patch and nucleosomal DNA. The homodimeric nature allows the engagement of 
both epitopes in simultaneous binding. Figure generated using the author-provided PDB file [70].
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Ran-binding interface. Before the crystal structure of nucleosome-bound RCC1 was solved, 
a data-driven model was reported, which does feature Ran-nucleosome interactions. [62]. 
The authors suggest that, upon Ran binding, the nucleosomal DNA contacts with RCC1 
N-terminal tail observed in the crystal are broken in favor of Ran-nucleosome interactions as 
observed in model. Even though additional studies have to elucidate the exact mechanism of 
RCC1-Ran nucleosome binding, the use of crystal structure and data-driven model in combi-
nation outlines a possible mechanism to further investigate.
4.9. Debating H1
Another cardinal topic is the nucleosome-bound state of linker histone H1. To date, the struc-
ture of the chromatosome, consisting of the four canonical histones and 166bp of DNA in a 
complex with linker histones, is strongly debated. In this case as well, there are contradictions 
between structural models and a nucleosome-bound crystal structure of the chromatosome. 
The crystal structure reported by Zhou et al. displays the globular domain of linker histone 
H5 (chicken H5) with truncated tails in an on-dyad binding mode encountering both entering 
and leaving ends of linker DNA [75]. As for linker histone H1 (X. laevis H1.0b, human H1.5), a 
similar on-dyad binding mode was reported by cryo-EM and crystallography independently 
from absence or presence of H1 tails [45]. In fact, while not vital for linker histone position-
ing, the H1 C-terminal domain engages in binding of one of both linker DNAs preferably, 
introducing asymmetry into the nucleosome-bound complex.
In contrast to the proposed on-dyad complex, computational studies on linker histone bind-
ing suggest an alternative, off-dyad binding geometry of the complex in which the linker 
histone shows interactions with but one strand of linker DNA [103]. This binding mode was 
shown experimentally in the case of the globular domain of linker histone H1 (D. melano-
gaster). Here, NMR-based distance information, obtained through paramagnetic relaxation 
enhancement (PRE), was used to derive the nucleosome-binding mode of H1, showing an 
asymmetric, off-dyad binding [43]. Interestingly, it was shown by PRE as well that the muta-
tion of a set of five crucial amino acids in H5 to its equivalents in H1 is sufficient to change the 
binding mode of H5 from on-dyad (crystal) to off-dyad [90]. This points out the importance 
of linker histone subtype sequence and the interacting residues in determining the binding 
mode towards the nucleosome [44].
5. Conclusions
Chromatin structural biology is an equally important as demanding field. This is not only 
clear from the tremendous efforts necessary for the first nucleosome structure but also from 
the limited number of structures for nucleosome-protein complexes. While crystallography 
and cryo-EM resulted in various high-resolution structures, not every interaction is acces-
sible this way due to either of many experimental limitations, such as the need for crystalliza-
tion, the fleeting nature of some complexes or the pervasive role of highly dynamic protein 
regions. Here, an increasing number of studies shift towards a combined approach utilizing 
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various sources of interaction data to direct sophisticated data-driven docking. This way all 
knowledge on a nucleosome-interacting system can be integrated into a structural model 
that is otherwise inaccessible. These models strongly depend on the quality and quantity 
of data and contain an inherent ambiguity. However, as in the case of linker histone H1, 
structural models can point to alternative binding modes and thus result in new, testable 
hypotheses. Additionally, crucial residues for nucleosome binding can be identified, allow-
ing design of, for example, loss of function or loss of binding mutants to silence specific 
pathways. It also offers the possibility to drive the design of competing small molecule or 
peptide structures as potential candidates for epigenetic drugs interfering with specific effec-
tor binding. Remarkably, these developments might be otherwise lost due to the lack of a 
structure. However, as for now, a database for such structural models, akin to the RCSB 
protein databank, remains to be established. This might however be essential to advance the 
study of chromatin effector proteins. Publicly available structures including their data-based 
restraints could be used for further refinements upon availability of new, additional datasets 
from an array of techniques. It also would offer the possibility of negative results, otherwise 
rarely reported, to contribute to drive or score the quality of already reported models. Data-
driven modeling of nucleosome-protein complexes has the potential to yield unique funda-
mental insights into nucleosome-binding dynamics and enable advances in modulation of 
chromatin effector proteins, which would be otherwise inaccessible.
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Abstract
The dynamics organization of the nuclear genome is essential for many biological pro-
cesses and is often altered in cells from diseased tissue. In the presence of double-strand 
break (DSBs) in S. cerevisiae and some mammalian cell lines, DNA mobility is dramati-
cally altered. These changes in DNA mobility act as a double-edged sword since they 
promote homologous pairing in diploid yeast for example, but in some cases, they lead 
to potentially mutagenic DNA repair event and are the source of chromosomal transloca-
tions. In this chapter, we will present the state of the art in the field of chromosomes 
mobility in response to DNA damage. After introducing the importance of genome orga-
nization and dynamics, we will present in a clear and accessible manner several methods 
used in the literature to measure and quantify chromatin mobility inside living cells. We 
will then give an overview of the important findings in the field, both in yeast and in 
mammalian cells.
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1. Introduction
1.1. Levels of chromatin organization
The eukaryotic genome is highly packaged into chromatin, a nucleoprotein complex com-
posed of DNA wrapped into nucleosomes. Chromatin displays several levels of organization 
ranging from the 2-nanometers diameter of the DNA double helix to a few micrometers of 
chromosome territories in the nucleus.
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1. Introduction
1.1. Levels of chromatin organization
The eukaryotic genome is highly packaged into chromatin, a nucleoprotein complex com-
posed of DNA wrapped into nucleosomes. Chromatin displays several levels of organization 
ranging from the 2-nanometers diameter of the DNA double helix to a few micrometers of 
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The primary chromatin structure consists in nucleosomes distributed along a DNA fiber simi-
lar to a “beads on a string” structure. For many years, it has been proposed that this structure 
spontaneously folds into a thicker 30-nm fiber observed in vitro [1, 2]. However, several studies 
failed to observe such a structure inside living cells, and this classical view has been revised 
[3, 4]. More recently, a study of chromatin structure at super resolution in mammalian cells 
proposed that nucleosomes associate along the chromatin fiber in heterogeneous groups of 
varying sized named “nucleosomes clutches” [5]. These clutches are spaced by nucleosomes-
depleted regions, and the number of nucleosomes per clutch is very heterogeneous in a given 
nucleus, arguing against the existence of a well-ordered chromatin fiber. The size of these 
nucleosomes clutches is dependent on the differentiation state with differentiated cells con-
taining on average larger and denser clutches than stem cells [5]. The existence of nucleosomes 
clutches remains to be confirmed, and future microscopy studies at super resolution will prob-
ably clarify the precise chromatin structure at this scale.
The secondary level of chromatin organization consists of “chromatin loops” formed by long-
distance interactions along the chromatin fiber [6]. These loops frequently link promoters and 
enhancers, correlate with gene activation, and show conservation across cell types and species 
[6]. The size of chromatin loops is around 100 kilobases long; however, their precise distribu-
tion along the genome and their dynamics remain unknown. At a larger scale, these chroma-
tin loops group together to form a larger level of chromatin organization named “Topological 
Associated Domains” or TADs. TADs are continuous regions of enriched contact frequency, 
corresponding to about 1 megabases of DNA, in which physical interactions occur relatively 
frequently [7–9]. It has been proposed that TADs are formed through a dynamics process of 
loop extrusion [10], and it has been proposed that cohesin and CTCF proteins are associated 
with the dynamics formation of TADs and loops [11]. Chromatin organization in TADs is not 
found in all organisms: for example, TADs appear to be absent in A. thaliana (genome size 
135 Mb) [12, 13] but present in other plants [14]; in M. pneumonia, bacterial TAD-like domains 
of 15–33 kb (named chromosomal interaction domains, CIDs) have been described [15]. In 
Saccharomyces cerevisiae yeast, the primary level of organization appears to be shorter than 
TADs, with domains of 1–5 genes forming compact gene crumples, or globules, rather than 
loops [16], although the conclusion that TADs and loops are absent in budding yeast remains 
contentious [17, 18].
The third level of chromatin organization corresponds to chromosomes compartments [19]. 
These compartments are constituted of several DNA megabases and regroup several TADs 
sharing similar characteristics such as chromatin compaction, genes density, etc. The chromo-
some positioning inside the nucleus is not random and can be altered in cells from diseased 
tissue [20].
Within these complex levels of organization, chromatin is generally constrained in its motion, 
but large movements can occur in specific situations [21]. Indeed, chromatin movements 
up to 1 μm have frequently been reported both in yeast and in mammalian cells [22–24]. 
Chromatin mobility plays an essential role in many biological processes such as transcrip-
tion, DNA repair [23, 25, 26], or differentiation [27]. Here, we will focus on the changes 
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in chromatin mobility in response to DNA damage in both mammalian and Saccharomyces 
cerevisiae yeast cells.
1.2. Studying chromatin dynamics in the context of DNA damage
Our genome is constantly damaged by a variety of exogenous and endogenous agents. These 
DNA damages can result in missing or altered bases, bubbles due to deletion or insertion of 
a nucleotide, linked pyrimidines, single or double strand breaks, or cross-linked strands [28]. 
Each human cell undergoes tens of thousands lesions per day, among them, 50 endogenous 
double-strand breaks (DSBs) per cell cycle [29]. In contrast with their small numbers, DSBs are 
the most cytotoxic and genotoxic, since both strands of the DNA double helix are simultane-
ously cut [30]. Failure to repair such lesions leads to genomic instability and/or cell death. In 
higher eukaryotes, mutations in DNA repair genes lead to diseases such as Werner, Bloom, 
and other cancer predisposition syndromes [31].
DNA repair is an essential process for genome integrity preservation. Chromatin dynamics have 
mainly been studied following DSBs, the most deleterious form of DNA damage. Eukaryotic 
organisms use two major mechanisms to repair DSBs: non-homologous end-joining (NHEJ) 
and homologous recombination (HR). NHEJ consists in directly ligating the two broken ends 
with no or minimal end processing [32]. NHEJ can occur throughout the cell cycle and is the 
preferred pathway in mammalian cells.
In contrast to NHEJ, HR occurs primarily in S/G2 phase cells and uses the undamaged 
homologous sister chromatid DNA sequence as a template for copying the missing infor-
mation. The genetics and biochemistry of DSB repair by homologous recombination have 
been extensively investigated in vitro and in vivo [33–37]. In eukaryotes, HR is orchestrated 
by mega-Dalton multiprotein complexes of 500–2000 proteins that co-localize with the 
DSB [38]. These protein centers can be visualized in living cells as fluorescent foci using 
fluorescently tagged HR proteins [38, 39]. Among the proteins occupying these centers are 
the enzymes of the highly conserved Rad52 epistasis group, including Rad51, Rad52, and 
Rad54 [40, 41]. When a DSB forms and the HR recombination pathway is chosen, the 5′ 
ends of the DNA break undergo resection by nucleases to yield 3′ single-stranded DNA 
(ssDNA) tails on which the repair proteins polymerize [34, 42]. This repair protein-ssDNA 
complex, called a nucleoprotein filament, then searches for homologous sequences among 
neighboring double-stranded DNA (dsDNA) molecules. A common source for an intact 
duplex DNA donor is the undamaged sister chromatid; however, homologous sequences 
on either the homolog or on a different chromosome can be captured by the presynaptic 
nucleofilament to perform inter-homolog recombination or ectopic recombination, respec-
tively. Once homology is found, the invading strand primes DNA synthesis on the homolo-
gous template, ultimately restoring genetic information disrupted by the DSB. The search 
for a homologous dsDNA across the genome is a key step of HR; however, the pairing of 
homologous sequences remains the most enigmatic stage of HR with implications reaching 
beyond the range of DNA repair alone [43].
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been extensively investigated in vitro and in vivo [33–37]. In eukaryotes, HR is orchestrated 
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fluorescently tagged HR proteins [38, 39]. Among the proteins occupying these centers are 
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Rad54 [40, 41]. When a DSB forms and the HR recombination pathway is chosen, the 5′ 
ends of the DNA break undergo resection by nucleases to yield 3′ single-stranded DNA 
(ssDNA) tails on which the repair proteins polymerize [34, 42]. This repair protein-ssDNA 
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on either the homolog or on a different chromosome can be captured by the presynaptic 
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tively. Once homology is found, the invading strand primes DNA synthesis on the homolo-
gous template, ultimately restoring genetic information disrupted by the DSB. The search 
for a homologous dsDNA across the genome is a key step of HR; however, the pairing of 
homologous sequences remains the most enigmatic stage of HR with implications reaching 
beyond the range of DNA repair alone [43].
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Considerable progress has been recently made to understand the molecular basis of repair 
pathway choice, pointing toward cell cycle stage and chromatin landscape as key determi-
nants for the choice of the repair pathway. Although chromatin packing may protect the 
genome against DNA damage [44], multiple studies suggest that DNA repair processes 
are less efficient in densely packed heterochromatin [45], leading to an accumulation of 
mutations in these regions [46]. Recent findings also suggest that DSB occurring in tran-
scriptionally active genes displays dedicated repair mechanisms. Indeed, in contrast to the 
rest of the euchromatic genome (intergenic and inactive genes), damaged active genes are 
preferentially repaired by HR in G2 cells, thanks to a chromatin modification (H3K36me3) 
dependent pathway [47], while in G1, they exhibit delayed repair and enhanced clustering 
[48]. Such results thus highlight the major impact of the chromatin landscape on the DNA 
repair processes.
Investigating the nature of DNA diffusion in the context of DNA repair is particularly relevant 
to understand how cells maintain genome integrity. When a DSB occurs, the two broken ends 
first need to stay in close proximity, both for NHEJ and HR. Following this first step, chroma-
tin mobility probably differs depending on the repair pathway used. Since HR requires the 
search for a homologous sequence, many studies investigated chromatin mobility in response 
to DSB repaired by HR. In the following section, we will present several techniques that have 
been used in the literature to investigate chromatin mobility.
2. Methods to quantify chromatin dynamics
2.1. Microscopy techniques to visualize chromatin mobility
During the last 15 years, powerful microscopy techniques have allowed the visualization of 
chromatin mobility inside living cells. One method to image chromatin dynamics consists 
in uniformly labeling chromatin, using for example fluorescently tagged histones, or DNA 
intercalant. Local chromatin movements can then be investigated by FRAP (Fluorescence 
Recovery After Photo-bleaching) or image correlation methods for example [49]. However, 
this approach is limited in resolution. In the FRAP approach, the size of the laser spot used to 
photo-bleach or photo-convert the tagged chromatin or labeled DNA probably encompasses 
several megabases of DNA wrapped around thousands of nucleosomes. Another common 
labeling approach uses repeated bacterial sequences (lac or tet operators) integrated into the 
genome [50]. These lacO/tetO arrays are bound by LacI/TetR proteins, which are fused to 
fluorescent proteins (Figure 1A). These arrays are visible by microscopy as distinct spots 
that can be tracked through time to measure the chromatin dynamics. Importantly, the lacO/
LacI and tetO-TetR systems offer the possibility to fluorescently tag genomic loci at a defined 
genomic locus. Another tagging method, consisting of the ParB-INT DNA labeling system, 
has also been developed to fluorescently mark genomic loci [51]. To increase the resolu-
tion and have access the position and the dynamics of individual histones, a uniform chro-
matin labeling can be performed using photo-activable fluorophors. Such approach allows 
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the visualization of chromatin organization at 20 nm resolution [52] or the measurement of 
histones dynamics [53, 54] (Figure 1B). However, in contract with the previous approaches 
(lacO, tetO arrays or ParB-INT DNA labeling system), a uniform chromatin labeling does 
not give access to the DNA sequence to which a specific histone is bound to. To combine 
the visualization of a single region of the genome at super resolution, a recent technique has 
been developed, named Oligopaint FISH [55]. Overall, these different approaches allow us 
to access different scales of chromatin organization and dynamics, from several megabases 
to a single nucleosome.
Figure 1. (A) Illustration of the lacO/LacI-GFP system to fluorescently mark a specific genomic locus. (B) Single-
nucleosome image of a human HeLa cell nucleus expressing H2B-PA-mCherry. Each dot represents single nucleosome 
[54]. (C) Representative trajectories of fluorescently labeled single nucleosome (50 ms per frame), with permission 
from [54].
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2.2. Quantification of chromatin loci mobility
Several theoretical studies have shown that the mode of diffusion of a moving object drasti-
cally changes the way it explores the available space. The time to reach a specific target can 
dramatically change depending on the way a particle samples its surrounding environment 
[56]. To quantify the mobility of a chromatin locus marked using a lacO/LacI system, the most 
common method consists in measuring its position (x, y, z) over time and calculating its mean 
square displacement (MSD) (Eq. (1)) [57]. The MSD curve represents the amount of space a 
locus has explored in the nucleus (Figure 2A).
  MSD (n ⋅ Δt) =  1 ____ N − n  ∑ i=0
 
N−1−n
 [ ( x i+n −  x i ) 2 +  ( y i+n −  y i ) 2 +  ( z i+n −  z i ) 2 ] (1)
The shape of MSD curves then reveals the nature of DNA motion. Four main types of motion 
have been described in the literature (Figure 2B): confined motion, anomalous sub-diffusion, 
Brownian motion, and directive motion.
The simplest type of motion is Brownian diffusion: when a particle freely diffuses, its MSD 
curve is linear with time and its motion is called “Brownian.” However, in living cells, DNA 
motion is often slower than Brownian diffusion and is called “sub-diffusive” [58]. Several 
Figure 2. (A) Illustration of trajectories: from the left to the right, points are represented spaced by 1.Δt, 2.Δt and 3.Δt and 
(B) mean square displacement for normal anomalous and confined diffusion, with a representation of the corresponding 
trajectories.
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types of sub-diffusive motion have been observed. When a chromosomal locus is confined 
inside a sub-volume of the nucleus, the motion is called confined sub-diffusion and the MSD 
exhibits a plateau. Confined motion has been observed and quantified in living cells, when 
chromatin motion is examined during several minutes [23, 59, 60]. In that case, the MSD curves 
can be fitted by  MSD ∝  L 2 (1 −  e −4Dt/ L 2  ) , where L is the plateau of the MSD curve (proportional 
to the radius of confinement) and D is the diffusion coefficient.
When the force or structure that restricts the motion is not a simple confinement but is modu-
lated in time and space with scaling properties, the motion is called anomalous sub-diffusion 
[58, 61]. In this case, sub-diffusive loci are constrained, but unlike confined loci, they can 
diffuse without boundary and thus reach further targets if given enough time. For sub-diffu-
sive motion, the MSD exhibits a power law (MSD ~ Atα), where α, the anomalous exponent, 
is smaller than 1. The anomalous exponent α is linked to the degree of recurrence of DNA 
exploration, that is, the number of times a DNA locus reiteratively scans neighboring regions 
before reaching a distant position [62]. When α is small, the locus explores recurrently the 
same environment for a long time, while a large α indicates that the locus is able to explore 
new environments often. The anomalous diffusion coefficient A represents the amplitude of 
DNA motion; it is proportional to the diffusion coefficient only in the case of normal diffusion 
(when α = 1), which is rarely observed in biological systems [58]. Finally, a moving particle 
moves in a directive manner toward a target, and the motion is called directive.
The MSD is a standard statistical tool that describes a set of trajectories of similar objects. 
However, numerous artifacts perturb this statistic. The localization accuracy can have a strong 
impact on the MSD curve, even computed on simple Brownian motion [63]. Considering the 
movement of a single photon emitter, the localization accuracy can be divided into:
i. The error in the determination of the accurate particle position due to convolution with 
the point spread function (PSF) and the finite number of photons. This error is more 
important for short acquisition times since the number of photons collected is small.
ii. The error due to the movement of the particle during the camera acquisition. This error is 
more important with higher exposure times and is sometimes referred to as “motion blur.”
For 2D Brownian motion with a diffusion coefficient D, Michalet computed the formula of the 
converged MSD including the corrections for localization accuracy (see Eq. (2)) [64]:
  MSD (t)  = 4Dt +  σ 0 2 (1 +  
 Dt E  ___ s 0 2 
 ) −  
4 __3  Dt E (2)
where  σ 
0
 2 is the localization accuracy of an immobile particle;  s 
0
 2 is the variance of the PSF;  t 
E
 is 
the exposure time of the camera.
The term 4Dt is the theoretical MSD for simple Brownian motion. The term  σ 
0








 ) accounts for 
the motion blur of the particle along its path during acquisition. Since the localization accuracy 
σ 
0
 2 is inversely proportional to the number of collected photons, we have  σ 0 2 ∝  
1 __  t E . The motion 
blur term therefore converges to a fixed value as the exposure time increases. The term  4 __3  Dt E 
accounts for the correlation between successive displacements due to the exposure overlap.
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2.2. Quantification of chromatin loci mobility
Several theoretical studies have shown that the mode of diffusion of a moving object drasti-
cally changes the way it explores the available space. The time to reach a specific target can 
dramatically change depending on the way a particle samples its surrounding environment 
[56]. To quantify the mobility of a chromatin locus marked using a lacO/LacI system, the most 
common method consists in measuring its position (x, y, z) over time and calculating its mean 
square displacement (MSD) (Eq. (1)) [57]. The MSD curve represents the amount of space a 
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The shape of MSD curves then reveals the nature of DNA motion. Four main types of motion 
have been described in the literature (Figure 2B): confined motion, anomalous sub-diffusion, 
Brownian motion, and directive motion.
The simplest type of motion is Brownian diffusion: when a particle freely diffuses, its MSD 
curve is linear with time and its motion is called “Brownian.” However, in living cells, DNA 
motion is often slower than Brownian diffusion and is called “sub-diffusive” [58]. Several 
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types of sub-diffusive motion have been observed. When a chromosomal locus is confined 
inside a sub-volume of the nucleus, the motion is called confined sub-diffusion and the MSD 
exhibits a plateau. Confined motion has been observed and quantified in living cells, when 
chromatin motion is examined during several minutes [23, 59, 60]. In that case, the MSD curves 
can be fitted by  MSD ∝  L 2 (1 −  e −4Dt/ L 2  ) , where L is the plateau of the MSD curve (proportional 
to the radius of confinement) and D is the diffusion coefficient.
When the force or structure that restricts the motion is not a simple confinement but is modu-
lated in time and space with scaling properties, the motion is called anomalous sub-diffusion 
[58, 61]. In this case, sub-diffusive loci are constrained, but unlike confined loci, they can 
diffuse without boundary and thus reach further targets if given enough time. For sub-diffu-
sive motion, the MSD exhibits a power law (MSD ~ Atα), where α, the anomalous exponent, 
is smaller than 1. The anomalous exponent α is linked to the degree of recurrence of DNA 
exploration, that is, the number of times a DNA locus reiteratively scans neighboring regions 
before reaching a distant position [62]. When α is small, the locus explores recurrently the 
same environment for a long time, while a large α indicates that the locus is able to explore 
new environments often. The anomalous diffusion coefficient A represents the amplitude of 
DNA motion; it is proportional to the diffusion coefficient only in the case of normal diffusion 
(when α = 1), which is rarely observed in biological systems [58]. Finally, a moving particle 
moves in a directive manner toward a target, and the motion is called directive.
The MSD is a standard statistical tool that describes a set of trajectories of similar objects. 
However, numerous artifacts perturb this statistic. The localization accuracy can have a strong 
impact on the MSD curve, even computed on simple Brownian motion [63]. Considering the 
movement of a single photon emitter, the localization accuracy can be divided into:
i. The error in the determination of the accurate particle position due to convolution with 
the point spread function (PSF) and the finite number of photons. This error is more 
important for short acquisition times since the number of photons collected is small.
ii. The error due to the movement of the particle during the camera acquisition. This error is 
more important with higher exposure times and is sometimes referred to as “motion blur.”
For 2D Brownian motion with a diffusion coefficient D, Michalet computed the formula of the 
converged MSD including the corrections for localization accuracy (see Eq. (2)) [64]:
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For anomalous motion with a diffusion coefficient D, the MSD formula including the correc-
tions for localization accuracy is described in [65].
3. Increased mobility in response to DNA damage
3.1. Evidence of increased mobility in response to DSB
Most of the studies on chromatin mobility are based on the analysis of MSD curves calculated 
from the trajectories of fluorescently labeled chromatin loci. Using this approach, the diffusion 
coefficients reported in the literature varies from 5 × 10−5 to 10−3 μm2/s depending on the organ-
isms, the loci studied, and the type of damage [66, 67]. In several studies, chromatin undergoes 
confined diffusion [22, 59, 68–71], while others have reported anomalous diffusion [69, 70, 
72–75]. So far, no consensus has been reached to describe the nature of DNA motion prob-
ably because these studies have been performed using different microscopy techniques and 
illumination settings. Indeed, multi time-scales observation of chromatin motion revealed that 
chromatin is driven by different types of diffusion at each time scale [76–78]. As a consequence, 
the type of diffusion depends on the time scale of observation. While comparing studies on 
chromatin dynamics, it is thus important to compare studies performed at similar time scales.
Several studies have investigated DNA motion in the context of DNA damage. Since DSB is the 
most deleterious type of damage in the cell, chromatin dynamics in the context of DNA repair 
has been mainly investigated in response to DSBs. The changes in chromatin architecture and 
dynamics following DSB have been studied mostly in yeast, Drosophila and mammalian nuclei. 
In budding yeast, chromatin mobility has been investigated during the process of HR, when a 
Rad52 focus is already formed at the damaged locus [23, 25]. In diploid, where a homologous 
template is available, chromatin mobility is dramatically increased at the damaged site, allow-
ing the damaged locus to explore a nuclear volume 10 times larger [23]. Increased mobility 
may facilitate homology search; however, haploid yeast cells, where no homologous template 
is present, also exhibit increased mobility in response to DSBs [25]. Since the two broken ends 
stay in contact during the process of HR repair [79], the current view is that the two broken 
ends explore the nuclear space together.
Importantly, only induced DSB associated to Rad52 foci display increased mobility. Indeed, dur-
ing resection, the early stage of HR, a strong inhibition of chromatin mobility has been reported 
in yeast, highlighting the importance of the stage of DNA repair in chromatin mobility changes 
[51]. Finally, different types of damages have very different consequences on DNA mobility. 
For example, in yeast, spontaneous DSBs occurring during DNA replication exhibit decreased 
mobility [80]; DSBs induced by a protein-DNA adduct display no change in motion and campto-
thecin (CPT)-induced Rad52 foci display no increased mobility [25].
In mammalian cells, while several studies have reported increased chromatin mobility upon 
DNA damage, others fail to observe significant changes. In HeLa cells, after α-particle-
induced DSBs, γH2AX foci are more mobile [81, 82]. Similarly, uncapped telomeres exhibit 
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increased mobility in mouse cells, and this movement is dependent on the 53BP1 repair pro-
tein [83]. Movement of heterochromatic DSBs toward euchromatin was observed in mouse 
embryo fibroblasts (MEFs), HeLa cells [84], and Drosophila cells [45]. It was proposed that 
re-localization of heterochromatic DSBs close to euchromatin regions prevents rearrange-
ments between repetitive DNA sequences present in heterochromatin. Taken together, these 
studies suggest that chromosome mobility increases significantly in the presence of DSBs. 
By contrast, in other studies using MEFs [85], HeLa, or U2OS cells [86], DSBs generated 
by UV laser or γ-irradiation did not significantly alter chromosome mobility. Only energy-
dependent local expansion of chromatin was observed around the initial damaged zone 
immediately after DNA damage [85]. These contradictory observations in mammalian cells 
probably result from variation between cell lines, the regions of chromatin damaged, and the 
type of damage induced. Recent studies suggest that DSBs induced in active genes, naturally 
enriched in the trimethyl form of histone H3 lysine 36 (H3K36me3), are repaired by HR 
[87]. These DSBs are susceptible to exhibit increased mobility, while DSBs repaired by Non-
Homologous End Joining are rather immobile. Further systematic studies will be necessary 
to confirm these observations.
3.2. Local versus global increased mobility
Changes in chromatin conformation have been extensively described around the site of dam-
age but an important question is whether these changes in chromatin mobility also affect 
the rest of the genome. Interestingly, in budding yeast, increased chromatin mobility is not 
an intrinsic property of the damaged locus. Indeed, in diploid yeast, after induction of four 
random DSBs per nucleus by γ-irradiation, undamaged loci explore a 2.4 times larger nuclear 
volume than in the absence of irradiation [23]. Moreover, the global increased mobility is 
dose-dependent since upon induction of approximately 20 DSBs, the chromosomes explore 
almost the entire yeast nucleus [23]. Figure 3 illustrates the mobility observed for different 
levels of γ-irradiation in a diploid yeast cell. Global increased mobility is observed in haploid 
yeast, although it required higher doses of damages and it has been tested with a different 
type of DSBs (zeocin-induced DSBs) [88].
In mammalian cells, changes in mobility far from a damaged locus are not reported in the lit-
erature. Since mammalian nuclei are much larger than the yeast nuclei, but chromatin motion 
exhibits very similar constrained (~0.5 μm of confined radius), it is likely that global mobility 
is specific to organisms with small nuclei and is therefore not present in mammalian cells.
Importantly, most of these studies investigated chromatin mobility at one specific time scale. 
However, when studying the diffusion of a specific locus, the time scale at which data are 
collected reflects a specific spatial scale of the exploration studied. From nucleosomes to fiber, 
the different scales of chromatin organization might exhibit different diffusion behaviors. 
Using fast microscopy, a recent study investigated DNA mobility at several time scales, up 
to 1000 times faster than previously observed [65]. These experiments revealed that DNA 
motion following DNA damage is more complex than what had been previously described. 
Chromatin dynamics therefore appears to be scale-dependent: in response to DNA damage, 
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For anomalous motion with a diffusion coefficient D, the MSD formula including the correc-
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from the trajectories of fluorescently labeled chromatin loci. Using this approach, the diffusion 
coefficients reported in the literature varies from 5 × 10−5 to 10−3 μm2/s depending on the organ-
isms, the loci studied, and the type of damage [66, 67]. In several studies, chromatin undergoes 
confined diffusion [22, 59, 68–71], while others have reported anomalous diffusion [69, 70, 
72–75]. So far, no consensus has been reached to describe the nature of DNA motion prob-
ably because these studies have been performed using different microscopy techniques and 
illumination settings. Indeed, multi time-scales observation of chromatin motion revealed that 
chromatin is driven by different types of diffusion at each time scale [76–78]. As a consequence, 
the type of diffusion depends on the time scale of observation. While comparing studies on 
chromatin dynamics, it is thus important to compare studies performed at similar time scales.
Several studies have investigated DNA motion in the context of DNA damage. Since DSB is the 
most deleterious type of damage in the cell, chromatin dynamics in the context of DNA repair 
has been mainly investigated in response to DSBs. The changes in chromatin architecture and 
dynamics following DSB have been studied mostly in yeast, Drosophila and mammalian nuclei. 
In budding yeast, chromatin mobility has been investigated during the process of HR, when a 
Rad52 focus is already formed at the damaged locus [23, 25]. In diploid, where a homologous 
template is available, chromatin mobility is dramatically increased at the damaged site, allow-
ing the damaged locus to explore a nuclear volume 10 times larger [23]. Increased mobility 
may facilitate homology search; however, haploid yeast cells, where no homologous template 
is present, also exhibit increased mobility in response to DSBs [25]. Since the two broken ends 
stay in contact during the process of HR repair [79], the current view is that the two broken 
ends explore the nuclear space together.
Importantly, only induced DSB associated to Rad52 foci display increased mobility. Indeed, dur-
ing resection, the early stage of HR, a strong inhibition of chromatin mobility has been reported 
in yeast, highlighting the importance of the stage of DNA repair in chromatin mobility changes 
[51]. Finally, different types of damages have very different consequences on DNA mobility. 
For example, in yeast, spontaneous DSBs occurring during DNA replication exhibit decreased 
mobility [80]; DSBs induced by a protein-DNA adduct display no change in motion and campto-
thecin (CPT)-induced Rad52 foci display no increased mobility [25].
In mammalian cells, while several studies have reported increased chromatin mobility upon 
DNA damage, others fail to observe significant changes. In HeLa cells, after α-particle-
induced DSBs, γH2AX foci are more mobile [81, 82]. Similarly, uncapped telomeres exhibit 
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increased mobility in mouse cells, and this movement is dependent on the 53BP1 repair pro-
tein [83]. Movement of heterochromatic DSBs toward euchromatin was observed in mouse 
embryo fibroblasts (MEFs), HeLa cells [84], and Drosophila cells [45]. It was proposed that 
re-localization of heterochromatic DSBs close to euchromatin regions prevents rearrange-
ments between repetitive DNA sequences present in heterochromatin. Taken together, these 
studies suggest that chromosome mobility increases significantly in the presence of DSBs. 
By contrast, in other studies using MEFs [85], HeLa, or U2OS cells [86], DSBs generated 
by UV laser or γ-irradiation did not significantly alter chromosome mobility. Only energy-
dependent local expansion of chromatin was observed around the initial damaged zone 
immediately after DNA damage [85]. These contradictory observations in mammalian cells 
probably result from variation between cell lines, the regions of chromatin damaged, and the 
type of damage induced. Recent studies suggest that DSBs induced in active genes, naturally 
enriched in the trimethyl form of histone H3 lysine 36 (H3K36me3), are repaired by HR 
[87]. These DSBs are susceptible to exhibit increased mobility, while DSBs repaired by Non-
Homologous End Joining are rather immobile. Further systematic studies will be necessary 
to confirm these observations.
3.2. Local versus global increased mobility
Changes in chromatin conformation have been extensively described around the site of dam-
age but an important question is whether these changes in chromatin mobility also affect 
the rest of the genome. Interestingly, in budding yeast, increased chromatin mobility is not 
an intrinsic property of the damaged locus. Indeed, in diploid yeast, after induction of four 
random DSBs per nucleus by γ-irradiation, undamaged loci explore a 2.4 times larger nuclear 
volume than in the absence of irradiation [23]. Moreover, the global increased mobility is 
dose-dependent since upon induction of approximately 20 DSBs, the chromosomes explore 
almost the entire yeast nucleus [23]. Figure 3 illustrates the mobility observed for different 
levels of γ-irradiation in a diploid yeast cell. Global increased mobility is observed in haploid 
yeast, although it required higher doses of damages and it has been tested with a different 
type of DSBs (zeocin-induced DSBs) [88].
In mammalian cells, changes in mobility far from a damaged locus are not reported in the lit-
erature. Since mammalian nuclei are much larger than the yeast nuclei, but chromatin motion 
exhibits very similar constrained (~0.5 μm of confined radius), it is likely that global mobility 
is specific to organisms with small nuclei and is therefore not present in mammalian cells.
Importantly, most of these studies investigated chromatin mobility at one specific time scale. 
However, when studying the diffusion of a specific locus, the time scale at which data are 
collected reflects a specific spatial scale of the exploration studied. From nucleosomes to fiber, 
the different scales of chromatin organization might exhibit different diffusion behaviors. 
Using fast microscopy, a recent study investigated DNA mobility at several time scales, up 
to 1000 times faster than previously observed [65]. These experiments revealed that DNA 
motion following DNA damage is more complex than what had been previously described. 
Chromatin dynamics therefore appears to be scale-dependent: in response to DNA damage, 
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chromatin is more mobile at large time scales but, surprisingly, its mobility is reduced at 
short time scales, this effect being stronger at the damaged site. Such a pattern of dynamics 
is consistent with a global chromatin stiffness that has been proposed to arise in response to 
DNA damage [65, 89, 90]. These results underline the importance of performing multiscale 
tracking to fully understand the complex dynamics of chromatin at each scale.
3.3. DSBs clustering
In addition to the increased chromatin mobility, several studies indicate that multiple DSBs 
cluster together into a single “repair center.” Clustering of unrelated DSBs might be a con-
sequence of increased mobility, although such clusters of DSBs might promote transloca-
tions and their functions is not clear. In yeast, several DNA lesions collapse together into 
the same repair focus, suggesting that these multiple DSBs are driven to a shared loca-
tion, in so-called “repair centers” or “repair factories” [91]. In mammalian cells, clusters 
of radiation-induced foci have been observed in many independent studies [45, 81, 85, 86]. 
DSB clusters could be formed by collisions and fusion of several DSBs. One interesting 
hypothesis is that repair foci have a higher viscosity than the rest of the nucleus, due to 
their high concentration of repair proteins around the damaged site. It has been proposed 
that several repair foci act as dynamic liquid droplets that are able to fuse together when 
they collide [92].
3.4. Factors controlling local and global increased mobility
To investigate the mechanism of increased chromatin mobility in response to DSBs, sev-
eral studies have tested chromatin mobility in mutant cells [23, 25, 65, 81, 83, 88, 90, 93–95]. 
Figure 3. Examples of the dynamics of URA3 loci (chromosome V) in budding yeast as a function of the number of double-
strand breaks (DSBs) in the nucleus. The lines indicate a 2D projection of the trajectories of the two URA3 loci taken at 
between 10- and 30-s time intervals for approximately 15 min. (A) In the absence of DSBs, the two homologous loci are 
distant and explore only 3% of the nuclear volume. (B) In the presence of one to four DSBs induced on chromosomes 
III, the mobility of the URA3 loci increases and each locus can explore 11% of the nuclear volume. (C) After about 20 
random γ-irradiation-induced DSBs per nucleus (200 Gy), URA3 loci explore almost the entire nuclear volume and their 
trajectories overlap. The scale is 1 μm. These three examples illustrate that more DSBs in the nucleus induce greater DNA 
mobility, thereby increasing the probability of collisions between loci (with permission from [66]).
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These studies revealed that several genes involved in DSBs repair and chromatin remod-
eling are involved in chromatin mobility changes. In diploid yeast, Rad51, the central 
protein of HR, is required for chromate in mobility [23], as well as for increased chro-
matin rigidity [65]. Several checkpoint proteins acting earlier than Rad51 nucleoprotein 
filament formation are also essential for increasing the mobility of the damaged locus. For 
example, Rad9, a protein containing a BRCT domain roughly equivalent to human MDC1, 
BRCA1, and 53BP1, is also required for increased mobility at the damaged site in haploid 
yeast [25]. MEC1 and SML1, but not RAD53 and Tel1, are essential for increasing the 
mobility of the damaged locus [23, 25, 66]. Interestingly, the activation of the checkpoint 
protein Mec1 at a specific locus is sufficient to promote increased mobility, even in the 
absence of physical DSB [88]. Finally, in mouse cells, increased chromosome movements 
are associated with uncapped telomeres, and this movement is dependent on the 53BP1 
repair protein [83].
Another study proposed that centromere and telomere release following DSBs are at the 
origin of chromatin changes in mobility. Strecker et al. found that a combined disruption 
of telomeres and centromeres can reproduce chromatin mobility observed after a DSB [96]; 
they identified the Mec1-dependent phosphorylation of Cep3, a kinetochore component, as 
an essential player in global increased chromatin mobility on DSBs.
More recently, it has been shown that molecular motors play an important role in DSBs mobil-
ity [93–95]. For example, in fly in human genomes, heterochromatin constitutes about 30% of 
the genome [97], and “safe” repair of heterochromatic DSBs by homologous recombination 
relies on the relocalization of repair foci to the nuclear periphery. During this process, nuclear 
actin filaments form at repair sites to drive heterochromatin DSBs at the periphery and disas-
semble after relocalization [93]. Actin filaments act in concert with Smc5/6, Arp2/3, Arp2/3 
activators Scar and Wash, nuclear myosins Myo1A, Myo1B, and MyoV. Interestingly, in U2OS 
cells, ARP2/3-mediated actin polymerization enhances DSBs motion during homologous 
recombination, increasing the clustering of repair foci [94]. In budding yeast, DNA-damaged 
induced nuclear microtubule filaments (DIMs) form in response to endogenous or exogenous 
DNA damage [95]. These DIM filaments, formed at repair sites, reach the nuclear periphery to 
dive irreparable DSBs and disassemble after relocalization. Such DSBs motion is mediated by 
the Rad9 DNA damage response mediator and the Kar3 kinesin motor. Another model impli-
cating microtubules has been proposed by Lawrimore et al. to explain the global increased 
mobility observed in yeast in response to DNA damage: in their model, microtubules would 
be responsible for a global chromatin shake-up that would be essential for global increase 
mobility on DSBs [98].
In these different examples, DSBs mobility is promoted by molecular motors, and DSBs 
exhibit a complex motion including mixture of directive and Brownian motions [93] or 
nonlinear directive motion [95]. Overall, these recent studies revealed the essential role 
of molecular motors in DSBs mobility to drive heterochromatic or irreparable DSBs to the 
nuclear periphery or in clustering of multiple DSBs. Importantly, these mechanisms are 
conserved through several organisms (human, Drosophila melanogaster, Xenopus laevis, and 
budding yeast).
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chromatin is more mobile at large time scales but, surprisingly, its mobility is reduced at 
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In addition to the increased chromatin mobility, several studies indicate that multiple DSBs 
cluster together into a single “repair center.” Clustering of unrelated DSBs might be a con-
sequence of increased mobility, although such clusters of DSBs might promote transloca-
tions and their functions is not clear. In yeast, several DNA lesions collapse together into 
the same repair focus, suggesting that these multiple DSBs are driven to a shared loca-
tion, in so-called “repair centers” or “repair factories” [91]. In mammalian cells, clusters 
of radiation-induced foci have been observed in many independent studies [45, 81, 85, 86]. 
DSB clusters could be formed by collisions and fusion of several DSBs. One interesting 
hypothesis is that repair foci have a higher viscosity than the rest of the nucleus, due to 
their high concentration of repair proteins around the damaged site. It has been proposed 
that several repair foci act as dynamic liquid droplets that are able to fuse together when 
they collide [92].
3.4. Factors controlling local and global increased mobility
To investigate the mechanism of increased chromatin mobility in response to DSBs, sev-
eral studies have tested chromatin mobility in mutant cells [23, 25, 65, 81, 83, 88, 90, 93–95]. 
Figure 3. Examples of the dynamics of URA3 loci (chromosome V) in budding yeast as a function of the number of double-
strand breaks (DSBs) in the nucleus. The lines indicate a 2D projection of the trajectories of the two URA3 loci taken at 
between 10- and 30-s time intervals for approximately 15 min. (A) In the absence of DSBs, the two homologous loci are 
distant and explore only 3% of the nuclear volume. (B) In the presence of one to four DSBs induced on chromosomes 
III, the mobility of the URA3 loci increases and each locus can explore 11% of the nuclear volume. (C) After about 20 
random γ-irradiation-induced DSBs per nucleus (200 Gy), URA3 loci explore almost the entire nuclear volume and their 
trajectories overlap. The scale is 1 μm. These three examples illustrate that more DSBs in the nucleus induce greater DNA 
mobility, thereby increasing the probability of collisions between loci (with permission from [66]).
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These studies revealed that several genes involved in DSBs repair and chromatin remod-
eling are involved in chromatin mobility changes. In diploid yeast, Rad51, the central 
protein of HR, is required for chromate in mobility [23], as well as for increased chro-
matin rigidity [65]. Several checkpoint proteins acting earlier than Rad51 nucleoprotein 
filament formation are also essential for increasing the mobility of the damaged locus. For 
example, Rad9, a protein containing a BRCT domain roughly equivalent to human MDC1, 
BRCA1, and 53BP1, is also required for increased mobility at the damaged site in haploid 
yeast [25]. MEC1 and SML1, but not RAD53 and Tel1, are essential for increasing the 
mobility of the damaged locus [23, 25, 66]. Interestingly, the activation of the checkpoint 
protein Mec1 at a specific locus is sufficient to promote increased mobility, even in the 
absence of physical DSB [88]. Finally, in mouse cells, increased chromosome movements 
are associated with uncapped telomeres, and this movement is dependent on the 53BP1 
repair protein [83].
Another study proposed that centromere and telomere release following DSBs are at the 
origin of chromatin changes in mobility. Strecker et al. found that a combined disruption 
of telomeres and centromeres can reproduce chromatin mobility observed after a DSB [96]; 
they identified the Mec1-dependent phosphorylation of Cep3, a kinetochore component, as 
an essential player in global increased chromatin mobility on DSBs.
More recently, it has been shown that molecular motors play an important role in DSBs mobil-
ity [93–95]. For example, in fly in human genomes, heterochromatin constitutes about 30% of 
the genome [97], and “safe” repair of heterochromatic DSBs by homologous recombination 
relies on the relocalization of repair foci to the nuclear periphery. During this process, nuclear 
actin filaments form at repair sites to drive heterochromatin DSBs at the periphery and disas-
semble after relocalization [93]. Actin filaments act in concert with Smc5/6, Arp2/3, Arp2/3 
activators Scar and Wash, nuclear myosins Myo1A, Myo1B, and MyoV. Interestingly, in U2OS 
cells, ARP2/3-mediated actin polymerization enhances DSBs motion during homologous 
recombination, increasing the clustering of repair foci [94]. In budding yeast, DNA-damaged 
induced nuclear microtubule filaments (DIMs) form in response to endogenous or exogenous 
DNA damage [95]. These DIM filaments, formed at repair sites, reach the nuclear periphery to 
dive irreparable DSBs and disassemble after relocalization. Such DSBs motion is mediated by 
the Rad9 DNA damage response mediator and the Kar3 kinesin motor. Another model impli-
cating microtubules has been proposed by Lawrimore et al. to explain the global increased 
mobility observed in yeast in response to DNA damage: in their model, microtubules would 
be responsible for a global chromatin shake-up that would be essential for global increase 
mobility on DSBs [98].
In these different examples, DSBs mobility is promoted by molecular motors, and DSBs 
exhibit a complex motion including mixture of directive and Brownian motions [93] or 
nonlinear directive motion [95]. Overall, these recent studies revealed the essential role 
of molecular motors in DSBs mobility to drive heterochromatic or irreparable DSBs to the 
nuclear periphery or in clustering of multiple DSBs. Importantly, these mechanisms are 
conserved through several organisms (human, Drosophila melanogaster, Xenopus laevis, and 
budding yeast).
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3.5. Modifications of chromatin compaction in response to DSB and perspectives
In addition to chromatin mobility, many studies investigated the modulation of the chro-
matin compaction state both at a specific damaged site and throughout the genome. Several 
studies showed a chromatin decondensation visible at the micrometer scale accessible by 
conventional light microscopy [85, 99]. In the recent studies, super resolution imaging of a 
lacO array before and after damage allows the visualization of chromatin decompaction at the 
damaged site in haploid yeast [90, 100]. In mammalian cells, most of the studies report chro-
matin decondensation at the damaged site. However, it has been shown that following this 
initial fast decondensation, the damaged chromatin area slowly recondenses to reach higher 
compaction levels than before damage induction [101]. In addition, both chromatin expansion 
and compaction occur at the same time but in different regions of the chromatin near the DSBs 
[49]. Overall, chromatin changes in compaction are tuned in space and time upon DSBs, but 
the precise role of each step remains to be elucidated.
An interesting way to interpret chromatin changes in dynamics and compaction upon DSBs 
is to think in terms of mechanical properties of chromatin, such as chromatin stiffness (or per-
sistence length). As illustrated in Figure 4, the persistence length of a polymer is a mechanical 
property that quantifies its stiffness. The persistence length is the length over which correla-
tions in the direction of the tangent are lost.
Changes in chromatin persistence length following DNA damage have been discussed, 
however, with contradictories interpretations. While some studies suggest that chromatin is 
more flexible following DSBs [100, 102, 103], other results indicate that chromatin is globally 
stiffer upon DSBs [65, 90]. One proposed explanation for chromatin stiffening upon DSBs 
could be the presence of negative charges due to H2A S129 phosphorylation [90]. Further 
studies will be required to solve to this open question and more generally to understand the 
physical mechanisms underlying the modifications of chromatin dynamics in response to 
DNA damage.
4. Conclusion
Thanks to recent advanced in fast and high-resolution microscopy, it became possible to 
quantify chromatin mobility with unprecedented precision and to understand how chromatin 
Figure 4. Illustration of the persistence of a polymer, where Lp is the polymer persistence length and L is the polymer 
length.
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explores the nuclear space. Following DSBs, chromatin mobility is dramatically altered in 
budding yeast both at the site of DNA damage and genome wide. In mammalian cells, DSBs 
mobility is strongly influenced by cell cycle stage, chromatin state, and repair pathway choice. 
For example, while DSBs induced in pericentric heterochromatin during the S and G2 phases 
of the cell cycle are more mobile and relocate to the nuclear periphery, DSBs generated during 
the G1 phase remain stable. Changes of chromatin mobility upon DNA damage is an intrigu-
ing phenomenon, and over the last five years, several views to explain it have been proposed 
in the literature. They can be grouped into two classes: (1) increase in chromatin motion is 
due to intrinsic chromatin modifications which require chromatin remodelers, kinases, and 
repair proteins involved in the DNA response machinery; (2) increase in chromatin motion 
due to changes of external mechanical constraints that maintain chromatin and to the action 
of molecular motors. It is likely that both mechanisms act in concert to drive differently dam-
aged chromatin depending on the type of damages, the chromatin state, or the cell cycle.
Several questions remain open: how changes in chromatin dynamics alter its organization at 
the scale of TADs? Is there a global change in mechanical properties of the chromatin upon 
DSBs, such as an increase in chromatin rigidity? In the future, it will be an exciting challenge 
to investigate changes in chromatin organization and dynamics upon DNA damage com-
bining different approaches from live cell microscopy, super resolution imaging, and Hi-C.
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mobility is strongly influenced by cell cycle stage, chromatin state, and repair pathway choice. 
For example, while DSBs induced in pericentric heterochromatin during the S and G2 phases 
of the cell cycle are more mobile and relocate to the nuclear periphery, DSBs generated during 
the G1 phase remain stable. Changes of chromatin mobility upon DNA damage is an intrigu-
ing phenomenon, and over the last five years, several views to explain it have been proposed 
in the literature. They can be grouped into two classes: (1) increase in chromatin motion is 
due to intrinsic chromatin modifications which require chromatin remodelers, kinases, and 
repair proteins involved in the DNA response machinery; (2) increase in chromatin motion 
due to changes of external mechanical constraints that maintain chromatin and to the action 
of molecular motors. It is likely that both mechanisms act in concert to drive differently dam-
aged chromatin depending on the type of damages, the chromatin state, or the cell cycle.
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to investigate changes in chromatin organization and dynamics upon DNA damage com-
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genome sequences and epigenetic histone modifications. That chromosomes form territories 
with functional relevant positioning within the cell nucleus and that chromosomal subdo-
mains exist has been also determined to a fair degree of detail. Only recently, however, we 
were finally able to fill the much debated gap in-between by establishing that nucleosomes 
compact into a quasi-fibre folded into stable loops which form stable multi-loop aggregates/
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1. Introduction to the History and State of the Art
Inheritance has always played a central part in the quest for elucidating the origin of nature, 
life and mankind. Beyond the epic mythical assumptions, it also has been obvious for millen-
nia that the evolutionary transfer of information plays a key role during the manipulation of 
inheritance by mating and breeding. Already in antique times many a "theory" was devoted 
to the apparent, as well as especially to the obvious fact that nature seemed to be composed 
of small, similar, and consistent subcomponents—so called atoms. With the description of the 
tissue of plants (including its substructures of vesicles and bubbles) by Robert Hooke or in 
the case of the cell nucleus by Anton van Leeuwenhook, in the 17th century new momentum 
entered the field. Nevertheless, it took until 1830 when Robert Brown defined the cell nucleus 
as such and until 1939 when Theodor Schwann established the cell as the fundamental unit 
of all plant and animal tissues while linking to the assumed fundamental design principle 
of life as well as nature in general. Despite fast growing microscopic resolutions there were 
huge challenges: not only staining and visualization methods were lacking, but also huge 
preparatory issues were faced especially concerning the "notorious" hard to stain cell nucleus. 
With the development of the natural sciences many a discovery was made culminating in the 
structural description of the DNA double helix [1] and the discovery of the nucleosome [2–4] 
at the atomic level, full genome sequences and finally histone modifications defining epigen-
etic landscapes. It also became obvious that the structure and function of genomes co-evolved 
as an inseparable system allowing the physical storage, replication, and expression of genetic 
information [5–7].
However, the immense size and structural complexity of genomes spanning many orders 
of magnitude has always imposed huge experimental challenges. Thus, the higher-order 
architecture has been and still is widely discussed with many interesting details yet to be 
described. Already how nucleosomes are spaced, positioned, remodelled, and whether and 
how nucleosome chains fold into fibres at physiological salt concentrations have been mat-
ters of continuing debate: e.g. Finch and Klug [8] proposed a relatively regular solenoid and 
in vivo neutron scattering experiments revealed a fibre diameter of 30 ± 5 nm as a dominant 
nuclear feature [9–12]. In contrast more recent work suggested no compaction at all (rev. [13, 
14]), and highly polymorphic, nucleosome position- [15] and dynamic function-dependent 
structures [16, 17], which are essential to explain nucleosome concentration distributions 
[18–20], or dynamic and functional properties such as the nuclear diffusion of macromol-
ecules. Moreover, the fine-structured multi-scaling long-range correlation behaviour of the 
DNA sequence also predicts a compacted chromatin fibre [21–24]. With a novel chromatin 
interaction technique—T2C—we were, however and indeed, able to show that nucleosomes 
form in general a quasi-fibre with a differential compaction of ~5 ± 1 nucleosomes/11 nm 
[25, 26], which is in agreement with a novel in vivo fluorescence correlation spectroscopy 
(FCS) approach measuring the dynamics of chromatin [27].
The higher-order chromatin architecture has been a matter of even greater debate: 
Pioneering light microscopy studies by Rabl [28] and Boveri [29] hinted towards a hierar-
chical self-similar, territorial organization. Electron microscopy suggested a more random 
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interphase organization as in the models of Comings [30, 31] or Vogel and Schroeder [32]. 
In the radial-loop-scaffold model of Paulson and Laemmli [33] ~60 kbp-sized chromatin 
loops attached to a nuclear matrix/scaffold explained the condensation degree of meta-
phase chromosomes. According to Pienta and Coffey [34], these loops persisted in inter-
phase and formed stacked rosettes in metaphase. Micro-irradiation studies by C. Cremer 
and T. Cremer [35, 36] and fluorescence in situ hybridization (FISH) by Lichter [37] as well 
as C. Cremer and T. Cremer [38] and publications thereafter [39, 40], confirmed a territorial 
organization of chromosomes, their arms, and stable sub-chromosomal domains during 
interphase, including their structural persistence during metaphase (de-)condensation. 
The assumption since then has been that the ~850 G, Q, R, and C ideogram bands [41, 
42] split into and thus also consist actually of ~2500 subchromosomal interphase domains. 
Chromatin rosettes explaining a (sub-)territorial folding were first visualized using elec-
tron microscopy by Jekatrina Erenpreisa [43] and others [44] but remained unappreciated, 
until Belmont and Bruce proposed the EM-based helical hierarchy chromonema fibre (CF) 
model [45]. Spatial distance measurements between small FISH-labelled genetic regions, led 
to the Random-Walk/Giant-Loop (RW/GL) model with the first analytical looped polymer 
description by Sachs [46–48]. Here, 1 to 5 Mbp loops are attached to a non-protein backbone, 
following the line of Pienta and Coffey [34]. Later, a combination of distance measurements 
using structure-preserving FISH protocols, high-resolution microscopy, and huge parallel 
polymer simulations of chromosomes and entire cell nuclei, only were compatible with 
the rosette-like Multi-Loop-Subcompartment (MLS) model in which around 60 to 120 kbp 
loops form rosettes connected by similar sized linkers [7, 21–24, 49, 50]. Thereafter, the RW/
GL model has then been discussed in terms of methodological “demolition” of the archi-
tecture [21, 22, 51, 52]. This is also in agreement with studies on replication (see [39] and 
thereafter). Again in vivo FCS measurements of nucleosome concentration distributions 
and dynamic and functional properties such as the diffusion of macromolecules are only in 
agreement with a small multi-loop aggregate/rosette-like chromatin folding [18–20, 22, 53, 
54]. The fine-structured multi-scaling long-range correlations of the DNA sequence once 
again also predict this [22–24, 55].
To further distinguish between the different architecture proposals, proximity crosslinking 
techniques (developed and used already in the last century) were further developed into a 
family of interaction capture techniques such as 3C [56, 57], 3C-qPCR [58], 4C [59], 3C-seq/4C-
seq [60], 5C [61], and Hi-C [62]. They once more confirmed the existence of looping and sub-
chromosomal domains, now inconsistenly referred to as topologically associated domains 
(TAD; [63]) with a somewhat higher localization accuracy when compared to FISH. These 
approaches also led to a number of - although by the underlying (raw) data basically unsup-
ported - conjectures (Imam et al., in preparation), e.g. the fractal globule model [62], the loop 
array architecture of mitotic chromosomes [64], and the highly dynamic loop formation based 
on single-cell experiments [65] or in a genome wide assay [66]. In contrast, with the introduc-
tion of targeted chromatin capture T2C [25, 67–69], we were able to show that the chromatin 
quasi-fibre forms small stable loops of ~30-100 kbp which form stable multi-loop aggregates/
rosettes connected by linkers of similar sizes as the loops [25, 26]. The development of our 
novel in vivo FCS approach came to the same conclusion [27].
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in vivo neutron scattering experiments revealed a fibre diameter of 30 ± 5 nm as a dominant 
nuclear feature [9–12]. In contrast more recent work suggested no compaction at all (rev. [13, 
14]), and highly polymorphic, nucleosome position- [15] and dynamic function-dependent 
structures [16, 17], which are essential to explain nucleosome concentration distributions 
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ecules. Moreover, the fine-structured multi-scaling long-range correlation behaviour of the 
DNA sequence also predicts a compacted chromatin fibre [21–24]. With a novel chromatin 
interaction technique—T2C—we were, however and indeed, able to show that nucleosomes 
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[25, 26], which is in agreement with a novel in vivo fluorescence correlation spectroscopy 
(FCS) approach measuring the dynamics of chromatin [27].
The higher-order chromatin architecture has been a matter of even greater debate: 
Pioneering light microscopy studies by Rabl [28] and Boveri [29] hinted towards a hierar-
chical self-similar, territorial organization. Electron microscopy suggested a more random 
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interphase organization as in the models of Comings [30, 31] or Vogel and Schroeder [32]. 
In the radial-loop-scaffold model of Paulson and Laemmli [33] ~60 kbp-sized chromatin 
loops attached to a nuclear matrix/scaffold explained the condensation degree of meta-
phase chromosomes. According to Pienta and Coffey [34], these loops persisted in inter-
phase and formed stacked rosettes in metaphase. Micro-irradiation studies by C. Cremer 
and T. Cremer [35, 36] and fluorescence in situ hybridization (FISH) by Lichter [37] as well 
as C. Cremer and T. Cremer [38] and publications thereafter [39, 40], confirmed a territorial 
organization of chromosomes, their arms, and stable sub-chromosomal domains during 
interphase, including their structural persistence during metaphase (de-)condensation. 
The assumption since then has been that the ~850 G, Q, R, and C ideogram bands [41, 
42] split into and thus also consist actually of ~2500 subchromosomal interphase domains. 
Chromatin rosettes explaining a (sub-)territorial folding were first visualized using elec-
tron microscopy by Jekatrina Erenpreisa [43] and others [44] but remained unappreciated, 
until Belmont and Bruce proposed the EM-based helical hierarchy chromonema fibre (CF) 
model [45]. Spatial distance measurements between small FISH-labelled genetic regions, led 
to the Random-Walk/Giant-Loop (RW/GL) model with the first analytical looped polymer 
description by Sachs [46–48]. Here, 1 to 5 Mbp loops are attached to a non-protein backbone, 
following the line of Pienta and Coffey [34]. Later, a combination of distance measurements 
using structure-preserving FISH protocols, high-resolution microscopy, and huge parallel 
polymer simulations of chromosomes and entire cell nuclei, only were compatible with 
the rosette-like Multi-Loop-Subcompartment (MLS) model in which around 60 to 120 kbp 
loops form rosettes connected by similar sized linkers [7, 21–24, 49, 50]. Thereafter, the RW/
GL model has then been discussed in terms of methodological “demolition” of the archi-
tecture [21, 22, 51, 52]. This is also in agreement with studies on replication (see [39] and 
thereafter). Again in vivo FCS measurements of nucleosome concentration distributions 
and dynamic and functional properties such as the diffusion of macromolecules are only in 
agreement with a small multi-loop aggregate/rosette-like chromatin folding [18–20, 22, 53, 
54]. The fine-structured multi-scaling long-range correlations of the DNA sequence once 
again also predict this [22–24, 55].
To further distinguish between the different architecture proposals, proximity crosslinking 
techniques (developed and used already in the last century) were further developed into a 
family of interaction capture techniques such as 3C [56, 57], 3C-qPCR [58], 4C [59], 3C-seq/4C-
seq [60], 5C [61], and Hi-C [62]. They once more confirmed the existence of looping and sub-
chromosomal domains, now inconsistenly referred to as topologically associated domains 
(TAD; [63]) with a somewhat higher localization accuracy when compared to FISH. These 
approaches also led to a number of - although by the underlying (raw) data basically unsup-
ported - conjectures (Imam et al., in preparation), e.g. the fractal globule model [62], the loop 
array architecture of mitotic chromosomes [64], and the highly dynamic loop formation based 
on single-cell experiments [65] or in a genome wide assay [66]. In contrast, with the introduc-
tion of targeted chromatin capture T2C [25, 67–69], we were able to show that the chromatin 
quasi-fibre forms small stable loops of ~30-100 kbp which form stable multi-loop aggregates/
rosettes connected by linkers of similar sizes as the loops [25, 26]. The development of our 
novel in vivo FCS approach came to the same conclusion [27].
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2. Finalizing the 3D Genome Architecture & Dynamics
Heuristically, it is very instructive how the central part of the 3D genome architecture and 
dynamics could now be determined by us in detail, and how out of this process immediately 
an also evolutionary consistent model (Figure 1) arises in agreement with the entire history 
and heuristics of the field. This has been achieved by a highly integrated systems approach 
linking holistically: i) a novel high-quality selective high-throughput high-resolution chro-
mosome interaction capture (T2C) technique [25, 26, 67–69] (elucidating the structure with 
unprecedented resolution of some base pairs), ii) a novel in vivo FCS approach [27] exploring 
the structure and dynamics by measuring chromatin movement, and iii) a novel analytical 
approach [27] and improvement of super-computer simulations of individual chromosomes 
and entire cell nuclei [7, 21–24, 26, 49–52, 70] to predict, analyse, and interpret the 3D archi-
tecture and dynamics from a theoretical standpoint, and combining all these with iv) scaling 
analysis of the 3D-architecture [21, 22, 26] and the DNA sequence itself [22, 24, 26] since the 
architecture and its dynamics leaves sequence "footprints" due to the co-evolutionary entan-



















base pair nucleosome chromatinquasi-fibre
super-helix
double-helix
Figure 1. Overview on the size and time scaling of genome organization: The scaling and the levels of organization 
range over 9, 12, and 14 orders of magnitude! Initially base pairs are formed composing the DNA double helix (image 
see [22]), forming with a histone core complex the nucleosome (image from [22]), which condense into a chromatin 
quasi-fibre (simulation image; courtesy G. Wedemann). The DNA double helix forms also superhelices (AFM image of 
plasmid DNA; courtesy K. Rippe). The next compaction step consists of stable chromatin loops (FISH image; courtesy 
P. Fransz) forming stable loop aggregates/rosettes connected by a linker (EM image from [44]), which make up interphase 
chromosome arms and territories (FISH image; courtesy S. Dietzel) and the metaphase ideogram bands (image see [22]). 
46 chromosomes compose the human nucleus and are decondensed in interphase (EM image; courtesy K. Richter) and 
condensed for separation during mitosis (image from [22]).
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model for genome organization, but re-evaluation of the development of the entire field in 
the last ~170 years fostered this conclusion also tremendously and directly resulted in an 
evolutionary consistent model of genome organization in general.
2.1. Detailed Structure Determination by T2C
To finally determine and structurally sequence with highest resolution, signal-to-noise 
ratio, interaction frequency range, and statistical significance the 3D genome architec-
ture we developed targeted chromatin capture (T2C) - a chromatin interaction technique 
though with far-better quality specifically addressing the needs for genome architectural 
"sequencing" [25, 26 67–69]. Briefly: i) after chromatin crosslinking, ii) cell permeabiliza-
tion for intra-nuclear enzymatic DNA restriction, iii) the extracted and largely diluted 
cross-linked DNA is re-ligated primarily within the crosslinked complexes. After iv) de-
crosslinking, purification, and final shortening to <500 bp of the chimeric DNA ligates, v) a 
purified region-specific DNA interaction fragment library is selected by using DNA capture 
arrays, before finally vi) high-throughput sequencing, mapping to the reference genome, 
interaction partner determination and visual/quantitative analysis is conducted (Figure 2). 
Notably, we use only uniquely mapped sequences without applying any other corrections 
a
b c d
Figure 2. Simulated chromosome models [7, 21–23, 26, 49–52]: Volume rendered images of simulated Random-Walk/
Giant-Loop (RW/GL) and Multi-Loop-Subcompartment (MLS) models. As a starting conformation with metaphase 
chromosome form and size (top), rosettes were stacked (a). Thereof, interphase chromosomes in thermodynamic 
equilibrium, were decondensed by Monte-Carlo and relaxing Brownian Dynamics. The simulated RW/GL model 
containing here large 5 Mbp loops notably shows that the large loops do not form distinct structures but intermingle 
freely (b). In contrast, in the MLS model with 126 kbp loops and linkers, the rosettes form distinct subchromosomal 
domains and chromatin territories in which the loops do not intermingle freely (c). In an RW/GL model with 126 kbp 
loops and 63 kbp linkers, again distinct chromatin territories are formed but in contrast to the MLS model without 
subchromosomal domains (d). It is obvious that the MLS model not only balances stability and flexibility considerations 
in storage and transcriptional respects, but also is optimal for replication due to its in essence two-dimensional topology 
allowing controlled duplication and separation during mitosis.
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bearing information loss due to the very nature of T2C. This specific setup is not only far 
superior due to its improvement of 3 to 4 orders of magnitude compared to other interac-
tion approaches (see Introduction), but also allows nearly unlimited opportunities e.g. such 
as multiplexing for complex research and diagnostics.
Most importantly, however, T2C allows reaching fundamental resolution limits where 
"genomic" statistical mechanics and uncertainty principles apply [26]: With fragment length 
and thus resolutions of a couple of base pairs, a high interaction frequency range, and high 
signal-to-noise ratio, not only molecular resolution is reached and thus the fundamental lim-
its of cross-linking techniques, but also the mechanism of observation is now on the same 
scale as the observables (in analogy to classic and quantum mechanics). Actually due to the 
stochastics following the bias of the system behaviour, the observables, the observation, and 
thus the measured values are constrained by what we call “genomic” statistical mechanics 
with corresponding uncertainty principles. This originates from the individual complex-
ity of each highly resolved interaction with a unique but coupled individual probabilistic 
fragment setting in each cell at a given time. Hence, the actual conditions and components 
can be determined only partially with high accuracy while with low accuracy otherwise and 
are eventually even entirely destroyed by the measurement. Thus, the central limit theorem 
applies with an overlap of system inherent and real noise stochastics, and hence in the end 
only probabilistic analyses and statements can be drawn as hitherto is well known from clas-
sical mechanics, and more so from quantum (mesoscopic) systems. Consequently, popula-
tion based or multiple single-cell experiments have to be interpreted and understood in a 
“genome” statistical mechanics manner with uncertainty principles due to the inseparability 
of factors/parameters also seen there. Thus, in practical terms, valid results are obtained when 
the statistical limit is reached, i.e. when scaling up the experiment does not narrow down 
the distribution any further and does not lead to fundamental (overall) changes anymore in 
observables. Nevertheless, if the statistical limit is reached and if the quality parameters like 
resolution, frequency range, and signal-to-noise ratio are sound, conclusions could be drawn 
as in the many cases of classic mechanics, and more so of quantum (mesoscopic) systems.
Consequently, due to this sensitivity of T2C, we [26] were able to determine finally the miss-
ing parts of the 3D architecture on scales where a "genomic" statistical mechanics applies 
with stable reproducibility as one can already see visually in colour coded interaction maps 
(Figure 2): Not only are rare interactions stably detected within an unprecedented frequency 
range spanning 5-6 orders of magnitude, but also the maps are reproducibly mostly empty 
(<10% of possible signals are taken). Both interactions and non-interactions show clearly 
dedicated interaction patterns on all spatial scales within and between domains, including 
their re-emergence as attenuated repetition on other scales since obviously genomes are scale-
bridging systems [22, 23]—all of which can be immediately identified as structural features 
- briefly (Figure 2):
i. On the largest genomic and thus spatial scale, subchromosomal domains are visible 
as square-like interaction domains (often unfortunately called TADs; [63]) featuring in 
general a higher average uniform interaction degree compared to interactions between 
domains, with a sharp drop at the edge of domains, as well as a clear linker region 
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between the domains that connects them. The borders of the domains can be deter-
mined down to the single fragment level and thus a very high resolution (see below). 
The interaction of domains with each other and a closer inspection of the interactions in 
the vicinity of the linker interacting often more frequently compared to other domain 
parts are mainly due to the breaking of spatial isotropy.
ii. At intermediate scales within the subchromosomal domains, the interaction pattern 
shows clearly distinct gaps and a quantifiable grid-like arrangement of interactions, 
which also continues outside and “crosses” with the linear pattern originating from 
sequentially subsequent domain(s). These interactions on scales of tens of kilo base pairs 
are doubt-free originating from stable chromatin loops, forming a stable loop aggregate/
rosette like architecture, due to several consecutive loops coinciding.
iii. On the smallest scale, a dense and high interaction frequency pattern is observed in 
the region from 3 to 10 kbp (i.e. < ~5-15, and ~50 nucleosomes, respectively) along the 
diagonal. It varies independently of the local fragment size with distinct interactions 
and non-interacting “gaps”. This suggests, that there are defined stable interactions on 
the nucleosome scale forming an irregular yet locally defined and compacted structure, 
i.e. a quasi-fibre with average properties (e.g. an average linear mass density).
A detailed quantification [26, 27] of several regions leads to a quasi-fibre compaction of 5 ± 1 
nucleosomes per 11 nm, with an average chromatin quasi-fibre persistence length of ~80 to 
120 nm, loops and linkers of ~30 to 100 kbp, forming multi-loop aggregates/rosettes with 
typically 300 kbp to 1.5 Mbp subchromosomal domain sizes. Different cell types, species, or 
functional conditions showed only a relatively small variation of this theme [26, 27].
All this is consistent with a variety of previous observations and predictions such as compacted 
fibre structures described throughout the literature (see e.g. [16, 17]), the internal structure of 
subchromosomal domains [7, 21, 22, 24, 38–40, 43, 49, 50] agreeing on all structural levels 
with the absolute nucleosome concentration distributions [18, 19], the dynamic and functional 
properties such as the architectural stability and movement of chromosomes [7, 22, 54, 71, 72], 
chromatin dynamics [73], as well as the diffusion of molecules inside nuclei (e.g. [22, 54, 72]), 
and recent genome wide in vivo FCS measurements of the chromatin quasi-fibre dynamics 
[27] also suggesting such a chromatin quasi-fibre with variable,  function-dependent proper-
ties. Beyond, other hypothesis (see Introduction; [26, 27]) about the 3D genome organization 
on these scales can clearly be ruled out: e.g. no-compaction or a highly-regular chromatin 
fibre, unstable/dynamic loops or unstable/dynamic loop aggregates/rosettes can clearly be 
ruled out, because they simple would lead to other interaction patterns and the intrinsic chro-
matin fibre dynamics with movements on the milli-second scale (Movies 1, 2 [26]) would lead 
to immediate structural dissolution. Most importantly no other model leads to a consistent 
functional framework bridging consistently the here described scales as can also be shown by 
the agreement with scaling analysis of the 3D-architecture [21, 22, 26] and the DNA sequence 
itself [22, 24, 26]. Beyond, not only functional aspects as the easy (de-)condensation during 
mitosis can be easily explained, but we were also able to find this organization in the data of 
others across species and even across specie-kingdoms (Imam et al., in preparation).
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2.2. Dynamics and Structure Revealed by FCS
To investigate the 3D genome architecture and dynamics also by an orthogonal genome wide 
and in vivo approach, a novel in vivo FCS technique exploring the structure and dynamics by 
measuring chromatin movement combined with a novel analytical approach was introduced 
[27]. It is based on the fact that a specific chromatin quasi-fibre and its higher-order archi-
tecture directly influences its intrinsic dynamics. Thus, the concept dissects intra-molecular 
polymer dynamics from fluorescence intensity fluctuations measured with FCS to investigate 
meso-scale chromatin dynamics in living cells and connects this to the underlying three-
dimensional organization. Besides, the classical analytical polymer models where extended to 
include dynamics, physical properties, and accessibility. As primary tracer protein for chro-
matin movement a linker histone H1.0-EGFP construct was chosen [18, 19, 22]. On the one 
hand, H1.0 decorates chromatin globally and reflects its density. On the other hand, it binds 
only transiently such that photobleached molecules are constantly replaced by fluorescent 
ones, and thus chromatin dynamics becomes amenable to FCS analysis (see also [20, 54]): 
Here, topologically and dynamically independent chromatin domains of 500 kbp to 1.5 Mbp 
in size were identified that are best described by a compacted chromatin fibre and a loop-
cluster polymer model under theta-solvent conditions. In more detail again the formation 
of stable loops and stable multi-loop aggregates/rosettes from a chromatin fibre with certain 
density and flexibility properties emerged as prominent structural feature of dynamically 
independent domains - and this throughout the cell nucleus in living cells! The detailed quan-
titative values for the involved parameters again lead in essence to the same values as found 
already in the T2C data: a quasi-fibre compaction of 5 ± 1 nucleosomes per 11 nm, with an 
average persistence length of ~80 to 120 nm, and loops and linkers of ~30 to 100 kbp [27]. 
Notably, it cannot be stressed enough that the loops and multi-loop aggregates/rosettes form 
stable entities on the time scales which were approachable by FCS (between 10 μs and 10 to 
20 s) and do neither open, close, or in any other way reform (longer timescale up to hours 
are historically known). This not only moves many an assumption currently proposed (see 
Introduction) into the realm of fairy tales—conceptually and by hard experimental facts in 
agreement with the research of the last ~30 years (e.g. [18–20, 22, 54, 71]). Visualization of 
simulated structures illustrates this clearly (Movies 1, 2 [26]): structures described consis-
tently throughout the literature would dissolve immediately - what has never been observed 
(though attempted to be measured) - and also in consistent agreement with the T2C results 
measured at the limit of resolution. Beyond, also characteristic variations were found between 
eu- and heterochromatin: Hydrodynamic relaxation times and gyration radii of independent 
chromatin domains are larger for open (161 ± 15 ms, 297 ± 9 nm) than for dense chromatin 
(88 ± 7 ms, 243 ± 6 nm) and increase globally upon chromatin hyperacetylation or ATP deple-
tion. Thus, functional changes are a variation of a basic theme, e.g. more compact hetero-
chromatic domains have a larger inaccessible volume fraction than more open euchromatic 
ones. Nevertheless, molecular diffusion is fast enough to roam a complete domain within 
few microseconds, during which the domain itself appears static. Relaxation of domains in 
the 100 ms range affects genome access in a protein concentration-dependent manner: highly 
abundant molecules at several 100 nM concentrations ‘fill’ the fluctuating domain so that a 
larger volume fraction than for a static TAD becomes adiabatically accessible. In contrast, 
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for low-abundance molecules encounters with specific loci within a domain are diffusion-
limited. They sense a higher inaccessible volume fraction. Thus, domain dynamics result in a 
concentration-dependent differential accessibility that is more pronounced in heterochroma-
tin than in euchromatin due to its shorter relaxation times [20, 22, 27, 54]. In this manner the 
FCS approach can be extended to acquire complete nuclear maps and thus to "sequence" the 
dynamic organization of nuclei in living cells.
2.3. Analytical and Computer Simulations Theoretic Evaluation
To better understand the 3D genome organisation suggested e.g. by the above results, to 
evaluate hypotheses, and to plan future experiments, we were the first who have - since 1996 
- developed polymer models with pre-set conditions for in silico super-computer simulations 
(i.e. without attempting to fit data; [7, 21–23, 26, 49–52, 70]) and later also an analytical math-
ematics framework [27]. The simulations use a stretchable, bendable, and volume excluded 
polymer (hydrodynamic) approximation of the 30 nm chromatin fibre consisting of indi-
vidual homogenous segments with a resolution of ~1.0 to 2.5 kbp while combining Monte 
Carlo and Brownian Dynamics approaches (Figures 2–4). The analytical polymer approach 
extends and applies for the first time Gaussian chain and Kratky-Porod model descriptions 
in combination with the Rouse and Zimm models for polymer dynamics to complex star and 
rosette topologies under real excluded volume conditions as well as dilute and semi-dilute 
solvent conditions [27]. Whereas the analytical model is exact, the simulations explore emerg-
ing effects not explicitly introduced into the analytical model.
Simulations (Figure 2) of the Random-Walk/Giant-Loop model in which large individual 
loops (0.5–5.0 Mbp) are connected by a linker resembling a flexible backbone, as well as the 
Multi-Loop Subcompartment (MLS) model with rosette-like aggregates (0.5–2 Mbp) with 
smaller loops (60–250 kbp) connected by linkers (60–250 kbp), have already predicted that 
only an MLS model, i.e. a compacted quasi-fibre forming stable loops and stable loop aggre-
gates/rosettes connected by a linker, can properly explain the formation of chromosome arms 
and territories [22], the spatial distances measured both using fluorescence in situ hybridiza-
tion (FISH) experiments [7, 21–23, 26, 49–52, 70], and beyond even the general morphology of 
nuclei in vivo using histone fluorescence fusion proteins [22, 51], nucleosome concentration 
distributions, as well as dynamic and functional properties such as the diffusion of macromol-
ecules [18, 19, 22, 53, 54]. These models also contained already enough information/aspects to 
cover other architectures such as free random-walks, random or fractal globules as well as their 
stability and dynamics. Additionally, the visualization (Figures 2–4, Movies 1, 2 [26]) creates 
an immediate feeling for the behaviour of genomes in 3D - a fact which already by pure visual 
inspection rules out many of the introduction mentioned obscure suggestions immediately.
With the unprecedented quality of both the interaction mapping by T2C and the FCS dynamic 
measurements (see above) the introduction of simulation and analytical models complex 
enough to approximate the 3D genome organization adequately showed even more clearly 
that only a quasi-fibre, stable loop, stable loop aggregate/rosette-like architecture is compat-
ible with the measurements: In essence the simulations and analytical models describe even 
the slightest details of the T2C and FCS measurements correctly including many at first sight 
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2.2. Dynamics and Structure Revealed by FCS
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chromatic domains have a larger inaccessible volume fraction than more open euchromatic 
ones. Nevertheless, molecular diffusion is fast enough to roam a complete domain within 
few microseconds, during which the domain itself appears static. Relaxation of domains in 
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paradoxical results as e.g. i) that high numbers of especially small loops in a rosette result 
due the high density in steric exclusion and thus stretched loops eventually even “shielding” 
inner-rosette parts, ii) that inter-domain interactions are influenced by the connecting linker, 
loop size and numbers, and how non-equilibrium effects would appear, as well as iii) the isot-
ropy breaking of consecutive subchromosomal domains as seen in the interactions at the bor-
der of domains and the domain-domain interactions. On a more general level the simulations 
support also the large and at first sight remarkable emptiness of interaction matrices and its 
link to the existence of a dedicated chromatin quasi-fibre. Additionally, the simulations hint 
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Figure 3. Determination of the 3D architecture in the IGF/H19 11p 15.5-15.4 region by T2C interaction mapping and 
computer simulations: Interaction matrices (logarithmic and colour coded scale; left & right) in HB2 and HEK293T TEV 
cells [26] show in unprecedented clarity the formation of a quasi-chromatin fibre, folding into stable loops (red lines; 
xL: number of loops), forming due to the grid-like pattern stable multi-loop aggregates/rosettes, i.e. subchromosomal 
domains separated by a linker (borders: pink lines, right; D1s, D1e: start and end of domains). A grid-like pattern is also 
visible in the interactions between the domains and corresponds to trans-domain loop interactions. The aggregation into 
a chromatin quasi-fibre is visible near the diagonal and loop internal structures are also detectable. Between different 
cell types or functional states only some local differences are visible resulting in a consensus architecture and allowing 
simulation of the 3D architecture (middle; resolution < ~1 kbp). Note that the simulation is driven by the dominant 
consensus architecture.
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to a relatively low crosslink probability, radius, and frequency in experiments comparing the 
clearly visible fine-structure (such as the (anti-)parallel neighbouring of the chromatin quasi-
fibre at loop bases [26]. Also both the simulation and analytical approach describe in detail 
every aspect of the experimentally found multi-scaling behaviour with a fine-structure not 
only of the architecture and dynamics, but also of the DNA sequence (see below) to a degree 
of detail even we are still astonished about. The stability of the architecture with respect to the 
intrinsic chromatin fibre dynamics can also be illustrated by e.g. the decondensation from a 
mitotic chromosome into interphase (Movie 1 [26]) or just in a normal interphase state (Movie 
2 [26]). This also shows that any 3D architecture would dissolve within seconds if it would 













Figure 4. Insight into the spatial and dynamic/diffusional properties and morphology of the 3D organization of entire 
nuclei: The detailed view from the outside into a simulation for an MLS model with 126 kbp loops and linkers [22] 
shows the structure and low overlap of chromosome territories, the rosette like subchromosomal domains, and that the 
mean spacing between quasi-fibres ranges at least from 50 to 100 nm. Hence, the obstruction of diffusing particles (see 
spherical legend) is proportional to their size. Thus, small molecules as nucleotides and most (subunits of) proteins or 
gene transcripts reach every location of the nucleus by moderately obstructed diffusion. Consequently, active transport 
of molecules should be restricted to few exceptions and a channel like network for transportation (proposed by the Inter 
Chromosomal Domain model) is not necessary. Nevertheless, obviously the rosette core is denser leading to a general 
diffusion limited access. Thus, the interplay between accessibility and obstruction while considering the fast Brownian 
dynamics of the quasi-fibre and the entire system is of functional relevance.
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to a relatively low crosslink probability, radius, and frequency in experiments comparing the 
clearly visible fine-structure (such as the (anti-)parallel neighbouring of the chromatin quasi-
fibre at loop bases [26]. Also both the simulation and analytical approach describe in detail 
every aspect of the experimentally found multi-scaling behaviour with a fine-structure not 
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consistently to the same conclusion whatever orthogonal high-quality method is used and 
thus are a theoretical framework for the understanding, test, and engineering of genomes.
2.4. DNA-Sequence Fine-Structured Multi-Scaling
Since what is near in physical space should also be near (i.e. in terms of similarity) in DNA 
sequence space and this presumably genome-wide [22–24, 55], and because evolutionary sur-
viving mutations of all sorts will be biased by the genome architecture itself and vice versa, 
the correlation and thus scaling behaviour of the DNA sequence [22–24, 26, 55] and its con-
nection to the 3D genome architecture scaling - either from T2C interaction mapping [26] or 
from simulations [21–23] - allows for comprehensive investigation of genome organization in 
a unified scale-bridging manner from a few to the mega base pair level. Using to this end, the 
perhaps simplest correlation analysis possible (to avoid information loss or biases), we calcu-
lated the mean square deviation of the base pair composition (purines/pyrimidines) within 
windows of different sizes and calculating the function C(l) and its local slope δ(l), which 
measures the correlation degree, or in more practical lay-men terms, is similar to a spectral 
measure [22–24, 26]: in relation to mammalian genome organization for each of two different 
human and mouse strains i) long-range power-law correlations were found on almost the 
entire observable scale, ii) with the local correlation coefficients showing a species specific 
multi-scaling behaviour with close to random correlations on the scale of a few base pairs, a 
first maximum from 40 bp to 3.6 kbp, and a second maximum from 8 × 104 to 3 × 105 bp, and 
iii) an additional fine-structure is present in the first and second maxima. The correlation 
degree and behaviour within the species are nearly identical comparing different chromo-
somes (with larger differences for the X and Y chromosomes). The behaviour on all scales 
is equivalent concerning the different measures used to investigate the long-range multi-
scaling of the genome architecture with the transitions of behaviours even at similar scaling 
positions [26] and can be associated with a single base pair resolution i) the nucleosome, ii) 
the compaction into a quasi-fibre, iii) the chromatin fibre regime, iv) the formation of loops, 
v) subchromosomal domains, and vi) their connection by linkers. Additionally, the already 
previously proven association to nucleosomal binding on the fine-structural level [22–24] is 
not only found again, but also is in agreement with the fine-structure found in the interac-
tion scaling. Since the correlation analysis is genome-wide (in contrast to the T2C analysed 
regions so far) and since individual chromosomes show a highly similar scaling this clearly 
shows the genome-wide validity of the 3D organization. Moreover, the existence and details 
of this behaviour show the stability and persistence of the architecture since sequence reshuf-
fling or other destructive measures would result in a loss of this pattern. This would also be 
the case for an unstable architecture, which would not leave a defined footprint within the 
sequence. This is again in agreement with our simulations of the dynamics or the genome 
wide in vivo FCS measurements [27]. Consequently, this shows not only by two analysis of 
completely independent “targets” (the T2C interaction experiments and the analysis of the 
DNA sequence) the compaction into a chromatin quasi-fibre and a stable multi-loop aggre-
gate/rosette genome architecture again, but proved here also the long discussed notion that 
what is near in physical space is also near, i.e. more similar, in sequence space. Hence, the 3D 
architecture and DNA sequence organization are co-evolutionarily tightly entangled (review 
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of previous notions in [22, 24]). Thus, in the future from the DNA sequence and other higher-
order codes (e.g. the epigenetic code) most architectural genome features can be potentially 
determined, since most structural/architectural features left a footprint on the DNA sequence 
and other code levels and vice versa as one would expect from a stable scale bridging systems 
genomic entity.
3. Systems Consistency of the 3D Genome Organization
The above described holistic combination of several new orthogonal approaches [26, 27] includ-
ing the heuristics of the field leads interestingly undoubtedly to a consistent picture of genome 
architecture, dynamics, and in general organization, by establishing that nucleosomes com-
pact into a quasi-fibre folded into stable loops, forming stable multi-loop aggregates/rosettes 
connected by linkers creating chromosome arms and entire chromosomes. Nevertheless, the 
heuristics of the field immediately questions whether i) we really now have an evolutionary 
consistent picture of genome organization, ii) whether this is the unavoidable outcome of 
Darwinian natural selection and Lamarkian self-referenced manipulation (what we introduce 
here), and iii) finally whether we can understand now genome organization in its systems 
context within cells, organs, and the entire organism? This in essence already relates back to 
the fundamental question of how life emerged from the primordial soup [5, 6, 22]; see details 
in following sections) but in the context discussed here can be addressed by first reflecting on 
the existing major functions of genomes, thus setting the stage: i) genomes need to stably store 
genetic information, ii) the information needs to be differentially read out to give rise to and 
regulate the molecular machinery, and iii) genomes need to replicate and mutate to spread 
and evolve:
i. Obviously the by far most important function is to stably store over long periods of 
time genetic information though with enough flexibility including mutations - or in 
short: without proper storage neither information retrieval, nor replication, nor evo-
lutionary development exist. This involves obviously being resistant against physical/
chemical and/or in- or external mechanical destruction. Whereas, the first act mainly as 
from the bottom up involving one or a group of chemical bonds in proximity by direct 
interactions in the molecular soup, the latter depends on the large-scale structure of 
the basic molecular components and thus acts indirectly top-down on chemical bonds, 
i.e. that in- or external global stress is transferred and eventually accumulated via the 
global structure down to molecular levels while leading to mechanical failure. Both this 
physico-chemical and structural conformation-based destruction paradigms, influ-
ence genome architecture on all its levels under evolutionary pressure. They can be 
formulated such that a) mechanical failure rates are minimized regarding very long time 
spans, and b) in- or external mechanical failure rates reach an optimum due to the right 
balance between internal stability increasing with scale (for sensible ranges) and external 
stress decreasing the stability with increasing scale. From the well known average DNA 
breaking length of ~300–500 bp after already relatively severe sonication, this translates 
right away to the nucleosome and chromatin quasi-fibre level assuming that internal 
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pact into a quasi-fibre folded into stable loops, forming stable multi-loop aggregates/rosettes 
connected by linkers creating chromosome arms and entire chromosomes. Nevertheless, the 
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lutionary development exist. This involves obviously being resistant against physical/
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from the bottom up involving one or a group of chemical bonds in proximity by direct 
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breaking length of ~300–500 bp after already relatively severe sonication, this translates 
right away to the nucleosome and chromatin quasi-fibre level assuming that internal 
A Consistent Systems Mechanics Model of the 3D Architecture and Dynamics of Genomes
http://dx.doi.org/10.5772/intechopen.89836
79
nucleosomal attachment increases the stability and elongating it by a factor 146 bp to 
200 bp (repeat length), i.e. the average breakage length of an uncompacted chromatin 
fibre is 44 kbp or in the extreme 100 kbp balancing the quasi-fibre internal stability 
increase by further compaction counteracted by the bigger mechanical susceptibility 
due to local compaction clusters. Thus, the found loops size of 30-100 kbp as well as its 
chromatin quasi-fibre persistence length of 80-120 nm is just what one would theoreti-
cally expect as the evolutionary outcome. The same holds for the formation of stable 
multi-loop aggregates/rosettes where the major player is internal stability, which is a 
function of quasi-fibre compaction, loops sizes, and loop numbers [51, 52], giving rise to 
the natural found size distribution between ~0.3-1.5 Mbp [21–24, 26, 27, 40–42]. Also on 
the entire chromosome level again in- and external stability criteria have reached an opti-
mum during evolution concerning the number of subchromosomal domains as well as 
their total size and number within a genome which again would just fit what one would 
theoretically expect: subchromosomal domain linkers are in the ballpark of loop sizes, 
the number of subchromosomal domains is <200-300 which just is the optimum size 
where mechanical stress does not too much destruct mitotic chromosomes under normal 
conditions. Consequently, the stability criteria are clearly satisfied while obviously still 
allowing enough flexibility by variation of this theme within the relatively broad bound-
ary limits and various levels compensating individual stretching of limits (e.g. bigger 
loops might be stabilised by higher quasi-fibre compaction). Beyond, destruction of a 
complete structural element (e.g. nucleosome, loop) in relation to the characteristic scale 
seems never really to exceed 1-5% - an important criterion for overall system resilience.
ii. Access to and obstruction of genetic information, i.e. genetic information retrieval in 
a regulated fashion is, of course, next to pure storage the major task for a genome, 
although without a stable information storage retrieval gets arbitrarily complicated 
whether replication takes place or not. Since the information is readout with similar 
means as the storage itself, i.e. in a molecular way in contrast e.g. to an optical readout, 
this relies in principle on two major conditions: a) the physical space for the regulation 
of the 3D architecture needed that a readout takes place, and b) accessibility/obstruction 
to the genetic information for the readout-machinery as well as post-processing and 
transport of the transcribed information. For the first the DNA, nucleosomes, chromatin 
quasi-fibre, loops and loop aggregates/rosettes, need to have the space to be modified 
and get rearranged, i.e. that a volume several times bigger than the actual structure exists 
for ease of change. This involves, naturally a certain compaction, since a homogenous 
soup would not allow this. Since the regulation and readout is done by molecular mecha-
nisms, it is also obvious that a low spatial occupancy allows moderately obstructed diffu-
sional access of both the regulation and readout machinery only for DNA with a certain 
compaction degree. For such a scenario the volume occupancy of the architecture in 
aqueous solution should be well (!) below the limit of ~50% (model depending) as known 
from percolation studies [74], i.e. in terms of the performance expected for genomes, 
volume occupancy should be <10% since both the genomic architecture as well as the 
machinery should be able to access it for regulation by modification as well as readout. 
For chromatin, experimental values are between 2.5% to ~8% with a homogenous mesh 
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spacing ranging from 115 to 65 nm ([22] and literature cited therein). Together with 
other factors and molecules in the cell nucleus like proteins and RNA, which all have 
a similar density, the volume occupancy is still <25%. These percolation assumptions 
hold, of course, also for the dynamics of the structure itself as pointed out above. At 
first sight this seems to be a dense system but the architecture is moving constantly by 
Brownian motion like in a spaghetti soup with additional floating components [18–20, 
22, 27, 53, 54]. For chemical reactions this is well known for diffusion limited aggregation 
processes [75] as well as for percolating systems [75]. Due to the described consistent 
multi-layered 3D organizations showing also a multi-scaling of its volume occupancy as 
well as the space in-between this creates now even more and especially a scale depend-
ent accessibility and obstruction to enhance the theoretic predictions of homogeneous 
though compacted systems with percolating space. Thus, under such conditions the 
necessary machinery for transcription as well as transcript transport is based mainly on 
moderately obstructed diffusion and despite of its high overall concentrations acts as an 
adequate multi-scale space [22, 53]. Consequently, similar to diffusion limited (catalytic) 
processes modification of the intrinsic architecture and dynamics of the entire genome 
organization is used for locally or globally fine-tuning of processes and thus functional 
regulation. Concerning, the stability of the 3D architecture only a quasi-fibre with stable 
loop aggregates/rosettes allows in terms of stability and flexibility local containment of 
large-scale interactions during the initiation of transcription e.g. by enhancer promoter 
interactions. For knot-free replication of the genome these (spatial) arguments also apply: 
whereas accessibility allows access of the machinery and space for the duplication, 
spatial obstruction protects the structural integrity. Interestingly, none of the described 
alternative architectures and dynamics hypothesis (see Introduction) agree to even a 
sufficient degree with these fundamental necessities to guaranty genome function.
iii. Replication and extinction of genetic information is the most crucial intervention into 
genome organization, since in contrast to the readout and regulation of genetic informa-
tion by transcription, the entire structure and dynamics are affected by copying every 
single component of the organization. Here, an exact copy within a constrained space 
not only sequence wise, but also of its 3D architecture and dynamics as well as its 
disentanglement are the crucial parameters while still allowing structural stability/flex-
ibility and even the access/obstruction of genetic information. From protein folding it is 
well known, that already during the amino-acid chain synthesis in the ribosome folding 
takes place, leading to a different 3D folding compared to the relaxation of finished and 
stretched out amino-acid chains. Obviously, also chromosome replication is such an 
adiabatic process (also chromosomes never fold from scratch, i.e. de novo, and always go 
continuously from one state to another), which takes place in parallel in the entire cell 
nucleus. And here again, genome architecture and dynamics are enabling replication to 
take place easily in principle only compatible with a chromatin quasi-fibre arranged in 
stable multi-loop aggregates/rosettes. This is due to the fact this architecture on the level 
of stable multi-loop aggregates/rosettes follows a knot-free two-dimensional topol-
ogy. Of course, genome architecture is not a simple two-dimensional object in space 
considering the DNA-double helix and nucleosomal twist and writhe but nevertheless 
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nucleosomal attachment increases the stability and elongating it by a factor 146 bp to 
200 bp (repeat length), i.e. the average breakage length of an uncompacted chromatin 
fibre is 44 kbp or in the extreme 100 kbp balancing the quasi-fibre internal stability 
increase by further compaction counteracted by the bigger mechanical susceptibility 
due to local compaction clusters. Thus, the found loops size of 30-100 kbp as well as its 
chromatin quasi-fibre persistence length of 80-120 nm is just what one would theoreti-
cally expect as the evolutionary outcome. The same holds for the formation of stable 
multi-loop aggregates/rosettes where the major player is internal stability, which is a 
function of quasi-fibre compaction, loops sizes, and loop numbers [51, 52], giving rise to 
the natural found size distribution between ~0.3-1.5 Mbp [21–24, 26, 27, 40–42]. Also on 
the entire chromosome level again in- and external stability criteria have reached an opti-
mum during evolution concerning the number of subchromosomal domains as well as 
their total size and number within a genome which again would just fit what one would 
theoretically expect: subchromosomal domain linkers are in the ballpark of loop sizes, 
the number of subchromosomal domains is <200-300 which just is the optimum size 
where mechanical stress does not too much destruct mitotic chromosomes under normal 
conditions. Consequently, the stability criteria are clearly satisfied while obviously still 
allowing enough flexibility by variation of this theme within the relatively broad bound-
ary limits and various levels compensating individual stretching of limits (e.g. bigger 
loops might be stabilised by higher quasi-fibre compaction). Beyond, destruction of a 
complete structural element (e.g. nucleosome, loop) in relation to the characteristic scale 
seems never really to exceed 1-5% - an important criterion for overall system resilience.
ii. Access to and obstruction of genetic information, i.e. genetic information retrieval in 
a regulated fashion is, of course, next to pure storage the major task for a genome, 
although without a stable information storage retrieval gets arbitrarily complicated 
whether replication takes place or not. Since the information is readout with similar 
means as the storage itself, i.e. in a molecular way in contrast e.g. to an optical readout, 
this relies in principle on two major conditions: a) the physical space for the regulation 
of the 3D architecture needed that a readout takes place, and b) accessibility/obstruction 
to the genetic information for the readout-machinery as well as post-processing and 
transport of the transcribed information. For the first the DNA, nucleosomes, chromatin 
quasi-fibre, loops and loop aggregates/rosettes, need to have the space to be modified 
and get rearranged, i.e. that a volume several times bigger than the actual structure exists 
for ease of change. This involves, naturally a certain compaction, since a homogenous 
soup would not allow this. Since the regulation and readout is done by molecular mecha-
nisms, it is also obvious that a low spatial occupancy allows moderately obstructed diffu-
sional access of both the regulation and readout machinery only for DNA with a certain 
compaction degree. For such a scenario the volume occupancy of the architecture in 
aqueous solution should be well (!) below the limit of ~50% (model depending) as known 
from percolation studies [74], i.e. in terms of the performance expected for genomes, 
volume occupancy should be <10% since both the genomic architecture as well as the 
machinery should be able to access it for regulation by modification as well as readout. 
For chromatin, experimental values are between 2.5% to ~8% with a homogenous mesh 
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spacing ranging from 115 to 65 nm ([22] and literature cited therein). Together with 
other factors and molecules in the cell nucleus like proteins and RNA, which all have 
a similar density, the volume occupancy is still <25%. These percolation assumptions 
hold, of course, also for the dynamics of the structure itself as pointed out above. At 
first sight this seems to be a dense system but the architecture is moving constantly by 
Brownian motion like in a spaghetti soup with additional floating components [18–20, 
22, 27, 53, 54]. For chemical reactions this is well known for diffusion limited aggregation 
processes [75] as well as for percolating systems [75]. Due to the described consistent 
multi-layered 3D organizations showing also a multi-scaling of its volume occupancy as 
well as the space in-between this creates now even more and especially a scale depend-
ent accessibility and obstruction to enhance the theoretic predictions of homogeneous 
though compacted systems with percolating space. Thus, under such conditions the 
necessary machinery for transcription as well as transcript transport is based mainly on 
moderately obstructed diffusion and despite of its high overall concentrations acts as an 
adequate multi-scale space [22, 53]. Consequently, similar to diffusion limited (catalytic) 
processes modification of the intrinsic architecture and dynamics of the entire genome 
organization is used for locally or globally fine-tuning of processes and thus functional 
regulation. Concerning, the stability of the 3D architecture only a quasi-fibre with stable 
loop aggregates/rosettes allows in terms of stability and flexibility local containment of 
large-scale interactions during the initiation of transcription e.g. by enhancer promoter 
interactions. For knot-free replication of the genome these (spatial) arguments also apply: 
whereas accessibility allows access of the machinery and space for the duplication, 
spatial obstruction protects the structural integrity. Interestingly, none of the described 
alternative architectures and dynamics hypothesis (see Introduction) agree to even a 
sufficient degree with these fundamental necessities to guaranty genome function.
iii. Replication and extinction of genetic information is the most crucial intervention into 
genome organization, since in contrast to the readout and regulation of genetic informa-
tion by transcription, the entire structure and dynamics are affected by copying every 
single component of the organization. Here, an exact copy within a constrained space 
not only sequence wise, but also of its 3D architecture and dynamics as well as its 
disentanglement are the crucial parameters while still allowing structural stability/flex-
ibility and even the access/obstruction of genetic information. From protein folding it is 
well known, that already during the amino-acid chain synthesis in the ribosome folding 
takes place, leading to a different 3D folding compared to the relaxation of finished and 
stretched out amino-acid chains. Obviously, also chromosome replication is such an 
adiabatic process (also chromosomes never fold from scratch, i.e. de novo, and always go 
continuously from one state to another), which takes place in parallel in the entire cell 
nucleus. And here again, genome architecture and dynamics are enabling replication to 
take place easily in principle only compatible with a chromatin quasi-fibre arranged in 
stable multi-loop aggregates/rosettes. This is due to the fact this architecture on the level 
of stable multi-loop aggregates/rosettes follows a knot-free two-dimensional topol-
ogy. Of course, genome architecture is not a simple two-dimensional object in space 
considering the DNA-double helix and nucleosomal twist and writhe but nevertheless 
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in terms of replication disentanglement it is. Consequently, replication origins can be 
situated and start replication everywhere in each chromatin loop with replication forks 
leading towards both directions until they hit a loop base (which is the reason for the 
bidirectional CTCF sites functioning as linear DNA markers for the directional oriented 
replication machinery). During this procedure even the twist and writhe are copied and 
need to be untangled as in the case of transcription. While hitting the loop bases then 
the two forks coming from two loops have to be joined and untangled, but no complex 
network of knots as they would appear even in a Random-Walk/Giant-Loop or even 
more so in a fractal globule like replication scenario would have to be cut and re-joined. 
Again here theoretical predictions for loop size and loop numbers are just fitting the 
experimental findings (see e.g. [39] and thereafter). Due to the two-dimensional topol-
ogy of the multi-loop aggregates/rosettes, they can just be separated very easily in 3D 
space (this idea was proposed and illustrated to the author by his at the time 6 year old 
son Leander Aurelius!). And again the compaction and volume occupancy in the cell 
nucleus play an important role: the compaction into a chromatin fibre reduces not only 
the formation of DNA knots largely (perhaps almost to zero), but also provides with 
the volume occupancy in the cell nucleus the room for undisturbed replication, with the 
right flexibility provided by the intrinsic dynamics, allowing the disentanglement of rep-
licated structures with minimal e.g. topoisomerase/decatenase driven active processes.
In summary, the above proves even further and especially in a holistic combination with 
the presented new orthogonal approaches [26, 27] and including the heuristics of the field, 
that indeed the described 3D genome organization - DNA forming nucleosomes compacted 
into a quasi-fibre folded into stable loops, forming stable multi-loop aggregates/rosettes con-
nected by linkers creating chromosome arms and entire chromosomes (Figure 1) - presents 
without doubt a consistent scale bridging systems statistical mechanics genomics fulfilling 
the functional conditions necessary for storage, transcription, and replication. Additionally, 
the actual values found for the various parameters involved are just found in those "regions" 
one would expect as the unavoidable outcome of Darwinian natural selection and Lamarkian 
self-referenced manipulation (see below).
4. A Systems Genomics Statistical Mechanics
The heuristics leading to the here described consistent 3D genome organization has also 
resulted in another fundamental breakthrough besides merely clarifying the missing gap(s): 
the emergence of a multilistic systems statistical mechanics with uncertainty principles by 
reaching the fundamental resolution limits (see Section 2.1 above; [26]. Hence, this allows 
directly not only i) to extend the atomic theory based on ancient Greek philosophy and 
the notion of Theodor Schwann of cells being the fundamental atomic unit of tissues to the 
mesoscopic scale of genome architecture/dynamics, but also ii) to analyse and to describe 
how from the collective behaviour of these elements a holistic meta level, i.e. a phenotype, 
emerges. Thus, by reaching fundamental resolution limits now the statistical and uncertainty 
properties of each architectural/dynamic level can be determined both by experimental 
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measurements as well as theoretical descriptions. Hence, from each of these "atomistic" 
basic units/elements their collective behaviour can be derived by a statistical mechanics on 
each individual level as wells as a complex interwoven scale-bridging, i.e. a hierarchic back 
referencing networked systems statistical mechanics - which obviously exists - can now be 
established in detail. This exceeds and is much more complex than establishing the statistical 
mechanics at the turn of the 20th century where from the individual components e.g. gas 
molecules a statistical mechanics established the collective properties of the entire system, 
e.g. the entire gas, because genome organization is not only a simple dualistic system of e.g. 
two levels but a complex multilistic network system with back references: In detail this means 
determining experimentally the behaviour of a genome structural/dynamic level precisely 
with its entire statistics and then doing the same on the level emerging from the underlying 
level. In principle this is what we have started already by setting up an experimental and the-
oretic framework over the past 20 years to elucidate genome organization [7, 18–24, 26, 27, 49, 
50], although only now with the complete description of the general 3D genome architecture/
dynamics it is possible to fill the existing lack of knowledge in detail, determine the values 
for parameters with high precision, and in constant cycles of refinement adjust the descrip-
tion to an ever higher degree of approximation. Thus, the difference to the development of 
statistical mechanics in classical and later quantum physics at the turn to the 20th century is 
that in biology many and also much higher levels still are determined by and also act back 
even on the very first level to a much higher degree. This also immediately unites the at 
first sight contradicting theoretic descriptions of living systems of Ilia Prigogine [75], stating 
that living systems are far away from thermodynamic equilibrium, with those proposed by 
Georgi Gladyshev [76] stating that hierarchic substance stability is locally in thermodynamic 
equilibrium. Actually, these descriptions are even extended due to the multilistic statistical 
systems mechanics, i.e. manifold recursive hierarchically back-referencing, which are until 
now not described but e.g. envisioned in efforts to extend quantum mechanics to higher 
order complexities [77]. Consequently, a genomic multilistic statistical systems mechanics 
allows not only to describe and test basic properties of life, but also to answer perhaps the 
most fundamental questions of life as e.g. whether life time-wise can be extended beyond the 
currently obvious or thought of limits by manipulated engineering in one of its most central 
parts - the genome - a quest of epic dimensions appearing already at least between the lines 
in "What Is Life ?" by Erwin Schrödinger [78].
5. Genotype-Phenotype-Entanglement and Genome Ecology
The most important implication from the findings described above is most likely the multilis-
tic entanglement between genotype and phenotype being the natural outcome of Darwinian 
natural selection and Lamarkian self-referenced manipulation in a genome ecology frame-
work, which is connected directly to the origin of genomes and life itself: While entropy 
grows like an inexorable river, local disturbances lead to ever more ordered self-organizing 
and self-sustaining resistors, more complex structures, and finally life. In the 1970s Manfred 
Eigen [5, 6] showed how from the primordial soup autocatalytic chemical reaction-networks 
emerged and how they form ever more complex cooperatively organized networks and 
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in terms of replication disentanglement it is. Consequently, replication origins can be 
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network of knots as they would appear even in a Random-Walk/Giant-Loop or even 
more so in a fractal globule like replication scenario would have to be cut and re-joined. 
Again here theoretical predictions for loop size and loop numbers are just fitting the 
experimental findings (see e.g. [39] and thereafter). Due to the two-dimensional topol-
ogy of the multi-loop aggregates/rosettes, they can just be separated very easily in 3D 
space (this idea was proposed and illustrated to the author by his at the time 6 year old 
son Leander Aurelius!). And again the compaction and volume occupancy in the cell 
nucleus play an important role: the compaction into a chromatin fibre reduces not only 
the formation of DNA knots largely (perhaps almost to zero), but also provides with 
the volume occupancy in the cell nucleus the room for undisturbed replication, with the 
right flexibility provided by the intrinsic dynamics, allowing the disentanglement of rep-
licated structures with minimal e.g. topoisomerase/decatenase driven active processes.
In summary, the above proves even further and especially in a holistic combination with 
the presented new orthogonal approaches [26, 27] and including the heuristics of the field, 
that indeed the described 3D genome organization - DNA forming nucleosomes compacted 
into a quasi-fibre folded into stable loops, forming stable multi-loop aggregates/rosettes con-
nected by linkers creating chromosome arms and entire chromosomes (Figure 1) - presents 
without doubt a consistent scale bridging systems statistical mechanics genomics fulfilling 
the functional conditions necessary for storage, transcription, and replication. Additionally, 
the actual values found for the various parameters involved are just found in those "regions" 
one would expect as the unavoidable outcome of Darwinian natural selection and Lamarkian 
self-referenced manipulation (see below).
4. A Systems Genomics Statistical Mechanics
The heuristics leading to the here described consistent 3D genome organization has also 
resulted in another fundamental breakthrough besides merely clarifying the missing gap(s): 
the emergence of a multilistic systems statistical mechanics with uncertainty principles by 
reaching the fundamental resolution limits (see Section 2.1 above; [26]. Hence, this allows 
directly not only i) to extend the atomic theory based on ancient Greek philosophy and 
the notion of Theodor Schwann of cells being the fundamental atomic unit of tissues to the 
mesoscopic scale of genome architecture/dynamics, but also ii) to analyse and to describe 
how from the collective behaviour of these elements a holistic meta level, i.e. a phenotype, 
emerges. Thus, by reaching fundamental resolution limits now the statistical and uncertainty 
properties of each architectural/dynamic level can be determined both by experimental 
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e.g. the entire gas, because genome organization is not only a simple dualistic system of e.g. 
two levels but a complex multilistic network system with back references: In detail this means 
determining experimentally the behaviour of a genome structural/dynamic level precisely 
with its entire statistics and then doing the same on the level emerging from the underlying 
level. In principle this is what we have started already by setting up an experimental and the-
oretic framework over the past 20 years to elucidate genome organization [7, 18–24, 26, 27, 49, 
50], although only now with the complete description of the general 3D genome architecture/
dynamics it is possible to fill the existing lack of knowledge in detail, determine the values 
for parameters with high precision, and in constant cycles of refinement adjust the descrip-
tion to an ever higher degree of approximation. Thus, the difference to the development of 
statistical mechanics in classical and later quantum physics at the turn to the 20th century is 
that in biology many and also much higher levels still are determined by and also act back 
even on the very first level to a much higher degree. This also immediately unites the at 
first sight contradicting theoretic descriptions of living systems of Ilia Prigogine [75], stating 
that living systems are far away from thermodynamic equilibrium, with those proposed by 
Georgi Gladyshev [76] stating that hierarchic substance stability is locally in thermodynamic 
equilibrium. Actually, these descriptions are even extended due to the multilistic statistical 
systems mechanics, i.e. manifold recursive hierarchically back-referencing, which are until 
now not described but e.g. envisioned in efforts to extend quantum mechanics to higher 
order complexities [77]. Consequently, a genomic multilistic statistical systems mechanics 
allows not only to describe and test basic properties of life, but also to answer perhaps the 
most fundamental questions of life as e.g. whether life time-wise can be extended beyond the 
currently obvious or thought of limits by manipulated engineering in one of its most central 
parts - the genome - a quest of epic dimensions appearing already at least between the lines 
in "What Is Life ?" by Erwin Schrödinger [78].
5. Genotype-Phenotype-Entanglement and Genome Ecology
The most important implication from the findings described above is most likely the multilis-
tic entanglement between genotype and phenotype being the natural outcome of Darwinian 
natural selection and Lamarkian self-referenced manipulation in a genome ecology frame-
work, which is connected directly to the origin of genomes and life itself: While entropy 
grows like an inexorable river, local disturbances lead to ever more ordered self-organizing 
and self-sustaining resistors, more complex structures, and finally life. In the 1970s Manfred 
Eigen [5, 6] showed how from the primordial soup autocatalytic chemical reaction-networks 
emerged and how they form ever more complex cooperatively organized networks and 
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systems of so called hypercycles. With environmental separation by the emergence of units 
as cells and specialization of subunits, then genomes have developed as specialized keepers 
of the blueprint needed to maintain, regulate, and develop this syntropic machinery. Since 
genetic information is physically stored in molecular structures with dedicated architecture 
and dynamics, it is thus also obvious that the material carrier for the storage, usage, and rep-
lication of genetic information co-evolved inseparably. Yet another inevitable consequence 
of our results leading to the consistent statistical systems genome mechanic framework is 
indeed our proof [26, 27] that architecture, dynamics, and DNA sequence are co-evolutionary 
unseparably entangled (in a quantum mechanical sense): All architecture/dynamics levels 
have not only left a footprint on the DNA sequence level but beyond also all levels have 
left a footprint on all other levels with an astonishing degree of detail (see Section 2.4). 
Consequently, the co-evolution of all levels has also co-evolved not only to a higher degree 
























Figure 5. Genome ecology emerging from the system mechanics of genomes in relation to the genotype-phenotype 
entanglement and its embedding in- and environment: Genomes are interwoven holistic multi-scale hierarchic systems 
entities in which all organizational levels are also manifest, i.e. fingerprinting, on all other levels. Thus, immediately each 
level is a phenotype of its underlying genotype immediately conditioning back on it recursively. Thus, both genotype 
and phenotype are entangled inseparably in a (due to the involvement and entanglement of all levels) multilistic manner. 
In consequence this not only unites Darwinian and Lamarckian evolutionary paradigms, but also embeds and relates 
genomes with their in- and environment, and thus giving rise to a general genome ecology.
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In evolutionary terminology the genotype (i.e. the double helix) creates a phenotype (the nucleo-
some) and this phenotype recursively conditions the genotype (i.e. again the double helix). The 
nucleosome is also a genotype conditioning the quasi-fibre phenotype, recursively conditioning the 
nucleosome and DNA, etc. Since this is happening with all levels simultaneously this inseparable 
dualism extends in the present genome organisation to a multilism, shaping evolutionary develop-
ment in hierarchical terms from bottom to top by Darwinian natural selection as well as from top 
to bottom by Lamarkian self-referenced manipulation. Thus, our finding that indeed all genome 
architecture/dynamic levels are tightly entangled with each other also immediately resolves the 
falsely assumed paradoxes between Darwinian and Lamarckian evolution by uniting them at least 
on the genome level. This is remarkable not only in historic terms considering the even politi-
cally and religiously extremely hot debates/fights about "man evolving from apes" as well as the 
"intentionally planed long neck of giraffes", but also heuristically, since the in principle relatively 
simple final completion of the 3D genome architecture/dynamics at the limit of the resolution leads 
not only to a consistent 3D genome organization and statistical systems genome mechanics, but 
beyond reveals in one go some and perhaps the most important fundamentals of life (Figure 5).
Beyond, this strong entanglement over several orders of magnitude (Figures 1, 2) within the 
genome, the described genotype-phenotype-entanglement can be driven conceptually even fur-
ther considering the influence of both the a) hierarchically constituting elements giving rise to 
the system, i.e. chemical molecular base, atomic, and subatomic units, which will be called here 
i(!)nvironment, and b) the hierarchical higher levels, i.e. tissues, organs, animal etc., which are the 
environment. Although this may seem far fetched, but influences from both "directions" are well 
known (see e.g. Section 3), although due to their complexity this is often hard to track down in 
a reductionistic manner, thus hence their degree of influence is just emerging. In this respect the 
found entanglements bridging so many multi-scale levels and orders of magnitude in space and 
time, are on the one hand already astonishing in terms of the obviously wrong assumption that 
such influences would die-off very fast, while on the other hand this has general implications for 
all hierarchic systems showing that complex inter-, cross-, and even multi-cross-level influences 
are much more frequent and far reaching. Actually, the here shown multilistic genotype-pheno-
type entanglement shows a highly interwoven, networked, and recursive structure: instead of 
more or less separate hierarchic layers where only first or at the most secondary neighbour layers 
are connected, there are also influential connections to more distant layers at least locally if not 
in every part of the layer space. Thus, the genotype-phenotype entanglement embedded within 
an i(!)n- and environment actually results in a genome ecology in direct analogy to e.g. human 
ecology, autopoieses of social systems, or just any kind of systems theoretic entity [77–82].
6. Conclusion
Nature has created ever more complex forms of life by creating structural and dynamical islands 
of systems with specialized organelles such as genomes being responsible for storage, access, 
and replication of the information for their persistence and development. Despite the epic quest 
to determine the details and origin of inheritance, only recently we were finally able to fill the 
debated gaps of the central part of genome architecture and dynamics - despite the pioneering 
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systems of so called hypercycles. With environmental separation by the emergence of units 
as cells and specialization of subunits, then genomes have developed as specialized keepers 
of the blueprint needed to maintain, regulate, and develop this syntropic machinery. Since 
genetic information is physically stored in molecular structures with dedicated architecture 
and dynamics, it is thus also obvious that the material carrier for the storage, usage, and rep-
lication of genetic information co-evolved inseparably. Yet another inevitable consequence 
of our results leading to the consistent statistical systems genome mechanic framework is 
indeed our proof [26, 27] that architecture, dynamics, and DNA sequence are co-evolutionary 
unseparably entangled (in a quantum mechanical sense): All architecture/dynamics levels 
have not only left a footprint on the DNA sequence level but beyond also all levels have 
left a footprint on all other levels with an astonishing degree of detail (see Section 2.4). 
Consequently, the co-evolution of all levels has also co-evolved not only to a higher degree 
























Figure 5. Genome ecology emerging from the system mechanics of genomes in relation to the genotype-phenotype 
entanglement and its embedding in- and environment: Genomes are interwoven holistic multi-scale hierarchic systems 
entities in which all organizational levels are also manifest, i.e. fingerprinting, on all other levels. Thus, immediately each 
level is a phenotype of its underlying genotype immediately conditioning back on it recursively. Thus, both genotype 
and phenotype are entangled inseparably in a (due to the involvement and entanglement of all levels) multilistic manner. 
In consequence this not only unites Darwinian and Lamarckian evolutionary paradigms, but also embeds and relates 
genomes with their in- and environment, and thus giving rise to a general genome ecology.
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In evolutionary terminology the genotype (i.e. the double helix) creates a phenotype (the nucleo-
some) and this phenotype recursively conditions the genotype (i.e. again the double helix). The 
nucleosome is also a genotype conditioning the quasi-fibre phenotype, recursively conditioning the 
nucleosome and DNA, etc. Since this is happening with all levels simultaneously this inseparable 
dualism extends in the present genome organisation to a multilism, shaping evolutionary develop-
ment in hierarchical terms from bottom to top by Darwinian natural selection as well as from top 
to bottom by Lamarkian self-referenced manipulation. Thus, our finding that indeed all genome 
architecture/dynamic levels are tightly entangled with each other also immediately resolves the 
falsely assumed paradoxes between Darwinian and Lamarckian evolution by uniting them at least 
on the genome level. This is remarkable not only in historic terms considering the even politi-
cally and religiously extremely hot debates/fights about "man evolving from apes" as well as the 
"intentionally planed long neck of giraffes", but also heuristically, since the in principle relatively 
simple final completion of the 3D genome architecture/dynamics at the limit of the resolution leads 
not only to a consistent 3D genome organization and statistical systems genome mechanics, but 
beyond reveals in one go some and perhaps the most important fundamentals of life (Figure 5).
Beyond, this strong entanglement over several orders of magnitude (Figures 1, 2) within the 
genome, the described genotype-phenotype-entanglement can be driven conceptually even fur-
ther considering the influence of both the a) hierarchically constituting elements giving rise to 
the system, i.e. chemical molecular base, atomic, and subatomic units, which will be called here 
i(!)nvironment, and b) the hierarchical higher levels, i.e. tissues, organs, animal etc., which are the 
environment. Although this may seem far fetched, but influences from both "directions" are well 
known (see e.g. Section 3), although due to their complexity this is often hard to track down in 
a reductionistic manner, thus hence their degree of influence is just emerging. In this respect the 
found entanglements bridging so many multi-scale levels and orders of magnitude in space and 
time, are on the one hand already astonishing in terms of the obviously wrong assumption that 
such influences would die-off very fast, while on the other hand this has general implications for 
all hierarchic systems showing that complex inter-, cross-, and even multi-cross-level influences 
are much more frequent and far reaching. Actually, the here shown multilistic genotype-pheno-
type entanglement shows a highly interwoven, networked, and recursive structure: instead of 
more or less separate hierarchic layers where only first or at the most secondary neighbour layers 
are connected, there are also influential connections to more distant layers at least locally if not 
in every part of the layer space. Thus, the genotype-phenotype entanglement embedded within 
an i(!)n- and environment actually results in a genome ecology in direct analogy to e.g. human 
ecology, autopoieses of social systems, or just any kind of systems theoretic entity [77–82].
6. Conclusion
Nature has created ever more complex forms of life by creating structural and dynamical islands 
of systems with specialized organelles such as genomes being responsible for storage, access, 
and replication of the information for their persistence and development. Despite the epic quest 
to determine the details and origin of inheritance, only recently we were finally able to fill the 
debated gaps of the central part of genome architecture and dynamics - despite the pioneering 
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works of the last 170 years - by establishing that nucleosomes compact into a quasi-fibre which 
is folded into stable loops, forming stable multi-loop aggregates/rosettes connected by linkers 
creating chromosome arms and entire chromosomes [26, 27]. Although the heuristics of the 
field leads already to a sound basis, this could only be achieved - as we summarized here - by 
a highly integrated systems approach linking holistically i) a by far superior selective chromo-
some interaction (T2C) technique, ii) a novel in vivo FCS dynamic method, iii) a novel analytical 
approach and improved super-computer simulations, and iv) finally scaling analysis of the 
3D-architecture and the DNA sequence itself. Including the heuristics of the field this leads to 
a consistent picture of genome organization, which match all the criteria necessary for storage, 
transcription, and replication as one would expect them as the outcome of Darwinian natural 
selection and Lamarkian self-referenced manipulation as shown here. In parallel, a multilis-
tic systems statistical mechanics with uncertainty principles has emerged while reaching the 
fundamental resolution limits in the above holistic approach, which represents a theoretical 
framework which also reunites the overall far from thermodynamic equilibrium notion with 
local hierarchic substance stability. Beyond, the tight entanglement of genome levels having 
left footprints on all levels, has not only shown that genomes have evolved as an entire system, 
but also the multilistic entanglement between genotype and phenotype. Hence, the natural out-
come of Darwinian natural selection and Lamarkian self-referenced manipulation is united in a 
genome ecology framework, which we consider a major step in the systems theory of life. Thus, 
this not only leads to a solid basis for sequencing genetic information holistically and thus for 
applied diagnostics and treatment of disease, as well as future genome manipulation and engi-
neering efforts, but more importantly paves the path to a true understanding of genomes, their 
function and evolution, and thus of life in general - earthbound, extra-terrestrial, or artificial.
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Legends Movie 1 and 2
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Movie 1. Brownian Dynamics simulated decondensation from a metaphase starting configu-
ration of a simulated Multi-Loop-Subcompartment model with 126 kbp loops and linkers with 
segment length of 50 nm (~5.2 kb) [26]. The whole 750 ms long movie shows how abruptly 
the metaphase chromosome expands due to its high density while opening the linker, which 
is constrained/condensed/pulled into a loop in metaphase. Nevertheless, the rosettes form 
distinct chromatin territories in which the loops do not intermingle freely in contrast to other 
models (see Introduction) such as the RW/GL model (Figure 2). The final shape and form in a 
whole nucleus would be determined by the limitations the other adjacent chromosomes pro-
vide (for more details see [22]). The different densities during decondensation also resemble 
nicely the conditions of shorter linkers, general genome regions with higher densities, or also 
the variation of nuclear volumes. Notably, the intrinsic movement of the chromatin fibre is 
clearly taking place on the millisecond scale, and hence, obviously a topological preformed 
architecture would dissolve within seconds if it would not be stable [26, 27].
Movie 2. Brownian Dynamics simulation of the consensus architecture (i.e. with the real 
measured loop and linker sizes) of the of the IGF/H19 region at HS11p15.5–15.4 (Figure 3), 
with a segment length of 20 nm (~2.0 kbp; colours of loops like in Figure 3 middle, with addi-
tional linkers at the beginning and end of the region in red; for details see [26]). The whole 
movie encompasses 146 ms and shows the high intrinsic dynamics of the loops and the loop 
aggregate/rosette. Obviously, the single subchromosomal domains are constrained by the 
subsequent subchromosomal domains. Hence, and also obviously a topological preformed 
architecture would dissolve within seconds if it would not be stable [26, 27]. Nevertheless, the 
loop aggregates/rosettes form distinct subchromosomal domains in which the loops do not 
intermingle freely in contrast to other models (see Introduction) such as the RW/GL model 
(Figure 2). The final shape and form in a whole nucleus would be determined by the limita-
tions adjacent chromosomes provide (for more details see [22]).
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Abstract
Plasmodium spp. and Toxoplasma gondii present a conserved nucleosome composition 
based on canonical H3 and variants, H4, canonical H2A and variants, and H2B. One-off, 
the phylum has also a variant H2B, named H2B.Z, which was shown to form a double 
variant nucleosome H2A.Z/H2B.Z. These histones also present conserved and unique 
post-translational modifications (PTMs). Histone variants have shown particular genomic 
localization and PTMs along euchromatin and heterochromatin, including telomere-
associated sequences (TAS), suggesting fine-grained chromatin structure modulation. 
Several other nonhistone proteins present remarkable participation in controlling chro-
matin state, especially at TAS. Based on that, we discuss the role of epigenetics (PTMs 
and histone variants) in Plasmodium and Toxoplasma gene expression, replication, and 
DNA repair. We also discuss TAS structures and chromatin composition and its impact 
on antigenic variant expression in Plasmodium.
Keywords: Plasmodium, Toxoplasma, epigenetics, histone variants, H2B.Z, chromatin, 
antigenic variation, telomere-associated region
1. Introduction
Apicomplexa is a large phylum of unicellular obligate intracellular protozoan parasites respon-
sible for a range of human and animal diseases with considerable medical and economic impact 
worldwide [1]. The phylum comprises several well-known genera such as Cryptosporidium, 
Eimeria, Babesia, and Theileria, but the most studied genera are Plasmodium and Toxoplasma.
Plasmodium genus is comprised by several species of which five infect humans: P. falciparum, 
P. ovale, P. malariae, P. vivax, and P. knowlesi. The infection due to Plasmodium genus is known 
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as Malaria, a mosquito-borne infectious disease endemic in the tropical and subtropical zones 
of Asia, Africa, South, and Central America. Malaria also constitutes a serious problem for 
travelers as well as for people working in endemic regions. In 2016, an infection rate of 216 
million cases was reported, causing some 445,000 deaths globally. Data show a stalling in 
declining burden of Plasmodium observed over the last decade (http://apps.who.int/iris/bits
tream/10665/259492/1/9789241565523-eng.pdf?ua=1). In addition, the mass drug adminis-
tration program has shown a limit due to the spreading of multidrug-resistant malaria [2]. 
The severe disease is mainly caused by P. falciparum, whereas P. vivax causes the majority 
of malaria morbidity outside Africa. The clinical manifestations of malaria include fever, 
shivering, arthralgia (joint pain), vomiting, jaundice, hemoglobinuria, convulsions, metabolic 
alterations, renal failure, liver and lung dysfunctions, anemia, and cerebral malaria (coma).
Toxoplasma gondii is the only one species of the Toxoplasma genus, and it is able to infect birds 
and mammals, including human, and cause toxoplasmosis. The infection occurs worldwide 
and the chronic stage reaches more than 500 million people [3]. During the first few weeks 
of infection, toxoplasmosis is either asymptomatic or causes a mild flu-like illness. However, 
those with a weakened immune system, such as AIDS patients, infected fetus during ges-
tation or newborns with a congenital infection, may become seriously ill, and occasionally 
die. The parasite can cause encephalitis (inflammation of the brain) and neurologic diseases, 
and can affect the heart, liver, inner ears, and eyes (chorioretinitis). Recent research has also 
linked toxoplasmosis with neuropsychiatric symptoms such as attention-deficit hyperactiv-
ity disorder, obsessive compulsive disorder, bipolar disease, and schizophrenia [4–8]. The 
present chemotherapy for toxoplasmosis is efficient but, sometimes, it is not well tolerated by 
individuals with AIDS, and it is effective against the acute or active stage, but not against the 
chronic/latent stage.
2. Genome and nucleus
Both Plasmodium protozoan parasites and T. gondii present a highly complex life cycle, involv-
ing several stages along the cycle (Figure 1). The genome sizes are 23.3 Mb for Plasmodium and 
80 Mb for Toxoplasma, being haploid (1 N) almost all their life cycle but diploid during sexual 
replicative stages (2 N) (Figure 1). Plasmodium genus and T. gondii were the first apicomplexan 
parasites to be included in genome projects [9, 10]. Since then, several other apicomplexan 
parasites genome projects were taken forward and the data uploaded at EuPathDB (https://
eupathdb.org/eupathdb/). From these databases, it could be observed that T. gondii and P. fal-
ciparum present about 5300 (https://protists.ensembl.org/Plasmodium_falciparum/Info/Index) 
and 8172 (http://protists.ensembl.org/Toxoplasma_gondii/Info/Annotation/#assembly) gene 
transcripts, respectively, organized as single copy genes along the chromosomes, and in gen-
eral, they are not clustered by function, pathway, or stage of expression. All of these data 
suggest that these genes are finely regulated throughout the cell cycle and the life cycle by 
transcriptional regulators and chromatin. Regarding transcription factors, they are poorly 
represented in apicomplexan, with only one large family of transcriptional regulators, with 
24 AP2 family factors in P. falciparum and 68 in T. gondii [11, 12]. In this context, epigenetic 
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control was proposed as a key element to facilitate parasite gene expression, DNA replication, 
and DNA repair [13–15].
An interesting aspect of apicomplexan parasites is that they never lose the nuclear envelope 
during cell division, and their chromosomes do not present the higher order level of condensa-
tion observed in metaphase chromosomes of higher eukaryotes [16]. So, the nucleus presents 
Figure 1. (A) Life cycles of T. gondii and P. falciparum. Haploid and diploid DNA content is referred to as 1 and 
2 N. Black arrows and letters represent common parasite stages, blue arrows and letters represent T. gondii specific 
stages, and red arrows and letters represent P. falciparum-specific stages. (B) Epichromatin labeling in T. gondii. 
Epichromatin is a conformational epitope formed by DNA and histones H2A and H2B localized only at the exterior 
chromatin surface. During tachyzoite replication, the 2 N nucleus is divided, entering one genome to each budding cell, 
forming a typical U shape. The nuclear envelope does not disappear, and chromosomes do not present high level of 
condensation. Epichromatin labels predominantly one side of the nucleus, suggesting a nonhomogeneous organization 
of chromosomes and nuclear envelope interaction. IMC1: inner membrane complex 1.
Apicomplexa and Histone Variants: What’s New?
http://dx.doi.org/10.5772/intechopen.81409
97
as Malaria, a mosquito-borne infectious disease endemic in the tropical and subtropical zones 
of Asia, Africa, South, and Central America. Malaria also constitutes a serious problem for 
travelers as well as for people working in endemic regions. In 2016, an infection rate of 216 
million cases was reported, causing some 445,000 deaths globally. Data show a stalling in 
declining burden of Plasmodium observed over the last decade (http://apps.who.int/iris/bits
tream/10665/259492/1/9789241565523-eng.pdf?ua=1). In addition, the mass drug adminis-
tration program has shown a limit due to the spreading of multidrug-resistant malaria [2]. 
The severe disease is mainly caused by P. falciparum, whereas P. vivax causes the majority 
of malaria morbidity outside Africa. The clinical manifestations of malaria include fever, 
shivering, arthralgia (joint pain), vomiting, jaundice, hemoglobinuria, convulsions, metabolic 
alterations, renal failure, liver and lung dysfunctions, anemia, and cerebral malaria (coma).
Toxoplasma gondii is the only one species of the Toxoplasma genus, and it is able to infect birds 
and mammals, including human, and cause toxoplasmosis. The infection occurs worldwide 
and the chronic stage reaches more than 500 million people [3]. During the first few weeks 
of infection, toxoplasmosis is either asymptomatic or causes a mild flu-like illness. However, 
those with a weakened immune system, such as AIDS patients, infected fetus during ges-
tation or newborns with a congenital infection, may become seriously ill, and occasionally 
die. The parasite can cause encephalitis (inflammation of the brain) and neurologic diseases, 
and can affect the heart, liver, inner ears, and eyes (chorioretinitis). Recent research has also 
linked toxoplasmosis with neuropsychiatric symptoms such as attention-deficit hyperactiv-
ity disorder, obsessive compulsive disorder, bipolar disease, and schizophrenia [4–8]. The 
present chemotherapy for toxoplasmosis is efficient but, sometimes, it is not well tolerated by 
individuals with AIDS, and it is effective against the acute or active stage, but not against the 
chronic/latent stage.
2. Genome and nucleus
Both Plasmodium protozoan parasites and T. gondii present a highly complex life cycle, involv-
ing several stages along the cycle (Figure 1). The genome sizes are 23.3 Mb for Plasmodium and 
80 Mb for Toxoplasma, being haploid (1 N) almost all their life cycle but diploid during sexual 
replicative stages (2 N) (Figure 1). Plasmodium genus and T. gondii were the first apicomplexan 
parasites to be included in genome projects [9, 10]. Since then, several other apicomplexan 
parasites genome projects were taken forward and the data uploaded at EuPathDB (https://
eupathdb.org/eupathdb/). From these databases, it could be observed that T. gondii and P. fal-
ciparum present about 5300 (https://protists.ensembl.org/Plasmodium_falciparum/Info/Index) 
and 8172 (http://protists.ensembl.org/Toxoplasma_gondii/Info/Annotation/#assembly) gene 
transcripts, respectively, organized as single copy genes along the chromosomes, and in gen-
eral, they are not clustered by function, pathway, or stage of expression. All of these data 
suggest that these genes are finely regulated throughout the cell cycle and the life cycle by 
transcriptional regulators and chromatin. Regarding transcription factors, they are poorly 
represented in apicomplexan, with only one large family of transcriptional regulators, with 
24 AP2 family factors in P. falciparum and 68 in T. gondii [11, 12]. In this context, epigenetic 
Chromatin and Epigenetics96
control was proposed as a key element to facilitate parasite gene expression, DNA replication, 
and DNA repair [13–15].
An interesting aspect of apicomplexan parasites is that they never lose the nuclear envelope 
during cell division, and their chromosomes do not present the higher order level of condensa-
tion observed in metaphase chromosomes of higher eukaryotes [16]. So, the nucleus presents 
Figure 1. (A) Life cycles of T. gondii and P. falciparum. Haploid and diploid DNA content is referred to as 1 and 
2 N. Black arrows and letters represent common parasite stages, blue arrows and letters represent T. gondii specific 
stages, and red arrows and letters represent P. falciparum-specific stages. (B) Epichromatin labeling in T. gondii. 
Epichromatin is a conformational epitope formed by DNA and histones H2A and H2B localized only at the exterior 
chromatin surface. During tachyzoite replication, the 2 N nucleus is divided, entering one genome to each budding cell, 
forming a typical U shape. The nuclear envelope does not disappear, and chromosomes do not present high level of 
condensation. Epichromatin labels predominantly one side of the nucleus, suggesting a nonhomogeneous organization 
of chromosomes and nuclear envelope interaction. IMC1: inner membrane complex 1.
Apicomplexa and Histone Variants: What’s New?
http://dx.doi.org/10.5772/intechopen.81409
97
the same aspect along the cell cycle. However, it seems to be not homogenous: Toxoplasma 
gondii nuclear envelope and chromosomes seem to have a dynamic relocalization and/or rota-
tion inside the nucleus during parasite budding as observed by epichromatin localization 
(Figure 1B). Epichromatin is a conformational epitope formed by DNA and histones H2A and 
H2B localized only at the exterior chromatin surface [17, 18]. More recently, it was observed 
that epichromatin forms superbead domains associated to DNA-A at the nuclear envelope 
[19]. A 3D analysis also shows that P. falciparum nucleus presents a polarization of the nuclear 
pore complex: in the early multinucleated schizont, it clusters in the nucleus region facing the 
mother plasma membrane, whereas in the late stages, when prepared for budding, it clusters 
toward the cytoplasm of the incipient merozoite [20].
In addition to putative polarization of the genome inside the nucleus of Apicomplexan para-
sites, in T. gondii, it was observed that the centromeres (CenH3, see below) are localized at a 
single spot at the apical region of the nucleus, indicating that all of them are attached to the 
centrocone, a structure associated to the nuclear envelope, which is traversed by microtubules 
coordinating the cell division [21]. Similarly, Chromo1, a T. gondii protein that binds to the 
telomere, presents a focalized localization in the nucleus, also suggesting a certain degree of 
chromosome organization within the parasite nucleus [22]. In P. falciparum prior to replica-
tion, in late ring stages and young trophozoites, CenH3 localizes to a single nuclear focus 
suggesting that centromeres are clustered in a single spot that most likely continues to be 
attached to the mitotic spindle until the end of schizogony and the intraerythrocytic develop-
mental cycle, similar to that observed in T. gondii [23].
3. H3 histones: a multivariant family
H3 histone family presents canonical forms: H3, H3.1, H3.2 and variants: H3.3 and cenH3 
[24]. H3.3 differs from canonical H3s in various aspects. Canonical H3s are expressed and 
associate to chromatin during the S-phase of cell cycle. Canonical H3s and H3.3 are highly 
identical differing in only four to five amino acids. The CAF-1 complex is involved in the 
incorporation of canonical H3s whereas CHD1/ATRX remodelers as well as HIRA chaperone 
complex are involved in the incorporation of H3.3 [25–30]. In addition, H3.3 is enriched in 
transcribed genes, enhancers, regulatory elements, and also heterochromatic repeats, includ-
ing telomeres and pericentromeric regions [31–34]. In general, H3.3 is linked to gene activa-
tion or open chromatin. Moreover, it has been found to be methylated at K4, K36, and K79 and 
acetylated at K9 and K14, all being marks of active chromatin [32, 35]. H3.3 and H2A.Z were 
detected at active promoters generating nucleosomes that promote gene transcription [36–38]. 
Recently, it was found that H3.3 plays an essential biological role during mammal develop-
ment since mice that lack H3.3 presented developmental retardation and early embryonic 
lethality [39]. Rather than gene expression troubles, H3.3 depletion causes genome instability 
due to dysfunction of heterochromatin structures at telomeres, centromeres, and pericentro-
meric regions of chromosomes, leading to mitotic defects.
There is little information regarding H3 histone family and the variants H3.3 in Apicomplexan 
parasites. The first approach is from W.J Sullivan [40] who was able to clone the entire ORFs 
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encoding H3 and H3.3 in Toxoplasma gondii and also in Plasmodium falciparum. In this work, it 
was confirmed that, like in most other organisms, there is not much difference between the 
two variants: only four amino acids in T. gondii and eight between the P. falciparum variants. In 
most other species, the critical residues that differ between H3 and H3.3, resulting in different 
roles of these histones, are a motif, which contains SAVM in H3 canonical histone, but changes 
to AAIG in H3.3 [24]. However, while PfH3 has the typical SAVM motif, it changes to QAVL 
in PfH3.3, whereas in TgH3, the motif is SAVL and changes to QAIL in TgH3.3 [40]. Besides, 
there is another difference in Apicomplexa, which seems to be exclusive: KF changes for RY 
at position 54–55 in H3.3 [40].
In Plasmodium, H3.3 had a similar expression pattern to another important histone variant, 
H2A.Z, namely localization to active chromatin [41] (see Figure 2). As observed in other 
eukaryotic cells, it has been recently demonstrated by ChiP-seq experiments that euchro-
matic regions in the genome are demarcated by the presence of the H3.3 variant histone [42]. 
However, in P. falciparum, there is a particular AT versus GC content along the genome with 
euchromatic intergenic regions richer in AT-content compared to coding sequences with less 
AT content [23]. Fraschka et al. [42] have seen a particular correlation between enrichment in 
PfH3.3 histone variant and GC content, with this variant mainly located not only in euchro-
matic GC-rich sequences, but also in subtelomeric GC-rich repetitive regions. Interestingly, 
this correlation with the nucleotide composition is also observed with the double-variant 
nucleosome H2A.Z-H2B.Z (see below), but in this case, it is just the contrary: the regions 
with more AT content show abundance of this nucleosome [42]. However, GC-poor intergenic 
regions show the lowest H3.3 coverage, but the authors still argue that the incorporation of 
this variant to coding regions is more dependent on GC content than transcriptional activity.
It is well documented that P. falciparum depends on the var multigene family, encoding for 
a highly variable cytoadherence protein called P. falciparum erythrocyte membrane protein 1 
(PfEMP1) to avoid host immunity [43–46]. This is due to the expression of only one of the ~60 
var gene family members in any given parasite.
Regarding this important gene family, H3.3 stably occupies the promoter region and coding 
sequence of the active var gene but is evidently less incorporated into the promoter and cod-
ing sequence of silenced var genes [42] (see Figure 3). Additionally, it has been demonstrated 
that the PTMs affecting histone H3 are extremely important in the regulation of var expres-
sion. Data from fluorescence in situ hybridization (FISH) suggest that the P. falciparum SETvs 
(P. falciparum variant-silencing SET gene), which encodes an ortholog of Drosophila melanogaster 
ASH1 and controls histone H3 lysine 36 trimethylation (H3K36me3) on var genes, is specifi-
cally involved in var gene silencing, and its knock-out results in the transcription of virtually 
all var genes in the single parasite nuclei [47]. Besides, ChIP-qPCR analysis showed that the 
TSS occupancy of H3K36me3 is considerably higher in the silent var genes compared to the 
active one (see Figure 3) [47].
A detailed mass spectrometry study has been accomplished for P. falciparum histone PTMs 
by Trelle et al. [48], and it has been established that lysines 4, 9, 14, 18, 23, and 27 of both H3 
and H3.3 are capable of being modified by acetylations and/or methylations. Also, arginine 
in position 17 may be mono or bimethylated. Some of these modifications had already been 
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sites, in T. gondii, it was observed that the centromeres (CenH3, see below) are localized at a 
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coordinating the cell division [21]. Similarly, Chromo1, a T. gondii protein that binds to the 
telomere, presents a focalized localization in the nucleus, also suggesting a certain degree of 
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3. H3 histones: a multivariant family
H3 histone family presents canonical forms: H3, H3.1, H3.2 and variants: H3.3 and cenH3 
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tion or open chromatin. Moreover, it has been found to be methylated at K4, K36, and K79 and 
acetylated at K9 and K14, all being marks of active chromatin [32, 35]. H3.3 and H2A.Z were 
detected at active promoters generating nucleosomes that promote gene transcription [36–38]. 
Recently, it was found that H3.3 plays an essential biological role during mammal develop-
ment since mice that lack H3.3 presented developmental retardation and early embryonic 
lethality [39]. Rather than gene expression troubles, H3.3 depletion causes genome instability 
due to dysfunction of heterochromatin structures at telomeres, centromeres, and pericentro-
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encoding H3 and H3.3 in Toxoplasma gondii and also in Plasmodium falciparum. In this work, it 
was confirmed that, like in most other organisms, there is not much difference between the 
two variants: only four amino acids in T. gondii and eight between the P. falciparum variants. In 
most other species, the critical residues that differ between H3 and H3.3, resulting in different 
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with more AT content show abundance of this nucleosome [42]. However, GC-poor intergenic 
regions show the lowest H3.3 coverage, but the authors still argue that the incorporation of 
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ing sequence of silenced var genes [42] (see Figure 3). Additionally, it has been demonstrated 
that the PTMs affecting histone H3 are extremely important in the regulation of var expres-
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(P. falciparum variant-silencing SET gene), which encodes an ortholog of Drosophila melanogaster 
ASH1 and controls histone H3 lysine 36 trimethylation (H3K36me3) on var genes, is specifi-
cally involved in var gene silencing, and its knock-out results in the transcription of virtually 
all var genes in the single parasite nuclei [47]. Besides, ChIP-qPCR analysis showed that the 
TSS occupancy of H3K36me3 is considerably higher in the silent var genes compared to the 
active one (see Figure 3) [47].
A detailed mass spectrometry study has been accomplished for P. falciparum histone PTMs 
by Trelle et al. [48], and it has been established that lysines 4, 9, 14, 18, 23, and 27 of both H3 
and H3.3 are capable of being modified by acetylations and/or methylations. Also, arginine 
in position 17 may be mono or bimethylated. Some of these modifications had already been 
Apicomplexa and Histone Variants: What’s New?
http://dx.doi.org/10.5772/intechopen.81409
99
identified for H3 and H3.3 also by Miao et al. [41]. More recently, a lysine residue in the 
core of H3, K56, was also indicated as a site of acetylation [49, 50]. In the same way, T. gondii 
histone H3 has many lysines and also arginines capable of being modified: lysines in the posi-
tions 4, 9, 14, 23, 27 and also 36, 37, 56, 115 and 122 can be acetylated, methylated and besides 
some of them receive formylation, ubiquitination, or succinylation [51]. Besides, arginines 2, 
17, 26, 40, and 83 can be methylated [51].
But not only acetylations and methylations are marking histones; with the development of 
improved acid and high-salt purification methods for P. falciparum histone phosphoprotein 
analysis, multiple phosphorylation sites have been found mostly at the N-terminal region of 
Figure 2. (A) Schematic model for double-variant nucleosome in T. gondii and P. falciparum. Hypothetical active (or 
poised) and silenced genes are represented with the nucleosome composition in each promoter and also downstream 
the genes. PTM marks are represented as well and listed below with the differences found in the literature between both 
the parasites. Specific HATs and HDACs are speculated to acetylate/deacetylate the unique H2B.Z histone variant. (B) 
Sequence alignment of histone variant H2B.Z in Apicomplexa. Pf: Plasmodium falciparum, Tg: Toxoplasma gondii, Et: 
Eimeria tenella, Vb: Vitrella brassicaformis, Bv: Babesia bovis, Cf: Cytauxzoon felis, Gn: Gregarina niphandrodes and 
Cp: Cryptosporidium parvum. All sequences can be found in EuPathDB (https://eupathdb.org/eupathdb/).
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most histones, including H3 and H3.3 [52]. These marks are frequently seen in combination 
with neighboring lysine acetylation (and methylation). In this work, they also described a 
Pf14-3-3 as a phosphohistone mark binding protein.
In parasites, among the most conserved modifications is histone 3 trimethylation of lysine 4 
(H3K4me3), a marker of potentially active promoters. Opposed to that is H3K9 methylation, 
associated with silent genes and densely packed heterochromatin, although protozoan parasite 
histones are more highly enriched in the activation marks associated with euchromatin with 
Figure 3. Hypothetical telomeric and subtelomeric structure in T. gondii (upper panel) and P. falciparum (lower panel). 
Here, we show the TgTAS and PfTAS composition and the possible protein interactors listed in Table 1 and described 
in Section 6. In P. falciparum, we only illustrate three of the six TAREs associated. The punctuated lines define proteins 
described in other organisms, but some of them present an ortholog in any of those parasites. The proteins represented in 
continuous lines have already been described for those parasites. Proteins illustrated in grey are unknown proteins. We 
also show the possible histone variant exchange on silenced or active tsf or var genes. Specific PTMs on silenced or active 
genes are described in the figure. The questions are open because these proteins and PTMs have not been confirmed yet 
in these TAS regions.
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lower abundance of histone modifications associated with heterochromatin [53]. However, it 
has been shown that the epigenome in P. falciparum is highly dynamic, and dependent on the 
stage, and, for example, H3K4me3 and H3K9ac are cycle regulated at P. falciparum genes [49]. 
This could also probably be true for T. gondii, where the tachyzoite to bradyzoite conversion 
is regulated at an epigenetic level. In this sense, it has been speculated that the H3R17me2 
mark may have significance during the tachyzoite to bradyzoite differentiation process, as it 
was found only restricted to a subset of promoters, and taking into account the importance 
of arginine methylation during early development of mouse embryo [54]. In this study, using 
ChIP-on-chip technique, they found that H3K9ac, H4ac, and H3K4me3 modifications co-
localize at focused loci in the T. gondii genome and correlate with significant gene expression, 
while the H3K4me1 and the H3K4me2 modifications were found at equal amounts in active 
and inactive chromatin [54].
4. Centromeric H3
CenH3, the centromere-specific H3, has been observed in animals, fungi, and plants [24] and 
also in Apicomplexa, including T. gondii, Plasmodium spp., and N. caninum [55]. This fact was 
recently confirmed by Fraschka et al. [42] who found the centromeres depleted of PfH3.3 and 
PfH3, but occupied by PfCenH3. In T. gondii, this histone variant was characterized with the 
aim to understand the way in which chromosomes are delivered to the daughter cells after 
mitosis, a process that is still intriguing [21]. In this work, the authors labeled all the histone 
H3 variants, and used TgCenH3 as a marker of centromeres, to perform ChIP and microarray 
assays [21]. They found a particular combination of histone PTMs surrounding centromeres; 
this region had a huge concentration of H3K9 di- and trimethylation, marks usually associ-
ated to heterochromatin and found in subtelomeric regions in P. falciparum but not in T. gondii. 
In this parasite, these modifications concentrate in two peaks directly flanking the center of 
the centromere in each chromosome, while H3K4me3 or H3K9ac are not present [21, 52]. In 
contrast, H3K9me3 and heterochromatin protein 1 (HP1, chromodomain protein that binds 
to H3K9me3) were not associated with centromeres in P. falciparum [23], but rather found in 
islands of the genome that contain transcriptionally silent members of multigene families [56]. 
In this parasite, the enrichment of PfCenH3 on centromeres of all the chromosomes has also 
been demonstrated by genome-wide ChIP-seq analysis [23]. Besides, it has been character-
ized that a region within the carboxy-terminal histone fold domain, which is also named 
CENP-A targeting domain (CATD), is essential for mediating centromere targeting, while the 
N-terminus is not [57].
5. H2A.Z-H2B.Z: the double variant nucleosome
H2A family also has a canonical H2A and several variants: H2A.Z, H2A.X, both exchange-
able by H2A.Z-H2B or H2A.X-H2B, allowing the modulation of gene transcription, DNA 
replication, and/or DNA damage repair [58, 59]. In vertebrates, the H2A family has two more 
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variants: H2Abd and macro-H2A. When talking about H2A-H2B and the incorporation of 
variants into such nucleosomes, there are vast differences if we take a glance at Apicomplexan 
parasites compared to most other eukaryotes. One of the most surprising discoveries in these 
parasites was the presence of a novel H2B variant (formerly named H2Bv, but recently reclas-
sified as H2B.Z [60]), a histone, which is known to be deficient in variants, similar to H4 [58, 
61]. Variants of this histone family, though, are not only found in these parasites, but also in 
Trypanosomatids (even though they are not evolutionary related), and some rare testis-specific 
variants in human and other mammalian species (reviewed in [55]).
Different studies performed in Toxoplasma have shown a nucleosome composition in which 
H2A.Z, but not H2A.X, dimerizes with H2B.Z, while H2A.X dimerizes with canonical H2B 
(H2Ba in T. gondii), but never with H2B.Z [62, 63]. This fact is also seen in P. falciparum, 
although this parasite lacks H2A.X variant [41] and has driven the hypothesis of a new double 
variant nucleosome exclusive of parasites with particular characteristics that will be described 
in this section [64, 65] (Figure 2A). As it can be observed in the sequence alignment of H2B.Z 
in many Apicomplexan species, this histone variant is quite conserved (Figure 2B), suggest-
ing that this histone, and likely the double variant nucleosome H2A.Z-H2B.Z, may have had 
an important role in the expansion of the phylum.
Since H2B.Z is not represented in yeast, insects, or mammals, almost all the current knowledge 
about the double-variant nucleosome relies on H2A.Z studies. H2A.Z is so widespread that has 
been catalogued as “universal” because of its origin before the divergence of eukaryotes [66]. 
The first observation that appears is the hyperacetylation of its N-terminal tail in most species 
[48–50, 67–69]. It is thought that this possibility gives H2A.Z the faculty of mediating respon-
siveness to the environmental changes, with so varied and seemingly contradictory effects 
as gene activation, heterochromatic silencing, transcriptional memory, and others, depend-
ing on the binding of activating or repressive complexes [66]. H2A.Z containing nucleosomes 
mark active and bivalent promoters as well as enhancers, correlating with open chromatin [70, 
71]. However, acetylation of H2A.Z is necessary for gene induction and is most often associ-
ated with active gene transcription [67, 68, 70, 71], whereas ubiquitylation, which can occur 
at the C-terminal tail, is linked to transcriptional repression and polycomb silencing [72–75]. 
Acetylated H2A.Z composes nucleosomes flanking the nucleosome-depleted regions [76]. 
Regulation of gene expression by acetylation of H2A.Z histone tail may be a result of the par-
ticipation of other proteins as “readers” in the histone code; for example, the SWR-C chromatin 
remodeling enzyme and related INO80 family are well characterized to catalyze chromatin 
incorporation of the histone variant from yeast to human, and the acetylation of histone H3 on 
lysine 56 (H3-K56Ac) was said to lead to promiscuous dimer exchange in which either H2A.Z 
or H2A can be exchanged from nucleosomes, although this is in discussion [77–82]. NuA4 
acetylation activity, which is homologous to the TIP60/p400 complex, was found to be associ-
ated with SWR1-driven incorporation of H2A.Z into chromatin [83]. Besides, bromodomain-
containing proteins are known to be implicated in “reading” the acetylation patterns of H2A.Z: 
acetylated lysines in histones, and other proteins are recognized by this motif, common in 
remodelers [77, 78, 84, 85]. In fact, for SWR1, bromodomains have been studied to recognize a 
pattern of acetylation (including H3K14ac), which may influence the deposition of H2A.Z-H2B 
variant dimers into the appropriate nucleosome [77, 78]. By using Tetrahymena as a model, it 
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lower abundance of histone modifications associated with heterochromatin [53]. However, it 
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is regulated at an epigenetic level. In this sense, it has been speculated that the H3R17me2 
mark may have significance during the tachyzoite to bradyzoite differentiation process, as it 
was found only restricted to a subset of promoters, and taking into account the importance 
of arginine methylation during early development of mouse embryo [54]. In this study, using 
ChIP-on-chip technique, they found that H3K9ac, H4ac, and H3K4me3 modifications co-
localize at focused loci in the T. gondii genome and correlate with significant gene expression, 
while the H3K4me1 and the H3K4me2 modifications were found at equal amounts in active 
and inactive chromatin [54].
4. Centromeric H3
CenH3, the centromere-specific H3, has been observed in animals, fungi, and plants [24] and 
also in Apicomplexa, including T. gondii, Plasmodium spp., and N. caninum [55]. This fact was 
recently confirmed by Fraschka et al. [42] who found the centromeres depleted of PfH3.3 and 
PfH3, but occupied by PfCenH3. In T. gondii, this histone variant was characterized with the 
aim to understand the way in which chromosomes are delivered to the daughter cells after 
mitosis, a process that is still intriguing [21]. In this work, the authors labeled all the histone 
H3 variants, and used TgCenH3 as a marker of centromeres, to perform ChIP and microarray 
assays [21]. They found a particular combination of histone PTMs surrounding centromeres; 
this region had a huge concentration of H3K9 di- and trimethylation, marks usually associ-
ated to heterochromatin and found in subtelomeric regions in P. falciparum but not in T. gondii. 
In this parasite, these modifications concentrate in two peaks directly flanking the center of 
the centromere in each chromosome, while H3K4me3 or H3K9ac are not present [21, 52]. In 
contrast, H3K9me3 and heterochromatin protein 1 (HP1, chromodomain protein that binds 
to H3K9me3) were not associated with centromeres in P. falciparum [23], but rather found in 
islands of the genome that contain transcriptionally silent members of multigene families [56]. 
In this parasite, the enrichment of PfCenH3 on centromeres of all the chromosomes has also 
been demonstrated by genome-wide ChIP-seq analysis [23]. Besides, it has been character-
ized that a region within the carboxy-terminal histone fold domain, which is also named 
CENP-A targeting domain (CATD), is essential for mediating centromere targeting, while the 
N-terminus is not [57].
5. H2A.Z-H2B.Z: the double variant nucleosome
H2A family also has a canonical H2A and several variants: H2A.Z, H2A.X, both exchange-
able by H2A.Z-H2B or H2A.X-H2B, allowing the modulation of gene transcription, DNA 
replication, and/or DNA damage repair [58, 59]. In vertebrates, the H2A family has two more 
Chromatin and Epigenetics102
variants: H2Abd and macro-H2A. When talking about H2A-H2B and the incorporation of 
variants into such nucleosomes, there are vast differences if we take a glance at Apicomplexan 
parasites compared to most other eukaryotes. One of the most surprising discoveries in these 
parasites was the presence of a novel H2B variant (formerly named H2Bv, but recently reclas-
sified as H2B.Z [60]), a histone, which is known to be deficient in variants, similar to H4 [58, 
61]. Variants of this histone family, though, are not only found in these parasites, but also in 
Trypanosomatids (even though they are not evolutionary related), and some rare testis-specific 
variants in human and other mammalian species (reviewed in [55]).
Different studies performed in Toxoplasma have shown a nucleosome composition in which 
H2A.Z, but not H2A.X, dimerizes with H2B.Z, while H2A.X dimerizes with canonical H2B 
(H2Ba in T. gondii), but never with H2B.Z [62, 63]. This fact is also seen in P. falciparum, 
although this parasite lacks H2A.X variant [41] and has driven the hypothesis of a new double 
variant nucleosome exclusive of parasites with particular characteristics that will be described 
in this section [64, 65] (Figure 2A). As it can be observed in the sequence alignment of H2B.Z 
in many Apicomplexan species, this histone variant is quite conserved (Figure 2B), suggest-
ing that this histone, and likely the double variant nucleosome H2A.Z-H2B.Z, may have had 
an important role in the expansion of the phylum.
Since H2B.Z is not represented in yeast, insects, or mammals, almost all the current knowledge 
about the double-variant nucleosome relies on H2A.Z studies. H2A.Z is so widespread that has 
been catalogued as “universal” because of its origin before the divergence of eukaryotes [66]. 
The first observation that appears is the hyperacetylation of its N-terminal tail in most species 
[48–50, 67–69]. It is thought that this possibility gives H2A.Z the faculty of mediating respon-
siveness to the environmental changes, with so varied and seemingly contradictory effects 
as gene activation, heterochromatic silencing, transcriptional memory, and others, depend-
ing on the binding of activating or repressive complexes [66]. H2A.Z containing nucleosomes 
mark active and bivalent promoters as well as enhancers, correlating with open chromatin [70, 
71]. However, acetylation of H2A.Z is necessary for gene induction and is most often associ-
ated with active gene transcription [67, 68, 70, 71], whereas ubiquitylation, which can occur 
at the C-terminal tail, is linked to transcriptional repression and polycomb silencing [72–75]. 
Acetylated H2A.Z composes nucleosomes flanking the nucleosome-depleted regions [76]. 
Regulation of gene expression by acetylation of H2A.Z histone tail may be a result of the par-
ticipation of other proteins as “readers” in the histone code; for example, the SWR-C chromatin 
remodeling enzyme and related INO80 family are well characterized to catalyze chromatin 
incorporation of the histone variant from yeast to human, and the acetylation of histone H3 on 
lysine 56 (H3-K56Ac) was said to lead to promiscuous dimer exchange in which either H2A.Z 
or H2A can be exchanged from nucleosomes, although this is in discussion [77–82]. NuA4 
acetylation activity, which is homologous to the TIP60/p400 complex, was found to be associ-
ated with SWR1-driven incorporation of H2A.Z into chromatin [83]. Besides, bromodomain-
containing proteins are known to be implicated in “reading” the acetylation patterns of H2A.Z: 
acetylated lysines in histones, and other proteins are recognized by this motif, common in 
remodelers [77, 78, 84, 85]. In fact, for SWR1, bromodomains have been studied to recognize a 
pattern of acetylation (including H3K14ac), which may influence the deposition of H2A.Z-H2B 
variant dimers into the appropriate nucleosome [77, 78]. By using Tetrahymena as a model, it 
Apicomplexa and Histone Variants: What’s New?
http://dx.doi.org/10.5772/intechopen.81409
103
could be observed that these protozoa cannot survive with all acetylatable lysines replaced 
by arginines, indicating that H2A.Z acetylation modulates a charge patch with an essential 
function in chromatin regulation [69, 75]. Unlike the histone code, these changes need not to 
be site-specific. If this hypothesis is true, modulation of the charge at any one of a number of 
clustered sites could inhibit nucleosome condensation, facilitating transcription [86].
T. gondii H2A.Z, together with H2B.Z, was enriched in the promoters of active genes in tachyzo-
ites, while repressed genes were enriched with H2A.X-H2Ba nucleosomes [63] (Figure 2A). 
In addition, H2A.Z-H2B.Z was also recruited within the coding region of silent bradyzoite-
specific genes and within promoter regions but not coding regions of actively expressed genes 
[87]. It is tempting to speculate that the enrichment at active promoters or poised regions could 
be ruled by different PTM stages of these histone variants. In agreement with this, H2A.Z and 
H2B.Z have shown to be highly acetylated at the amino-terminal tail, in contrast to canonical 
H2A and H2B histones and the H2A.X variant [51]. Considering that H2A.Z has shown to be 
essential in regulating the changing gene expression program during differentiation [79–81, 
88–90], and recently, it was observed that overexpression of mutated version of H2A.Z, where 
all five potential acetylatable lysines on H2A.Z-GFP (K4, 7, 11, 13, and 15) were mutated to 
arginines, blocked myoblast differentiation through disruption of myoD expression [91], it 
may be that the H2B variant is involved in the T. gondii cell differentiation process as part of 
H2A.Z-H2B.Z nucleosome. Whether through a patch charge modulation and/or histone code 
remains an open question, considering that T. gondii presents several bromodomain-contain-
ing proteins that can recognize some of the acetylated lysine [92].
As stated above, the sequence alignment of H2B.Z in many Apicomplexan species reveals a 
high degree of conservation for this histone variant (Figure 2B). Interestingly, every lysine 
that has been proved to be acetylated in T. gondii and P. falciparum, H2B.Z was detected in the 
other Apicomplexan species, which is also true for H2A.Z [50, 53]. Maybe, the double-variant 
nucleosome is present in the phylum with same PTMs and similar biological role.
5.1. Double-variant nucleosome in var genes
In P. falciparum, H2A.Z-containing nucleosomes were proposed to demarcate intergenic/regu-
latory regions of the genome, serving as a scaffold for stage specific as well as transcription-
coupled recruitment of histone modifying enzymes [93]. H3K9ac and H3K4me3 were found 
preferentially placed/retained on or next to H2A.Z-containing nucleosomes [49]. However, 
it was observed that P. falciparum intergenic regions, including promoters, display a global 
nucleosome depletion, while telomeres harbored the highest nucleosomal occupancy, except 
for the var gene with the highest expression level, which again showed the lowest nucleoso-
mal occupancy [94]. Apparently, the little amount of nucleosomes in these areas is composed 
largely of variant nucleosomes. Petter et al. [95] also showed an enrichment of PfH2A.Z in 
the promoter of a set of developmentally regulated genes in the euchromatin compartment, 
although not correlated with transcription levels nor with acetylation status. P. falciparum 
H2A.Z-H2B.Z promoter occupancy in var genes was found to be strongly associated with 
transcriptional activity, whereas silent or poised var genes would be depleted of double-
variant nucleosome (see Figure 3) [65, 86]. The authors have speculated that it may function 
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as a similar physical switch to control gene expression in response to temperature change 
(for example, during fever or as P. falciparum is transmitted between its two hosts), as a ther-
mosensory response that was seen in Arabidopsis thaliana and yeast [96]. This could be due to 
reduced DNA wrapping of H2A.Z containing nucleosomes at higher temperatures, result-
ing in a relaxed chromatin structure, although this variant histone has also been associated 
with a tighter relationship with DNA, especially in heterotypic H2A.Z/H2A nucleosomes 
[97]. While heterochromatic intergenic regions showed to contain low levels of histone vari-
ant H2B.Z [64], it is interesting that double-variant nucleosomes are depleted from silent var 
gene promoters but not from silent promoters of heterochromatic invasion gene families, 
which have similar patterns of variegated expression [65]. Besides, this correlation between 
double-variant nucleosome presence and expression was only seen in var genes, while this 
nucleosome was also found enriched in intergenic regions across the genome, associated 
with euchromatic histone modifications and not necessarily associated with transcription [64, 
65, 86]. Moreover, long promoter containing intergenic regions that maintain higher variant 
histone levels as compared with 3’UTR containing regions, which are considerably shorter, 
presents higher AT content, so this correlation could simply be due to the minimal length 
of the AT-rich content in these short 3’UTR regions [64]. As it was previously observed for 
H3.3 variant histone (see Section 3), a correlation between nucleosome occupancy and GC/
AT content in the genome was observed, although contrary to H3.3 that was correlated with 
rich GC regions [42], here both H2B.Z and H2A.Z histone variant occupancy displayed a clear 
positive correlation toward genomic AT content [64]. In Figure 2A, a schematic representation 
of P. falciparum and T. gondii nucleosome occupancy is proposed.
6. Heterochromatin, telomeres, and subtelomeres
The telomere-associated sequences (TAS), also named subtelomeres, are heterochromatic 
regions adjacent to the telomeric-end looking toward the centromere. The telomeres and the 
TAS regions are the final structures at the chromosomes and integrate with the centromere 
the constitutive heterochromatin in the genome. These TAS regions have been described in 
Plasmodium and Toxoplasma with a size of 20–40 and near 30 Kpb, respectively (Figure 3) [98–
100]. In T. gondii, the structure contains three tandem repeated elements (TARE), separated 
by noncoding DNA and flanked at one end by the telomere and at the other, downstream 
TARE 3, by a Toxoplasma-specific gene family, the tsf gene, of unknown function [100]. In 
general, there is only one tsf gene per TAS. Interestingly, based on predicted amino acidic 
sequence, TSF proteins present a high degree of conservation in the N-tail and middle regions 
while being highly variable at the C-terminal end. Up to now, only few studies were per-
formed on chromatin modulation of T. gondii TAS.
The TAS element in Plasmodium, instead, has been deeply studied because of the presence 
of different families of genes associated to virulence and pathogenicity with a clonal pattern 
of expression [101, 102]. Telomeres are spatially restricted to nuclear periphery, where they 
form clusters of three to seven heterologous chromosome ends [103–105]. Plasmodium TAS 
is composed of six different TAREs, and the coding part of the genome is localized directly 
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arginines, blocked myoblast differentiation through disruption of myoD expression [91], it 
may be that the H2B variant is involved in the T. gondii cell differentiation process as part of 
H2A.Z-H2B.Z nucleosome. Whether through a patch charge modulation and/or histone code 
remains an open question, considering that T. gondii presents several bromodomain-contain-
ing proteins that can recognize some of the acetylated lysine [92].
As stated above, the sequence alignment of H2B.Z in many Apicomplexan species reveals a 
high degree of conservation for this histone variant (Figure 2B). Interestingly, every lysine 
that has been proved to be acetylated in T. gondii and P. falciparum, H2B.Z was detected in the 
other Apicomplexan species, which is also true for H2A.Z [50, 53]. Maybe, the double-variant 
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it was observed that P. falciparum intergenic regions, including promoters, display a global 
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mal occupancy [94]. Apparently, the little amount of nucleosomes in these areas is composed 
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the promoter of a set of developmentally regulated genes in the euchromatin compartment, 
although not correlated with transcription levels nor with acetylation status. P. falciparum 
H2A.Z-H2B.Z promoter occupancy in var genes was found to be strongly associated with 
transcriptional activity, whereas silent or poised var genes would be depleted of double-
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downstream TARE 6, and is characterized by members of multiple antigen gene families 
including var, rif, stevor, and pfmc-2tm genes [94, 95].
The telomeres and TAS regions are dynamic structures associated to a plethora of specific factors 
that not only give it structure, but also configures all the regions as constitutive heterochromatin 
that participates in an epigenetic way to regulate subtelomeric genes expression (Figure 3). This 
epigenetic mechanism is carried out by proteins that introduce, recognize, and implement a 
repressive state over the gene expression under normal environmental conditions. It has been 
reported that under nutritional or environmental stress, the repressed subtelomeric genes acti-
vate their expression in response to events promoting growth and survival [87, 106–109].
It is important to highlight that the T. gondii TAS regions show a nucleosome composi-
tion enriched in H2A.X and heterochromatin markers [100]. An in silico analysis using the 
Plasmodium and Toxoplasma databases reveals the presence of only some orthologs to the 
yeast and mammal’s telomeric-subtelomeric proteins as TRF1-2, HP1, KU70/KU80, and Sir2 
proteins (Table 1). But interestingly, the principal actor in this scenario would be the histone 
deacetylase type III -Sir2. This NAD+ deacetylase-dependent has also been implicated in dif-
ferent signaling pathways. P. falciparum has two Sir2 paralogues, Sir2A and B; with overlap-
ping but distinct roles that regulate different subsets of var genes[110], binding reversibly 
with the promoter regions of silent but not active subtelomeric var genes [111]. PfSir2A is 
implicated in telomere length regulation [112]. In T. gondii, two deacetylases containing the 
Sir2-domain were identified: TgSir2A and TgSir2B, but their function has not been character-
ized yet. Another protein that had been described in Plasmodium is PfOrc1 (origin recognition 
complex 1), which together with Sir2 promotes the epigenetic silencing in P. falciparum TAS 
[113]. PfOrc1 has a role in DNA replication but also cooperates with Sir2 to coordinate the 
spreading of heterochromatin and regulation of var gene expression [114]. In general, Sir2 
proteins act by removing acetyl groups in cytosolic targets and at the nuclear level at H3K9, 
K14 and K56, but it also was described to act on the histone mark H4K16 promoting the 
deposition of methyl groups on H4K20, H4K20me3 being a chromatin mark associated with 
heterochromatin [115]. Thus, Sir2 seems to play a very important role in linking signaling 
processes to gene expression and chromosome architecture.
Additionally, a member of the Alba protein family (PfAlba3) was demonstrated via ChIP 
assays to bind to telomeric and subtelomeric regions co-localizing with Sir2A in the periphery 
of the nucleus. PfAlba3 inhibits transcription in vitro by binding to DNA. PfSir2A was shown 
to interact with PfAlba3 deacetylating the lysine residue of N-terminal peptide of PfAlba3 
specific for DNA binding [116] (Figure 3). In archaea, this interaction had been reported, in 
which Sir2 regulates silencing through deacetylation of the major archaeal chromatin protein 
Alba, highlighting an ancestrally conserved mechanism of gene regulation [117].
As stated above, heterochromatin protein 1 (HP1) is a very important protein that has been 
described to recognize the trimethylation on H3K9, a critical mark for the establishment, 
maintenance and silencing of centromeric and telomeric heterochromatic regions in various 
model organisms. In P. falciparum, it has been identified as PfHP1 [118] and the H3K9me3 
mark was mainly associated with var genes at TAS regions, as said before [119]. Moreover, 
high levels of H3K9me3 correlate with genes localized to the nuclear periphery, implying 
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chromosome loop formation. In addition, an association between PfSir2 and H3K9me3 was 
found, since the lack of the sirtuin deacetylases causes changes in H3K9me3 localization at 
the chromosome and generates disruption of the monoallelic transcription of var genes, sug-
gesting the existence of perinuclear repressive centers associated with control of expression of 
malaria parasite genes involved in phenotypic variation and pathogenesis [119].
Flueck et al. [120] described the presence of an ApiAP2 family member in P. falciparum, desig-
nated as SIP2 that binds to TARE-2 and TARE-3 regions and the upstream regions of var upsB 
in vivo. Immunofluorescence and genome-wide high-resolution ChIP analyses demonstrated 
that P. falciparum SIP2 and HP1 proteins co-localize and associate with the same subtelomeric 
region, suggesting that both proteins participate in the assembly of telomeric heterochroma-
tin. A recent report from Gupta et al. [121] has demonstrated that the protein CAF-1, a chap-
erone that loads the H3-H4 to the nucleosome assembly after DDR, co-localizes with PfHP1 
Yeast Mammals T. gondii (ToxoDB number) P. falciparum (PlasmoDB PF3D7 
number)
Sir2 (P06700) Sir2 (Q8IXJ6) Sir2A (227020) Sir2A (1328800)
Sir2B (267360) Sir2B (1451400)
Sir3 (P06701) Sir3 (Q9NTG7) ATPase, AAA family protein 
(283900)*
Orc1/Sir3 like activity (1203000)*
Sir4 (P11978) Sir4 (Q9Y6E7) NF NF
RAP1 (P11938) RAP1 (Q9NYB0) NF NF
RIF1 (P29539) RIF1 (Q5UIP0) NF NF
RIF2 (Q06208) NF NF NF
Ku70 (P32807) XRCC6 (B1AHC9) Ku70 (248160) NF
Ku80 (Q04437) XRCC5 (P13010) Ku80 (312510) NF
Taz1 (P79005) TRF1 (P54274) NF NF
NF TRF2 (Q15554) NF NF
NF TIN2 (Q9BSI4) NF NF
NF HP1 (Q13185) Chromo1 (268280) HP1 (1220900)
Stn1 (P38960) NF NF NF
Ten1 (Q07921) NF NF NF
Cdc13 (P32797) NF NF NF
NF TPP1 (Q96AP0) NF NF
NF POT1 (Q9NUX5) NF NF
Pif1 (P07271) Pif1 (Q9H611) NF NF
NF: Not found.*P. falciparum Orc1 complement yeast Sir3 activity [113]. T. gondii counterpart was detected by searching 
ToxoDB with PfOrc1 amino acidic sequence by BlastP.
Table 1. Telomeric proteins.
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downstream TARE 6, and is characterized by members of multiple antigen gene families 
including var, rif, stevor, and pfmc-2tm genes [94, 95].
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reported that under nutritional or environmental stress, the repressed subtelomeric genes acti-
vate their expression in response to events promoting growth and survival [87, 106–109].
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ferent signaling pathways. P. falciparum has two Sir2 paralogues, Sir2A and B; with overlap-
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proteins act by removing acetyl groups in cytosolic targets and at the nuclear level at H3K9, 
K14 and K56, but it also was described to act on the histone mark H4K16 promoting the 
deposition of methyl groups on H4K20, H4K20me3 being a chromatin mark associated with 
heterochromatin [115]. Thus, Sir2 seems to play a very important role in linking signaling 
processes to gene expression and chromosome architecture.
Additionally, a member of the Alba protein family (PfAlba3) was demonstrated via ChIP 
assays to bind to telomeric and subtelomeric regions co-localizing with Sir2A in the periphery 
of the nucleus. PfAlba3 inhibits transcription in vitro by binding to DNA. PfSir2A was shown 
to interact with PfAlba3 deacetylating the lysine residue of N-terminal peptide of PfAlba3 
specific for DNA binding [116] (Figure 3). In archaea, this interaction had been reported, in 
which Sir2 regulates silencing through deacetylation of the major archaeal chromatin protein 
Alba, highlighting an ancestrally conserved mechanism of gene regulation [117].
As stated above, heterochromatin protein 1 (HP1) is a very important protein that has been 
described to recognize the trimethylation on H3K9, a critical mark for the establishment, 
maintenance and silencing of centromeric and telomeric heterochromatic regions in various 
model organisms. In P. falciparum, it has been identified as PfHP1 [118] and the H3K9me3 
mark was mainly associated with var genes at TAS regions, as said before [119]. Moreover, 
high levels of H3K9me3 correlate with genes localized to the nuclear periphery, implying 
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chromosome loop formation. In addition, an association between PfSir2 and H3K9me3 was 
found, since the lack of the sirtuin deacetylases causes changes in H3K9me3 localization at 
the chromosome and generates disruption of the monoallelic transcription of var genes, sug-
gesting the existence of perinuclear repressive centers associated with control of expression of 
malaria parasite genes involved in phenotypic variation and pathogenesis [119].
Flueck et al. [120] described the presence of an ApiAP2 family member in P. falciparum, desig-
nated as SIP2 that binds to TARE-2 and TARE-3 regions and the upstream regions of var upsB 
in vivo. Immunofluorescence and genome-wide high-resolution ChIP analyses demonstrated 
that P. falciparum SIP2 and HP1 proteins co-localize and associate with the same subtelomeric 
region, suggesting that both proteins participate in the assembly of telomeric heterochroma-
tin. A recent report from Gupta et al. [121] has demonstrated that the protein CAF-1, a chap-
erone that loads the H3-H4 to the nucleosome assembly after DDR, co-localizes with PfHP1 
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at the same subtelomeric localization, in the nuclear periphery, and also demonstrated its 
binding to TARE1-3 and co-localization with H3K56ac, a signal of completion on chromatin 
reassembly after DDR [122]. Interestingly, immunoprecipitation with PfCAF1 followed by 
LC-MS/MS analysis demonstrated that this protein would be interacting not only with PfHP1 
but also with PfAlba3 among others [121].
In T. gondii, an HP1 protein was identified as TgChromo1, linked to the sequestration of 
chromosomes at the nuclear periphery and the process of cell division of the parasite [22]. 
TgChromo1 has shown to localize at T. gondii telomeres but not subtelomeres. However, by 
that time, subtelomeric regions had not yet been described and, in some cases, the sequences 
in these regions were not correctly assembled. Also, the presence of H4K20me3 and H2A.X 
at some TARE sequences and a region near tsf gene, previously named TgIRE, was observed 
[62, 63, 100, 123].
7. Double-strand break repair: H2A.X and chromatin
Cells are exposed to DNA lesions produced by exogenous (e.g., chemicals, UV-irradiation, and 
ionization) or endogenous factors (e.g., DNA replication stress, meiotic recombination). One of 
the most deleterious forms of DNA damage is the double-strand break (DSB) [124]. DSBs acti-
vate the signal transduction pathway to induce DNA damage checkpoints that delay cell cycle 
progression, which allows the cell to activate DNA repair mechanism [125]. The phosphoryla-
tion of SQE/DФ motif (where Ф represents a hydrophobic residue) on histone H2A.X (referred 
to as γH2A.X) is one of the earliest responses to DSB [126, 127]. H2A.X seems to be incor-
porated randomly in the genome of resting cells [128], whereas γH2A.X is clearly observed 
forming foci, labeling the DSB and replication fork sites, spreading along the chromosome 
up to 2 Mb from the damaged site. In addition, chromatin is subjected to several changes at 
damage sites playing an important role in regulating DNA repair [129]. DSB can be produced 
by various events, either external as ionizing and UV radiations or internal such as collapse 
of replication forks and transcription-associated damage, among others [130, 131]. DSB can 
be repaired by two main mechanisms: nonhomologous end joining (NHEJ) and homologous 
recombination repair (HRR); the first is an error-prone mechanism available along the cell 
cycle, and the second is an error-free mechanism active at S/G2 phases of cell cycle because of 
the requirement of sister chromatid as template [131–134]. Both mechanisms were described in 
T. gondii [14, 135], but Plasmodium genus is thought to rely only on HRR [136–138].
Before the election of NHEJ or HRR mechanism, DSB triggers a cascade of events that starts 
with Mre11-RAD50-Nbs1/Xrs2 (MRN in mammals and MRX in yeast) complex binding to 
the damaged site, which recruits and activates ATM kinase (Figure 4A) [139]. ATM is able 
to phosphorylate H2A.X at SQE motif as well as other DSB repair enzymes allowing the 
spreading of γH2A.X and a correct DNA damage response (DDR) at DSB site (Figure 4A). 
ATM kinase is present in T. gondii and P. falciparum [14]. In T. gondii, the MYST family lysine 
acetyltransferase TgMYST-B has shown to mediate DDR induced by methyl methanesul-
fonate (MMS) and to stimulate the ATM expression at gene level [140]. In addition to this 
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finding, histone acetyltransferases (HATs) have a predominant role in DDR on the basis of 
chromatin modulation. Chromatin responds to DSB first by increasing the compaction stage 
by replacing H2A/H2A.X with the H2A.Z variant and by methylating H3K9 by suv39h1 
methyltransferase, which is recruited after spreading the DDR response at both sides of DSB 
sites (Figure 4B) [141, 142]. The arrival of H3K9me3 allows its interaction with the HAT Tip60 
and the acetylation of H4 on K16 together with the acetylation of ATM kinase, an important 
PTM for the activation of autophosphorylation and subsequent activation of ATM (Figure 4) 
[143, 144]. The H3K9me3 and H4K16ac marks were identified in T. gondii and P. falciparum by 
mass spectrometry analysis [48–51]. However, in the case of T. gondii, an acetylated residue 
was also detected in H3K9 in a more frequent fashion than H3K9me1,2,3, suggesting that 
chromatin is preferentially in an open state and that this lysine PTM can be regulated [51]. 
As it was stated before, H3K9me2/3 is also enriched in centromeres in T. gondii [21]. In addi-
tion, T. gondii H4K16ac was one of the most abundant PTMs found in the mass spectrometry 
analysis [51]. In the case of P. falciparum, the treatment with MMS has increased the level of 
H4K8ac and H4K16ac and reduction of H3K9ac [145]. Both, T. gondii and P. falciparum pres-
ent H3K9me1,2,3 and H3K9ac in normal conditions suggesting a conserved mechanism of 
chromatin modulation [51]. The role of these histone marks on Apicomplexan histones and 
the connections with DNA repair remain to be elucidated.
As mentioned above, γH2A.X spreading is a crucial step to initiate a correct DDR at DSB sites. 
In T. gondii, this PTM mark is accompanied by other DDR marks such as H3K9me2,3 and 
H4K16 in normal conditions of growth, opening the question whether DSBs are being pro-
duced during parasite replication [51, 135]. The T. gondii tachyzoite replicates at high rates, in 
a range of 5–9 hours [146]. So, a putative collapse of replication fork could be occurring in this 
stage. However, T. gondii ATM kinase could not be detected in normal conditions by Western 
blot, but it was detected by tachyzoites overexpressing MYST-B HAT [140].
The chromatin compaction that occurs early during DDR includes the remodeling of chroma-
tin at DSB sites in which the H2A-H2B dimer is replaced by H2A.Z-H2B [142, 147]. This event 
is transient, allowing the recruitment of repressive kap-1(TRIM28)/HP1/suv39h1 complex that 
can be important to inhibit transcription. The presence of H2A-H2B dimer in the nucleosomal 
core particle produces a unique negatively charged region on the surface of the nucleosome, 
called the “acidic patch,” which is extended in H2A.Z (Figure 4B) [148–150]. The acidic patch 
favors the binding of H4 N-tail, resulting in an increase in the interaction between nucleo-
somes and chromatin compaction [150]. Interestingly, this seems a necessary step to continue 
with a relaxed chromatin state, since this compaction and recruitment of kap-1(TRIM28)/HP1/
suv39h1 complex lead to methylation of H3K9 and phosphorylation of KAP-1 by ATM kinase, 
which in turn promote H4K16 acetylation by Tip60 and release kap-1(TRIM28)/HP1/suv39h1 
(Figure 4B) (see [142]). T. gondii and P. falciparum have the novel H2A.Z-H2B.Z double-variant 
nucleosome (see Section 5). However, T. gondii and P. falciparum H2A-H2B and variants con-
serve the acidic patch (Figure 4B). To note, T. gondii and P. falciparum do not appear to have 
KAP-1 protein at ToxoDB and PlasmoDB databases [151].
In higher eukaryotes, another important PTM mark associated to DDR is ubiquitination by 
E3 ubiquitin ligases RNF168 and RNF8 at DSB site after γH2A.X and MDC1 protein foci 
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at the same subtelomeric localization, in the nuclear periphery, and also demonstrated its 
binding to TARE1-3 and co-localization with H3K56ac, a signal of completion on chromatin 
reassembly after DDR [122]. Interestingly, immunoprecipitation with PfCAF1 followed by 
LC-MS/MS analysis demonstrated that this protein would be interacting not only with PfHP1 
but also with PfAlba3 among others [121].
In T. gondii, an HP1 protein was identified as TgChromo1, linked to the sequestration of 
chromosomes at the nuclear periphery and the process of cell division of the parasite [22]. 
TgChromo1 has shown to localize at T. gondii telomeres but not subtelomeres. However, by 
that time, subtelomeric regions had not yet been described and, in some cases, the sequences 
in these regions were not correctly assembled. Also, the presence of H4K20me3 and H2A.X 
at some TARE sequences and a region near tsf gene, previously named TgIRE, was observed 
[62, 63, 100, 123].
7. Double-strand break repair: H2A.X and chromatin
Cells are exposed to DNA lesions produced by exogenous (e.g., chemicals, UV-irradiation, and 
ionization) or endogenous factors (e.g., DNA replication stress, meiotic recombination). One of 
the most deleterious forms of DNA damage is the double-strand break (DSB) [124]. DSBs acti-
vate the signal transduction pathway to induce DNA damage checkpoints that delay cell cycle 
progression, which allows the cell to activate DNA repair mechanism [125]. The phosphoryla-
tion of SQE/DФ motif (where Ф represents a hydrophobic residue) on histone H2A.X (referred 
to as γH2A.X) is one of the earliest responses to DSB [126, 127]. H2A.X seems to be incor-
porated randomly in the genome of resting cells [128], whereas γH2A.X is clearly observed 
forming foci, labeling the DSB and replication fork sites, spreading along the chromosome 
up to 2 Mb from the damaged site. In addition, chromatin is subjected to several changes at 
damage sites playing an important role in regulating DNA repair [129]. DSB can be produced 
by various events, either external as ionizing and UV radiations or internal such as collapse 
of replication forks and transcription-associated damage, among others [130, 131]. DSB can 
be repaired by two main mechanisms: nonhomologous end joining (NHEJ) and homologous 
recombination repair (HRR); the first is an error-prone mechanism available along the cell 
cycle, and the second is an error-free mechanism active at S/G2 phases of cell cycle because of 
the requirement of sister chromatid as template [131–134]. Both mechanisms were described in 
T. gondii [14, 135], but Plasmodium genus is thought to rely only on HRR [136–138].
Before the election of NHEJ or HRR mechanism, DSB triggers a cascade of events that starts 
with Mre11-RAD50-Nbs1/Xrs2 (MRN in mammals and MRX in yeast) complex binding to 
the damaged site, which recruits and activates ATM kinase (Figure 4A) [139]. ATM is able 
to phosphorylate H2A.X at SQE motif as well as other DSB repair enzymes allowing the 
spreading of γH2A.X and a correct DNA damage response (DDR) at DSB site (Figure 4A). 
ATM kinase is present in T. gondii and P. falciparum [14]. In T. gondii, the MYST family lysine 
acetyltransferase TgMYST-B has shown to mediate DDR induced by methyl methanesul-
fonate (MMS) and to stimulate the ATM expression at gene level [140]. In addition to this 
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by replacing H2A/H2A.X with the H2A.Z variant and by methylating H3K9 by suv39h1 
methyltransferase, which is recruited after spreading the DDR response at both sides of DSB 
sites (Figure 4B) [141, 142]. The arrival of H3K9me3 allows its interaction with the HAT Tip60 
and the acetylation of H4 on K16 together with the acetylation of ATM kinase, an important 
PTM for the activation of autophosphorylation and subsequent activation of ATM (Figure 4) 
[143, 144]. The H3K9me3 and H4K16ac marks were identified in T. gondii and P. falciparum by 
mass spectrometry analysis [48–51]. However, in the case of T. gondii, an acetylated residue 
was also detected in H3K9 in a more frequent fashion than H3K9me1,2,3, suggesting that 
chromatin is preferentially in an open state and that this lysine PTM can be regulated [51]. 
As it was stated before, H3K9me2/3 is also enriched in centromeres in T. gondii [21]. In addi-
tion, T. gondii H4K16ac was one of the most abundant PTMs found in the mass spectrometry 
analysis [51]. In the case of P. falciparum, the treatment with MMS has increased the level of 
H4K8ac and H4K16ac and reduction of H3K9ac [145]. Both, T. gondii and P. falciparum pres-
ent H3K9me1,2,3 and H3K9ac in normal conditions suggesting a conserved mechanism of 
chromatin modulation [51]. The role of these histone marks on Apicomplexan histones and 
the connections with DNA repair remain to be elucidated.
As mentioned above, γH2A.X spreading is a crucial step to initiate a correct DDR at DSB sites. 
In T. gondii, this PTM mark is accompanied by other DDR marks such as H3K9me2,3 and 
H4K16 in normal conditions of growth, opening the question whether DSBs are being pro-
duced during parasite replication [51, 135]. The T. gondii tachyzoite replicates at high rates, in 
a range of 5–9 hours [146]. So, a putative collapse of replication fork could be occurring in this 
stage. However, T. gondii ATM kinase could not be detected in normal conditions by Western 
blot, but it was detected by tachyzoites overexpressing MYST-B HAT [140].
The chromatin compaction that occurs early during DDR includes the remodeling of chroma-
tin at DSB sites in which the H2A-H2B dimer is replaced by H2A.Z-H2B [142, 147]. This event 
is transient, allowing the recruitment of repressive kap-1(TRIM28)/HP1/suv39h1 complex that 
can be important to inhibit transcription. The presence of H2A-H2B dimer in the nucleosomal 
core particle produces a unique negatively charged region on the surface of the nucleosome, 
called the “acidic patch,” which is extended in H2A.Z (Figure 4B) [148–150]. The acidic patch 
favors the binding of H4 N-tail, resulting in an increase in the interaction between nucleo-
somes and chromatin compaction [150]. Interestingly, this seems a necessary step to continue 
with a relaxed chromatin state, since this compaction and recruitment of kap-1(TRIM28)/HP1/
suv39h1 complex lead to methylation of H3K9 and phosphorylation of KAP-1 by ATM kinase, 
which in turn promote H4K16 acetylation by Tip60 and release kap-1(TRIM28)/HP1/suv39h1 
(Figure 4B) (see [142]). T. gondii and P. falciparum have the novel H2A.Z-H2B.Z double-variant 
nucleosome (see Section 5). However, T. gondii and P. falciparum H2A-H2B and variants con-
serve the acidic patch (Figure 4B). To note, T. gondii and P. falciparum do not appear to have 
KAP-1 protein at ToxoDB and PlasmoDB databases [151].
In higher eukaryotes, another important PTM mark associated to DDR is ubiquitination by 
E3 ubiquitin ligases RNF168 and RNF8 at DSB site after γH2A.X and MDC1 protein foci 
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spreading (Figure 4A). MDC1 is also phosphorylated by ATM kinase allowing the recruitment 
of RNF168 and RNF8 [152]. Ubiquitination on H1 and H2A recruits several BRCT domain 
containing proteins such as BRCA1 and 53BP1 [129]. In the case of 53BP1, its binding requires 
the H2AK13/15ub and H4K20me2 and addresses the DDR to NHEJ pathway (Figure 4B). By 
contrast, the presence of H4K16ac impairs the 53BP1 binding to the nucleosome allowing the 
recruitment of BRCA, which addresses the DDR to HRR (Figure 4B) (see [141, 142]). As stated 
Figure 4. (A) Recognition of DSB and initial steps of DDR pathways. MRN complex and ATM kinase are recruited to a 
DSB. ATM phosphorylates several DDR proteins and checkpoint kinases. Phosphorylation by ATM allows the spreading 
of γH2A.X and DDR foci. RNF8 E3 ubiquitin ligase complexes ubiquitinate H2A and H1 histones to compact and generate 
histone marks, which will be read by other DDR factors such as MDC1 and E3 ubiquitin ligase RNF168. (B) Model of 
chromatin modulation after DSB. During PARylation, the p400 ATPase (NuA4-Tip60 complex) replaces H2A-H2B dimers 
by H2A.Z containing nucleosomes. Since T. gondii and P. falciparum present a double-variant nucleosome, we speculate 
that H2A-H2B or H2A.X-H2Ba dimers may be replaced by H2A.Z-H2B.Z dimers. This exchange might increase the 
interaction of the acidic patch with the N-tail of H4 increasing the chromatin compaction (see the sequence alignment: in 
red letters are written the acidic residues involved in generating the acidic patch). PARylation also produces an increase 
in H3K9me2/3 and histone deacetylation repressive marks. After a short time, the H2A.Z containing nucleosome is 
replaced by H2A-H2B dimer and N-tail of H4 is acetylated leading to a relaxed chromatin and recruitment of different 
DDR factors, among them those related to the DDR pathway choice, such as 53BP1 or BRCA1.
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above, in T. gondii and P. falciparum, the mark H4K20me1,2,3 was found [48, 51, 53]. However, 
T. gondii and P. falciparum H2As did not contain H2AK15ub and lysine 13 ubiquitylation was 
not detected either [51]. In addition, T. gondii and P. falciparum did not show the presence of 
orthologs of BRCA1 and/or 53BP1, though T. gondii presents three different BRCT domain 
containing proteins [14].
T. gondii and P. falciparum conserve several histone marks present in chromatin-associated DDR 
to DBS, as well as histone variants—in the case of T. gondii, the DDR, well studied H2A.X, is 
present, whereas Plasmodium has only canonical H2A [55], involved in the recruitment of sev-
eral factors that spread and choose the DDR pathway in higher eukaryotes. Although, T. gondii 
and P. falciparum lack some key DDR regulators such as KAP-1, 53BP1, BRCA1, MDC1, RNF168 
and RNF8 [14], both parasites present the HRR mechanism of DNA repair, whereas NHEJ is 
present only in T. gondii. So, the modulation of both DDR pathways is still an intriguing issue.
8. Concluding remarks
In protozoan parasites, the modulation of chromatin seems to be a key biological process to 
regulate gene expression, pathogenicity and DNA repair, the latter probably associated to 
DNA replication, ergo, the cell cycle. In Apicomplexa, highly evident in Plasmodium genus, 
the TAS or subtelomeric regions play an important role in the control of a group of genes 
essential in parasite pathogenicity. This fact suggests that subtelomeres have not a trivial 
impact in the evolution of these organisms, and their structure can influence the features of 
the cell. How this genomic domain has evolved within the Apicomplexa phylum remains to 
be elucidated. T. gondii, in which to date a scenario of variant antigenicity was not detected, 
has shown a someway conserved structure with the presence of tandem repeated boxes and 
a gene family of unknown function (tsf). Different from Plasmodium, which variant antigen-
associated gene is represented by hundreds of members, T. gondii has only one gene per 
TAS. However, the predicted protein sequences show conserved N-tail and middle regions, 
with highly variable C-terminal ends. We believe that the elucidation of the localization, role, 
and antigenic potential of these gene family proteins will be of high impact in our knowledge 
of this parasite. Also, it could be interesting to know if the members of this gene family show 
a regulation of gene expression similar to Plasmodium variable antigen gene family.
In addition to the presence of PTM marks similar to other organisms but with currently less-
well characterized readers and erasers, Apicomplexa chromatin presents a double-variant 
nucleosome based on the new histone variant H2B.Z. If considering the partitioned knowl-
edge in these parasites, specially P. falciparum, where H3.3 variant has been found in the same 
regions as this double-variant nucleosome, but in different studies, it would be possible that 
a triple-variant nucleosome exists in Apicomplexa. Since the presence of H2B.Z arose early in 
Apicomplexa evolution, it is expected that the double-variant nucleosome could have been 
important in the expansion of the phylum, maybe modulating chromatin structure during the 
execution of different biological processes. Interestingly, the genome-wide analyses seem to 
indicate that Plasmodium and Toxoplasma double-variant nucleosomes do not have the same 
behavior. In T. gondii, it is enriched in active and poised genes, whereas in P. falciparum, it is 
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spreading (Figure 4A). MDC1 is also phosphorylated by ATM kinase allowing the recruitment 
of RNF168 and RNF8 [152]. Ubiquitination on H1 and H2A recruits several BRCT domain 
containing proteins such as BRCA1 and 53BP1 [129]. In the case of 53BP1, its binding requires 
the H2AK13/15ub and H4K20me2 and addresses the DDR to NHEJ pathway (Figure 4B). By 
contrast, the presence of H4K16ac impairs the 53BP1 binding to the nucleosome allowing the 
recruitment of BRCA, which addresses the DDR to HRR (Figure 4B) (see [141, 142]). As stated 
Figure 4. (A) Recognition of DSB and initial steps of DDR pathways. MRN complex and ATM kinase are recruited to a 
DSB. ATM phosphorylates several DDR proteins and checkpoint kinases. Phosphorylation by ATM allows the spreading 
of γH2A.X and DDR foci. RNF8 E3 ubiquitin ligase complexes ubiquitinate H2A and H1 histones to compact and generate 
histone marks, which will be read by other DDR factors such as MDC1 and E3 ubiquitin ligase RNF168. (B) Model of 
chromatin modulation after DSB. During PARylation, the p400 ATPase (NuA4-Tip60 complex) replaces H2A-H2B dimers 
by H2A.Z containing nucleosomes. Since T. gondii and P. falciparum present a double-variant nucleosome, we speculate 
that H2A-H2B or H2A.X-H2Ba dimers may be replaced by H2A.Z-H2B.Z dimers. This exchange might increase the 
interaction of the acidic patch with the N-tail of H4 increasing the chromatin compaction (see the sequence alignment: in 
red letters are written the acidic residues involved in generating the acidic patch). PARylation also produces an increase 
in H3K9me2/3 and histone deacetylation repressive marks. After a short time, the H2A.Z containing nucleosome is 
replaced by H2A-H2B dimer and N-tail of H4 is acetylated leading to a relaxed chromatin and recruitment of different 
DDR factors, among them those related to the DDR pathway choice, such as 53BP1 or BRCA1.
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above, in T. gondii and P. falciparum, the mark H4K20me1,2,3 was found [48, 51, 53]. However, 
T. gondii and P. falciparum H2As did not contain H2AK15ub and lysine 13 ubiquitylation was 
not detected either [51]. In addition, T. gondii and P. falciparum did not show the presence of 
orthologs of BRCA1 and/or 53BP1, though T. gondii presents three different BRCT domain 
containing proteins [14].
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to DBS, as well as histone variants—in the case of T. gondii, the DDR, well studied H2A.X, is 
present, whereas Plasmodium has only canonical H2A [55], involved in the recruitment of sev-
eral factors that spread and choose the DDR pathway in higher eukaryotes. Although, T. gondii 
and P. falciparum lack some key DDR regulators such as KAP-1, 53BP1, BRCA1, MDC1, RNF168 
and RNF8 [14], both parasites present the HRR mechanism of DNA repair, whereas NHEJ is 
present only in T. gondii. So, the modulation of both DDR pathways is still an intriguing issue.
8. Concluding remarks
In protozoan parasites, the modulation of chromatin seems to be a key biological process to 
regulate gene expression, pathogenicity and DNA repair, the latter probably associated to 
DNA replication, ergo, the cell cycle. In Apicomplexa, highly evident in Plasmodium genus, 
the TAS or subtelomeric regions play an important role in the control of a group of genes 
essential in parasite pathogenicity. This fact suggests that subtelomeres have not a trivial 
impact in the evolution of these organisms, and their structure can influence the features of 
the cell. How this genomic domain has evolved within the Apicomplexa phylum remains to 
be elucidated. T. gondii, in which to date a scenario of variant antigenicity was not detected, 
has shown a someway conserved structure with the presence of tandem repeated boxes and 
a gene family of unknown function (tsf). Different from Plasmodium, which variant antigen-
associated gene is represented by hundreds of members, T. gondii has only one gene per 
TAS. However, the predicted protein sequences show conserved N-tail and middle regions, 
with highly variable C-terminal ends. We believe that the elucidation of the localization, role, 
and antigenic potential of these gene family proteins will be of high impact in our knowledge 
of this parasite. Also, it could be interesting to know if the members of this gene family show 
a regulation of gene expression similar to Plasmodium variable antigen gene family.
In addition to the presence of PTM marks similar to other organisms but with currently less-
well characterized readers and erasers, Apicomplexa chromatin presents a double-variant 
nucleosome based on the new histone variant H2B.Z. If considering the partitioned knowl-
edge in these parasites, specially P. falciparum, where H3.3 variant has been found in the same 
regions as this double-variant nucleosome, but in different studies, it would be possible that 
a triple-variant nucleosome exists in Apicomplexa. Since the presence of H2B.Z arose early in 
Apicomplexa evolution, it is expected that the double-variant nucleosome could have been 
important in the expansion of the phylum, maybe modulating chromatin structure during the 
execution of different biological processes. Interestingly, the genome-wide analyses seem to 
indicate that Plasmodium and Toxoplasma double-variant nucleosomes do not have the same 
behavior. In T. gondii, it is enriched in active and poised genes, whereas in P. falciparum, it is 
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localized in active and silent promoters, excepting the var genes, in which the presence of 
the double-variant nucleosome is associated to active promoters. The analysis of this novel 
nucleosome in the different genera of the phylum can give more information to elucidate the 
reason of the presence of this H2B variant.
Chromatin is also important to the DDR and has an important role in determining the dif-
ferent pathways of DNA repair after DSB. T. gondii seems to have every histone variant and 
histone mark as well as important proteins associated to every DDR pathway to repair a DSB: 
NHEJ (e.g., Ku70/Ku80) and HRR (RAD51). Different from T. gondii, Plasmodium does not 
present the histone variant H2A.X, whose phosphorylation (γH2A.X) is linked to the localiza-
tion of DSB on DNA. Moreover, T. gondii has shown a basal level of γH2A.X, even without 
damage. Not expected, the proteins associated to the DDR pathway choice (NHEJ or HRR), 
which read the chromatin, were not detected in T. gondii nor in Plasmodium. So, it is unknown 
if these marks are associated to other proteins (T. gondii has three BRCT domain containing 
proteins) with similar roles and/or chromatin modulates DDR in another way.
Taken all together, these differences are not only interesting at the light of evolution but also 
can be analyzed in the context of the identification of new parasite-specific drug targets. Gene 
regulation, DNA replication, pathogenicity, and DNA repair are crucial biological processes, 
and all of them may offer new targets to exploit as future treatments against Apicomplexan 
pathogens.
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ferent pathways of DNA repair after DSB. T. gondii seems to have every histone variant and 
histone mark as well as important proteins associated to every DDR pathway to repair a DSB: 
NHEJ (e.g., Ku70/Ku80) and HRR (RAD51). Different from T. gondii, Plasmodium does not 
present the histone variant H2A.X, whose phosphorylation (γH2A.X) is linked to the localiza-
tion of DSB on DNA. Moreover, T. gondii has shown a basal level of γH2A.X, even without 
damage. Not expected, the proteins associated to the DDR pathway choice (NHEJ or HRR), 
which read the chromatin, were not detected in T. gondii nor in Plasmodium. So, it is unknown 
if these marks are associated to other proteins (T. gondii has three BRCT domain containing 
proteins) with similar roles and/or chromatin modulates DDR in another way.
Taken all together, these differences are not only interesting at the light of evolution but also 
can be analyzed in the context of the identification of new parasite-specific drug targets. Gene 
regulation, DNA replication, pathogenicity, and DNA repair are crucial biological processes, 
and all of them may offer new targets to exploit as future treatments against Apicomplexan 
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Abstract
Circadian rhythms that function in behaviour and physiology have adaptive significance
for living organisms from bacteria to humans and reflect the presence of a biological clock.
The engine of circadian rhythms is a transcription-translation feedback loop that is fine-
tuned by epigenetic regulation in higher eukaryotes. We elucidated the chromatin struc-
ture of the Bmal1 gene, a critical component of the mammalian clock system, and have
continued to investigate transcriptional regulation including DNA methylation. Various
ailments including metabolic diseases can disrupt circadian rhythms, and many human
diseases are associated with altered DNA methylation. Therefore, regulated circadian
rhythms are important for human health. Here, we summarise the importance of epige-
netic clock gene regulation, including DNA methylation of the Bmal1 gene, from the
viewpoint of relationships to diseases.
Keywords: molecular clock, transcriptional mechanism, cytosine methylation, chromatin,
cancer, metabolic syndrome
1. Introduction
Circadian rhythms function in most living organisms and govern many behavioural and
biochemical processes with 24-h periodicity regardless of changes in the cellular environment.
This is closely associated with the natural rhythm of the sun, which provides light and heat
with 24-h periodicity. The master clock that generates circadian rhythms in mammals is
located in the suprachiasmatic nucleus (SCN) of the hypothalamus and is governed by blue-
light sensing in eyes. Peripheral organs also contain molecular clocks. These biological clocks
control all aspects of physiology such as sleep-wake cycles, body temperature, hormone
secretion, blood pressure and metabolism [1]. Biological clocks oscillate via a mechanism
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based on interlocking transcriptional-translational feedback loops that have both positive and
negative elements. The circadian oscillator orchestrates the rhythmic mRNA expression and
output of hundreds or thousands of clock-controlled genes (CCG) that temporally coordinate
many cellular functions [2]. Circadian transcriptional regulators are apparently involved in the
initial stages of RNA polymerase II recruitment and initiation, as well as the histone modifica-
tions associated with these events to set the stage for gene expression [3]. The methylation of
cytosine on CpG dinucleotides, which is also epigenetic regulation of gene expression, either
directly interferes with the binding of transcriptional regulators or indirectly inactivates a gene
by modulating chromatin to a repressive structure. About 43% of all protein-encoding genes in
mice exhibit circadian rhythms of mRNA abundance somewhere in the body, largely in an
organ-specific manner [4]. The temporal coordination of cellular functions is lost when circa-
dian rhythms are disrupted by age, the environment or genetic mutation, with deleterious
effects on health. For instance, the adrenal steroid hormone glucocorticoid that controls vari-
ous physiological processes, such as metabolism, the immune response, cardiovascular activity
and brain function, is under the control of the circadian clock [5], implying that several
diseases are closely associated with disrupted circadian rhythms.
2. Transcriptional mechanism of the circadian clock
2.1. Basic regulation of circadian transcription
The engine of the mammalian molecular clock consists of a transcription-translation feedback
loop initiated by the transcription factor BMAL1-CLOCK heterodimer. BMAL1 and CLOCK
have paralogs, known as BMAL2 and NPAS2, respectively. Heterodimers such as BMAL1-
CLOCK bind to E-box enhancer sequences and activate the transcription of three Per (Per1,
Per2 and Per3) and two Cry (Cry1 and Cry2) genes. The PER and CRY proteins subsequently
repress the transcription at their own promoters through negative feedback by acting on the
BMAL1-CLOCK heterodimer. The cellular circadian clock mediates the rhythmic output of the
hundreds or thousands of CCG transcripts that are regulated by transcription factors or
coregulators with rhythmic abundance that is a part of the cellular circadian clock [3]. The
prominent transcription factors activated by BMAL1-CLOCK are REV-ERB α and β, which
bind to ROREs, as well as DBP and E4BP4, which bind to D-boxes. E-box motifs contain a core
CANNTG sequence, which is recognised by a basic helix-loop-helix (bHLH) domain that
contains transcription factors. BMAL1-CLOCK binds tandem E boxes spaced 6 or 7 nucleo-
tides (nt) apart with high affinity [6]. The bHLH containing the oncoprotein Myc also binds to
E-boxes and directly activates the expression of multiple repressors of the clock, including Rev-
erbα and Rev-erbβ [7]. In addition, USF1 binds to the E-box motifs of Dbp, Per1 and Per2 [8]. The
RORE motif comprises an AT-rich sequence preceding a core (G/A) GGTCA motif. ROR and
REV-ERB, respectively, activate and repress the transcription of genes by binding to ROREs [9].
They co-ordinately maintain robust circadian expression of core clock proteins, such as BMAL1.
D-boxes are variants of basic leucine-zipper (bZIP) motifs and are 9- or 10-bp palindromes of
two GTAA (C/T) half-site sequences [10]. The D-box motif is bound by the proline- and acidic
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amino acid-rich bZIP (PAR-bZIP) transcription factor family, including DBP, E4BP4, HLF and
TEF [11, 12]. A combination of three binding elements, E-boxes, ROREs and D-boxes, coordi-
nates CCG transcription. Figure 1 shows that most core clock proteins including BMAL1,
CLOCK, PER, CRY, REB-ERB, ROR and E4BP4 bind to many thousands of sites in the genome
in a circadian manner [13].
2.2. Epigenetic mechanism: effect of chromatin structure
Transcriptional regulation initially requires the coordinated control of chromatin and the
genome structure [3]. In general, genetic information is packed into the chromatin structure,
of which the nucleosome is the most basic unit; it determines the large-scale chromatin struc-
ture as a building block and influences transcription. Eukaryotic promoter regions are thought
to have inactive states, assured by the tendency of nucleosomes to inhibit transcription by
protecting protein-DNA interaction. Therefore, chromatin remodelling and loosening of the
nucleosomal barrier including histone tail modifications are key steps in circadian modifica-
tions followed by sequence-specific, transcription factor binding that regulates gene expres-
sions [14]. Distinct chromatin states are determined by unique histone post-translational
modifications. First, histone acetylation levels fluctuate rhythmically at clock gene promoters
and enhancers. Specifically, acetylated histone H3 at Lys27 (H3K27ac), a marker of active
enhancers, and H3 at Lys9 (H3K9ac) are rhythmic and positively correlate with clock gene
expression. For example, rhythmic BMAL1-CLOCK binding and H3K9ac are required as well
as rhythmic histone H3 abundance at the start site for Dbp transcription [15]. Complexes of
clock proteins such as PER contain various interactive partners with known catalytic activity
towards chromatin [16, 17]. The acetylation of histone H3 (at Lys9 and Lys14) at Per1, Per2 and
Cry1 and of H4 at Per1 during the transcriptional activation phase has been identified [18, 19].
Rhythmic histone acetylation at clock loci is largely mediated by p300 and CBP histone
Figure 1. Hierarchical regulation mechanism of circadian transcription. E, RORE and D indicate transcription factor recogni-
tion sites: E-box, RORE and D-box, respectively.
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based on interlocking transcriptional-translational feedback loops that have both positive and
negative elements. The circadian oscillator orchestrates the rhythmic mRNA expression and
output of hundreds or thousands of clock-controlled genes (CCG) that temporally coordinate
many cellular functions [2]. Circadian transcriptional regulators are apparently involved in the
initial stages of RNA polymerase II recruitment and initiation, as well as the histone modifica-
tions associated with these events to set the stage for gene expression [3]. The methylation of
cytosine on CpG dinucleotides, which is also epigenetic regulation of gene expression, either
directly interferes with the binding of transcriptional regulators or indirectly inactivates a gene
by modulating chromatin to a repressive structure. About 43% of all protein-encoding genes in
mice exhibit circadian rhythms of mRNA abundance somewhere in the body, largely in an
organ-specific manner [4]. The temporal coordination of cellular functions is lost when circa-
dian rhythms are disrupted by age, the environment or genetic mutation, with deleterious
effects on health. For instance, the adrenal steroid hormone glucocorticoid that controls vari-
ous physiological processes, such as metabolism, the immune response, cardiovascular activity
and brain function, is under the control of the circadian clock [5], implying that several
diseases are closely associated with disrupted circadian rhythms.
2. Transcriptional mechanism of the circadian clock
2.1. Basic regulation of circadian transcription
The engine of the mammalian molecular clock consists of a transcription-translation feedback
loop initiated by the transcription factor BMAL1-CLOCK heterodimer. BMAL1 and CLOCK
have paralogs, known as BMAL2 and NPAS2, respectively. Heterodimers such as BMAL1-
CLOCK bind to E-box enhancer sequences and activate the transcription of three Per (Per1,
Per2 and Per3) and two Cry (Cry1 and Cry2) genes. The PER and CRY proteins subsequently
repress the transcription at their own promoters through negative feedback by acting on the
BMAL1-CLOCK heterodimer. The cellular circadian clock mediates the rhythmic output of the
hundreds or thousands of CCG transcripts that are regulated by transcription factors or
coregulators with rhythmic abundance that is a part of the cellular circadian clock [3]. The
prominent transcription factors activated by BMAL1-CLOCK are REV-ERB α and β, which
bind to ROREs, as well as DBP and E4BP4, which bind to D-boxes. E-box motifs contain a core
CANNTG sequence, which is recognised by a basic helix-loop-helix (bHLH) domain that
contains transcription factors. BMAL1-CLOCK binds tandem E boxes spaced 6 or 7 nucleo-
tides (nt) apart with high affinity [6]. The bHLH containing the oncoprotein Myc also binds to
E-boxes and directly activates the expression of multiple repressors of the clock, including Rev-
erbα and Rev-erbβ [7]. In addition, USF1 binds to the E-box motifs of Dbp, Per1 and Per2 [8]. The
RORE motif comprises an AT-rich sequence preceding a core (G/A) GGTCA motif. ROR and
REV-ERB, respectively, activate and repress the transcription of genes by binding to ROREs [9].
They co-ordinately maintain robust circadian expression of core clock proteins, such as BMAL1.
D-boxes are variants of basic leucine-zipper (bZIP) motifs and are 9- or 10-bp palindromes of
two GTAA (C/T) half-site sequences [10]. The D-box motif is bound by the proline- and acidic
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amino acid-rich bZIP (PAR-bZIP) transcription factor family, including DBP, E4BP4, HLF and
TEF [11, 12]. A combination of three binding elements, E-boxes, ROREs and D-boxes, coordi-
nates CCG transcription. Figure 1 shows that most core clock proteins including BMAL1,
CLOCK, PER, CRY, REB-ERB, ROR and E4BP4 bind to many thousands of sites in the genome
in a circadian manner [13].
2.2. Epigenetic mechanism: effect of chromatin structure
Transcriptional regulation initially requires the coordinated control of chromatin and the
genome structure [3]. In general, genetic information is packed into the chromatin structure,
of which the nucleosome is the most basic unit; it determines the large-scale chromatin struc-
ture as a building block and influences transcription. Eukaryotic promoter regions are thought
to have inactive states, assured by the tendency of nucleosomes to inhibit transcription by
protecting protein-DNA interaction. Therefore, chromatin remodelling and loosening of the
nucleosomal barrier including histone tail modifications are key steps in circadian modifica-
tions followed by sequence-specific, transcription factor binding that regulates gene expres-
sions [14]. Distinct chromatin states are determined by unique histone post-translational
modifications. First, histone acetylation levels fluctuate rhythmically at clock gene promoters
and enhancers. Specifically, acetylated histone H3 at Lys27 (H3K27ac), a marker of active
enhancers, and H3 at Lys9 (H3K9ac) are rhythmic and positively correlate with clock gene
expression. For example, rhythmic BMAL1-CLOCK binding and H3K9ac are required as well
as rhythmic histone H3 abundance at the start site for Dbp transcription [15]. Complexes of
clock proteins such as PER contain various interactive partners with known catalytic activity
towards chromatin [16, 17]. The acetylation of histone H3 (at Lys9 and Lys14) at Per1, Per2 and
Cry1 and of H4 at Per1 during the transcriptional activation phase has been identified [18, 19].
Rhythmic histone acetylation at clock loci is largely mediated by p300 and CBP histone
Figure 1. Hierarchical regulation mechanism of circadian transcription. E, RORE and D indicate transcription factor recogni-
tion sites: E-box, RORE and D-box, respectively.
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acetyltransferases (HAT) [15, 19], and CLOCK itself might also have intrinsic HAT activity
[20]. Levels of histone acetylation are also regulated by histone deacetylases (HDAC) as well as
by HAT. Several HDAC are important in the control of circadian histone acetylation. For
example, REV-ERBα represses transcription in part by recruiting the co-repressor complexes
NCoR and/or SMRT to ROREs [21]. One major mechanism of transcriptional repression medi-
ated by CRY and PER is the direct recruitment of the Sin3 complex, which contains HDAC1
and HDAC2 [17]. Another co-repressor complex containing HDAC1 and HDAC2 subunits,
NuRD, binds PER-CRY and deacetylates nearby histones, thereby represses clock genes [22].
Sirtuins are another class of HDAC involved in the core clock mechanism that associate with
the BMAL-CLOCK heterodimer, and levels of their common cofactor, nicotinamide adenine
dinucleotide, are under tight circadian control in many physiological systems [23, 24]. In
addition to being acetylated, lysine side chains can be methylated by methyltransferases, and
their deacetylation often precedes and facilitates an acetylation-methylation switch. Histone H3
at Lys9 methylation (H3K9me) promotes heterochromatin formation and transcriptional repres-
sion. Rhythmic H3K9me near circadian E boxes is mediated by SUV39 methyltransferase and is
antiphase to H3K9ac rhythms in the mouse liver [15]. The di- and trimethylation of H3 at Lys27
also proceed at Per1 and Per2 during the repressive phase [25]. The circadian clock regulates
global transcriptional integrity and chromatin status by regulating RNA polymerase II, because
circadian transcription is clustered in phase and accompanied by circadian control of RNA
polymerase II recruitment and initiation [26]. The above individual mechanism is governed by
the three-dimensional (3D) architecture of chromatin and its critical contributions to long-
distance cis-acting mechanisms of gene regulation [27]. Regulatory elements such as enhancers,
silencers and insulators built up functional 3D architectures in the nucleus and manage the
transcription factory with specific properties [28]. Several looping factors, such as components
of the Mediator complex, interact with clock transcription factors [29]. Deletion of one of the
factors important for looping, Smc3, causes major disruptions to the clock [30]. Recently, the
detailed 3D multi-loop aggregate/rosette chromatin architecture and functional dynamics have
been revealed [31, 32], and this may explain how physiological functions are regulated with a
tissue-specific rhythm in spite of the same core clock system. These results suggest that epige-
netic regulation caused by the chromatin structure is important for circadian transcription, and
further researches from the viewpoint of 3D chromatin structure are required to elucidate the
physiological function with circadian rhythm in the tissue.
2.3. DNA methylation
The most common epigenetic modification is DNA methylation, which is a covalent chemical
alteration that plays a crucial role in numerous biological processes. It occurs in mammals
predominantly on cytosine residues in cytosine-guanine (CpG) dinucleotides, and tissue-
specific genomic DNA methylation patterns play a fundamental role in establishing cell iden-
tity during differentiation. Generally, although about 70% of all CpG sequences in mouse and
human genomes are methylated, CpG islands in promoter sequences are methylated at a
relatively lower level [33]. Overall, DNA methylation exhibits no major rhythmic changes and
the cellular function of DNA methylation depends on which gene is methylated. One of the
most important issues regarding DNA methylation is how the machinery is directed towards
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and maintains specific genomic sequences. One mechanism might be the PML-RAT fusion
protein in leukaemia, which induces DNA hypermethylation and gene silencing at specific
target promoters [34]. Another is siRNA-mediated, RNA-directed DNA methylation, which is
a stepwise process initiated by dsRNA that recruits DNMT to catalyse the de novo DNA
methylation of specific regions [35]. Therefore, the susceptibility of individual CpG islands to
de novo methylation might intrinsically differ, but the mechanism remains obscure. In any
event, CpG methylation is strictly regulated and stable, and changes in methylation profiles
are associated with diseases, indicating close relationships among DNA methylation sites, the
mechanism of methylation and biological functions.
3. Transcriptional regulation of the Bmal1 gene
Bmal1was originally characterised due to its high expression levels in brain andmuscle cells [36].
The activity of Bmal1�/� mice immediately becomes arrhythmic in constant darkness; therefore,
BMAL1 is apparently an essential and non-redundant component of the mammalian clock [37].
Among the core clock genes, BmalL1 expression oscillates in the SCN and in peripheral clock
cells, in close association with circadian rhythms [38]. We evaluated the chromatin structure of
the Bmal1 gene and discovered a unique structure within the Bmal1 promoter. The Bmal1 pro-
moter region comprises mainly a general nucleosome structure upstream of a 50 SacI site, an
open chromatin structure around RORE and a nuclear matrix-like structure at a 30-flanking
region (Figure 2). Oscillatory transcription of the Bmal1 gene requires the chromatin structure to
undergo rhythmic alterations in vivo at the region around the ROREs and at the 30-flanking
region in response to SAF-A binding, indicating cooperative alteration of the chromatin structure
between the 30-flanking region and the ROREs [39]. The methylation of DNA on CpG islands
results in transcriptional repression either by interfering with transcription factor binding or by
including a repressive chromatin structure [40]. The methylation of CpG adjacent to the core Sp1
motif decreases Sp1/Sp3 binding [41], which might be associated with the repression of Bmal1
transcription by DNA methylation, because many putative Sp1-binding motifs are located
around the Bmal1 promoter. The level of DNA methylation within a �1 kb region surrounding
the transcription start site closely correlates with gene repression, and the promoter of clock
genes including Bmal1 is usually unmethylated [39]. However, the hypermethylation of CpG
islands in the promoter of Bmal1 transcriptionally silences its expression in haematological
Figure 2. Chromatin structure of Bmal1 promoter. Oval, unfilled boxes and arrow near BamHI indicate nucleosome,
RORE and transcription start site, respectively. RORE: recognition motifs for retinoic acid receptor-related orphan recep-
tor (ROR) and reverse Erb (REV-ERB) orphan nuclear receptors.
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acetyltransferases (HAT) [15, 19], and CLOCK itself might also have intrinsic HAT activity
[20]. Levels of histone acetylation are also regulated by histone deacetylases (HDAC) as well as
by HAT. Several HDAC are important in the control of circadian histone acetylation. For
example, REV-ERBα represses transcription in part by recruiting the co-repressor complexes
NCoR and/or SMRT to ROREs [21]. One major mechanism of transcriptional repression medi-
ated by CRY and PER is the direct recruitment of the Sin3 complex, which contains HDAC1
and HDAC2 [17]. Another co-repressor complex containing HDAC1 and HDAC2 subunits,
NuRD, binds PER-CRY and deacetylates nearby histones, thereby represses clock genes [22].
Sirtuins are another class of HDAC involved in the core clock mechanism that associate with
the BMAL-CLOCK heterodimer, and levels of their common cofactor, nicotinamide adenine
dinucleotide, are under tight circadian control in many physiological systems [23, 24]. In
addition to being acetylated, lysine side chains can be methylated by methyltransferases, and
their deacetylation often precedes and facilitates an acetylation-methylation switch. Histone H3
at Lys9 methylation (H3K9me) promotes heterochromatin formation and transcriptional repres-
sion. Rhythmic H3K9me near circadian E boxes is mediated by SUV39 methyltransferase and is
antiphase to H3K9ac rhythms in the mouse liver [15]. The di- and trimethylation of H3 at Lys27
also proceed at Per1 and Per2 during the repressive phase [25]. The circadian clock regulates
global transcriptional integrity and chromatin status by regulating RNA polymerase II, because
circadian transcription is clustered in phase and accompanied by circadian control of RNA
polymerase II recruitment and initiation [26]. The above individual mechanism is governed by
the three-dimensional (3D) architecture of chromatin and its critical contributions to long-
distance cis-acting mechanisms of gene regulation [27]. Regulatory elements such as enhancers,
silencers and insulators built up functional 3D architectures in the nucleus and manage the
transcription factory with specific properties [28]. Several looping factors, such as components
of the Mediator complex, interact with clock transcription factors [29]. Deletion of one of the
factors important for looping, Smc3, causes major disruptions to the clock [30]. Recently, the
detailed 3D multi-loop aggregate/rosette chromatin architecture and functional dynamics have
been revealed [31, 32], and this may explain how physiological functions are regulated with a
tissue-specific rhythm in spite of the same core clock system. These results suggest that epige-
netic regulation caused by the chromatin structure is important for circadian transcription, and
further researches from the viewpoint of 3D chromatin structure are required to elucidate the
physiological function with circadian rhythm in the tissue.
2.3. DNA methylation
The most common epigenetic modification is DNA methylation, which is a covalent chemical
alteration that plays a crucial role in numerous biological processes. It occurs in mammals
predominantly on cytosine residues in cytosine-guanine (CpG) dinucleotides, and tissue-
specific genomic DNA methylation patterns play a fundamental role in establishing cell iden-
tity during differentiation. Generally, although about 70% of all CpG sequences in mouse and
human genomes are methylated, CpG islands in promoter sequences are methylated at a
relatively lower level [33]. Overall, DNA methylation exhibits no major rhythmic changes and
the cellular function of DNA methylation depends on which gene is methylated. One of the
most important issues regarding DNA methylation is how the machinery is directed towards
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and maintains specific genomic sequences. One mechanism might be the PML-RAT fusion
protein in leukaemia, which induces DNA hypermethylation and gene silencing at specific
target promoters [34]. Another is siRNA-mediated, RNA-directed DNA methylation, which is
a stepwise process initiated by dsRNA that recruits DNMT to catalyse the de novo DNA
methylation of specific regions [35]. Therefore, the susceptibility of individual CpG islands to
de novo methylation might intrinsically differ, but the mechanism remains obscure. In any
event, CpG methylation is strictly regulated and stable, and changes in methylation profiles
are associated with diseases, indicating close relationships among DNA methylation sites, the
mechanism of methylation and biological functions.
3. Transcriptional regulation of the Bmal1 gene
Bmal1was originally characterised due to its high expression levels in brain andmuscle cells [36].
The activity of Bmal1�/� mice immediately becomes arrhythmic in constant darkness; therefore,
BMAL1 is apparently an essential and non-redundant component of the mammalian clock [37].
Among the core clock genes, BmalL1 expression oscillates in the SCN and in peripheral clock
cells, in close association with circadian rhythms [38]. We evaluated the chromatin structure of
the Bmal1 gene and discovered a unique structure within the Bmal1 promoter. The Bmal1 pro-
moter region comprises mainly a general nucleosome structure upstream of a 50 SacI site, an
open chromatin structure around RORE and a nuclear matrix-like structure at a 30-flanking
region (Figure 2). Oscillatory transcription of the Bmal1 gene requires the chromatin structure to
undergo rhythmic alterations in vivo at the region around the ROREs and at the 30-flanking
region in response to SAF-A binding, indicating cooperative alteration of the chromatin structure
between the 30-flanking region and the ROREs [39]. The methylation of DNA on CpG islands
results in transcriptional repression either by interfering with transcription factor binding or by
including a repressive chromatin structure [40]. The methylation of CpG adjacent to the core Sp1
motif decreases Sp1/Sp3 binding [41], which might be associated with the repression of Bmal1
transcription by DNA methylation, because many putative Sp1-binding motifs are located
around the Bmal1 promoter. The level of DNA methylation within a �1 kb region surrounding
the transcription start site closely correlates with gene repression, and the promoter of clock
genes including Bmal1 is usually unmethylated [39]. However, the hypermethylation of CpG
islands in the promoter of Bmal1 transcriptionally silences its expression in haematological
Figure 2. Chromatin structure of Bmal1 promoter. Oval, unfilled boxes and arrow near BamHI indicate nucleosome,
RORE and transcription start site, respectively. RORE: recognition motifs for retinoic acid receptor-related orphan recep-
tor (ROR) and reverse Erb (REV-ERB) orphan nuclear receptors.
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malignancies [42, 43]. Relationships between the DNA methylation of clock genes and diseases
have been identified. The ROREs, which are critical elements for Bmal1 oscillatory transcription
[44], are embedded in a unique GC-rich open chromatin structure. We also found that DNA
demethylation of the Bmal1 promoter enhances Bmal1, and then Per2 and Cry1 transcription that
function in the circadian oscillation of Bmal1 transcription recover, suggesting that the circadian
rhythm is restored [42, 43]. Furthermore, DNAmethylation might contribute to the developmen-
tal expression of clock genes [45]. These lines of evidence suggest that the DNA methylation of
clock genes, in particular, Bmal1, plays a key role in the disruption of circadian rhythms that are
closely associated with various diseases.
We recently found that recovery from DNA methylation by 5-aza-20-deoxycytidine (aza-dC)
differs between the Bmal1 and Rpib9 genes, suggesting that the release of methylation depends
on the locus/gene or sequence and that methylation status is specific to the DNA site [46].
Taken together, these findings imply that methylation is specific to gene function and that an
early response to the aza-dC demethylation of sites in Bmal1 might be functionally important
for adaptation to environmental change.
4. Disease
Appropriate circadian gene expression is necessary for the normal cell development. That is,
distorted clock gene expression leads to various diseases. This chapter focuses on cancers and
some other diseases.
4.1. Cancer
Close relationships between clock gene expression and the initiation and progression of cancer
are obvious from the findings of many studies. Clock gene expression is altered in many types of
malignancies including breast, lung, haematopoietic, pancreatic and skin cancers. Clock genes
are apt to be downregulated inmany cancer types, as shown inTable 1. These phenomena imply
that clock genes have some anti-tumour effects. The physiological disruption of circadian
Gene Expression Mechanism Cancer type DNA methylation References
Per1 Downregulated Apoptosis Colon, lung, breast — [38]
Per2 Downregulated Apoptosis Lung, lymphocyte — [36, 37]
Downregulated MYC-downregulation Lung, breast — [34, 36, 37]
Downregulated p53-upregulation Lung, breast — [36, 37]
Cry2 Downregulated Unknown Breast Hypermethylation [39, 40]
Bmal1 Downregulated p53 pathway Pancreas — [35]
Downregulated p300, CAT activation Leukaemia Hypermethylation [29, 33, 34]
Table 1. Clock genes and their possible functions for cancer suppression.
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rhythms and the genetic loss of Per2 or Bmal1 promote tumorigenesis in lung cancer [47], and
such disruptions are associated with upregulated c-Myc levels. The expression of Bmal1 is
suppressed in pancreatic cancer, and this gene activates the p53 tumour suppressor pathway,
playing an important role in cancer suppression [48]. Fu et al. found that PER2 is an important
factor for tumour suppression and the DNA damage response [49]. The overexpression of Per1
or Per2 can lead to the apoptosis of cancer cells [50, 51]. Mao et al. reported that Cry2 expression
is decreased in breast cancer, resulting in an altered methylation pattern in CpG islands [52]. The
findings of another study support this observation, and CRY2 suppression is closely associated
with risks for breast cancer [53]. From a mechanistic viewpoint, one of the main factors in such
disrupted circadian gene expression might be MYC. According to a report by Altman et al., this
gene directly activates REV-ERB, which suppresses Bmal1, and their constitutive expression
suspends clock mechanisms [7]. These findings suggest that the appropriate expression of clock
genes is necessary to maintain normal tissues. On the other hand, leukaemia stem cells in acute
myeloid leukaemia (AML) have intact circadian expression. Furthermore, knockdown studies
have shown that Bmal1 and Clock are required for AML cell growth and that disrupted circadian
rhythm machinery is an anti-leukaemic factor that leads to leukaemia stem cell differentiation
[54]. In addition, upregulated Clock plays critical roles in the proliferation of colorectal carcinoma
cells and the inhibition of apoptosis [55].
The roles of clock genes seem to differ among stages or tissues in patients with cancer. In
addition to classical genetic mutations, the epigenetic landscapes of cancer cells are rather
contorted. From an epigenetic perspective, clock genes functionally associate with histone mod-
ifying genes that are responsible for cancer progression and maintenance. Mixed lineage leukae-
mia (MLL) genes were originally discovered through detailed analyses of leukaemogenic
rearrangement but they are now thought to be responsible for histone H3K4 methyltransferase
activity and promoters of target gene transcription. Mutations of MLL genes literally trigger
mixed lineage leukaemia and are necessary to maintain malignancy through aberrant epigenetic
gene regulation [56]. The relationship between MLL genes and circadian rhythm maintenance
through histone modification has been studied in detail. According to Katada et al., MLL1 has
CLOCK-associated histone modifying activity, and it is necessary to generate circadian rhythms
in fibroblasts [57]. Kim et al. found that MLL3 and 4 are factors that regulate circadian rhythmic
homeostasis in the liver [58]. In addition, MLL3 contributes to circadian rhythm generation in
mouse embryonic fibroblasts (MEFs) [59]. The histone modifying enzyme EZH2 is another
histone-lysine N methyl transferase that is responsible for histone H3K27 methyl transfer. This
modification results in transcription repression. Ezh2 also promotes tumorigenesis by altering the
expression of numerous tumour suppressor genes [60]. EZH2 interacts with CLOCK-BMAL1
complexes and is necessary for circadian rhythm maintenance [25]. Although CLOCK per se is
not considered to be an oncogene, it might affect cancer cell proliferation if it is atypically
expressed [55].
Considering the altered methylation patterns of the promoter regions of clock genes, the
features of epigenetic abnormalities of cancer cells comprise highly methylated CpG islands
of specific genes accompanied by low methylation status of other genes [61]. Some studies
have indicated that this phenomenon is true for clock genes. The Cry2 promoter tends to be
highly methylated in patients with breast cancer, resulting in lower Cry2 expression compared
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malignancies [42, 43]. Relationships between the DNA methylation of clock genes and diseases
have been identified. The ROREs, which are critical elements for Bmal1 oscillatory transcription
[44], are embedded in a unique GC-rich open chromatin structure. We also found that DNA
demethylation of the Bmal1 promoter enhances Bmal1, and then Per2 and Cry1 transcription that
function in the circadian oscillation of Bmal1 transcription recover, suggesting that the circadian
rhythm is restored [42, 43]. Furthermore, DNAmethylation might contribute to the developmen-
tal expression of clock genes [45]. These lines of evidence suggest that the DNA methylation of
clock genes, in particular, Bmal1, plays a key role in the disruption of circadian rhythms that are
closely associated with various diseases.
We recently found that recovery from DNA methylation by 5-aza-20-deoxycytidine (aza-dC)
differs between the Bmal1 and Rpib9 genes, suggesting that the release of methylation depends
on the locus/gene or sequence and that methylation status is specific to the DNA site [46].
Taken together, these findings imply that methylation is specific to gene function and that an
early response to the aza-dC demethylation of sites in Bmal1 might be functionally important
for adaptation to environmental change.
4. Disease
Appropriate circadian gene expression is necessary for the normal cell development. That is,
distorted clock gene expression leads to various diseases. This chapter focuses on cancers and
some other diseases.
4.1. Cancer
Close relationships between clock gene expression and the initiation and progression of cancer
are obvious from the findings of many studies. Clock gene expression is altered in many types of
malignancies including breast, lung, haematopoietic, pancreatic and skin cancers. Clock genes
are apt to be downregulated inmany cancer types, as shown inTable 1. These phenomena imply
that clock genes have some anti-tumour effects. The physiological disruption of circadian
Gene Expression Mechanism Cancer type DNA methylation References
Per1 Downregulated Apoptosis Colon, lung, breast — [38]
Per2 Downregulated Apoptosis Lung, lymphocyte — [36, 37]
Downregulated MYC-downregulation Lung, breast — [34, 36, 37]
Downregulated p53-upregulation Lung, breast — [36, 37]
Cry2 Downregulated Unknown Breast Hypermethylation [39, 40]
Bmal1 Downregulated p53 pathway Pancreas — [35]
Downregulated p300, CAT activation Leukaemia Hypermethylation [29, 33, 34]
Table 1. Clock genes and their possible functions for cancer suppression.
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rhythms and the genetic loss of Per2 or Bmal1 promote tumorigenesis in lung cancer [47], and
such disruptions are associated with upregulated c-Myc levels. The expression of Bmal1 is
suppressed in pancreatic cancer, and this gene activates the p53 tumour suppressor pathway,
playing an important role in cancer suppression [48]. Fu et al. found that PER2 is an important
factor for tumour suppression and the DNA damage response [49]. The overexpression of Per1
or Per2 can lead to the apoptosis of cancer cells [50, 51]. Mao et al. reported that Cry2 expression
is decreased in breast cancer, resulting in an altered methylation pattern in CpG islands [52]. The
findings of another study support this observation, and CRY2 suppression is closely associated
with risks for breast cancer [53]. From a mechanistic viewpoint, one of the main factors in such
disrupted circadian gene expression might be MYC. According to a report by Altman et al., this
gene directly activates REV-ERB, which suppresses Bmal1, and their constitutive expression
suspends clock mechanisms [7]. These findings suggest that the appropriate expression of clock
genes is necessary to maintain normal tissues. On the other hand, leukaemia stem cells in acute
myeloid leukaemia (AML) have intact circadian expression. Furthermore, knockdown studies
have shown that Bmal1 and Clock are required for AML cell growth and that disrupted circadian
rhythm machinery is an anti-leukaemic factor that leads to leukaemia stem cell differentiation
[54]. In addition, upregulated Clock plays critical roles in the proliferation of colorectal carcinoma
cells and the inhibition of apoptosis [55].
The roles of clock genes seem to differ among stages or tissues in patients with cancer. In
addition to classical genetic mutations, the epigenetic landscapes of cancer cells are rather
contorted. From an epigenetic perspective, clock genes functionally associate with histone mod-
ifying genes that are responsible for cancer progression and maintenance. Mixed lineage leukae-
mia (MLL) genes were originally discovered through detailed analyses of leukaemogenic
rearrangement but they are now thought to be responsible for histone H3K4 methyltransferase
activity and promoters of target gene transcription. Mutations of MLL genes literally trigger
mixed lineage leukaemia and are necessary to maintain malignancy through aberrant epigenetic
gene regulation [56]. The relationship between MLL genes and circadian rhythm maintenance
through histone modification has been studied in detail. According to Katada et al., MLL1 has
CLOCK-associated histone modifying activity, and it is necessary to generate circadian rhythms
in fibroblasts [57]. Kim et al. found that MLL3 and 4 are factors that regulate circadian rhythmic
homeostasis in the liver [58]. In addition, MLL3 contributes to circadian rhythm generation in
mouse embryonic fibroblasts (MEFs) [59]. The histone modifying enzyme EZH2 is another
histone-lysine N methyl transferase that is responsible for histone H3K27 methyl transfer. This
modification results in transcription repression. Ezh2 also promotes tumorigenesis by altering the
expression of numerous tumour suppressor genes [60]. EZH2 interacts with CLOCK-BMAL1
complexes and is necessary for circadian rhythm maintenance [25]. Although CLOCK per se is
not considered to be an oncogene, it might affect cancer cell proliferation if it is atypically
expressed [55].
Considering the altered methylation patterns of the promoter regions of clock genes, the
features of epigenetic abnormalities of cancer cells comprise highly methylated CpG islands
of specific genes accompanied by low methylation status of other genes [61]. Some studies
have indicated that this phenomenon is true for clock genes. The Cry2 promoter tends to be
highly methylated in patients with breast cancer, resulting in lower Cry2 expression compared
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with controls [43]. Taniguchi et al. reported that CpG islands of the Bmal1 promoter are
hypermethylated in diffuse large B-cell lymphoma and in acute lymphocytic and myeloid
leukaemia [42]. We also reported this phenomenon and that the methylation pattern of the
Per2 promoter region does not change in RPMI8402 cells [46]. The aberrant methylation
pattern of the Bmal1 promoter was restored, and the intrinsic rhythm was revived after 1 day
of aza-dC treatment. These findings indicate that active mechanisms in leukaemia cells main-
tain the promoters of hypermethylated Bmal1 gene status.
As noted above, many studies have emphasised close relationships between epigenetic modifi-
cation and circadian clock genes in cancer proliferation and progression. However, the precise
mechanisms seem highly complex and remain obscure. Further investigation is required to
elucidate these mechanisms.
4.2. Other diseases
Circadian rhythms are also associated with diseases other than cancer through effects on the
cardiovascular, renal, immune, endocrine, neuropsychiatric and metabolic systems [5, 62–67].
Many physiological processes cannot be harmonised when the intrinsic rhythm is aberrant and
such dyssynchrony leads to many diseases.
Here, we consider neuropsychiatric disorders. Disrupted sleep-wake cycles, depression,
Alzheimer’s disease and mood disorders among neuropsychiatric disorders are notably linked
to altered circadian rhythms. However, circadian epigenomics have received less consideration
in studies of neuropsychiatric disorders compared with cancers.
Alzheimer’s disease is an age-dependent neurodegenerative disorder that is associated with
severe cognitive impairment, and its incidence is increasing, particularly in developed countries
due to extended life spans. The typical clinical symptoms are disordered circadian rhythms and
abnormal sleep patterns. Amyloid beta is a key molecule in this neurodegeneration [68], and it
reportedly degrades BMAL1 protein [69]. The lack of this powerful rhythm generator disrupts
circadian rhythms in many patients. Furthermore, the methylation rhythm of the Bmal1 pro-
moter changes in the neocortex of patients with this disease. These phenomena imply that the
aberrant methylation of the Bmal1 promoter and rapid BMAL1 degradation together affect
behavioural changes or cognitive impairments. Furthermore, a methylome study of the neocor-
tex of brains at autopsy revealed attenuated methylation rhythms in samples from patients with
Alzheimer disease compared with controls [70]. The neocortex is very rare in terms of tissues
with circadian methylation rhythms.
According to many studies, contorted clock gene expression patterns and mood disorders are
closely associated in experimental animal models. Genetic experiments have found that
CLOCK is a key factor in maniac states because Clock mutant mice (ClockΔ19) develop clear
features [71–73] of mania, circadian rhythm disruption, hyperactivity and decreased sleep. The
physiological features of these mutant mice include altered gene expression patterns and
excited neurons due to upregulated dopamine content in the ventral tegmental area (VTA)
[74]. Notably, knockdown of CLOCK in the VTA using RNA interference results in concomi-
tant mania-like (hyperactivity and decreased anxiety) and depression-like behaviours in mice.
Since patients with mania often experience depressive episodes, this knockdown mouse is a
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more appropriate model of mania in humans. However, precisely how these CLOCK disrup-
tions affect the upregulated dopamine content in the VTA remains obscure. The expression of
monoamine oxidase A (MAOA), which inactivates monoamine neurotransmitters including
dopamine, serotonin and norepinephrine, is regulated by circadian clock genes including Bmal1,
Npas2 and Per2 [75]. However, in this mechanism, CLOCK, unlike NPAS2, does not work as a
transcriptional activator. Therefore, the absence of CLOCK directly results in downregulated
MAOA activity, and consequent dopamine upregulation cannot be concluded. Some other
CLOCK functions including histone modification activity or an indirect action of CLOCK might
be involved in dopamine upregulation, and investigations into this are underway.
Patients with depression frequently have insomnia and abnormal circadian rhythms that could
reasonably relate to altered clock gene expression. Circadian clock gene expression has been
compared between post-mortem brain samples from patients with major depressive disorder
(MDD) and age-matched controls [76]. The findings showed abnormal clock gene phasing and
decreased Bmal1 and Per2 oscillation in most brain regions of the patients. These findings
provided direct evidence that clock gene expression is altered in the central nervous system of
patients with MDD. On the other hand, depression states and anti-depressant effects are often
tested in experimental animal models such as laboratory mice that are suspended by the tail or
forced to swim to mimic short duration stress or exposed to social defeat to mimic chronic stress
[77]. The volume of the hippocampus is reduced in both patients and in a model that develops
depressive pathophysiology after exposure to chronic stress, and this volume is restored by
administering anti-depressant medicine. Brain-derived neurotropic factor (BDNF) plays a very
important role in the hippocampus as an anti-depressant and for adaptation to stress. Anti-
depressants enhance BDNF expression in the mouse brain [78]; BDNF infused into the hippo-
campus has anti-depressant effects in behavioural mouse models of depression [78, 79] and the
action of the anti-depressant desipramine is attenuated mice with a BDNF deletion in the
forebrain [78, 80]. Expression of Bdnf gene is rhythmic in rat brain regions including hippocam-
pus. However, its downregulation in an animal model of depression was due to the methylation
status of the promoter region of the Bdnf gene [81]. Tsankova et al. found that the expression of
two BDNF variants, Bdnf III and IV, is downregulated and that the promoter regions of corresp-
onding variants are hypermethylated in laboratory mice exposed to defeat stress [82]. Further-
more, chronic imipramine administration increased histone acetylation on the corresponding
promoters, and this downregulation was reversed. The findings of the above studies indicate
that Bdnf gene expression is rhythmically maintained under normal conditions but is epigeneti-
cally regulated under stress. However, precisely how Bdnf expression is rhythmically maintained
remains unclear and awaits further investigation.
5. Assays of Bmal1 transcription modulators
The circadian clock controls the daily oscillations of gene expression and physiological function
at the cellular level, indicating that the control of circadian rhythms at the cellular level is
important for human health. After we elucidated the transcriptional mechanism of the non-
redundant essential unique clock gene, Bmal1, we developed a circadian functional assay system
that consists of luminescent reporter cells and the application of Bmal1 findings. We found that
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with controls [43]. Taniguchi et al. reported that CpG islands of the Bmal1 promoter are
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leukaemia [42]. We also reported this phenomenon and that the methylation pattern of the
Per2 promoter region does not change in RPMI8402 cells [46]. The aberrant methylation
pattern of the Bmal1 promoter was restored, and the intrinsic rhythm was revived after 1 day
of aza-dC treatment. These findings indicate that active mechanisms in leukaemia cells main-
tain the promoters of hypermethylated Bmal1 gene status.
As noted above, many studies have emphasised close relationships between epigenetic modifi-
cation and circadian clock genes in cancer proliferation and progression. However, the precise
mechanisms seem highly complex and remain obscure. Further investigation is required to
elucidate these mechanisms.
4.2. Other diseases
Circadian rhythms are also associated with diseases other than cancer through effects on the
cardiovascular, renal, immune, endocrine, neuropsychiatric and metabolic systems [5, 62–67].
Many physiological processes cannot be harmonised when the intrinsic rhythm is aberrant and
such dyssynchrony leads to many diseases.
Here, we consider neuropsychiatric disorders. Disrupted sleep-wake cycles, depression,
Alzheimer’s disease and mood disorders among neuropsychiatric disorders are notably linked
to altered circadian rhythms. However, circadian epigenomics have received less consideration
in studies of neuropsychiatric disorders compared with cancers.
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reportedly degrades BMAL1 protein [69]. The lack of this powerful rhythm generator disrupts
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moter changes in the neocortex of patients with this disease. These phenomena imply that the
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physiological features of these mutant mice include altered gene expression patterns and
excited neurons due to upregulated dopamine content in the ventral tegmental area (VTA)
[74]. Notably, knockdown of CLOCK in the VTA using RNA interference results in concomi-
tant mania-like (hyperactivity and decreased anxiety) and depression-like behaviours in mice.
Since patients with mania often experience depressive episodes, this knockdown mouse is a
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more appropriate model of mania in humans. However, precisely how these CLOCK disrup-
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transcriptional activator. Therefore, the absence of CLOCK directly results in downregulated
MAOA activity, and consequent dopamine upregulation cannot be concluded. Some other
CLOCK functions including histone modification activity or an indirect action of CLOCK might
be involved in dopamine upregulation, and investigations into this are underway.
Patients with depression frequently have insomnia and abnormal circadian rhythms that could
reasonably relate to altered clock gene expression. Circadian clock gene expression has been
compared between post-mortem brain samples from patients with major depressive disorder
(MDD) and age-matched controls [76]. The findings showed abnormal clock gene phasing and
decreased Bmal1 and Per2 oscillation in most brain regions of the patients. These findings
provided direct evidence that clock gene expression is altered in the central nervous system of
patients with MDD. On the other hand, depression states and anti-depressant effects are often
tested in experimental animal models such as laboratory mice that are suspended by the tail or
forced to swim to mimic short duration stress or exposed to social defeat to mimic chronic stress
[77]. The volume of the hippocampus is reduced in both patients and in a model that develops
depressive pathophysiology after exposure to chronic stress, and this volume is restored by
administering anti-depressant medicine. Brain-derived neurotropic factor (BDNF) plays a very
important role in the hippocampus as an anti-depressant and for adaptation to stress. Anti-
depressants enhance BDNF expression in the mouse brain [78]; BDNF infused into the hippo-
campus has anti-depressant effects in behavioural mouse models of depression [78, 79] and the
action of the anti-depressant desipramine is attenuated mice with a BDNF deletion in the
forebrain [78, 80]. Expression of Bdnf gene is rhythmic in rat brain regions including hippocam-
pus. However, its downregulation in an animal model of depression was due to the methylation
status of the promoter region of the Bdnf gene [81]. Tsankova et al. found that the expression of
two BDNF variants, Bdnf III and IV, is downregulated and that the promoter regions of corresp-
onding variants are hypermethylated in laboratory mice exposed to defeat stress [82]. Further-
more, chronic imipramine administration increased histone acetylation on the corresponding
promoters, and this downregulation was reversed. The findings of the above studies indicate
that Bdnf gene expression is rhythmically maintained under normal conditions but is epigeneti-
cally regulated under stress. However, precisely how Bdnf expression is rhythmically maintained
remains unclear and awaits further investigation.
5. Assays of Bmal1 transcription modulators
The circadian clock controls the daily oscillations of gene expression and physiological function
at the cellular level, indicating that the control of circadian rhythms at the cellular level is
important for human health. After we elucidated the transcriptional mechanism of the non-
redundant essential unique clock gene, Bmal1, we developed a circadian functional assay system
that consists of luminescent reporter cells and the application of Bmal1 findings. We found that
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the minimal essential region of the Bmal1 promoter for circadian transcription is embedded in an
open chromatin structure, suggesting that this region can remain functional even when inserted
into a reporter plasmid [39]. We then established stable reporter cell lines with which to analyse
circadian clock function [83] and the effects of DNAmethylation on circadian clock function [43].
Figure 3 shows the application of these systems to further dissection of the molecular mecha-
nisms underlying the mammalian circadian clock [46, 84, 85].
One of the most important findings was that altering the DNA configuration of the Bmal1
promoter causes the epigenetic regulation of Bmal1 circadian transcription [86]. Topoisomerase
I (TOP1) is located at an intermediate region between two ROREs that are critical cis-elements
of circadian transcription, which is required for transcriptional suppression in cooperation
with the distal RORE. The DNA fragment between the ROREs, where the TOP1-binding site
is located, behaved like a right-handed superhelical twist, and the modulation of TOP1 activity
by the TOP1 inhibitor, camptothecin and Top1 siRNA altered the footprint, indicating the
modulation of the chromatin structure. These findings indicated that TOP1 modulates the
chromatin structure of the Bmal1 promoter, regulates the Bmal1 transcription and influences
the circadian period.
Figure 3. Monitoring cellular circadian clock system using stable reporter cell line. (A) Monitoring method. Promoter
region (202 to +27) of Bmal1 was inserted into pGL3-dluc and used to create cell lines with stable, real-time reporter gene
to evaluate cellular circadian clock system. (B) Circadian oscillation monitored using host NIH3T3 cells. (C) Circadian
oscillation monitored using host CPT-K cells with hypermethylated Bmal1 promoter region. Cells with stable gene
expression derived from CPT-K cells were incubated with 2.5 μM aza-dC for 2 days, stimulated with 50% FBS for 2 h
and then bioluminescence was measured. Detrended fit curves are representative of at least three independent experi-
ments (control, grey; aza-dC, black). Dots, raw values; lines, fit curve data.
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Another important finding was the epigenetic inactivation or DNA methylation of the Bmal1
promoter. The methylation status of the Bmal1 promoter is critical for the circadian system.
Because the Bmal1 gene is inactivated by the DNA hypermethylation of its promoter, the
circadian oscillation of Bmal1 transcription was absent in the haematological malignant cells.
The demethylating agent aza-dC restored circadian oscillation, whereas continuous Bmal1
expression did not. Because BMAL1 protein has distinct tissue-specific regulation and func-
tions [87], tissue-specific regulation of BMAL1 expression might be required, and this can be
introduced endogenously by aza-dC to establish the negative feedback loop system and
restore circadian oscillation. Because the Bmal1 promoter is basically hypomethylated, the
methyltransferases DNMT3a and DNMT3b might be mainly responsible for introducing cyto-
sine methylation de novo at unmethylated CpG sites in the promoter [40]. The methylation of
DNA contributes to the expression of clock genes [45] in addition to Bmal1, a key player in the
disruption of circadian rhythms.
6. Conclusion
Circadian rhythms control all aspects of physiology. When they are disrupted by changes in clock
gene expression, various critical intracellular physiological processes become dysregulated, and
this can lead to diseases that are induced partly by epigenetic effects including DNA methyation.
The pathologies that are closely associated with disrupted circadian rhythms include cancer [88],
dementia [89], Parkinson’s disease [90] and obesity [91]. Among the clock genes, Bmal1 is unique
because the loss of BMAL1 protein in mice results in immediate and complete loss of circadian
rhythmicity [33], indicating the importance of a specific amount of BMAL1 expression for circa-
dian rhythms. In addition, DNAmethylation of the Bmal1 promoter disrupts the circadian system
even when the Per and Cry gene promoters are unmethylated, indicating that the Bmal1 gene is
functionally important [43]. Epigenetic regulation, especially DNA methylation status, is specific
to DNA sites and gene functions. Therefore, the finding that the epigenetic transcriptional regula-
tion of Bmal1 is functionally important for adaptation to environmental changes provides novel
insights into clock gene functions that should affect the clinical diagnosis and treatment of
diseases. Therefore, modulators of Bmal1 transcription are needed for the human health.
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the minimal essential region of the Bmal1 promoter for circadian transcription is embedded in an
open chromatin structure, suggesting that this region can remain functional even when inserted
into a reporter plasmid [39]. We then established stable reporter cell lines with which to analyse
circadian clock function [83] and the effects of DNAmethylation on circadian clock function [43].
Figure 3 shows the application of these systems to further dissection of the molecular mecha-
nisms underlying the mammalian circadian clock [46, 84, 85].
One of the most important findings was that altering the DNA configuration of the Bmal1
promoter causes the epigenetic regulation of Bmal1 circadian transcription [86]. Topoisomerase
I (TOP1) is located at an intermediate region between two ROREs that are critical cis-elements
of circadian transcription, which is required for transcriptional suppression in cooperation
with the distal RORE. The DNA fragment between the ROREs, where the TOP1-binding site
is located, behaved like a right-handed superhelical twist, and the modulation of TOP1 activity
by the TOP1 inhibitor, camptothecin and Top1 siRNA altered the footprint, indicating the
modulation of the chromatin structure. These findings indicated that TOP1 modulates the
chromatin structure of the Bmal1 promoter, regulates the Bmal1 transcription and influences
the circadian period.
Figure 3. Monitoring cellular circadian clock system using stable reporter cell line. (A) Monitoring method. Promoter
region (202 to +27) of Bmal1 was inserted into pGL3-dluc and used to create cell lines with stable, real-time reporter gene
to evaluate cellular circadian clock system. (B) Circadian oscillation monitored using host NIH3T3 cells. (C) Circadian
oscillation monitored using host CPT-K cells with hypermethylated Bmal1 promoter region. Cells with stable gene
expression derived from CPT-K cells were incubated with 2.5 μM aza-dC for 2 days, stimulated with 50% FBS for 2 h
and then bioluminescence was measured. Detrended fit curves are representative of at least three independent experi-
ments (control, grey; aza-dC, black). Dots, raw values; lines, fit curve data.
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Another important finding was the epigenetic inactivation or DNA methylation of the Bmal1
promoter. The methylation status of the Bmal1 promoter is critical for the circadian system.
Because the Bmal1 gene is inactivated by the DNA hypermethylation of its promoter, the
circadian oscillation of Bmal1 transcription was absent in the haematological malignant cells.
The demethylating agent aza-dC restored circadian oscillation, whereas continuous Bmal1
expression did not. Because BMAL1 protein has distinct tissue-specific regulation and func-
tions [87], tissue-specific regulation of BMAL1 expression might be required, and this can be
introduced endogenously by aza-dC to establish the negative feedback loop system and
restore circadian oscillation. Because the Bmal1 promoter is basically hypomethylated, the
methyltransferases DNMT3a and DNMT3b might be mainly responsible for introducing cyto-
sine methylation de novo at unmethylated CpG sites in the promoter [40]. The methylation of
DNA contributes to the expression of clock genes [45] in addition to Bmal1, a key player in the
disruption of circadian rhythms.
6. Conclusion
Circadian rhythms control all aspects of physiology. When they are disrupted by changes in clock
gene expression, various critical intracellular physiological processes become dysregulated, and
this can lead to diseases that are induced partly by epigenetic effects including DNA methyation.
The pathologies that are closely associated with disrupted circadian rhythms include cancer [88],
dementia [89], Parkinson’s disease [90] and obesity [91]. Among the clock genes, Bmal1 is unique
because the loss of BMAL1 protein in mice results in immediate and complete loss of circadian
rhythmicity [33], indicating the importance of a specific amount of BMAL1 expression for circa-
dian rhythms. In addition, DNAmethylation of the Bmal1 promoter disrupts the circadian system
even when the Per and Cry gene promoters are unmethylated, indicating that the Bmal1 gene is
functionally important [43]. Epigenetic regulation, especially DNA methylation status, is specific
to DNA sites and gene functions. Therefore, the finding that the epigenetic transcriptional regula-
tion of Bmal1 is functionally important for adaptation to environmental changes provides novel
insights into clock gene functions that should affect the clinical diagnosis and treatment of
diseases. Therefore, modulators of Bmal1 transcription are needed for the human health.
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Abstract
The regulation of chromatin structure and gene expression depends substantially on a 
dynamic and intricate layer of biological and chemical information that constitutes the 
epigenome. This epigenetic layer of information holds fundamental clues to the molecu-
lar mechanisms, not yet fully understood, by which a genotype can influence and con-
figure a specific phenotype. A profound understanding of the molecular underpinnings 
of epigenetic processes is, thus, essential to wield deliberate spatiotemporal control of 
gene activation and repression. However, only recently has the technology required to 
adequately probe the functional significance of specific epigenetic mechanisms become 
available. This chapter provides an overview of modern epigenome editing systems, 
including zinc finger proteins, TAL effectors, and CRISPR–Cas systems. It highlights the 
use of biotechnological tools to investigate the role of DNA and histone post-translational 
modifications as well as regulatory RNAs to manipulate specific patterns of gene expres-
sion. This chapter further discusses the technological limitations that have limited our 
ability to elucidate epigenetic mechanisms in local and genome-wide contexts.
Keywords: epigenome editing, epigenetic manipulation, CRISPR, CRISPR–dCas9, 
ZFNs, TALENs, epigenome engineering, targeted gene activation and repression, 
epigenetics
1. Introduction
Elucidating the underlying basis for the molecular links that bridge the gap between geno-
type and phenotype has propelled research and scientific discovery for decades. More than 
three-quarters of a century have passed since Conrad Waddington introduced the concept 
of “epigenetics.” The term signaled an attempt to describe the causal links by which genes 
give rise to specific phenotypes in the context of developmental changes that drive cellular 
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differentiation [1]. Waddington’s “epigenetic landscapes” [2] laid a foundation for exploring 
phenotypic plasticity as a phenomenon that is not entirely dependent on genetic mechanisms, 
but one which can also be shaped by environmental cues that concomitantly orchestrate the 
process of cell differentiation from an initial totipotent state [3].
The scope of epigenetics as a scientific discipline, much like its definition, has expanded with the 
passage of time. Today, the field broadly refers to the study of fundamental processes related to 
mitotic and meiotic stable and heritable changes that emerge without alteration of DNA sequences 
[3–5]. Stable changes encompass durable alterations in gene expression patterns, which may be 
neither permanent nor heritable. In contrast, heritable changes in gene expression may constitute 
persistent alterations that are carried onto the progeny of cells or individual organisms [6].
In the last two decades, the emerging field of epigenetics has revealed crucial information 
about the regulation of chromatin states in the eukaryotic nucleus. Heterochromatic DNA is 
organized into compact, higher order, chromatin fibers. By contrast, euchromatic DNA com-
prises lightly packed chromatin that represents an active and accessible part of the genome. 
Both states feature an array of nucleosomes, the basic subunits of chromatin, consisting of 
approximately 145–147 base pairs of DNA wrapped around a core histone octamer [7]. Each 
histone octamer carries two copies of all of the core histone proteins—H2A, H2B, H3, H4—
assembled into nucleosomes, which are subsequently stabilized into high-order chromatin 
structures by the presence of the linker histone H1 and linker DNA [7].
The organization and regulation of chromatin at the epigenetic level depend on dynamic 
and diverse combinations of covalent chemical modifications that occur on histone proteins—
known as histone post-translational modifications (PTMs)—and DNA bases, as well as the 
expression of regulatory noncoding RNA (ncRNA) molecules [3]. Together, these epigenetic 
signals and ncRNAs constitute a layer of information that controls the spatiotemporal regula-
tion of gene expression patterns by remodeling the structure of chromatin and modulating its 
bio-physicochemical properties.
The scientific community has made great strides in elucidating functional roles for epigenetic 
processes in recent years. Progress has come at the hand of biotechnologies aimed at manipu-
lating endogenous, site-specific epigenetic targets. The technologies rely on the use of catalyti-
cally active or scaffolding epigenetic effectors fused to programmable DNA-binding proteins 
that target specific genetic loci. This chapter focuses on the three most important platforms for 
modern targeted epigenome editing: zinc finger proteins, transcription activator-like effec-
tors (TALEs), and clustered, regularly interspaced, short palindromic repeats (CRISPR), and 
CRISPR-associated sequences (Cas) (CRISPR–Cas) systems.
Notwithstanding the progress made in recent years, much remains to be learned about 
epigenetic mechanisms in development, cellular programming, disease, and personalized 
medicine. Epigenome editing technologies are poised to make significant contributions to the 
field of epigenetics. This chapter provides an overview of each epigenome editing system, 
highlights their use for manipulating specific patterns of gene expression, and discusses the 
technological limitations that have thus far limited our ability to interrogate the mechanisms 
of epigenetic regulation in local and genome-wide contexts.
Chromatin and Epigenetics146
2. Programmable epigenome editing systems
Regulating endogenous levels of gene expression by targeting specific epigenetic modifications 
is a relatively nascent field. Basic scientific research in the last few decades has provided insights 
that facilitated the development of technologies aimed at interrogating epigenetic processes. At 
their core, epigenome editing tools are based on the concept of fusing programmable DNA-
binding proteins that target specific genetic loci, with catalytically active or scaffolding effector 
domains that exert some influence on epigenetic processes. The three most important molecular 
tools that have been developed for targeted epigenome editing are zinc finger proteins, TALEs, 
and CRISPR–Cas systems. All have been repurposed into epigenome editing platforms designed 
to manipulate gene expression patterns in particular contexts. An overview of each system is pro-
vided below. However, it should be noted that other, less common, tools have also been devel-
oped to probe epigenetic mechanisms and modulate gene expression in a sequence-dependent 
manner including synthetic polyamides [8] and triple helix-forming oligonucleotides (TFOs) [9].
2.1. Zinc finger-based systems
Zinc finger proteins are among the most characterized systems used for the manipulation 
of targeted, sequence-specific nucleic acids. Their discovery arose from research of tran-
scriptional mechanisms in Xenopus laevis oocytes dating back to over three decades ago. At 
the time, scientists realized that a unique set of proteins, containing repetitive zinc-binding 
domains of roughly 30 amino acid residues, was required for transcription factor-mediated 
gene regulation [10]. These finger-like peptide arrangements rely on interactions between 
conserved pairs of cysteine and histidine residues that are anchored by a centered and tet-
rahedrally coordinated zinc ion (Figure 1). From a structural standpoint, each zinc finger 
Figure 1. Crystal structure of two zinc finger proteins in complex with DNA. (A) Recognition of target DNA (blue) by 
two distinct zinc finger proteins (orange and green). A tetrahedrally coordinated zinc ion (red) stabilizes each zinc finger 




differentiation [1]. Waddington’s “epigenetic landscapes” [2] laid a foundation for exploring 
phenotypic plasticity as a phenomenon that is not entirely dependent on genetic mechanisms, 
but one which can also be shaped by environmental cues that concomitantly orchestrate the 
process of cell differentiation from an initial totipotent state [3].
The scope of epigenetics as a scientific discipline, much like its definition, has expanded with the 
passage of time. Today, the field broadly refers to the study of fundamental processes related to 
mitotic and meiotic stable and heritable changes that emerge without alteration of DNA sequences 
[3–5]. Stable changes encompass durable alterations in gene expression patterns, which may be 
neither permanent nor heritable. In contrast, heritable changes in gene expression may constitute 
persistent alterations that are carried onto the progeny of cells or individual organisms [6].
In the last two decades, the emerging field of epigenetics has revealed crucial information 
about the regulation of chromatin states in the eukaryotic nucleus. Heterochromatic DNA is 
organized into compact, higher order, chromatin fibers. By contrast, euchromatic DNA com-
prises lightly packed chromatin that represents an active and accessible part of the genome. 
Both states feature an array of nucleosomes, the basic subunits of chromatin, consisting of 
approximately 145–147 base pairs of DNA wrapped around a core histone octamer [7]. Each 
histone octamer carries two copies of all of the core histone proteins—H2A, H2B, H3, H4—
assembled into nucleosomes, which are subsequently stabilized into high-order chromatin 
structures by the presence of the linker histone H1 and linker DNA [7].
The organization and regulation of chromatin at the epigenetic level depend on dynamic 
and diverse combinations of covalent chemical modifications that occur on histone proteins—
known as histone post-translational modifications (PTMs)—and DNA bases, as well as the 
expression of regulatory noncoding RNA (ncRNA) molecules [3]. Together, these epigenetic 
signals and ncRNAs constitute a layer of information that controls the spatiotemporal regula-
tion of gene expression patterns by remodeling the structure of chromatin and modulating its 
bio-physicochemical properties.
The scientific community has made great strides in elucidating functional roles for epigenetic 
processes in recent years. Progress has come at the hand of biotechnologies aimed at manipu-
lating endogenous, site-specific epigenetic targets. The technologies rely on the use of catalyti-
cally active or scaffolding epigenetic effectors fused to programmable DNA-binding proteins 
that target specific genetic loci. This chapter focuses on the three most important platforms for 
modern targeted epigenome editing: zinc finger proteins, transcription activator-like effec-
tors (TALEs), and clustered, regularly interspaced, short palindromic repeats (CRISPR), and 
CRISPR-associated sequences (Cas) (CRISPR–Cas) systems.
Notwithstanding the progress made in recent years, much remains to be learned about 
epigenetic mechanisms in development, cellular programming, disease, and personalized 
medicine. Epigenome editing technologies are poised to make significant contributions to the 
field of epigenetics. This chapter provides an overview of each epigenome editing system, 
highlights their use for manipulating specific patterns of gene expression, and discusses the 
technological limitations that have thus far limited our ability to interrogate the mechanisms 
of epigenetic regulation in local and genome-wide contexts.
Chromatin and Epigenetics146
2. Programmable epigenome editing systems
Regulating endogenous levels of gene expression by targeting specific epigenetic modifications 
is a relatively nascent field. Basic scientific research in the last few decades has provided insights 
that facilitated the development of technologies aimed at interrogating epigenetic processes. At 
their core, epigenome editing tools are based on the concept of fusing programmable DNA-
binding proteins that target specific genetic loci, with catalytically active or scaffolding effector 
domains that exert some influence on epigenetic processes. The three most important molecular 
tools that have been developed for targeted epigenome editing are zinc finger proteins, TALEs, 
and CRISPR–Cas systems. All have been repurposed into epigenome editing platforms designed 
to manipulate gene expression patterns in particular contexts. An overview of each system is pro-
vided below. However, it should be noted that other, less common, tools have also been devel-
oped to probe epigenetic mechanisms and modulate gene expression in a sequence-dependent 
manner including synthetic polyamides [8] and triple helix-forming oligonucleotides (TFOs) [9].
2.1. Zinc finger-based systems
Zinc finger proteins are among the most characterized systems used for the manipulation 
of targeted, sequence-specific nucleic acids. Their discovery arose from research of tran-
scriptional mechanisms in Xenopus laevis oocytes dating back to over three decades ago. At 
the time, scientists realized that a unique set of proteins, containing repetitive zinc-binding 
domains of roughly 30 amino acid residues, was required for transcription factor-mediated 
gene regulation [10]. These finger-like peptide arrangements rely on interactions between 
conserved pairs of cysteine and histidine residues that are anchored by a centered and tet-
rahedrally coordinated zinc ion (Figure 1). From a structural standpoint, each zinc finger 
Figure 1. Crystal structure of two zinc finger proteins in complex with DNA. (A) Recognition of target DNA (blue) by 
two distinct zinc finger proteins (orange and green). A tetrahedrally coordinated zinc ion (red) stabilizes each zinc finger 




comprises an antiparallel β sheet and α helix, which are stabilized by the zinc ion and a set of 
hydrophobic residues [11]. The α helix of each zinc finger binds directly to the major groove 
of B-DNA. Residues from the NH2-terminal region of the helix mediate recognition of a three 
base-pair target site [11]. Thus, side chain residues in the α helix that can be engineered to 
recognize diverse nucleic acid base-pair triplets drive the double-stranded DNA sequence 
specificity of each zinc finger.
The intrinsic modularity of DNA recognition by zinc finger proteins led to the swift develop-
ment of a range of biotechnological applications. For example, manipulation of gene expres-
sion via site-specific, DNA-binding zinc finger proteins was first established by targeting a 9 
base-pair region of a BCR-ABL fusion oncogene [12]. Using a three-zinc finger peptide, scien-
tists demonstrated that transcriptional repression of a leukemic oncogene in a chromosomal 
DNA context was possible [12].
Similarly, the development of zinc finger nucleases (ZFNs) marked an important milestone 
for modern genome editing biotechnologies. ZFNs are engineered chimeric fusions composed 
of a set of tandem zinc finger DNA-binding proteins and a nuclease domain—such as the 
catalytic domain of the restriction endonuclease FokI—that cleaves DNA [13]. Synthetic zinc 
finger-FokI fusions coupled the DNA sequence specificity of zinc finger proteins with the non-
specific cleavage activity of FokI to trigger double-stranded breaks at desired genomic loci. 
Importantly, repurposing zinc finger proteins into ZFNs facilitated the path for epigenome 
editing biotechnologies aimed at controlling transcriptional activation and repression.
Zinc finger-related epigenome editing tools are based on the concept of fusing program-
mable, DNA binding, zinc finger proteins designed to target diverse sequences [14, 15] with 
catalytically active or scaffolding effector domains. The chimeric proteins are designed to alter 
gene expression patterns and act as artificial transcription factors (ATFs) [15]. Pioneer studies 
on transcriptional repression by directing DNA cytosine methylation [16] and local histone 
H3K9 methylation [17] deposition at specific promoter sequences established the feasibility of 
the approach in the late 1990s and early 2000s. The use of zinc finger-based epigenome edit-
ing tools has contributed valuable insights into epigenetic mechanisms, as will be discussed 
in the next section. However, the high cost and technical expertise required to engineer and 
validate context-dependent specificity in zinc finger proteins [18, 19] has greatly limited their 
widespread adoption.
2.2. TALE-based systems
Transcription activator-like effectors (TALEs) are proteins of bacterial origin. They were first 
reported in the literature in 2007, after two independent research groups discovered that cer-
tain bacterial proteins can bind specific promoter sequences in eukaryotic cells [20, 21]. Upon 
binding to DNA, the pathogenic effector proteins induce the expression of genes that promote 
the spread of bacterial infection in host cells. TALEs are secreted by gram-negative bacteria of 
the Xanthomonas genus and injected into eukaryotic cells via the type III secretion system [22]. 
Once inside the eukaryotic cell, they translocate directly to the nucleus where they act as tran-
scription factors to regulate the expression of genes that support bacterial infection [20, 21].
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The molecular basis for DNA recognition of each TALE comes from a central tandem amino 
acid repeat domain of approximately 33–35 residues in length [23, 24]. This tandem repeat is 
flanked by an N-terminal region required for type III secretion and a C-terminal region involved 
in nuclear localization and transcriptional activation. Each repeat folds into two left-handed α 
helices linked by a short loop that contains two hypervariable residues, known as the repeat 
variable diresidues (RVDs). The RVDs occupy positions 12 and 13 of each repeat, where the 
12th residue stabilizes the RVD loop by mediating contacts with the protein backbone, while 
the 13th residue interacts directly with a specific nucleotide nitrogenous base (Figure 2). Thus, 
the DNA specificity of TALEs is modular and encoded in the tandem repeat sequence [25, 26].
Unlike zinc fingers, which require triplet sequence recognition sites, TALEs are able to target a 
single nucleotide at a time through its RVDs. This characteristic makes TALEs simpler to engi-
neer and has enabled the rational design of artificial TALEs for biotechnological applications 
[26]. Indeed, borrowing from its ZFN predecessors, TALE proteins fused to the FokI nuclease 
domain gave rise to TALE nucleases (TALENs), which have been utilized for genome editing 
applications [27].
Similarly, fusions of TALEs to epigenetic effectors have been repurposed for epigenome editing 
to manipulate gene expression. For example, TALE fusions to activation domains have shown 
the ability to target specific genomic loci and induce robust transcriptional activation [28]. 
Inactivation of enhancer regulatory elements has also been demonstrated using TALE fusions to 
chromatin effectors targeting specific histone modifications [29], thereby establishing a platform 
to interrogate the function of specific regulatory elements in diverse chromatin landscapes.
Figure 2. Structure of a TAL effector bound to its target DNA. (A) The TALE tandem amino acid repeats (multi-colored 
helices) associate into a right-handed superhelix that wraps around the major groove of the target DNA (blue). (B) 
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Despite the advantages of possessing modular properties compared to zinc finger proteins 
and the improvements made in design and assembly of custom TALE-based systems [30, 
31], significant technological shortcomings remain to be addressed. The highly repetitive 
sequences associated with TALE tandem repeats make them susceptible to rearrangements 
when expressed in target cells due to recombination events that trigger deletions [32]. 
Moreover, the sheer size of TALE repeats creates obstacles to cellular delivery using some 
standard viral vectors—e.g., lentiviruses [32]. Such limitations have precluded wider adapt-
ability of TALE-based tools for epigenome editing.
2.3. CRISPR–Cas–based systems
Clustered, regularly interspaced, short palindromic repeats (CRISPR) and CRISPR-associated 
sequences (Cas) constitute bacterial and archaeal endogenous adaptive immunity systems. 
They were first reported over three decades ago upon publication of findings of a cryptic clus-
ter of unknown function in the bacterium Escherichia coli [33]. Advances in  bioinformatics—
alongside greater access to bacterial genomes in public databases around the turn of the 
century—led to the realization that such clusters exist in a wide range of bacteria and archaea 
[34]. Interest about the functional significance of the clusters in the scientific community grew 
steadily, which eventually led researchers to empirical evidence that CRISPR–Cas systems 
provide adaptive immunity against attack by viruses and plasmids [35] Figure 3.
Figure 3. Structural representation of CRISPR–Cas9 in complex with target double-stranded DNA and sgRNA. (A) 
Crystal structure of the CRISPR–Cas9 nuclease (gray) bound to a sgRNA (orange) and double-stranded target DNA 
(blue) primed for cleavage. Mutation of two Cas9 residues within the RuvC and HNH nuclease domains—D10A and 
H840A (green spheres)—abolishes the catalytic activity of the enzyme and transforms it into dCas9, which is able to 
bind its target sequence without triggering DNA cleavage. (B) Schematic cartoon representation of the CRISPR–Cas9–
sgRNA–DNA complex (colors as shown in A). [PDB 5F9R].
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CRISPR–Cas systems are currently classified into class 1 and class 2 groups, which are further 
divided into six different types and multiple subtypes [36]. Adaptive immunity to foreign nucleic 
acids is encoded in CRISPR arrays, which contain DNA sequences derived from the integration 
of invasive DNA as a new CRISPR spacer. CRISPR arrays are transcribed into precursor CRISPR 
RNAs (pre-crRNAs) and subsequently processed into mature CRISPR RNAs (crRNAs). After 
processing takes place, crRNAs mediate interference by acting as guides that recruit a variety of 
Cas effector proteins to complementary nucleic acids from invasive genetic elements [36]. Unlike 
zinc finger- and TALE-based systems, which rely on protein-DNA interactions to target specific 
genetic loci, CRISPR–Cas systems are DNA-encoded and RNA-guided. Thus, CRISPR–Cas sys-
tems harness nature’s principles of Watson-Crick base pairing of nucleic acids to identify the 
target genetic loci. This property confers significant advantages to CRISPR–Cas systems because 
they bypass the need for complex protein engineering to mediate DNA recognition.
The type II CRISPR–Cas9 system is the most characterized CRISPR–Cas system to date. This 
complex requires dual RNA molecules—a crRNA and a trans-activating crRNA (tracrRNA)—
that hybridize together and direct Cas9, a DNA endonuclease, to a target DNA sequence. 
Upon target recognition, Cas9 triggers double-stranded breaks a few nucleotides away from 
a protospacer adjacent motif (PAM) site [37]. The RNA-guided Cas9 endonuclease cleaves 
double-stranded DNA via conserved RuvC and HNH nuclease domains, which form a com-
pact catalytic core [38].
In recent years, the CRISPR–Cas9 system has been repurposed into an efficient genome edit-
ing tool by engineering a chimeric single guide RNA (sgRNA) that fuses the crRNA and 
tracrRNA into a programmable RNA molecule capable of sequence-specific DNA targeting 
[37]. Genome editing biotechnological applications take advantage of Cas9-induced double-
stranded DNA breaks to mediate DNA repair via one of two pathways: nonhomologous 
end joining (NHEJ), which introduces insertion or deletion mutations, or homology-directed 
repair (HDR), which introduces specific mutations or DNA sequences by recombination with 
a donor template. Importantly, adapting the CRISPR–Cas9 system for gene editing has also 
paved the path for repurposing the system for epigenome editing applications.
CRISPR-Cas9–mediated epigenome editing is based on the use of an engineered Cas9 protein, 
which has been purposefully stripped of its catalytic activity into a nuclease-null or “dead” 
Cas9 (dCas9). Mutating two residues—D10A and H840A—located in the RuvC and HNH 
nuclease domains is necessary and sufficient to deactivate the nuclease activity of the enzyme 
[38]. The mutations allow CRISPR–Cas9 to target specific DNA sequences and bind to them 
without cleaving DNA. Epigenetic effector proteins can then be fused to dCas9 to trigger 
desired local epigenetic changes, in much the same way mentioned earlier using zinc finger 
and TALE fusions to epigenetic effectors.
CRISPR–dCas9 has recently been used to demonstrate the feasibility of targeting specific epi-
genetic modifications to trigger transcriptional activation or repression. For instance, tether-
ing dCas9 to an epigenetic effector that acetylates histone tail residues led to transcriptional 
activation in one study [39], and a dCas9 fusion to a repression domain showed the CRISPR–
dCas9 system’s ability to recruit a heterochromatin-forming complex to silence gene expres-
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3. Epigenome editing to regulate gene expression
Manipulation of endogenous gene expression at target loci has thus far been achieved by cou-
pling DNA-binding proteins with (1) transcriptional activators and repressors, which modu-
late gene expression by acting as site-specific ATFs, or (2) epigenetic effectors, which catalyze 
the deposition or removal of specific epigenetic modifications at target loci. In addition, the 
CRISPR–dCas9 system has recently enabled engineering of modular sgRNA molecules that 
carry RNA aptamers as scaffolding platforms to recruit molecules for site-specific regulation.
3.1. Transcriptional activation
Transcriptional activator effector domains were first used to upregulate levels of gene expres-
sion by fusing the herpes simplex virus protein VP16—involved in recruitment of chromatin 
remodeling factors that increase chromatin accessibility—and its VP64 tetrameric form to zinc 
finger proteins [41, 42]. For instance, an early study demonstrated that zinc finger proteins 
targeted to 18 base-pair sequences of the 5′ untranslated region of the proto-oncogene erbB-2 
could upregulate transcription in an endogenous context [41]. Upregulation was also shown 
to occur even under control of an exogenous chemical inducer molecule [41]. Similarly, zinc 
finger fusions to the VP64 activation domain have been used to reactivate dormant genes. In 
one study, a dormant mammary serine protease inhibitor (maspin) tumor suppressor gene was 
reactivated by targeting the maspin promoter region, which is often epigenetically silenced in 
aggressive epithelial tumors [43]. Other transcriptional activator domains, such as the p65 
subunit of the NF-κB complex, have also been coupled to zinc finger proteins for targeted 
transcriptional activation [44].
The proof-of-concept studies using zinc fingers fused to transcriptional activation domains 
to modulate gene expression patterns served as blueprints for the subsequent use of acti-
vator domain fusions to TALEs and CRISPR–dCas9 systems. TALE activators targeted to 
promoter sites of the endogenous human VEGF-A, NTF3, and the microRNA miR-302/367 
cluster have been reported to induce increased target gene expression by fivefold or more 
[28]. Endogenous levels of gene expression of select human pluripotency factors have also 
been shown to increase by twofold to fivefold using TALE fusions to VP64 [45].
Furthermore, although single TALE fusions to transcriptional activators have demon-
strated the ability to upregulate gene expression, combinations of TALE-VP64 fusions 
targeting the promoter regions of genes implicated in inflammation, immunomodulation, 
and cancer pathways have established the occurrence of synergistic activation effects at 
target sites, which presents opportunities to develop tunable transcriptional networks [46]. 
Interestingly, it appears that different types of transcriptional activators induce varying 
levels of gene expression. In one study, the mean-fold activation induced with TALE-p65 
activators was lower than that with TALE-VP64 activators [28]. The combination of VP64 
and p65 activators exhibits synergistic effects on endogenous gene expression, which can 
provide a platform not only to design tools for targeted gene expression, but also to fine-
tune the fold activation induced by different combinations of activator domains fused to 
DNA-binding proteins [28].
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Recently, researchers have built upon work on zinc finger and TALE fusions to develop 
technologies for targeted gene expression utilizing the CRISPR–dCas9 system. RNA-guided 
transcriptional upregulation using CRISPR–dCas9-VP64 and CRISPR–dCas9-p65 fusions has 
been reported by several research teams in the last 5 years [47–50]. Introduction of individual 
sgRNAs for dCas9 targeting can induce transcriptional activity at desired loci, but the use 
of multiple sgRNAs to target a single locus can act synergistically to induce multifold gene 
expression [48–50]. The CRISPR–dCas9 system offers several advantages over zinc fingers 
and TALEs for targeted gene activation. Because CRISPR–dCas9 is an RNA-guided, DNA-
targeting system, it does not require complex protein engineering and could open additional 
research paths for spatiotemporal control of gene expression alongside complex chemical and 
optogenetic inducible systems. However, some studies have reported that dCas9-based acti-
vation tools induce weaker levels of transcription compared to TALE-based activators [50, 51].
In addition to the use of transcriptional activators for targeted gene expression, research teams 
have demonstrated the efficacy of using epigenetic effectors fused to DNA targeting proteins 
to manipulate epigenetic landscapes. In 2015, a study reported the use of CRISPR–dCas9, 
TALE, and zinc finger fusions to the p300 histone acetyltransferase (HAT) catalytic domain, 
which deposits H3K27 and other acetylation marks on histone tails, to trigger transactiva-
tion of genes [39]. Notably, the study showed that CRISPR–dCas9-p300 Core fusions led to 
more efficient and robust activation from proximal and distal enhancer regions compared to 
synthetic transcription factors engineered to carry activation domains that target promoters. 
Other epigenetic effectors that catalyze covalent modifications on DNA have also been fused 
to DNA-binding proteins to induce gene expression. For example, ten-eleven translocation 
(TET) demethylase enzymes that catalyze the sequential oxidation of 5-methyldeoxycytosine 
(m5dC) to form 5-hydroxymethylcytosine (hm5C), 5-formylcytosine (f5C), and 5-carboxylcyto-
sine (ca5C) have been used with zinc fingers [52–54], TALEs [55], and CRISPR–dCas9 [56, 57] 
to direct promoter-specific DNA demethylation and, thus, upregulate gene expression.
As mentioned earlier, CRISPR–dCas9 systems represent promising tools for the next genera-
tion of complex inducible systems. More recently, a novel system comprising CRISPR–dCas9 
fused to a tripartite activator featuring the constituent activation domains VP64, p65, and 
Rta (VPR) was shown to activate endogenous coding and noncoding regions while target-
ing several genes simultaneously [58]. Another platform built with CRISPR–dCas9 and a 
protein scaffold—namely, a repeating peptide array called the SUperNova tagging system 
(SunTag)—capable of recruiting multiple copies of an antibody fusion protein showed robust 
levels of endogenous gene activation at target sites [59]. Lastly, it has been demonstrated that 
CRISPR–Cas sgRNAs can be engineered to carry protein-binding cassettes, artificial aptam-
ers, and other ncRNAs directly into the sgRNA stem-loop structures, thereby creating modu-
lar CRISPR–dCas9 complexes that enable locus targeting, multiplexing, and highly inducible 
regulatory action to upregulate patterns of gene expression [60–62].
3.2. Transcriptional repression
Silencing endogenous gene expression at target loci has been achieved in similar ways to 
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The domain most commonly used to trigger gene silencing is the Krüppel-associated box 
(KRAB). KRAB repression is mediated by the recruitment of complexes that elicit forma-
tion of heterochromatin via interactions between the KRAB-associated protein 1 (KAP1) 
corepressor and other factors that catalyze histone methylation and deacetylation [17, 63]. 
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histones and DNA that trigger targeted epigenetic repression. Several studies have thus far 
tested and confirmed robust repression efficiency rates of histone methyltransferases [17], 
histone demethylases [29, 67], and DNA methyltransferases [68–70] with zinc finger, TALE, 
and CRISPR–dCas9 proteins at target promoter and enhancer regions.
Notably, a study featuring a CRISPR–dCas9 fusion to the catalytic domain of DNMT3A, 
a de novo DNA methyltransferase, found that multiplexing with several sgRNAs exhibits 
synergistic effects on site-specific CpG methylation [70]. Thus, CRISPR–dCas9-DNMT3A 
multiplexing can lead to a greater increase of methylation levels at target regions. Despite 
the synergistic effects seen with DNMT3A repressor fusions, it appears that dCas9-
DNMT3A epigenetic editing of target CpG methylation sites is not wholly stable and does 
not persist beyond the loss of expression of the editing construct [70]. To overcome this 
type of transient epigenetic editing, a study recently reported a system for inheritable 
silencing of endogenous genes by transiently expressing combinations of DNA-binding 
proteins fused to transcriptional repressors, including KRAB and DNMT3 domains, to 
prompt long-term memory of repressive epigenetic states [71]. Lastly, the modular nature 
of sgRNAs has enabled the creation of scaffolding systems to achieve multiplexing and 
multimerization of epigenetic effectors, which will be useful to study endogenous and 
synthetic gene repression [62, 72].
3.3. Technological limitations
Epigenome editing directed by catalytically active or scaffolding epigenetic effectors fused 
to programmable DNA binding proteins has contributed important insights about the causal 
relationships between epigenetic states and gene regulation. However, despite the progress 
made in recent years to uncover the molecular basis of epigenetic processes, epigenome editing 
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remains a nascent field that must overcome many technological challenges related to editing 
efficiency, delivery, cytotoxicity, and specificity.
A major current limitation concerns the spatio-temporal specificity of epigenome editing, 
which may involve multiple factors including, but not limited to, non-specific deposition or 
removal of select epigenetic marks on target DNA loci or histones, mitigation of off-target 
DNA binding effects, and temporal expression of epigenetic effectors in different cell types 
and chromatin contexts [3]. For example, enzymes that catalyze the deposition of histone 
PTMs—e.g., p300’s HAT domain, which catalyzes acetylation of multiple residues on all four 
core histones—have various degrees of histone substrate specificity. Thus, the inherent pro-
miscuity of an enzyme may pose challenges to the study of direct functional roles for unique 
PTMs in specific contexts [3].
Similarly, the expression levels and times at which an epigenetic effector is present in a cell 
type can exert effects on the efficiency of DNA binding specificity. Following target site satu-
ration, off-target binding activity is likely to increase if the effector remains, or continues to be 
expressed, in the cell. This could partly explain the extensive global off-target effects reported 
with the use of dCas9–methyltransferase fusions in one study [73]. Given the lack of target site 
specificity previously reported for dCas9–sgRNA complexes [74], further research is needed 
to establish whether other dCas9–effector fusions exhibit similar off-target activities. The 
use of zinc finger and TALE fusions to epigenetic effectors offers an alternative to mitigate 
possible dCas9-related off-target effects. However, zinc finger and TALE epigenome editing 
biotechnologies are limited by the complex protein engineering required to mediate DNA 
recognition.
Progress in other areas associated with challenges in delivery, efficiency, and stability of 
epigenetic states has come at a rapid pace [75–77]. Chemical and optogenetic molecules 
have expanded the toolbox for reversible and inducible epigenome editing in endogenous 
contexts [3, 66, 78]. And emerging technologies for RNA editing [79] could soon provide 
new insights about the epigenetic roles of ncRNAs. As the field matures, epigenome editing 
will undoubtedly make significant contributions to the advancement of basic and applied 
research.
4. Conclusion
Recent technological breakthroughs in epigenome editing have expanded our understanding 
of the underlying mechanisms responsible for the regulation of chromatin structure and the 
spatiotemporal control of gene activation and repression. As detailed in this chapter, modern 
epigenome editing systems are revolutionizing the field of epigenetics. Programmable DNA-
binding proteins fused to catalytically active or scaffolding epigenetic effectors represent 
invaluable tools to uncover the functional significance of site-specific epigenetic mechanisms 
in a myriad of contexts including development, cell differentiation, and disease. Undoubtedly, 
progress in this emerging field will offer great contributions to translational medicine and 
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Abstract
Epigenetic modifications and their regulations govern the identity of every cell type 
in an organism. Cell differentiation involves a switch in gene expression profile that is 
accompanied by heritable changes of epigenetic signatures in the differentiated cell type. 
Differentiation is generally not reversible, thereby conferring cell fate decisions once an 
altered epigenetic pattern is set. Nevertheless, attempts have been made to reverse a dif-
ferentiation cell fate to a pluripotent state by various experimental approaches, such as 
somatic cell nuclear transfer, cell fusion and ectopic expression of defined transcription 
factors. The fundamental basis of all these strategies is to mediate epigenetic reprogram-
ming, which allows a permanent and completed conversion of cell fate. A comprehensive 
understanding of the dynamic of epigenetic changes during cell differentiation would 
provide a more precise and efficient way of reprogramming cell fate. Here we summarize 
the epigenetic aspects of different reprogramming strategies and discuss the possible 
mechanisms underlying these epigenetic reprogramming events.
Keywords: epigenetic, reprogramming, somatic cell nuclear transfer, cell fusion, 
transcription factors, pluripotency, differentiation, cell fate
1. Introduction
Development is a complex process that involves a series of cell differentiation pathways 
starting from totipotent embryonic cells. According to Waddington’s concept of epigenetic 
landscape, a cell has to interact with surrounding stimuli and respond by giving a pheno-
type which defines its identity during development [1]. Each cell experiences different inter/
intra-cellular signals and hence has its epigenetic signature of cell identity, which in turn 
directs its own specific gene expression pattern without alteration of DNA sequences (with 
the exception of the immunoglobulin genes in B and T cells). It is now clear that the diversity 
of cell type specific gene expression pattern is mediated by means of epigenetic mechanisms, 
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such as DNA methylation, covalent histone modifications and chromatin remodeling. Once a 
cell’s identity is set, it is difficult to convert it to other unrelated lineages, thus leading to stable 
and irreversible differentiated cell states. Nevertheless, there are a few exceptions of cell fate 
conversion during embryo development and adult tissue/organ regeneration, e.g. vascular 
endothelium to smooth muscle cells [2], which involve changing a cell’s epigenetic signature 
into another unrelated kind.
Apart from a few exceptions of natural cell fate conversion events, different strategies have 
been developed aiming to reprogram differentiated somatic cell fate to a pluripotent state 
(Figure 1). A historical strategy of reprogramming is by somatic cell nuclear transfer (SCNT) 
experiments. SCNT involves transplantation of a cell nucleus into an enucleated egg/oocyte 
in order to generate a “cloned” animal with an equivalent genetic composition as the donor 
individual. It is possible to derive embryonic stem (ES) cells from nuclear transplanted (NT) 
embryos (ntES cells), which shows indistinguishable pluripotent gene expression profiles 
Figure 1. Strategies of reprogramming cell fate. Differentiated cells can be reprogrammed to pluripotent state by 
somatic cell nuclear transfer (SCNT), cell fusion, and ectopic expression of defined transcription factors. SCNT involves 
transplantation of a single differentiated cell nucleus into an enucleated egg/oocyte, which develops as a nuclear 
transplanted (NT) embryo. Cell fusion involves artificial fusion of a differentiated and a pluripotent cell to form a 
tetraploid pluripotent-like cell. Defined transcription factors (Oct4, Sox2, Klf4, c-Myc) can be ectopically expressed in 
differentiated cells and convert them to induced pluripotent stem (iPS) cells.
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when compared to the normal ES cells derived from fertilized embryos. Another strategy of 
reprogramming is achieved by fusion of a differentiated cell with a pluripotent cell in order 
to generate a pluripotent-like tetraploid hybrid cell [3–5]. It has been proposed that cellular 
components, such as transcription factors, in the pluripotent cell are able to reprogram the 
differentiated cell nucleus. This idea aligns with the use of cell extracts from pluripotent cell 
types to revert differentiated cells into a pluripotent-like state [6, 7]. Presumably the cyto-
plasmic “reprogramming factors” from the pluripotent cells can be isolated and concentrated 
to achieve a higher reprogramming efficacy. A third strategy involves ectopic expression 
of defined transcription factors in somatic differentiated cells to generate induced pluripo-
tent stem (iPS) cells. Delivery of the ectopic transcription factors can be achieved by viral 
approaches, such as the use of retrovirus, lentivirus, adeno-associated virus or Sendai virus, 
or by using episomal vesicles, or by direct mRNA or protein transfection. This technique has 
been successfully applied to reprogram a vast number of differentiated somatic cell types. 
Importantly, iPS cells can also be generated by using combinations of microRNAs (miRNAs) 
or small chemical molecules without the needs of ectopic expression of reprogramming fac-
tors [8]. The three reprogramming strategies show different reprogramming kinetics and 
efficiencies, which can be associated with the distinct epigenetic mechanisms in the erasure of 
somatic cell epigenetic signature and re-establishment of the pluripotent one. In this review, 
we focus on the dynamic changes of epigenetics mediated by different reprogramming strate-
gies and how the modulation of epigenetic status improves the reprogramming efficiency.
2. Epigenetic reprogramming by SCNT
SCNT was first done by Briggs and Kings in 1952, who transplanted a blastula nucleus into 
an enucleated egg of the amphibian Rana pipiens [9]. Few years later, Gurdon et al. succeeded 
by using differentiated Xenopus intestinal epithelial donor nuclei for SCNT [10]. In 1997, 
the first cloned mammal, Dolly the sheep, was generated [11], and since then, more than 
23 other mammalian species have now been successfully cloned [12]. Normal development 
of nuclear transplanted (NT) embryos requires recapitulation of the gene expression profile 
that supports the embryogenesis process by the differentiated donor nucleus. This involves 
re- activation of pluripotency genes, in particular Oct4, Nanog and Sox2, and repression of 
somatic lineage genes. In fact, the efficiency of reprogramming by SCNT is generally very low 
and less than 1% of NT embryos can develop into normal adults [13–15]. The cloned newborns 
often suffer from developmental abnormalities owing to incomplete reprogramming. It has 
been observed that Oct4 was aberrantly expressed in cloned mouse blastocysts derived from 
cumulus donor nuclei [16, 17]. Besides, continuous expression of other somatic donor marker 
genes was demonstrated in some Xenopus NT embryos [18]. Some imprinted genes in donor 
cells were found to be aberrantly expressed in cloned embryos, presumably owing to the 
incomplete epigenetic reprogramming of the regulatory regions of imprinting loci [19–21]. 
Dysregulation of imprinted genes, such as Igf2, Igf2r, H19, and Xist, in cloned embryos can 
lead to both fetal and placental overgrowth and result in embryonic lethality or an abnormal 
growth condition called “large offspring syndrome”, which is commonly found in cloned 
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such as DNA methylation, covalent histone modifications and chromatin remodeling. Once a 
cell’s identity is set, it is difficult to convert it to other unrelated lineages, thus leading to stable 
and irreversible differentiated cell states. Nevertheless, there are a few exceptions of cell fate 
conversion during embryo development and adult tissue/organ regeneration, e.g. vascular 
endothelium to smooth muscle cells [2], which involve changing a cell’s epigenetic signature 
into another unrelated kind.
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(Figure 1). A historical strategy of reprogramming is by somatic cell nuclear transfer (SCNT) 
experiments. SCNT involves transplantation of a cell nucleus into an enucleated egg/oocyte 
in order to generate a “cloned” animal with an equivalent genetic composition as the donor 
individual. It is possible to derive embryonic stem (ES) cells from nuclear transplanted (NT) 
embryos (ntES cells), which shows indistinguishable pluripotent gene expression profiles 
Figure 1. Strategies of reprogramming cell fate. Differentiated cells can be reprogrammed to pluripotent state by 
somatic cell nuclear transfer (SCNT), cell fusion, and ectopic expression of defined transcription factors. SCNT involves 
transplantation of a single differentiated cell nucleus into an enucleated egg/oocyte, which develops as a nuclear 
transplanted (NT) embryo. Cell fusion involves artificial fusion of a differentiated and a pluripotent cell to form a 
tetraploid pluripotent-like cell. Defined transcription factors (Oct4, Sox2, Klf4, c-Myc) can be ectopically expressed in 
differentiated cells and convert them to induced pluripotent stem (iPS) cells.
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when compared to the normal ES cells derived from fertilized embryos. Another strategy of 
reprogramming is achieved by fusion of a differentiated cell with a pluripotent cell in order 
to generate a pluripotent-like tetraploid hybrid cell [3–5]. It has been proposed that cellular 
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23 other mammalian species have now been successfully cloned [12]. Normal development 
of nuclear transplanted (NT) embryos requires recapitulation of the gene expression profile 
that supports the embryogenesis process by the differentiated donor nucleus. This involves 
re- activation of pluripotency genes, in particular Oct4, Nanog and Sox2, and repression of 
somatic lineage genes. In fact, the efficiency of reprogramming by SCNT is generally very low 
and less than 1% of NT embryos can develop into normal adults [13–15]. The cloned newborns 
often suffer from developmental abnormalities owing to incomplete reprogramming. It has 
been observed that Oct4 was aberrantly expressed in cloned mouse blastocysts derived from 
cumulus donor nuclei [16, 17]. Besides, continuous expression of other somatic donor marker 
genes was demonstrated in some Xenopus NT embryos [18]. Some imprinted genes in donor 
cells were found to be aberrantly expressed in cloned embryos, presumably owing to the 
incomplete epigenetic reprogramming of the regulatory regions of imprinting loci [19–21]. 
Dysregulation of imprinted genes, such as Igf2, Igf2r, H19, and Xist, in cloned embryos can 
lead to both fetal and placental overgrowth and result in embryonic lethality or an abnormal 
growth condition called “large offspring syndrome”, which is commonly found in cloned 
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mammals [22–24]. Since the SCNT process does not increase the frequency of genetic altera-
tions, it is suggested that the variable phenotypes observed in cloned embryos are associated 
with the reprogrammed epigenetic status of the donor nuclei [25]. This is supported by the 
findings that the developmental defects in cloned animals were not transmittable to the next 
offspring generation, indicating the presence of aberrant epigenetic reprogramming [26]. 
Aberrant DNA methylation patterns were indeed observed in NT embryos [27]. It was also 
demonstrated that the bovine NT blastocysts lack asymmetric patterns of both H3K9 methyla-
tion and acetylation between the inner cell mass and trophectoderm [28], which may account 
for abnormal cloned embryo development.
Although the rate of successful SCNT is very low, the reprogramming ability of factors in the 
egg/oocyte is highly efficient as the transplanted nuclei take less than 1 day to initiate cell divi-
sion and trigger the “normal” developmental program. The donor cell epigenetic status has to 
be reprogrammed in order to support the embryonic program of development. In fact, genome-
wide demethylation was observed in the cloned blastocysts [29]. It has been shown that the Oct4 
promoter of somatic cells undergoes DNA demethylation after nuclear transplantation into the 
germinal vesicle of Xenopus oocytes [30]. This demethylation of the Oct4 promoter was found to 
be mediated by Tet3 in a mouse SCNT study [31], which is essential for the reactivation of Oct4 
expression for successful SCNT. In addition, chromatin remodeling factors, such as ISWI and 
BRG1, are documented in facilitating the reprogramming of cell fate. It has been shown that 
ISWI, which is a chromatin remodeling ATPase, is able to dissociate TATA binding protein in 
somatic nuclei after incubation in the Xenopus egg extract, suggesting that ISWI-containing com-
plexes are facilitating epigenetic reprogramming in an egg environment [32]. Besides, Xenopus 
egg extract depleted of BRG1 protein showed an abolishment of the reprogramming ability and 
hence failed to induce Oct4 expression in the somatic nuclei [33]. Therefore, chromatin structure 
remodeling is believed to be one of the reprogramming mechanisms. In addition, the maternal-
derived histone H3 variant H3.3 in the enucleated egg was found to replace the canonical his-
tone H3 in the donor nuclei after SCNT, leading to the reactivation of key pluripotent genes that 
are originally associated with repressive histone marks [34]. Histone H2A variant, macroH2A, 
also plays an important role in the reactivation of female donor cell’s inactive X chromosome 
during reprogramming. It was shown that knockdown of macroH2A facilitates X-reactivation 
and the expression of pluripotent genes in cloned Xenopus embryos [35]. More recently, it has 
been demonstrated that the H3K9 tri-methylation (H3K9me3) of the donor cell genome is a 
major epigenetic barrier to SCNT. Ectopic expression of H3K9 demethylases Kdm4b or Kdm4d 
in the mouse donor cells de-repressed the genomic regions that are resistant to reprogramming 
and thus significantly improving SCNT efficiency [36, 37]. Similarly, removal of H3K9me3 by 
ectopic expression of other H3K9 demethylases also demonstrated improved reprogramming 
efficiency in human and bovine SCNT experiments [38, 39].
Interestingly, it has been shown that the epigenetic state of a differentiated cell is directly 
correlated with its reprogrammability [40]. SCNT with ES cell nuclei demonstrated a much 
higher efficiency of generation of NT blastocysts than using other somatic cell types [41]. This 
could be associated with a more relaxed chromatin configuration in ES cells that may render 
their epigenome more susceptible for reprogramming [42]. Alternatively, it has been dem-
onstrated that the cloning efficiency can be significantly improved by pre-treating the more 
Chromatin and Epigenetics168
differentiated and condensed chromatin state of somatic nuclei with epigenetic modifying 
agents, e.g. 5-aza-deoxycytidine and trichostatin A (TSA), that facilitate chromatin relaxation 
[43–45]. Interestingly, the effect of TSA treatment in improving SCNT is associated with the 
reactivation of a subset of genes that are repressed by H3K9me3 in the somatic cells [46], pre-
sumably through introducing histone hyper-acetylation at their promoters. Altogether, SCNT 
provides a quick route of epigenetic reprogramming for a differentiated cell to a pluripotent 
state. Identification of the responsible reprogramming factors in the egg and oocyte cytoplasm 
will be one of the key future directions to improve the efficiency of SCNT and therapeutic 
cloning.
3. Epigenetic reprogramming by cell fusion
Cell fusion is a natural event that is crucial for fertilization and in various organs such as pla-
centa, skeletal muscles and bones [47]. It has been proposed that the fusion of bone marrow-
derived stem cells and tissue cells, e.g. hepatocytes, is one of the mechanisms of tissue repair 
[48, 49]. Cell fusion experiments using pluripotent cells, e.g. an ES or embryonic germ (EG) 
cell, were shown to be able to reprogram a differentiated cell type [3–5]. Both ES and EG cells 
possess reprogramming ability and are able to reactivate pluripotent genes and silence differ-
entiation genes in the somatic cell nucleus within a tetraploid hybrid cell after cell fusion. It is 
indeed the case that the new transcription profile of a hybrid cell is partly contributed by the 
reprogrammed somatic nucleus to a pluripotent-like state. Moreover, injection of hybrid cells 
into normal diploid blastocysts demonstrated their contribution to all three germ layers in the 
chimeras [4, 50], indicating the pluripotent nature of hybrid cells. Similar to the SCNT, differ-
ent somatic cell types show different kinetics of reprogramming by the cell fusion approach, 
which could be associated with the somatic chromatin accessibility status [51, 52].
Cell fusion with a pluripotent cell can trigger extensive epigenetic reprogramming in the differ-
entiated cell nucleus. It has been shown that reactivation of Oct4 from the somatic nucleus occurs 
before DNA replication after cell fusion [53], suggesting the involvement of active demethylation 
process [54]. This was further supported by the functional roles of Tet1 and Tet2 in the demethyl-
ation of Oct4 and imprinted control regions by fusing somatic cells with EG cells [55]. Besides, in 
a cell fusion experiment using thymocytes and ES cells from two different mouse strains, it was 
observed that the epigenetic profile of the somatic cell nucleus was reprogrammed to a similar pat-
tern to that of the ES cell. Global histone H3 and H4 acetylation and H3K4 di- and tri- methylation 
were increased in the hybrid cell to a level comparable to ES cells, whereas these modifications 
are weak in the parental somatic thymocytes. Examination of gene specific loci showed that the 
Oct4 promoter was enriched with H3 acetylation and the promoter of the thymocyte marker Thy-
1 was enriched with H3K27 tri-methylation in both ES cell and hybrid cell chromatin, whereas 
these epigenetic modifications are missing in the thymocyte [56]. Hence, the somatic genome has 
undergone epigenetic reprogramming triggered by fusion with the ES cell, suggesting that the 
process of cell fusion mediates a transcription activation-permissive chromatin state in the hybrid 
genome. In addition, silencing the somatic differentiation genes was shown to be associated with 
polycomb repressive complexes in the cell fusion experiment using ES cells [57].
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sion and trigger the “normal” developmental program. The donor cell epigenetic status has to 
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germinal vesicle of Xenopus oocytes [30]. This demethylation of the Oct4 promoter was found to 
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expression for successful SCNT. In addition, chromatin remodeling factors, such as ISWI and 
BRG1, are documented in facilitating the reprogramming of cell fate. It has been shown that 
ISWI, which is a chromatin remodeling ATPase, is able to dissociate TATA binding protein in 
somatic nuclei after incubation in the Xenopus egg extract, suggesting that ISWI-containing com-
plexes are facilitating epigenetic reprogramming in an egg environment [32]. Besides, Xenopus 
egg extract depleted of BRG1 protein showed an abolishment of the reprogramming ability and 
hence failed to induce Oct4 expression in the somatic nuclei [33]. Therefore, chromatin structure 
remodeling is believed to be one of the reprogramming mechanisms. In addition, the maternal-
derived histone H3 variant H3.3 in the enucleated egg was found to replace the canonical his-
tone H3 in the donor nuclei after SCNT, leading to the reactivation of key pluripotent genes that 
are originally associated with repressive histone marks [34]. Histone H2A variant, macroH2A, 
also plays an important role in the reactivation of female donor cell’s inactive X chromosome 
during reprogramming. It was shown that knockdown of macroH2A facilitates X-reactivation 
and the expression of pluripotent genes in cloned Xenopus embryos [35]. More recently, it has 
been demonstrated that the H3K9 tri-methylation (H3K9me3) of the donor cell genome is a 
major epigenetic barrier to SCNT. Ectopic expression of H3K9 demethylases Kdm4b or Kdm4d 
in the mouse donor cells de-repressed the genomic regions that are resistant to reprogramming 
and thus significantly improving SCNT efficiency [36, 37]. Similarly, removal of H3K9me3 by 
ectopic expression of other H3K9 demethylases also demonstrated improved reprogramming 
efficiency in human and bovine SCNT experiments [38, 39].
Interestingly, it has been shown that the epigenetic state of a differentiated cell is directly 
correlated with its reprogrammability [40]. SCNT with ES cell nuclei demonstrated a much 
higher efficiency of generation of NT blastocysts than using other somatic cell types [41]. This 
could be associated with a more relaxed chromatin configuration in ES cells that may render 
their epigenome more susceptible for reprogramming [42]. Alternatively, it has been dem-
onstrated that the cloning efficiency can be significantly improved by pre-treating the more 
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reactivation of a subset of genes that are repressed by H3K9me3 in the somatic cells [46], pre-
sumably through introducing histone hyper-acetylation at their promoters. Altogether, SCNT 
provides a quick route of epigenetic reprogramming for a differentiated cell to a pluripotent 
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will be one of the key future directions to improve the efficiency of SCNT and therapeutic 
cloning.
3. Epigenetic reprogramming by cell fusion
Cell fusion is a natural event that is crucial for fertilization and in various organs such as pla-
centa, skeletal muscles and bones [47]. It has been proposed that the fusion of bone marrow-
derived stem cells and tissue cells, e.g. hepatocytes, is one of the mechanisms of tissue repair 
[48, 49]. Cell fusion experiments using pluripotent cells, e.g. an ES or embryonic germ (EG) 
cell, were shown to be able to reprogram a differentiated cell type [3–5]. Both ES and EG cells 
possess reprogramming ability and are able to reactivate pluripotent genes and silence differ-
entiation genes in the somatic cell nucleus within a tetraploid hybrid cell after cell fusion. It is 
indeed the case that the new transcription profile of a hybrid cell is partly contributed by the 
reprogrammed somatic nucleus to a pluripotent-like state. Moreover, injection of hybrid cells 
into normal diploid blastocysts demonstrated their contribution to all three germ layers in the 
chimeras [4, 50], indicating the pluripotent nature of hybrid cells. Similar to the SCNT, differ-
ent somatic cell types show different kinetics of reprogramming by the cell fusion approach, 
which could be associated with the somatic chromatin accessibility status [51, 52].
Cell fusion with a pluripotent cell can trigger extensive epigenetic reprogramming in the differ-
entiated cell nucleus. It has been shown that reactivation of Oct4 from the somatic nucleus occurs 
before DNA replication after cell fusion [53], suggesting the involvement of active demethylation 
process [54]. This was further supported by the functional roles of Tet1 and Tet2 in the demethyl-
ation of Oct4 and imprinted control regions by fusing somatic cells with EG cells [55]. Besides, in 
a cell fusion experiment using thymocytes and ES cells from two different mouse strains, it was 
observed that the epigenetic profile of the somatic cell nucleus was reprogrammed to a similar pat-
tern to that of the ES cell. Global histone H3 and H4 acetylation and H3K4 di- and tri- methylation 
were increased in the hybrid cell to a level comparable to ES cells, whereas these modifications 
are weak in the parental somatic thymocytes. Examination of gene specific loci showed that the 
Oct4 promoter was enriched with H3 acetylation and the promoter of the thymocyte marker Thy-
1 was enriched with H3K27 tri-methylation in both ES cell and hybrid cell chromatin, whereas 
these epigenetic modifications are missing in the thymocyte [56]. Hence, the somatic genome has 
undergone epigenetic reprogramming triggered by fusion with the ES cell, suggesting that the 
process of cell fusion mediates a transcription activation-permissive chromatin state in the hybrid 
genome. In addition, silencing the somatic differentiation genes was shown to be associated with 
polycomb repressive complexes in the cell fusion experiment using ES cells [57].
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Reprogramming to pluripotency by cell fusion approach requires lengthy selection of the suc-
cessfully reprogrammed hybrid cells. The reprogramming efficiency of cell fusion is usually 
less than 0.001%, depending on the somatic cell types [50, 58]. The low reprogramming effi-
ciency in hybrid cells can be largely enhanced by manipulation of key pluripotency-associated 
genes like Nanog [58, 59] and Sall4 [60], or by activation of the Wnt signaling pathway [61], 
emphasizing the importance of these factors in cell fusion reprogramming. Overexpression 
of Nanog or Sall4 in ES cells demonstrated a several hundred-fold increase in reprogram-
ming efficiency after cell fusion. Similarly, treatment of ES cells with Wnt3a for 24–48 hours 
enhanced the reprogramming of somatic cells by 20-fold. However, owing to the low repro-
gramming efficiency and the tetraploid genome of the resulting hybrid cells, reprogramming 
by the cell fusion approach becomes less promising in regenerative medicine.
4. Epigenetic reprogramming by defined transcription factors
In a groundbreaking discovery, Yamanaka et al. demonstrated that somatic cell state can be 
reprogrammed to a pluripotent state by the introduction of only four transcription factors; 
Oct4, Sox2, Klf4 and c-Myc, which are now also known as the Yamanaka factors. The first gen-
eration of iPS cells was obtained using a Fbx15-driven selection construct (Fbx15-iPS) and dis-
played a gene expression pattern very similar to that of normal pluripotent ES cells. However, 
the somatic epigenetic signature was only partially reprogrammed; the Oct4 promoter, for 
example, retained some DNA methylation and no germline transmission was observed for 
these cells in chimeric mice. Hence these first-generation iPS cells were not fully pluripotent in 
nature [62]. Given the potential reprogramming capacity of these four factors, the second gen-
eration of iPS cells was generated by selection with a Nanog reporter construct (Nanog-iPS) 
[63, 64]. During the reprogramming process, the virally delivered transgenes were silenced, 
but on the contrary, the endogenous Oct4 and Sox2 loci were re-activated for the maintenance 
of pluripotency in iPS cells. In contrast to the Fbx15-iPS cells, these Nanog-iPS cells were able 
to undergo germline transmission in chimeric mice, and thus share this crucial feature of 
pluripotency with normal ES cells. These landmark studies that pioneered the derivation of 
mouse iPS cells led to the possibility of using the same strategy to generate human iPS cells. 
An initial study was performed by Thomas et al. in which a different combination of factors, 
OCT4, SOX2, NANOG and LIN28, was used to reprogram human fibroblasts into iPS cells 
[65]. Thereafter, Yamanaka and other groups succeeded in generating human iPS cells by 
using the same 4 Yamanaka factors as in the mouse iPS systems [66, 67]. To date, a number of 
different somatic cell types have been successfully reprogrammed into iPS cells, e.g. neural 
stem cells, keratinocytes, hepatocytes, gastric epithelia cells, pancreatic β cells, terminally dif-
ferentiated B and T cells [8].
By using the defined transcription factor approach to reprogram cell fate, about 0.1–3% of 
the somatic starting cell population can be converted into iPS cells in around 2–3 weeks. The 
reprogramming efficiency is believed to be correlated with the differentiation state of the 
starting somatic cells. It has been shown that hematopoietic stem and progenitor cells can be 
reprogrammed to iPS cells 300 times more efficient than the terminally differentiated B and 
T cells [68]. Interestingly, partially de-differentiating mature B cells by either knockdown of 
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Pax5 or forced expression of C/EBPα resulted in efficient reprogramming by the Yamanaka 
factors [69], suggesting that the epigenetic status of differentiated cells is crucial in successful 
reprogramming. The dynamics of transcription profile and epigenetic patterns during the 
reprogramming process from somatic to iPS cells were studied in details. The reprogramming 
of somatic cell fate is a sequential stochastic event which involves a gradual silencing of the 
somatic lineage genes and the viral transgenes, and a sequential expression of alkaline phos-
phatase and SSEA1 in partially reprogrammed cells, whereas endogenous Oct4 and Nanog 
are only activated in fully reprogrammed iPS cells. Induction of the four Yamanaka factors 
results in an immediate cellular response of inactivation of thousands of somatic lineage 
distal enhancers and, to a smaller extent, the H3K4me3-enriched somatic gene promoters 
[70, 71], leading to down-regulation of somatic identity genes. This initial phase of repro-
gramming is also accompanied by a global reduction of H3K27me3 resulting in loss of het-
erochromatin [72]. Meanwhile, mesenchymal transcription factors, such as Snail1/2, Zeb1/2, 
are repressed [70, 73, 74], whereas epithelial transcription factors, such as Cdh1, Epcam, are 
activated [75, 76], resulting in mesenchymal-epithelial transition (MET). This is associated 
with an increase in H3K4me2 at epithelial genes, but a decrease in H3K4me2 and H3K79me2 
at mesenchymal genes [71, 77]. Despite an increase in global H3K36me2/3 level, loss of 
H3K36me2/3 was observed at the Ink4-Arf locus, leading to enhanced cell proliferation during 
reprogramming [78]. The following phase of reprogramming is marked by upregulation of 
endogenous pluripotency genes to establish transcriptional program, which is independent 
of transgene expression [73, 79]. The final phase of reprogramming involves elongation of 
telomeres, X-reactivation in female iPS cells, and upregulation of DNA methylation genes 
[79]. This coincides with loss of DNA methylation and downregulation of Xist expression in 
the somatic inactive X chromosome [80, 81].
A number of epigenetic remodeling factors are involved in the reprogramming events. Both 
polycomb (PcG) and trithorax (TrxG) group proteins were found to be crucial in the derivation 
of iPS cell colonies. Upon knockdown of Wdr5, which is a core component of TrxG protein 
complex, cells failed to establish H3K4me3 at the pluripotent genes, like Oct4 and Nanog, for 
their reactivation [82]; whereas inhibition of the core components of the polycomb repressive 
complex 1 and 2 reduced reprogramming efficiency [83], partly because of the dysregulation of 
genes involved in the MET process [84]. This is similar to the findings that inhibition of H3K79 
methyltransferase DOT1L facilitates the loss of H3K79me2 mark at the mesenchymal genes 
to promote MET during reprogramming [83]. The H3K27 demethylase Kdm6a (also known 
as Utx) can directly interact with Oct4/Sox2/Klf4 to remove the repressive H3K27me3 mark 
from the early pluripotent genes in somatic cells for their reactivation [85]. This is in agreement 
with the findings that depletion of histone H2A variant, macroH2A, enhances reprogramming, 
owing to its co-occupancy with H3K27me3 to repress pluripotent genes [86, 87]. Besides, the 
H3K36 demethylase Kdm2b (also known as Jhdm1b) enhances the activation of early respon-
sive genes (Cdh1, Epcam, Dsg2, Dsp, Irf6) during reprogramming through the removal of 
H3K36me2 at their promoters [88]. Interestingly, H3K9me3 was also found to be one of the 
major epigenetic barriers in the generation of iPS cells [89], similar to the findings in SCNT 
experiments. Depletion of the H3K9 methyltransferases SUV39H1/H2, Ehmt1/2 and Setdb1 or 
inhibition of Cbx3, a protein that recognizes H3K9 methylation, enhances reprogramming by 
de-repressing Nanog and abolishing the cellular responses to BMP signaling [89–91]. Although 
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reprogrammed to iPS cells 300 times more efficient than the terminally differentiated B and 
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genes involved in the MET process [84]. This is similar to the findings that inhibition of H3K79 
methyltransferase DOT1L facilitates the loss of H3K79me2 mark at the mesenchymal genes 
to promote MET during reprogramming [83]. The H3K27 demethylase Kdm6a (also known 
as Utx) can directly interact with Oct4/Sox2/Klf4 to remove the repressive H3K27me3 mark 
from the early pluripotent genes in somatic cells for their reactivation [85]. This is in agreement 
with the findings that depletion of histone H2A variant, macroH2A, enhances reprogramming, 
owing to its co-occupancy with H3K27me3 to repress pluripotent genes [86, 87]. Besides, the 
H3K36 demethylase Kdm2b (also known as Jhdm1b) enhances the activation of early respon-
sive genes (Cdh1, Epcam, Dsg2, Dsp, Irf6) during reprogramming through the removal of 
H3K36me2 at their promoters [88]. Interestingly, H3K9me3 was also found to be one of the 
major epigenetic barriers in the generation of iPS cells [89], similar to the findings in SCNT 
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Dnmt3a/b were found to be dispensable [92], DNA demethylation of key pluripotency loci 
mediated by Tet proteins is required for efficient reprogramming [93–95].
Previous studies demonstrated that the partially reprogrammed iPS cells contained signifi-
cantly fewer genes marked by the bivalent chromatin signature (co-existence of both H3K4 
and H3K27 methylation) and an enrichment of DNA hyper-methylated loci when compared 
to the wild-type ES cells and the fully reprogrammed iPS cells [70]. Therefore, it is proposed 
that completion of the epigenetic reprogramming process is pre-requisite for the acquisition of 
pluripotency. This is supported by the observation that treatment of partially reprogrammed 
iPS cells with the DNA methyltransferase inhibitor 5-aza-cytidine was able to promote their 
transition into the fully reprogrammed pluripotent state [70]. Besides, inhibition of H3K27 
methyltransferase Ezh2 by small molecule, GSK-126, reduced reprogramming efficiency [84], 
whereas inhibition of DOT1L by small molecule, EPZ004777, showed enhancement of repro-
gramming [83]. Various histone deacetylase inhibitors (HDACi) were also shown to improve 
reprogramming [96–100]. In combination with HDACi valproic acid, human iPS cells can be 
generated only with Oct4 and Sox2 with a comparable reprogramming efficiency by the four 
Yamanaka factors [101]. Interestingly, it was found that vitamin C can increase reprogram-
ming efficiency by promoting the transition of pre-iPS cells to fully reprogrammed cells [102], 
potentially through acting as a cofactor of Kdm2b to induce H3K36me2/3 demethylation [78], 
activation of H3K9 demethylases (Kdm3a, 3b, 4c and 4d) to remove H3K9me3 [89], and pro-
moting Tet-mediated DNA demethylation [103]. With the aid of small chemical molecules, the 
iPS cell reprogramming efficiency and duration could be further improved.
5. “Epigenetic memory” in reprogrammed cells
“Epigenetic memory” refers to the persistent expression of parental genes in the daughter 
cells through the inheritance of distinctive epigenetic marks. Consequently, the epigenetic 
profile of a parent cell is faithfully passed on to its daughter cells such that the gene expression 
pattern is memorized and maintained throughout cell generations. In the situation of repro-
gramming cell fate, the persistent somatic cell epigenetic signature and the expression of lin-
eage genes in the reprogrammed cells is thus regarded as an example of epigenetic memory.
Even though it has been shown that prolonged in vitro culture of mammalian embryos can 
lead to aberrant expression of imprinted and non-imprinted genes owing to associated epi-
genetic ‘errors’ [104, 105]. It has been shown that many cloned embryos demonstrate differ-
ent degrees of resemblance with donor cell gene expression patterns. The aberrant epigenetic 
pattern in cloned embryos is thought to be the result of persistence of the epigenetic memory 
of the donor cells. Indeed, the resemblance of DNA and histone modification patterns of NT 
embryos to those of the donor cell types supports this conclusion [45–47]. For example, both 
global and gene-specific patterns of DNA methylation in cloned bovine and mouse embryos 
were shown to be similar to those of their respective donor somatic cell types [28, 106, 107]. The 
phenomenon of epigenetic memory is also highlighted by the X inactivation pattern in cloned 
embryos. In normal fertilized embryos, the paternal X chromosome is preferentially silenced 
in the trophectoderm and extraembryonic endoderm lineages, whereas random X inactivation 
occurs in the inner cell mass. However, in NT embryos generated from female donor nuclei, the 
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inactive X chromosome of the donor cell is preferentially chosen for inactivation in the trophec-
toderm, which is in contrast to the random X inactivation in the embryo proper, demonstrating 
a certain extent of memory of the inactive X chromosome status [48]. Random X inactivation in 
the placenta was found in deceased cloned bovine embryos, which suggests that the persistence 
of this inactive X chromosome memory in the placenta may be crucial for fetal survival [49].
The epigenetic memory in NT embryos that maintains the donor expression gene states can 
be explained by the inheritance of DNA methylation patterns. Heritability of DNA methyla-
tion is mediated by the activity of the maintenance DNA methyltransferase Dnmt1 which 
preferentially targets hemi-methylated DNA. Thus, Dnmt1 restores the parental methylation 
status on the newly synthesized daughter DNA strand, thereby maintaining a silent gene 
state after cell division [108]. Methylated donor genes, such as pluripotency genes, remain 
inactivated after SCNT, apparently owing to the persistent donor-specific methylation pattern 
in the cloned embryos, possibility mediated by the residual somatic form of Dnmt in the donor 
nucleus. DNA methylation therefore provides a plausible mechanism for the propagation of 
a silent memory state in SCNT [109]. On the other hand, an active gene memory of the donor 
differentiation state is also observed in NT embryos. For example, both the donor endoderm 
and neurectoderm markers, Edd and Ncam, were found to be aberrantly expressed in Xenopus 
NT embryos derived from the respective donor cell types [18]. This active gene memory was 
further demonstrated to be associated with the incorporation of a histone H3 variant H3.3 at 
the active gene loci in Xenopus NT embryos [110]. Histone variant H3.3 is enriched in the regu-
latory region of active genes and is preferentially marked by modifications associated with an 
active chromatin state, such as H3K4 methylation, H3K9 acetylation and H3K79 methylation 
[111, 112]. Experiments using a mutant form of H3.3 demonstrated that the K4 residue on 
H3.3 plays a key role in the inheritance of active epigenetic memory [110], proposing a model 
in which H3.3 K4 methylation creates an “active histone environment” for the recovery of 
active chromatin configuration in daughter cells after chromosomal replication [113].
Early studies of iPS cells demonstrated that the Nanog-iPS cells displayed not only a 
highly similar transcriptome to wild-type ES cells, but also an ES cell histone modifica-
tion profile. Genome-wide comparison of histone modifications (H3K4 and H3K27 tri-
methylation) between ES cells, MEFs and MEF-derived iPS cells demonstrated that more 
than 94% of the ES- or MEF-signature genes in iPS cells have identical histone methyla-
tion marks as in ES cells. Only 0.7% of these signature genes retain the histone methyla-
tion status of the original MEFs [63]. However, other gene expression profile studies of iPS 
cells showed that a significant number of differentiation genes have a similar expression 
pattern to that in the somatic cell of origin, but not in ES cells [114–117]. This transcrip-
tional memory in iPS cells was found to be correlated with biased differentiation towards 
the original cell lineage, and with less competence in differentiation to other unrelated 
somatic lineages [115, 118–121]. Importantly, the persistent expression of somatic genes 
in iPS cells was associated with the somatic DNA methylation pattern [117, 122–124], 
highlighting the crucial role of epigenetic regulation in the retention of memory. This is 
in fact similar to the observation that an incomplete removal of donor cell DNA meth-
ylation pattern was observed in some aberrantly developed NT embryos [125]. Strikingly, 
the addition of epigenetic modifying agents, such as DNA methyltransferase inhibitor 
5-aza-2’-deoxycytidine (5-aza-dC), can enhance the iPS cell reprogramming efficiency [70] 
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generated only with Oct4 and Sox2 with a comparable reprogramming efficiency by the four 
Yamanaka factors [101]. Interestingly, it was found that vitamin C can increase reprogram-
ming efficiency by promoting the transition of pre-iPS cells to fully reprogrammed cells [102], 
potentially through acting as a cofactor of Kdm2b to induce H3K36me2/3 demethylation [78], 
activation of H3K9 demethylases (Kdm3a, 3b, 4c and 4d) to remove H3K9me3 [89], and pro-
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pattern is memorized and maintained throughout cell generations. In the situation of repro-
gramming cell fate, the persistent somatic cell epigenetic signature and the expression of lin-
eage genes in the reprogrammed cells is thus regarded as an example of epigenetic memory.
Even though it has been shown that prolonged in vitro culture of mammalian embryos can 
lead to aberrant expression of imprinted and non-imprinted genes owing to associated epi-
genetic ‘errors’ [104, 105]. It has been shown that many cloned embryos demonstrate differ-
ent degrees of resemblance with donor cell gene expression patterns. The aberrant epigenetic 
pattern in cloned embryos is thought to be the result of persistence of the epigenetic memory 
of the donor cells. Indeed, the resemblance of DNA and histone modification patterns of NT 
embryos to those of the donor cell types supports this conclusion [45–47]. For example, both 
global and gene-specific patterns of DNA methylation in cloned bovine and mouse embryos 
were shown to be similar to those of their respective donor somatic cell types [28, 106, 107]. The 
phenomenon of epigenetic memory is also highlighted by the X inactivation pattern in cloned 
embryos. In normal fertilized embryos, the paternal X chromosome is preferentially silenced 
in the trophectoderm and extraembryonic endoderm lineages, whereas random X inactivation 
occurs in the inner cell mass. However, in NT embryos generated from female donor nuclei, the 
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toderm, which is in contrast to the random X inactivation in the embryo proper, demonstrating 
a certain extent of memory of the inactive X chromosome status [48]. Random X inactivation in 
the placenta was found in deceased cloned bovine embryos, which suggests that the persistence 
of this inactive X chromosome memory in the placenta may be crucial for fetal survival [49].
The epigenetic memory in NT embryos that maintains the donor expression gene states can 
be explained by the inheritance of DNA methylation patterns. Heritability of DNA methyla-
tion is mediated by the activity of the maintenance DNA methyltransferase Dnmt1 which 
preferentially targets hemi-methylated DNA. Thus, Dnmt1 restores the parental methylation 
status on the newly synthesized daughter DNA strand, thereby maintaining a silent gene 
state after cell division [108]. Methylated donor genes, such as pluripotency genes, remain 
inactivated after SCNT, apparently owing to the persistent donor-specific methylation pattern 
in the cloned embryos, possibility mediated by the residual somatic form of Dnmt in the donor 
nucleus. DNA methylation therefore provides a plausible mechanism for the propagation of 
a silent memory state in SCNT [109]. On the other hand, an active gene memory of the donor 
differentiation state is also observed in NT embryos. For example, both the donor endoderm 
and neurectoderm markers, Edd and Ncam, were found to be aberrantly expressed in Xenopus 
NT embryos derived from the respective donor cell types [18]. This active gene memory was 
further demonstrated to be associated with the incorporation of a histone H3 variant H3.3 at 
the active gene loci in Xenopus NT embryos [110]. Histone variant H3.3 is enriched in the regu-
latory region of active genes and is preferentially marked by modifications associated with an 
active chromatin state, such as H3K4 methylation, H3K9 acetylation and H3K79 methylation 
[111, 112]. Experiments using a mutant form of H3.3 demonstrated that the K4 residue on 
H3.3 plays a key role in the inheritance of active epigenetic memory [110], proposing a model 
in which H3.3 K4 methylation creates an “active histone environment” for the recovery of 
active chromatin configuration in daughter cells after chromosomal replication [113].
Early studies of iPS cells demonstrated that the Nanog-iPS cells displayed not only a 
highly similar transcriptome to wild-type ES cells, but also an ES cell histone modifica-
tion profile. Genome-wide comparison of histone modifications (H3K4 and H3K27 tri-
methylation) between ES cells, MEFs and MEF-derived iPS cells demonstrated that more 
than 94% of the ES- or MEF-signature genes in iPS cells have identical histone methyla-
tion marks as in ES cells. Only 0.7% of these signature genes retain the histone methyla-
tion status of the original MEFs [63]. However, other gene expression profile studies of iPS 
cells showed that a significant number of differentiation genes have a similar expression 
pattern to that in the somatic cell of origin, but not in ES cells [114–117]. This transcrip-
tional memory in iPS cells was found to be correlated with biased differentiation towards 
the original cell lineage, and with less competence in differentiation to other unrelated 
somatic lineages [115, 118–121]. Importantly, the persistent expression of somatic genes 
in iPS cells was associated with the somatic DNA methylation pattern [117, 122–124], 
highlighting the crucial role of epigenetic regulation in the retention of memory. This is 
in fact similar to the observation that an incomplete removal of donor cell DNA meth-
ylation pattern was observed in some aberrantly developed NT embryos [125]. Strikingly, 
the addition of epigenetic modifying agents, such as DNA methyltransferase inhibitor 
5-aza-2’-deoxycytidine (5-aza-dC), can enhance the iPS cell reprogramming efficiency [70] 
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and improve the differentiation competency to other unrelated somatic lineages [120]. 
Interestingly, it has been demonstrated that continuous passaging of iPS cells abrogates 
somatic DNA methylation patterns [115], which suggests a passive replication-dependent 
mechanism in loss of the parental memory in iPS cells. Nevertheless, a study showed that the 
epigenetic memory in some iPS cell lines cannot be removed even after extended passages 
[124]. Apart from DNA methylation, microRNA expression pattern was also shown to have a 
role in the retention of somatic memory in iPS cells derived from hematopoietic progenitors 
[126]. However, it should be emphasized that other profiling studies of iPS cells failed to find 
the gene expression and epigenetic differences when compared to ES cells [127, 128]. It thus 
proposes that the “somatic memory” in iPS cells could be an artifact of incomplete repro-
gramming resulting in variation between iPS cell lines [129]. It is also possible that there 
are individual iPS cell lines expressing gene signatures owing to culture conditions and 
laboratory practices [130], similar to the scenario that some ES cell lines exhibit preferential 
differentiation towards specific lineages [131–133]. In summary, the epigenetic memory in 
iPS cells remains a contentious issue.
6. Conclusions and perspectives
Although the term “epigenetic landscape” was first introduced by Waddington in 1942 [1], 
our understanding of how the epigenome of a cell type is maintained and altered during 
differentiation is still far from complete. The reversal of the differentiated state of a cell has 
important implications for our understanding of normal development and for regenerative 
medicine. Epigenetic reprogramming provides heritable changes of cell identity, and thus 
is a key event for the complete and permanent conversion of cell fate (Figure 2). Although 
reprogramming of cell fate can be achieved by different strategies, the rate (reprogramming 
time) and efficiency (number of reprogrammed cells) are far from comparable to the natural 
event during fertilization/de-differentiation. Achieving a complete epigenetic reversion to 
generate reprogrammed cells or iPS cells with a comparable potency state of early embryos 
would imply that these cells can respond correctly to differentiation-promoting signals, and 
more importantly, decrease the tumorigenic potential owing to pre-disposing epimutations. 
Notably, the status of epigenetic memory in iPS cells can be regarded as a state of incom-
plete reprogramming. The biased differentiation owing to the persistent somatic epigenetic 
memory in iPS cells might be useful in efficient differentiation to the desired cell type of 
origin, which usually results in a heterogeneous cell population by using un-optimized dif-
ferentiation protocols. On the contrary, it has been shown that in vitro culture condition can 
alter the epigenetic status of iPS cells [134]. With an optimized culture condition, a more 
homogeneous population of iPS cells can be obtained, which corresponds to the naïve state 
of pluripotency, and hence, further abrogate the somatic “epigenetic memory”. A more 
recent approach in reprogramming involves the use of a combination of small chemical 
molecules and epigenetic modifying agents, without any ectopic expression of transcrip-
tion factors [135, 136]. This approach seems to induce pluripotent reprogramming process 
different from the transcription factor-mediated approach. Therefore, unlocking the secrets 
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of epigenetic resetting mechanisms during cell differentiation can shed light on the develop-
ment of more efficient and complete reprogramming approaches to further advance regen-
erative medicine.
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Figure 2. Mechanisms of epigenetic reprogramming. Epigenetic patterns in differentiated cells need to be reprogrammed 
to those of pluripotent cells, which results in silencing of differentiated genes and reactivation of pluripotency genes. 
Epigenetic reprogramming can be achieved by modulation of DNA methylation and histone modifications by various 
epigenetic modifying enzymes, such as Dnmt, Tet, Kdm2b, Kdm4b, Utx, Ezh2 (PcG), histone variant replacement, and 
chromatin remodeling enzymes. Other epigenetic mechanisms may also be involved. It is believed that a collaborative 
contribution of different epigenetic mechanisms is required for complete reversal of the differentiated cell state.
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Figure 2. Mechanisms of epigenetic reprogramming. Epigenetic patterns in differentiated cells need to be reprogrammed 
to those of pluripotent cells, which results in silencing of differentiated genes and reactivation of pluripotency genes. 
Epigenetic reprogramming can be achieved by modulation of DNA methylation and histone modifications by various 
epigenetic modifying enzymes, such as Dnmt, Tet, Kdm2b, Kdm4b, Utx, Ezh2 (PcG), histone variant replacement, and 
chromatin remodeling enzymes. Other epigenetic mechanisms may also be involved. It is believed that a collaborative 
contribution of different epigenetic mechanisms is required for complete reversal of the differentiated cell state.
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Abstract
Vast emerging evidences are linking the base modifications and gene expression involved 
in essential metabolic pathways. Among the base modification markers extensively stud-
ied, 5-methylcytosine (5mC) and its oxidative derivatives (5-hydroxymethylcytosine 
(5-hmC), 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC)) dynamically occur 
in DNA and RNA and have been acknowledged as the important epigenetic markers 
involved in regulation of cellular biological processes. The modification of C has been 
characterized biochemically, molecularly, and phenotypically, including elucidation 
of its methyltransferase complexes (writer), demethylases (eraser), 10-11 translocation 
proteins (TETs), and direct interaction proteins (readers). The levels and the landscapes 
of these epigenetic markers in the epitranscriptomes and epigenomes are precisely 
and dynamically regulated by the fine-tuned coordination of the writers and erasers 
in accordance with stages of the growth, development, and reproduction as naturally 
programmed during the life span. In mammalian genome, the TET family is consisted of 
three members, including TET1, TET2, and TET3. The link between aberrant modifica-
tions and diseases, such as cancers, neurodegenerative disorders, and heart diseases, has 
been appreciated. This review article will highlight the research advances in the writers 
and erasers for the modifications of cytosine in genome, as well as the dual function of 
TET1 in tumorigenesis as a tumor suppressor and a promoter. Additionally, the future 
research directions are addressed.
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1. Introduction
Epigenetics is defined as the investigation on gene expression alterations heritable to next gen-
erations caused by nongenetic but heritable cellular memory other than DNA sequence varia-
tions [1]. The epigenetic memories including dynamic base modifications (DNA methylation/
demethylation), histone modifications, chromatin architecture, and noncoding RNAs main-
tain all the biological processes in the programmed tracks. Any aberrant alterations could lead 
to development of abnormality and initiation of diseases such as neurological disorders and 
cancers as reviewed in [2–8]. A micro-event in base modification could lead to strong “earth-
quake” in the signaling pathways and the consequent alteration of organism phenotypes, even 
diseases. The most extensively studied modifications are methylation and demethylation of 
5-cytosine (5-C).
DNA base modifications such as methylation of 5-mC [9–14] and 5-hydroxymethylcytosine 
(5-hmC) [15–21] have been acknowledged as the best characterized epigenetic markers in 
mammalian brains [20, 22–24] and ES cells [25–27], essentially regulating chromatin struc-
ture and consequently gene expression with the potential mechanisms. This review article 
mainly focuses on the recent advances in methylation/demethylation modifications of 5-C in 
mammalian genomes, including methylation/demethylation machineries, methyltransferase 
complexes (writers) and demethylase complexes (erasers), as well as the distinct functions of 
TET1 in the regulation of tumorigenesis.
2. Cytosine modifications
To maintain the normal life process, any base modification must be dynamically and tightly 
regulated in accordance with stages of the growth, development, and reproduction, includ-
ing modification generation by methyltransferase complexes (writers), removal by demethyl-
transferases (erasers), as well as the preferential binding protein components (readers), to get 
the related epigenetic markers into the biochemical effects.
2.1. Methyltransferases of cytosine methylation
DNA methylation, particularly the most abundant CpG methylation marker 5-mC, is an essen-
tial modification of DNA in the mammalian genome, typically linked with gene silencing and 
involved in gene regulation, development, genome defense, and disease. A family of DNA 
methyltransferases named (DNMTs) is responsible for the addition of methyl groups to the 
5-position of the carbon, including DNMT1, DNMT2, DNMT3a, DNMT3b, and DNMT3L. The 
five members are structurally and functionally distinct. The three methyltransferase enzymes 
DNMT1, DNMT3a, and DNMT3b serve as writers for the de novo CpG methylation pattern 
during embryogenesis [28, 29], while DNMT1 could confer the maintenance of parent DNA 
methylation patterns to the new daughter strand DNA during DNA replication [30].
Traditionally, DNMT1 was regarded as the maintenance methyltransferase copying methyla-
tion marks of hemimethylated DNA to the newly synthesized daughter strand during DNA 
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replication, making the enzyme indispensable for dividing progenitor cells [29, 39, 40]. This is 
supported by the finding that DNMT1 has higher affinity to hemimethylated DNA [41, 42] and 
that gene knockout of Dnmt1 in the central nervous system leads to lethal in mice [43]. While 
Dnmt1 deletion in all dividing somatic cells is also lethal [43–47], mouse embryonic stem 
cells are viable, despite the resulting global loss of DNA methylation [48]. Notably, human 
embryonic stem cells (ESCs) also displayed a global demethylation upon Dnmt1 deletion [49].
However, in accordance with the special requirement, the DNMT1 and DNMT3A are function-
ally correlated. For example, in the adult brain, both methyltransferases could carry out cytosine 
methylation in the promoter and gene body regions, leading to transcription repression [31].
While DNMT1 is believed to function mainly for the maintenance of established patterns of 
DNA methylation in normal living cells, in the diseased cells such as cancer cells, DNMT1 
alone is not sufficient to maintain the programmed normal gene hypermethylation. As such, 
the collaboration of DNMT1 and DNMT3b is indispensable for the maintenance function.
Dnmt3l is believed to function as a stimulator of the Dnmt3A and Dnmt3B, and has related 
function with DNMT2 [32, 36–38].
Sirt1 regulates DNA methylation and differentiation potential of embryonic stem cells by 
antagonizing Dnmt3l. DNMT2, a tRNA methyltransferase and the most conserved member 
of the DNMTs methylates tRNAs to protect them from ribonuclease digestion. More impor-
tantly, DNMT2 is functionally related to the sperm small RNA (sncRNAs) mediated essen-
tially in writing the “paternal epigenetic signature” to sperm RNA [32]. The mechanism is 
that the DNMT2-conferred m5C in sncRNAs regulates the secondary structure and biological 
properties of sncRNAs, suggesting that sperm RNA modifications could serve as one of the 
carriers for paternally imprinted epigenetic memories [33].
Coordination of the DNA methylation by DNMTs as well as histone modifications contributes 
to the regulation of cell death through development, aging, and disease [34, 35].
2.2. Demethylation and demethylases
The dynamic DNA methylation/demethylation is tightly regulated during the whole life span. 
DNA demethylation, the removal of a methyl group, is not just a reverse process of methyla-
tion, but rather very complicated metabolic pathways indispensable for reactivation of genes and 
directly involved in pathogenesis of diseases such as cancers and neurological disorders. Either 
passive, active, or combination of both, leads to demethylation of DNA. The passive mechanism 
renders the automatic demethylation in a way that dilution and gradual loss of methylation in 
the newly synthesized DNA strands during successive replication rounds. In contrast, the active 
demethylation is believed to be the most important mechanism for active DNA demethylation via 
5-mC oxidation catalyzed by the 10-11 translocation proteins (TETs) in alpha-ketoglutarate (a-KG) 
and Fe(II) dependent manner [22]. In addition to TETs, several other enzymes are acknowledged 
to be involved in the active mechanisms for demethylation, such as activation-induced cytidine 
deaminase (AID) [50], TET [51, 52], and thymine DNA glycosylase (TDG) [53–55].
5-hmC is generated by oxidation of 5-mC by TET, and the 5-hmC faces several fates once it is 
generated. First, the 5-hmC could be directly converted to regular cytosine through mechanisms 




Epigenetics is defined as the investigation on gene expression alterations heritable to next gen-
erations caused by nongenetic but heritable cellular memory other than DNA sequence varia-
tions [1]. The epigenetic memories including dynamic base modifications (DNA methylation/
demethylation), histone modifications, chromatin architecture, and noncoding RNAs main-
tain all the biological processes in the programmed tracks. Any aberrant alterations could lead 
to development of abnormality and initiation of diseases such as neurological disorders and 
cancers as reviewed in [2–8]. A micro-event in base modification could lead to strong “earth-
quake” in the signaling pathways and the consequent alteration of organism phenotypes, even 
diseases. The most extensively studied modifications are methylation and demethylation of 
5-cytosine (5-C).
DNA base modifications such as methylation of 5-mC [9–14] and 5-hydroxymethylcytosine 
(5-hmC) [15–21] have been acknowledged as the best characterized epigenetic markers in 
mammalian brains [20, 22–24] and ES cells [25–27], essentially regulating chromatin struc-
ture and consequently gene expression with the potential mechanisms. This review article 
mainly focuses on the recent advances in methylation/demethylation modifications of 5-C in 
mammalian genomes, including methylation/demethylation machineries, methyltransferase 
complexes (writers) and demethylase complexes (erasers), as well as the distinct functions of 
TET1 in the regulation of tumorigenesis.
2. Cytosine modifications
To maintain the normal life process, any base modification must be dynamically and tightly 
regulated in accordance with stages of the growth, development, and reproduction, includ-
ing modification generation by methyltransferase complexes (writers), removal by demethyl-
transferases (erasers), as well as the preferential binding protein components (readers), to get 
the related epigenetic markers into the biochemical effects.
2.1. Methyltransferases of cytosine methylation
DNA methylation, particularly the most abundant CpG methylation marker 5-mC, is an essen-
tial modification of DNA in the mammalian genome, typically linked with gene silencing and 
involved in gene regulation, development, genome defense, and disease. A family of DNA 
methyltransferases named (DNMTs) is responsible for the addition of methyl groups to the 
5-position of the carbon, including DNMT1, DNMT2, DNMT3a, DNMT3b, and DNMT3L. The 
five members are structurally and functionally distinct. The three methyltransferase enzymes 
DNMT1, DNMT3a, and DNMT3b serve as writers for the de novo CpG methylation pattern 
during embryogenesis [28, 29], while DNMT1 could confer the maintenance of parent DNA 
methylation patterns to the new daughter strand DNA during DNA replication [30].
Traditionally, DNMT1 was regarded as the maintenance methyltransferase copying methyla-
tion marks of hemimethylated DNA to the newly synthesized daughter strand during DNA 
Chromatin and Epigenetics188
replication, making the enzyme indispensable for dividing progenitor cells [29, 39, 40]. This is 
supported by the finding that DNMT1 has higher affinity to hemimethylated DNA [41, 42] and 
that gene knockout of Dnmt1 in the central nervous system leads to lethal in mice [43]. While 
Dnmt1 deletion in all dividing somatic cells is also lethal [43–47], mouse embryonic stem 
cells are viable, despite the resulting global loss of DNA methylation [48]. Notably, human 
embryonic stem cells (ESCs) also displayed a global demethylation upon Dnmt1 deletion [49].
However, in accordance with the special requirement, the DNMT1 and DNMT3A are function-
ally correlated. For example, in the adult brain, both methyltransferases could carry out cytosine 
methylation in the promoter and gene body regions, leading to transcription repression [31].
While DNMT1 is believed to function mainly for the maintenance of established patterns of 
DNA methylation in normal living cells, in the diseased cells such as cancer cells, DNMT1 
alone is not sufficient to maintain the programmed normal gene hypermethylation. As such, 
the collaboration of DNMT1 and DNMT3b is indispensable for the maintenance function.
Dnmt3l is believed to function as a stimulator of the Dnmt3A and Dnmt3B, and has related 
function with DNMT2 [32, 36–38].
Sirt1 regulates DNA methylation and differentiation potential of embryonic stem cells by 
antagonizing Dnmt3l. DNMT2, a tRNA methyltransferase and the most conserved member 
of the DNMTs methylates tRNAs to protect them from ribonuclease digestion. More impor-
tantly, DNMT2 is functionally related to the sperm small RNA (sncRNAs) mediated essen-
tially in writing the “paternal epigenetic signature” to sperm RNA [32]. The mechanism is 
that the DNMT2-conferred m5C in sncRNAs regulates the secondary structure and biological 
properties of sncRNAs, suggesting that sperm RNA modifications could serve as one of the 
carriers for paternally imprinted epigenetic memories [33].
Coordination of the DNA methylation by DNMTs as well as histone modifications contributes 
to the regulation of cell death through development, aging, and disease [34, 35].
2.2. Demethylation and demethylases
The dynamic DNA methylation/demethylation is tightly regulated during the whole life span. 
DNA demethylation, the removal of a methyl group, is not just a reverse process of methyla-
tion, but rather very complicated metabolic pathways indispensable for reactivation of genes and 
directly involved in pathogenesis of diseases such as cancers and neurological disorders. Either 
passive, active, or combination of both, leads to demethylation of DNA. The passive mechanism 
renders the automatic demethylation in a way that dilution and gradual loss of methylation in 
the newly synthesized DNA strands during successive replication rounds. In contrast, the active 
demethylation is believed to be the most important mechanism for active DNA demethylation via 
5-mC oxidation catalyzed by the 10-11 translocation proteins (TETs) in alpha-ketoglutarate (a-KG) 
and Fe(II) dependent manner [22]. In addition to TETs, several other enzymes are acknowledged 
to be involved in the active mechanisms for demethylation, such as activation-induced cytidine 
deaminase (AID) [50], TET [51, 52], and thymine DNA glycosylase (TDG) [53–55].
5-hmC is generated by oxidation of 5-mC by TET, and the 5-hmC faces several fates once it is 
generated. First, the 5-hmC could be directly converted to regular cytosine through mechanisms 
Cytosine Modifications and Distinct Functions of TET1 on Tumorigenesis
http://dx.doi.org/10.5772/intechopen.83709
189
involving the base excision repair pathway. Second, stepwise, a small percentage (~10%) of 
the 5-hmC is converted to 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), respectively 
[56, 57]. The 5-fC and 5-caC are finally converted into regular cytosine [58] with the help of 
Thymine-DNA glycosylase (TDG). Finally, in some tissues such as stem cells and adult neuron 
cells, high 5-hmC levels could be detected particularly in transcribed regions adjacent to the 
promoter and enhancers, positively correlating with gene expression. The low turnover rates 
of 5-hmC in some tissues suggest that besides serving as an intermediate of active demeth-
ylation, the stable accumulation of the 5-hmC forms a dynamic 5-hmC landscape to serve as 
special epigenetic markers, potentially altering the local chromatin structures via recruiting 
or repelling some special protein components with high affinity to or low even repellent to 
5-hmC-harboring DNA [59, 60]. For example, 5-hmC loss has become a hall marker for cancer 
cells [61–66]. In addition, the TET members are acknowledged as the tumor suppressors as Tet 
gene mutations or deletions have been identified in some tumor tissues [67].
In mammalian genome, the TET family is consisted of three members, including TET1, TET2, 
and TET3. While all three TET members could function as hydroxylases for conversion of 
5-mC to 5-hmC and further stepwise from 5-hmC to 5-fC and 5-fC to 5-caC, their functions 
involved in diverse biological pathways are in the development stage and specifically in 
tissue-dependent manners [25, 68].
2.2.1. TET1 and regulation of its target gene expression
Highly expressed in ESCs, PGCs, and inner cell mass of blastocyst, TET1 protein has been proven 
to be mainly responsible for the initial oxidation of 5-mC to 5-hmC, and to establish the para-
doxically dual distinct epigenetic patterns in transcriptional activation and repression in accor-
dance with life processes of growth and development. Alternative splicing mechanism leads 
to several TET1 isoforms, including the full-length canonical and the short transcripts [69–73]. 
TET1 expression is regulated by very complicated factors including the reprogramming factors 
such as Oct3/4, Nanog, and Myc [68, 70] in early embryos, ESCs and PGCs [69], the transcription 
factors in the differentiated cells, and STAT3/STAT5 in acute myeloid leukemia (AML) [74].
The full length of TET1 protein is believed to have multiple functions in regulation of gene 
expression. In general, TET1 catalyzes the oxidation of 5-mC to 5-hmC, which serves as an epi-
genetic marker and intermediate for active demethylation, leading to transcription activation. 
The more emerging evidence has supported the TET1 conferred transcription activation and 
repression of its direct target genes [75–77] at the transcriptional level. At the molecular level, 
the interaction between TET1 and SIN3a facilitates transcription activation of their target genes 
at the transcription level. More importantly, the interaction has been detected between TET1/
TET2 and E26 transformation-specific or E-twenty-six (ETS) family, one of the largest transcrip-
tion factor families. For example, ETS variant 2 (ETV2), an ETS family transcription factor, 
interacts with TET1/TET2 to recruit the demethylases to the Robo4 promoter for demethylation-
mediated transcription activation during endothelial differentiation. More recently, the Methyl-
CpG-binding domain (MBD) protein, such as MBD1, through its CXXC domain recruits TET1 
other than TET2 and TET3 to the heterochromatin for oxidation of 5-mC to 5-hmC, whereas the 
resulting 5-hmC releases the MBD1 from the binding sites by affinity-based displacement [78].
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On the other hand, TET1 also confers transcription repression of its target genes. It is accepted 
that the TET1-mediated transcription repression does not require the catalytic activity of the 
TET1 in conversion of 5-mC to 5-hmC, but rather the interaction between TET1 and some 
other protein components that contain repressor complexes [79]. Several mechanisms for 
TET1-mediated transcription repression have been proposed. First of all, TET1 binds a large 
number of polycomb target genes and interacts with SIN3A, the core component of the SIN3A 
co-repressor complex, leading to the transcription repression of their co-target genes via the 
SIN3A conferred histone deacetylation [76, 80].
The second mechanism of the TET1 conferred transcription repression is involved in TET1 
interaction with recruitment of MBD repression complexes such as MBD3 [78, 81] at least in 
ES cells. The evidence of the mechanism includes the co-localization of TET1 and MBD3 in 
ESCs, higher affinity to 5-hmC than 5-mC, and association of the MBD3 knockdown with 
reduced level of 5-hmC as well as the enhanced expression of the 5-hmC-modified genes.
Several other mechanisms that TET1 represses the transcription have been also uncovered. It 
is convinced that TET1 is involved in the repression of polycomb-targeted regulator genes in 
accordance with the development stage by recruiting polycomb repressive complex 2 (PRC2) 
to the CpG-rich promoters of these genes [82]. Further study indicated requirement of the 
catalytic activity in oxidation of 5-mC to 5-hmC for the PRC repressive complex-mediated 
repression, evidenced by the fact that the PRC2 was co-localized with 5-hmC [80], while TET1 
recruits the EZH2 DNMT-containing PRC complex targeting H3K27 methylation.
During the early stages of epiblast differentiation, repression of TET1 target genes was 
conferred by the interaction between TET1 and the JMJD8 and enhancement of the JMJD8 
demethylase transcriptional repressor expression [83], but does not require the TET1 oxidation 
activity. Although TET1, TET2, and TET3 are all expressed in gonadotrope-precursor cells, the 
TET1 expression was dramatically decreased in the differentiated cells. Differentiation with 
according increase in the expression of the luteinizing hormone gene (Lhb). The short iso-
form of TET1 with deletion of the N-terminal CXXC-domain binds the H3K27me2/3 enriched 
region located at the upstream promoter of the Lhb gene, downregulating its expression and 
leading to differentiation deficiency [73].
3. Distinct functions of TET1 on tumorigenesis
3.1. Tet1 functions as an oncogene in some cancers
Initially, given the mutations and the deletions as predominant variation of TET proteins, par-
ticularly TET1, in human cancer genomes, it was accepted that TET1 functions as a tumor sup-
pressor [61, 65, 66]. Indeed, TET1 and TET3 bear the predominant mutations in some tumors 
including colorectal cancer, melanoma, and cutaneous squamous cell carcinoma [88–90]. 
However, emerging evidences are connecting the TET1 overexpression and tumorigenesis as 
well, most likely attributed to activation of cancer-specific oncogenic pathways mediated by 
TET1 conferred hypomethylation [72, 84] (Figures 1 and 2).
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involving the base excision repair pathway. Second, stepwise, a small percentage (~10%) of 
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resulting 5-hmC releases the MBD1 from the binding sites by affinity-based displacement [78].
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On the other hand, TET1 also confers transcription repression of its target genes. It is accepted 
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according increase in the expression of the luteinizing hormone gene (Lhb). The short iso-
form of TET1 with deletion of the N-terminal CXXC-domain binds the H3K27me2/3 enriched 
region located at the upstream promoter of the Lhb gene, downregulating its expression and 
leading to differentiation deficiency [73].
3. Distinct functions of TET1 on tumorigenesis
3.1. Tet1 functions as an oncogene in some cancers
Initially, given the mutations and the deletions as predominant variation of TET proteins, par-
ticularly TET1, in human cancer genomes, it was accepted that TET1 functions as a tumor sup-
pressor [61, 65, 66]. Indeed, TET1 and TET3 bear the predominant mutations in some tumors 
including colorectal cancer, melanoma, and cutaneous squamous cell carcinoma [88–90]. 
However, emerging evidences are connecting the TET1 overexpression and tumorigenesis as 
well, most likely attributed to activation of cancer-specific oncogenic pathways mediated by 
TET1 conferred hypomethylation [72, 84] (Figures 1 and 2).
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Figure 2. Sequestration of miR-26 by its target 3’UTRs of Tet1 leads to miR-26 deficiency to target its target Ezh2, an 
oncogene. (A) In normal cells, due to low level of Tet1 expression, majority of the miR-26 targets to Ezh2 leads to 
sufficient silencing of the oncogene. (B) In some cancer cells, dramatically enhanced transcription of Tet1 sequestrates 
the miR-26, conferring the miR-26 deficiency to target its Ezh2 target 3’UTRs. Consequently, miR-26 deficiency to the 
Ezh2 releases the miRNA-mediated expression repression of the oncogenes, conferring the initiation of tumorigenesis.
Figure 1. TET1 functions as a tumor promoter by activation of the oncogenes via demethylation of the methylated 
promoter regions in the oncogenes. (A) In normal cells, the promoter regions of the oncogenes are usually methylated 
and therefore silenced. (B) However, in some cells, TET1 is highly expressed and recruited by its interaction partners 
to the methylated promoter regions of the oncogenes, leading to demethylation and the activation of the oncogenes. 
Consequently, the oncoproteins initiate tumorigenesis.
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3.1.1. TET1 demethylation associated activation of the members in the oncogenic pathways
TET1 overexpression accounts for about 40% of patients with triple-negative breast cancer 
(TNBC) that belongs to the most hypomethylated cancers observed, leading to about 10% 
hypomethylation of the queried CGI and activation of oncogenic pathways including PI3K, 
EGFR, and PDGF. Thus, TET1 seems functioning as a potential oncogene and could serve 
as a target for intervention therapy [84]. This phenomenon was observed not only in NTBC, 
but also in MLL-rearranged leukemia where TET1 is believed to activate the downstream 
oncogenic pathways by its demethylase activity, serving as an oncogene [86]. Additionally, 
via DNA hypomethylation, TET1 was demonstrated to regulate the expression of MUC4, one 
member of the mucin (MUC) family and an essential factor for carcinogenesis and tumor 
invasion in lung neoplasms, functioning as the potential oncogene [86, 87].
TET1 functions as an important oncoprotein in acute myeloid leukemia (AML) as evidenced by 
the high level expression of TET1 in AML, indicating that efficient inhibition of TET1 expres-
sion could serve as a powerful strategy for AML therapy. Drug screening led to identification 
of two compounds NSC-370284 and its structure analogue UC-514321, which repress TET1 
transcription by targeting directly to target STAT3/5, TET1 transcriptional activators, suggest-
ing the potential of the compounds targeting the STAT/TET1 for efficient therapy of AML [74].
Full length TET1 (TET1FL) has a CXXC domain that binds to unmethylated CpG islands 
(CGIs), allowing TET1 to protect CGIs from aberrant methylation and limiting its ability to 
regulate genes outside of CGIs. An isoform of TET1 (TET1ALT) without CXXC domain but 
still with catalytic domain is repressed in ES cells while it is activated in embryonic and adult 
tissues in contrast to TET1FL’s expression in ESCs and repression in adult tissues. TET1ALT 
aberrant activation is detected in breast cancer, uterine and ovarian cancer, and glioblastoma, 
leading to worse overall survival in these types of cancers. As for the pathogenesis mediated 
by the TET1ALT isoform, a predominantly activated isoform of TET1 in cancer cells does 
not protect from CGI methylation but likely mediates dynamic site-specific demethylation 
outside of CGIs.
3.1.2. Hypoxia induced promotion of TET1 expression
Enhanced expression of TET1 by hypoxia induction has been reported to upregulate cancer 
cell migration, invasion, and proliferation via the HIF1α signaling pathway in JEG3 cells [100], 
suggesting the oncogenic function of TET1 under hypoxia condition.
3.1.3. Overexpression of Tet1 mRNA 3’UTRs leads to sequestration of miRNAs, which 
target the oncogenic transcripts as well, leading to miRNA deficiency to target the oncogenic 
transcript
Transcription levels of TETs were significantly elevated while the protein levels were not in 
gastric cancer (GC) tissues compared to the adjacent normal tissues, suggesting the essential 
role(s) of the endogenous TET transcripts in gastric carcinogenesis and prognosis. Further 
study showed that overexpression of 5’UTRs, CDs, and 3’UTRs contributed to varied effects 
in a way that overexpression of TET 3’UTRS promoted GC growth and proliferation. Given 
that miR-26 targets 3’UTRs of both TET1 and EZH2 mRNAs, overexpression of TET members 
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by the TET1ALT isoform, a predominantly activated isoform of TET1 in cancer cells does 
not protect from CGI methylation but likely mediates dynamic site-specific demethylation 
outside of CGIs.
3.1.2. Hypoxia induced promotion of TET1 expression
Enhanced expression of TET1 by hypoxia induction has been reported to upregulate cancer 
cell migration, invasion, and proliferation via the HIF1α signaling pathway in JEG3 cells [100], 
suggesting the oncogenic function of TET1 under hypoxia condition.
3.1.3. Overexpression of Tet1 mRNA 3’UTRs leads to sequestration of miRNAs, which 
target the oncogenic transcripts as well, leading to miRNA deficiency to target the oncogenic 
transcript
Transcription levels of TETs were significantly elevated while the protein levels were not in 
gastric cancer (GC) tissues compared to the adjacent normal tissues, suggesting the essential 
role(s) of the endogenous TET transcripts in gastric carcinogenesis and prognosis. Further 
study showed that overexpression of 5’UTRs, CDs, and 3’UTRs contributed to varied effects 
in a way that overexpression of TET 3’UTRS promoted GC growth and proliferation. Given 
that miR-26 targets 3’UTRs of both TET1 and EZH2 mRNAs, overexpression of TET members 
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Figure 3. TET1 functions as a tumor suppressor. (A) In normal cells, TET1 expression is maintained at a regular level. 
The TET1 is recruited to the methylated promoter area of the tumor suppressor genes for demethylation so that the 
tumor suppressor could be expressed at the normal levels. (B) Due to mutation of the Tet1 genes or some other factors, 
Tet1 expression silenced, leading to silencing of the suppressor genes and activation of the oncogenes such as Ezh2. 
Expression of the oncoproteins initiates the tumorigenesis or enhances cancer cell growth and metastasis.
mRNA sequestrates miR-26 competitively and leads to release of the miR-26 mediated repres-
sion of EZH2. Thus, activation of EZH2 expression facilitates gastric carcinogenesis and pro-
gression [87] (Figure 2).
3.2. TET1 serves as a tumor suppressor
The pathogenic contributions the TET members made in various human cancers by functioning 
as tumor suppressors or promoters have been proven to be versatile. The hypermethylation-
based transcriptional silencing of TET1 is frequently detected in non-Hodgkin B cell lymphoma 
(B-NHL), suggesting TET1 as a tumor suppressor of hematopoietic malignancy [91]. Similarly, 
TET1 is downregulated upon NF-κB activation in multiple cancers including basal-like breast 
cancer (BLBC), melanoma, lung, and thyroid cancers, demonstrating that TET1 is the tumor 
suppressor that relies on involvement of the immune system [92].
3.2.1. TET1 methylation-mediated activation of tumor suppressor genes
It is acknowledged that 5hmC depletion initiates carcinogenesis caused by either TET1 expres-
sion repression or aberrant localization. Significantly lower 5-hmC and TET1 expression level 
and subcellular mislocalization in gastric cancer tissues demonstrate the crucial role of TET1 
as a cancer repressor [97] (Figure 3).
In the tested epithelial ovarian cancer (EOC), undetected TET1 expression suggests that the 
consequence of TET1 repression induces the tumorigenesis, in accordance with the inhibition 
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of colony formation, cell migration, and invasion by ectopic expression of TET1 in SKOV3 and 
OVCAR3 cells. The potential mechanism is the TET1 conferred demethylation and the conse-
quent activation of the expression of two key proteins SFRP2 and DKK1 in the canonical Wnt/β-
catenin signaling pathway, associated with inhibition of EMT and metastasis [101].
TET1 is identified as a key tumor suppressor player in ovarian cancer cell lines as well by 
demethylating a CpG site within the Ras association domain family member 5 (RASSF5) 
promoter to enhance expression of the RASSF5, leading to the growth inhibition of ovarian 
cancer cells [102].
More evidences show that EGFR-mediated TET1 repression induces silencing of tumor sup-
pressors in cancer cells such as lung adenocarcinomas and glioblastomas. If only the oncogenic 
EGFR expression is inhibited, TET1 could bind to promoters of the tumor suppressors to activate 
their expression via DNA demethylation. TET1 overexpression inhibits lung and glioblastoma 
tumor growth, and vice versa, in agreement with the significant decrease in TET1 expression 
or TET1 cytoplasmic localization in the majority of lung cancer samples. Thus, it is plausible 
to speculate that TET1 may serve as the therapeutic target for oncogenic EGFR-induced lung 
cancers and glioblastomas [93]. However, Lai et al. could not draw the same conclusion in 
human NSCLC patient samples. They did not detect the EGFR-mediated TET1 silencing, but 
rather observed the significant elevation of the TET1 expression levels in patient samples with 
EGFR mutations, suggesting the inconclusiveness in EGFR-mediated TET1 silencing among 
the cellular and animal models and human lung cancer patients [94].
Eicosapentaenoic acid (EPA), one of the major polyunsaturated fatty acids, could enhance 
the formation of PPARγ-RXRα-TET1 to recruit TET1 to a hypermethylated CpG island on the 
p21 gene for rapid demethylation and consequent expression of p21Waf1/Cip1, leading to 
inhibition of cancer cell-cycle progression in hepatocarcinoma cells. This suggests the bridge 
requirement for TET1 exerting the anti-tumor function and potential of EPA for solid tumor 
therapy such as live cancer [97].
3.2.2. TET1 silencing and loss of 5-hmC induces initiation of tumors
Loss of 5-hydroxymethylcytosine (5 hmC) caused by TET1 dysfunction could induce tumor 
initiation and enhance malignancy by promoting cancer cell growth, migration, and invasion 
in DLD1 colon cancer cells mediated by EZH2 [96]. With loss of TET1, EZH2 repression is 
released, but H3K27 demethylase UTX-1 expression is repressed, enhancing histone H3K27 
tri-methylation and consequently repressing the target gene E-cadherin (DH1). Accordingly, 
even at the condition of TET1 deficiency, either the H3K27 demethylase UTX-1 overexpres-
sion or EZH2 depletion both could enhance H3K27 demethylation at CDH1 promoter, 
thereby impeding EMT and tumor invasion. Likewise, either EZH2 overexpression or UTX-1 
depletion both could promote EMT and tumor metastasis in DLD1 cells. Thus, these results 
elucidate regulation interplay among TET1, E-cadherin, and EZH2 and indicate the critical 
mediator role the EZH2 plays in the E-cadherin repression and tumor progression [95].
3.2.3. miRNA-mediated repression of TET1 expression
Some miRNAs are identified to be involved in regulation of cancer progression or repres-
sion, and one of the mechanisms refers to the oncogenic miRNA-mediated TET1 repression 
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Figure 3. TET1 functions as a tumor suppressor. (A) In normal cells, TET1 expression is maintained at a regular level. 
The TET1 is recruited to the methylated promoter area of the tumor suppressor genes for demethylation so that the 
tumor suppressor could be expressed at the normal levels. (B) Due to mutation of the Tet1 genes or some other factors, 
Tet1 expression silenced, leading to silencing of the suppressor genes and activation of the oncogenes such as Ezh2. 
Expression of the oncoproteins initiates the tumorigenesis or enhances cancer cell growth and metastasis.
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gression [87] (Figure 2).
3.2. TET1 serves as a tumor suppressor
The pathogenic contributions the TET members made in various human cancers by functioning 
as tumor suppressors or promoters have been proven to be versatile. The hypermethylation-
based transcriptional silencing of TET1 is frequently detected in non-Hodgkin B cell lymphoma 
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and the consequent loss of 5-hmC. Indeed, miR-21-5p has been confirmed to target Tet1 in 
colorectal cancer (CRC), serving as a biomarker for diagnostics and prognostics in CRC [98]. 
Similarly, miR-4284 directly targeting Tet1 mRNA downregulates TET1 levels of both mRNA 
and protein in human gastric cancer SGC-7901 cells, and thus serves as an oncogenic marker 
[99], suggesting that miR-4284 could provide a potential target for gastric cancer therapy.
3.2.4. Dual function of miRNA by interaction with Tet mRNA 3’UTRs
Some miRNAs are reported to function as both a suppressor and a promoter in some cancers 
such as miR29b in breast cancer (BC) cells by regulation of BC cell proliferation, metastasis, 
and epithelial-mesenchymal transition (EMT). Significantly decreased expression of miR-29b 
in BC samples and cell lines suggests the role of TET1 as a BC suppressor. However, miR-29b 
overexpression promotes cell proliferation, colony formation, migration, and EMT, indicat-
ing that miR-29b functions as a BC promoter [103]. In vitro assay TET1 has been identified 
as one of the miR-29b targets, and it turns out that overexpression of miR29b leads to TET1 
downregulation-mediated promotion of proliferation, colony formation, invasion, and EMT 
in GC cells such as MDA-MB-231 and MCF-7. Further study showed that the TET1-mediated 
suppression of the BC attributed to TET1 conferred disruption of ZEB2 expression by binding 
to the promoter of ZEB2. While the miR-29b/TET1/ZEB2 pathway offers understanding for 
the mechanism of miR-29b and TET1-mediated BC promotion, the suppression mechanism 
for TET1 remains to be elusive in GC [104].
4. Concluding remarks
In the past decades, particularly recent years, significant achievements have been made in 
epigenetic study particularly 5-mC and its derivatives such as 5-hmC, 5-fC, and 5-caC, in 
understanding the generation, dynamic alteration, machinery, distribution, and biological 
functions and connection between the modifications and the pathogenesis of diseases such as 
neurological disorders and cancers. However, a large number of unknown epigenetic events 
related to pathogenesis of many diseases particularly cancers remain to be elusive. Although 
the individual members of the methyltransferase complexes (writer) for cytosine modifica-
tions have been characterized, their coordination in conducting the methylation in response 
to tumorigenesis has not yet been comprehensively investigated. Similarly, the functional 
study on the TET proteins (the erasers for methylation) stays only at the conversion of 5-mC 
to 5-hmC, identification of the targeting miRNAs, and identification of serving as tumor sup-
pressors or promoters by several known mechanisms. However, it is logical to speculate that 
as such huge protein molecules, TET proteins may have much more unidentified functions. 
Further study on the unknown functions will provide essential information for dissecting 
the cancer pathogenesis. First, only limited information is available for the physical interac-
tion components of the TETs; identification of the TET interaction proteins may help us better 
understand how and where the TETs are recruited to function as demethylase to maintain 
the dynamic balance of 5-mC/5-hmC and the chromatin remodeling. Then, identification of 
other functions of TETs other than demethylase will be of importance. Given that the 5-hmC 
is not so much serving an intermediate of demethylation as the important dynamic 5-hmC 
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landscape, it is essential to investigate how the epigenetic information stored in the land-
scape is transformed into the biological effect. To this end, for identification of the readers 
of the 5-hmC modification, the specific 5-hmC binding proteins might be the prerequisite. A 
better understanding the functions of methyltransferase complex for cytosine methylation, 
TETs for demethylation of 5-mC and interaction protein components as well as the other 
known functions, and the specific readers of the 5-hmC marker could identify some epigen-
etic components for therapeutic targets for treatments of cancers and other diseases such as 
neurological disorders.
It has been reported that Tet1 alternative splicing forms have distinct functions [74]. However, 
the information regarding the Tet1 alternative splicing is still limited. Further alternative splic-
ing study may identify more unknown functions conferred by the different isoforms which 
may bear the potential for therapeutic targets.
Additionally, the chemical biology approach based on further identification of small molecule 
compounds that target the 5-mC/5-hmC machineries or the signaling pathways in which 
5-mC/5-hmC involved could help explore therapeutic targets for some stubborn diseases such 
as cancers and neurological diseases.
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Abstract
Helicobacter pylori (H. pylori) infection causes aberrant DNA methylation of various genes 
in the gastric mucosa. Cyclooxygenases (COX) play a critical role in peptic ulcer develop-
ment and healing. Human COX-2 has CpG islands (CGIs) in its promoter region, suggest-
ing a possible epigenetic regulation. Here, we evaluated COX-2 promoter methylation in 
the gastric mucosa of patients with various gastric diseases and found that COX-2 meth-
ylation levels in the gastric mucosa were significantly increased in patients with H. pylori 
infection. We further investigated the roles of COX-2 during the healing of acetic acid-
induced gastric ulcers in H. pylori-infected Mongolian gerbils (MGs). While COX-2 mRNA 
expression levels on the edges of acetic acid-induced gastric ulcers were significantly 
increased after ulcer induction in MGs in the absence of H. pylori, no such induction was 
observed in H. pylori-infected gastric mucosa. Cloning of the MG COX-2 gene revealed 
abundant CGIs in the promoter region. COX-2 mRNA expression in MG-derived gastric 
carcinoma MGC2 cells was significantly increased by addition of the demethylating agent 
5-Aza-dC. Additionally, COX-2 methylation levels were higher in H. pylori-infected MG 
gastric mucosa than in control mucosa. These results indicated that epigenetic inhibition 
of COX-2 mRNA induced by H. pylori impairs gastric ulcer healing.
Keywords: COX-2, gastric ulcer healing, Helicobacter pylori, methylation,  
Mongolian gerbils, MGC2 cells
1. Introduction
Helicobacter pylori (H. pylori) is a Gram-negative bacterium that selectively colonizes the gastric 
epithelium of humans and is the leading cause of peptic ulcers [1]. Although the majority of 
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individuals infected with H. pylori remain asymptomatic throughout their life, essentially all 
infected individuals develop chronic inflammation. Patients with antral-predominant gastri-
tis are predisposed to duodenal ulcers, while patients with corpus-predominant gastritis and 
multifocal atrophy are more likely to have gastric ulcers. Eradication of H. pylori drastically 
lowers the recurrence of H. pylori-associated peptic ulcers. In addition, the observed delayed 
ulcer healing has been reported to involve H. pylori-induced inflammation, increased apoptosis 
of epithelial cells at the ulcer margin, overexpression of inflammatory cytokines, and reduced 
gastric microcirculation [2]. Cyclooxygenase (COX) is a membrane-bound glycoprotein that 
functions as the rate-limiting enzyme in prostaglandin (PG) synthesis. PGs increase the resis-
tance of the gastric mucosa to injury by downregulating inflammatory responses. Two major 
COX isoforms have been identified, COX-1, which is constitutively expressed and considered a 
housekeeping enzyme, and COX-2, whose mRNA levels rise rapidly in response to inflamma-
tory and mitogenic stimuli. There is a known synergism between H. pylori infection and non-
steroidal anti-inflammatory drug (NSAID) use in the development of peptic ulcers and ulcer 
bleeding [3]. These findings indicate possible interactions between H. pylori infection, COX 
activity, and ulcerogenesis. Aberrant methylation of 5′-CpG islands (CGIs) has been implicated 
in the transcriptional silencing of a wide range of genes involved in various diseases, such as 
cancer. Human COX-2 has CG-rich CGIs in its promoter region, which suggests epigenetic 
regulation. Here, we report and discuss our recent results on the epigenetic regulation of COX-2 
activity in H. pylori-infected gastric mucosa of humans and Mongolian gerbils (MGs), and the 
possible relationship between COX-2 methylation and delayed gastric ulcer healing.
2. COX and the gastric mucosal barrier
In 1971, Vane and colleagues first demonstrated that aspirin and other NSAIDs inhibited the 
synthesis of PGs by blocking COX activity [4]. COX plays pivotal roles in the gastric muco-
sal barrier [5, 6]. COX catalyzes the conversion of arachidonic acid to the common precur-
sor prostanoids, prostaglandin (PG) H2, and PGG2. The major PGs produced by the human 
and rodent gastric mucosa are PGE2 and PGI2, with lesser amounts of PGF2 and PGD2. Each 
of these metabolites binds to a specific G protein-coupled receptor to trigger intracellular 
responses. PGs have been shown to accelerate ulcer healing in experimental models and 
humans [7]. COX exists in two isoforms commonly referred to as COX-1 and COX-2. COX-1 
is constitutively expressed in various tissues. In the stomach, prostanoids synthesized via the 
COX-1 pathway are responsible for cytoprotection of the gastric mucosa and the production 
of thromboxane by platelets. Although COX-2 is generally expressed at very low levels in 
healthy tissues, including in the stomach, it is expressed at particularly high levels at sites of 
inflammation.
It was originally thought that only COX-1 was involved in the gastric mucosal defense system; 
however, several clinical trials have suggested that a COX-2 selective inhibitor produces lesser, 
but some, gastrointestinal toxicity compared to traditional NSAIDs [8, 9]. In accordance with 
this finding, animal studies have suggested that both COX-1 and COX-2 are necessary for gas-
tric mucosal healing, and COX-1 inhibition alone, which can be induced pharmacologically 
Chromatin and Epigenetics208
by specific inhibitors or genetically by gene targeting [10], does not cause gastric mucosal 
injury. It has been shown that a combination of selective COX-1 and COX-2 inhibitors is 
required to cause hemorrhagic erosion of the gastric mucosa, which is comparable to that 
observed with indomethacin [11]. Prostanoids produced by COX-2, especially PGE2, enhance 
cell proliferation. The beneficial effects of PGE2 on gastric ulcer healing in rodents appear 
to be mediated via the EP4 receptor [12]. In addition, COX-2-derived PG stimulates vascu-
lar endothelial growth factor (VEGF) release from gastric fibroblasts, which is an important 
contributor to ulcer healing [13, 14], likely via stimulation of new blood vessel growth. The 
increase in COX-2 immunoreactivity that is observed in monocytes, macrophages, fibroblasts, 
and endothelial cells at the ulcer margin is closely correlated, both temporally and spatially, 
with the increase in cell proliferation [15]. COX-2 appears to represent a second line of defense 
that is activated during ulcer healing to compensate for the temporary loss of COX-1 in the 
mucosa adjacent to the ulcer and assists COX-1 in protecting gastric mucosal integrity. The 
healing-impairment effect of NSAIDs is also observed with selective COX-2 inhibitors [16].
3. H. pylori infection and COX-2 in gastric mucosa
The pathophysiological roles of COX-2 in H. pylori-infected gastric mucosa are intriguing. 
H. pylori has been implicated as an inducer of COX-2 in the stomach [17–19]. In addition, 
COX-2 expression is elevated within H. pylori-induced gastritis and malignant lesions [20], 
and H. pylori induced COX-2 expression and enhanced PGE2 production in a human gastric 
carcinoma cell line. Both H. pylori infection and NSAID use independently and significantly 
increase the risk of peptic ulcers and ulcer bleeding. While COX-2 is necessary for gastric 
mucosal healing [21], H. pylori infection is the leading cause of gastric ulceration. To under-
stand the bimodal effects of H. pylori infection on COX-2 induction during ulcer healing, we 
explored the effects of epigenetic regulation and H. pylori infection on the induction of COX-2 
in vivo and in vitro.
H. pylori infection causes aberrant DNA methylation of various genes in the gastric mucosa, 
including COX-2 [22–25]. Human COX-2 has CGIs in its promoter region. Thus, we com-
pared COX-2 promoter methylation levels in the gastric mucosa in H. pylori-positive and 
H. pylori-negative cases [26]. As mentioned above, in qualitative experiments, COX-2 gene 
promoter methylation levels were significantly higher in H. pylori-positive cases than in 
H. pylori- negative cases (Figure 1). COX-2 promoter methylation levels were significantly 
lower in patients with H. pylori eradication than in those with H. pylori infection. We then 
investigated the effects of COX-2 promoter methylation on COX-2 mRNA expression in vitro 
using the human gastric adenocarcinoma cell line Kato III, in which the COX-2 promoter is 
densely methylated [22]. COX-2 mRNA expression was not observed in these cells, despite 
the addition of the protein kinase C stimulator α-phorbol 12,13-dibutyrate (PDBu). However, 
COX-2 expression was observed after the addition of the demethylating agent 5-Aza-dC, 
and expression was enhanced by adding PDBu (Figure 2) [26]. These results indicate that H. 
pylori infection causes reversible COX-2 promoter methylation in the gastric mucosa, and that 
COX-2 mRNA expression is regulated through an epigenetic mechanism.
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Figure 2. Effects of a PKC stimulator (α-phorbol 12,13-dibutyrate; PDBu) on COX-2 mRNA expression with or without 
5-aza-dC in the human gastric adenocarcinoma cell line KATO-III. KATO-III cells were treated with vehicle (1 μmol/L) 
with or without 5-Aza-dC for 5 days. The figure is modified from Ref. [26].
Figure 1. COX-2 DNA methylation levels in patients with or without H. pylori infection, and patients previously with 
successfully eradicated H. pylori infection. The figure is modified from Ref. [26].
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4. Acetic acid-induced gastric ulcer healing and COX mRNA levels 
in Mongolian gerbils with or without H. pylori infection
H. pylori infection in humans is best modeled in Mongolian gerbils (MGs), and chronic 
infection with H. pylori induces inflammatory cell infiltration in the gastric mucosa in MGs 
(Figure 3A). It was previously shown that H. pylori infection significantly delayed acetic 
acid-induced ulcer healing in mice and MGs [27–29]. H. pylori infection induces aberrant 
DNA methylation of several CGIs in MGs [30]. As described above, COX-2-derived PGs are 
important for gastric ulcer healing, and the COX-2 promoter is densely methylated in the 
human gastric mucosa in the presence of H. pylori infection. To investigate the roles of COX-2 
Figure 3. A. Microscopic features of H. pylori-infected gastric mucosa of Mongolian gerbils (MGs). Sections were stained 
with hematoxylin and eosin. B. Gross appearance 10 days after gastric ulcer induction of H. pylori-infected MGs. 
C. Microphotograph 10 days after gastric ulcer induction in H. pylori-infected MGs. D. Serial changes in acetic acid-
induced gastric ulcer areas in MGs with or without H. pylori infection. H. pylori (ATCC43504; American Type Culture 
Collection, Rockville, MD) was grown in Brucella broth (Becton Dickinson, Cockeysville, MD) containing 10% v/v horse 
serum for 40 h at 37°C under microaerobic conditions (15% CO2) and high humidity with shaking (150 rpm). Male MGs 
(MGs/Sea) were purchased from Kyudo (Saga, Japan). At 11 weeks of age, H. pylori (0.8 mL samples of Brucella broth 
containing 1.0 × 109 colony-forming units) was delivered intragastrically using an oral catheter after fasting for 24 h. 
Gastric ulcers were induced experimentally in MGs according to the method described by Wang et al. [40]. Briefly, 
after anesthetization with ketalar, the abdomen was opened through a midline incision, and 50 μL of 25% acetic acid 
was injected in the subserosa of the anterior wall of the stomach. The MGs were killed at5, 10, and 20 days after ulcer 
induction, and the stomach was dissected and removed. The maximum and minimum diameters of the ulcers were 
measured, and the ulcer area, which was approximately elliptical, was calculated and was compared between MGs 
with and without H. pylori infection. Values are the mean ± SE. The animal care committee of St. Marianna University 
approved the experimental design, and the animals were cared for in accordance with institutional guidelines.
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(Figure 3A). It was previously shown that H. pylori infection significantly delayed acetic 
acid-induced ulcer healing in mice and MGs [27–29]. H. pylori infection induces aberrant 
DNA methylation of several CGIs in MGs [30]. As described above, COX-2-derived PGs are 
important for gastric ulcer healing, and the COX-2 promoter is densely methylated in the 
human gastric mucosa in the presence of H. pylori infection. To investigate the roles of COX-2 
Figure 3. A. Microscopic features of H. pylori-infected gastric mucosa of Mongolian gerbils (MGs). Sections were stained 
with hematoxylin and eosin. B. Gross appearance 10 days after gastric ulcer induction of H. pylori-infected MGs. 
C. Microphotograph 10 days after gastric ulcer induction in H. pylori-infected MGs. D. Serial changes in acetic acid-
induced gastric ulcer areas in MGs with or without H. pylori infection. H. pylori (ATCC43504; American Type Culture 
Collection, Rockville, MD) was grown in Brucella broth (Becton Dickinson, Cockeysville, MD) containing 10% v/v horse 
serum for 40 h at 37°C under microaerobic conditions (15% CO2) and high humidity with shaking (150 rpm). Male MGs 
(MGs/Sea) were purchased from Kyudo (Saga, Japan). At 11 weeks of age, H. pylori (0.8 mL samples of Brucella broth 
containing 1.0 × 109 colony-forming units) was delivered intragastrically using an oral catheter after fasting for 24 h. 
Gastric ulcers were induced experimentally in MGs according to the method described by Wang et al. [40]. Briefly, 
after anesthetization with ketalar, the abdomen was opened through a midline incision, and 50 μL of 25% acetic acid 
was injected in the subserosa of the anterior wall of the stomach. The MGs were killed at5, 10, and 20 days after ulcer 
induction, and the stomach was dissected and removed. The maximum and minimum diameters of the ulcers were 
measured, and the ulcer area, which was approximately elliptical, was calculated and was compared between MGs 
with and without H. pylori infection. Values are the mean ± SE. The animal care committee of St. Marianna University 
approved the experimental design, and the animals were cared for in accordance with institutional guidelines.
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methylation and H. pylori infection in gastric ulcer healing, COX mRNA levels in samples 
prepared from acetic acid-induced gastric ulcers in MGs were examined. Then, the effects 
of COX-2 methylation on COX-2 mRNA expression were also investigated in vitro using an 
H. pylori-infected MG stomach-derived cell line.
Gastric ulcers were produced by injecting 25% of acetic acid (0.03 mL) into the submucosal 
layer of the gastric wall of the antral-oxyntic border in MGs 48 weeks after inoculation with 
an H. pylori suspension in Brucella broth. The MGs were killed at 5, 10, and 20 days after 
ulcer induction, and the stomachs were dissected and removed. The maximum and minimum 
diameters of the ulcers were measured, and the area of each ulcer, which was approximately 
elliptical, was calculated and compared between MGs with and without H. pylori infection. 
The ulcer area was largest on day 5, and then gradually decreased. In accordance with previ-
ous reports [29], the gastric ulcer area was larger in H. pylori-infected MGs than in uninfected 
MGs (Figure 3B–D). While COX-2 mRNA expression at the ulcer edge was increased 5 days 
after acetic acid injection in MGs without H. pylori infection, as was reported in rats and mice 
[31], no increases in COX-2 mRNA levels were observed in H. pylori-infected MGs. In contrast, 
gastric ulceration was not associated with a change in COX-1 mRNA levels in MGs with or 
without H. pylori infection (Figure 4A,B). Thus, H. pylori infection caused delayed ulcer heal-
ing and impaired COX-2 induction in MG stomachs.
Figure 4. COX mRNA levels during healing of an acetic acid-induced gastric ulcer in MGs with or without H. pylori 
infection. COX mRNA levels in acetic-acid-induced gastric ulcers in MGs were measured by real-time PCR. First-strand 
cDNA was prepared by reverse transcription of 5 μg of total RNA using superscript III reverse transcriptase (Applied 
Biosystems, Carlsbad, CA, USA). Real-time quantitative reverse transcription PCR was carried out using TaqMan Gene 
Expression Assays with a 7500 real-time PCR system (Applied Biosystems) according to the manufacturer’s instructions. 
Primers for COX-1, COX-2, and β-actin were designed based on their cDNA sequences (GenBank accession nos. AB 
044783, AB044784, and AB040445, respectively) and according to previous reports [33]. SDS2.1 software (Applied 
Biosystems) was used to perform the comparative Δ-Ct analysis. Glyceraldehyde-3-phosphate dehydrogenase was 
used as an endogenous control. Values are the mean ± SE. β-Actin left: gctacagcttcaccaccaca, right: ccatctcttgctcgaagtcc, 
93 bp. COX-1 left: gtggctatttcctgcagctc, right: agtgggtgccagtggtagag, 112 bp. COX-2 left: tgggcgtgaaaggaaataag, right: 
ggggatcagggatgaacttt, 87 bp.
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5. Effects of COX-2 methylation on its mRNA expression in MGs  
in vitro
As discussed above, COX-2 mRNA expression is regulated by an epigenetic mechanism 
in KATO-III human gastric carcinoma cells in which COX-2 is densely methylated [22]. To 
investigate the role of methylation in COX-2 mRNA expression in H. pylori-infected gastric 
mucosa of MGs, we treated MGC2 cells with 5-aza-dC, a methyltransferase inhibitor, or 
trichostatin A (TSA), a histone deacetylase inhibitor. MGC2 is an adenocarcinoma cell line 
established from the gastric cancer tissue of a H. pylori-infected MG [32]. COX-2 mRNA 
expression levels in these cells were restored after the addition of 5-aza-dC. In contrast, 
treatment with TSA did not induce COX-2 mRNA expression (Figure 5). These results 
indicated that COX-2 mRNA expression in MGs is regulated via both transcriptional and 
epigenetic mechanisms. Histone acetylation was not involved in silencing COX-2 expression 
in these cells.
6. Cloning the MG COX-2 promoter region
As mentioned above, human COX-2 has abundant CGIs in the promoter region. To examine 
whether CGIs are present in the COX-2 promoter region of MGs, we performed genomic 
Figure 5. Effects of 5-aza-dC, a methyltransferase inhibitor, or trichostatin A (TSA), a histone deacetylase inhibitor, on 
COX-2 mRNA expression in MG gastric adenocarcinoma MGC2 cells. The MGC2 cells [32] were a generous gift from 
Dr. Tatematsu and were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS; Gibco, 
Grand Island, NY, USA) plus serum expander MITO (0.1%, Collaborative Biomedical Products Bedford, MA, USA) on 
a type I collagen-coated dish (Asahi Techno Glass, Japan). All the cultures were incubated at 37°C with 95% air and 
5% CO2. COX-2 mRNA expression was measured by real-time PCR in the cell lines grown in the presence of vehicle with 
or without 5-Aza-dC (1 μmol/L) or TSA for 5 days. Values shown are the mean ± SE.
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Role of COX-2 Promoter Methylation and Helicobacter pylori Infection in Impaired Gastric Ulcer…
http://dx.doi.org/10.5772/intechopen.79973
213
PCR with primers designed using as previously reported MG cDNA (Accession #: AB177842) 
[33]. The PCR product has an intron sequence in the promoter region. Then, gene walking 
was performed using a primer in this intron. The promoter region of the MG COX-2 gene 
was obtained (Figure 6), and the sequence contains more CGIs than the mouse genome, and 
Figure 6. Human, MG, and mouse COX-2 promoter regions. Genome walking to isolate genomic, the COX-2 promoter 
region of MGs, was performed by using the Straight Walk Kit [41] according to the manufacturer’s instructions 
(Bex, Tokyo, Japan). Amplified fragments were cloned into the pSTBlue-1 vector (Novagen, Madison, WI, USA) and 
sequenced. More abundant CGIs were observed in the MG genome when compared to the mouse genome, and the 
number was comparable to human genome.
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is comparable to that of the human genome. Pyrosequencing showed several methylated 
CGIs (>15%) in the MGC2 cells. Treatment with 5-aza-dC decreased the methylation levels 
in these cells (Figure 7). As was observed in the human stomach, COX-2 methylation levels 
were increased in H. pylori-infected gastric mucosa of MGs when compared to the levels in 
the control mucosa (Figure 8).
Figure 7. Effect of 5-aza-dC treatment on COX-2 methylation levels in MGC2 cells. Cells were treated with vehicle (A) 
with 5-aza-dC (B, 1 μmol/L) for 5 days, and then methylation levels of COX-2 were analyzed by quantitative bisulfite-
pyrosequencing methods as previously reported [42]. Bisulfite treatment of gDNA was performed with the EpiTect 
bisulfite kit (QIAGEN, Valencia, CA, USA) according to the manufacturer’s protocol. Bisulfite-treated DNA (1 μL) was 
used as a template in subsequent PCR experiments. For most assays, we used touchdown PCR. All PCR assays included 
a denaturation step at 95°C for 30 s, followed by annealing at various temperatures for 30 s, and extension at 72°C for 30 s. 
After PCR, the biotinylated strand was captured on streptavidin-coated beads (Amersham Bioscience, Uppsala, Sweden) 
and incubated with sequencing primers. Pyrosequencing was performed using PSQ HS 96 Gold single-nucleotide 
polymorphism reagents on a PyroMark Q24 pyrosequencing machine (QIAGEN). The protocol for pyrosequencing 
was described in detail previously [42]. Pyrosequencing quantitatively measures the methylation status of CpG sites in 
a target region. Adjacent sites usually show highly concordant methylation. Therefore, the mean percent methylation in 
detected sites can be used as a representative value for each gene promoter. Cases with the methylation density > 15% 
were regarded as methylation positive. Forward primer: tgggtgaggggaattttataga, reverse primer: aaaccctaaccatccttacaa; 
and sequencing primer: aggagtttgtttaggaag.
Role of COX-2 Promoter Methylation and Helicobacter pylori Infection in Impaired Gastric Ulcer…
http://dx.doi.org/10.5772/intechopen.79973
215
PCR with primers designed using as previously reported MG cDNA (Accession #: AB177842) 
[33]. The PCR product has an intron sequence in the promoter region. Then, gene walking 
was performed using a primer in this intron. The promoter region of the MG COX-2 gene 
was obtained (Figure 6), and the sequence contains more CGIs than the mouse genome, and 
Figure 6. Human, MG, and mouse COX-2 promoter regions. Genome walking to isolate genomic, the COX-2 promoter 
region of MGs, was performed by using the Straight Walk Kit [41] according to the manufacturer’s instructions 
(Bex, Tokyo, Japan). Amplified fragments were cloned into the pSTBlue-1 vector (Novagen, Madison, WI, USA) and 
sequenced. More abundant CGIs were observed in the MG genome when compared to the mouse genome, and the 
number was comparable to human genome.
Chromatin and Epigenetics214
is comparable to that of the human genome. Pyrosequencing showed several methylated 
CGIs (>15%) in the MGC2 cells. Treatment with 5-aza-dC decreased the methylation levels 
in these cells (Figure 7). As was observed in the human stomach, COX-2 methylation levels 
were increased in H. pylori-infected gastric mucosa of MGs when compared to the levels in 
the control mucosa (Figure 8).
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with 5-aza-dC (B, 1 μmol/L) for 5 days, and then methylation levels of COX-2 were analyzed by quantitative bisulfite-
pyrosequencing methods as previously reported [42]. Bisulfite treatment of gDNA was performed with the EpiTect 
bisulfite kit (QIAGEN, Valencia, CA, USA) according to the manufacturer’s protocol. Bisulfite-treated DNA (1 μL) was 
used as a template in subsequent PCR experiments. For most assays, we used touchdown PCR. All PCR assays included 
a denaturation step at 95°C for 30 s, followed by annealing at various temperatures for 30 s, and extension at 72°C for 30 s. 
After PCR, the biotinylated strand was captured on streptavidin-coated beads (Amersham Bioscience, Uppsala, Sweden) 
and incubated with sequencing primers. Pyrosequencing was performed using PSQ HS 96 Gold single-nucleotide 
polymorphism reagents on a PyroMark Q24 pyrosequencing machine (QIAGEN). The protocol for pyrosequencing 
was described in detail previously [42]. Pyrosequencing quantitatively measures the methylation status of CpG sites in 
a target region. Adjacent sites usually show highly concordant methylation. Therefore, the mean percent methylation in 
detected sites can be used as a representative value for each gene promoter. Cases with the methylation density > 15% 
were regarded as methylation positive. Forward primer: tgggtgaggggaattttataga, reverse primer: aaaccctaaccatccttacaa; 
and sequencing primer: aggagtttgtttaggaag.
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7. Role of COX-2 methylation and H. pylori infection in gastric 
mucosal healing
Nonselective COX inhibitors damage the gastrointestinal mucosa, and gastrointestinal 
injury represents the most significant side effect of chronic nonsteroidal anti-inflammatory 
drug (NSAID) use [34]. Thus, selective COX-2 inhibitors have been developed as ideal anti- 
inflammatory drugs, devoid of GI toxicity, and clinical trials have suggested that selective 
COX-2 inhibitors produce less gastrointestinal injury than conventional NSAIDs [8, 9]. In 
support of this, animal studies have also suggested that, in contrast to the initial concept, the 
importance of COX-2 in the repair of gastric mucosal damage has been recognized [31, 35]. In 
rat gastric mucosa, markedly elevated levels of COX-2 mRNA were observed after induction 
of damage by ischemia-reperfusion [35, 36]. COX-2 mRNA and protein expression increase 
during repair of gastric mucosal lesions, and selective COX-2 inhibitors delay mucosal heal-
ing in mice [31]. PGs derived from ulceration-induced COX-2 at the ulcer margin enhanced 
epithelial cell proliferation and increased the expression of growth factors, including hepato-
cyte growth factor, epidermal growth factor, transforming growth factor-α, and VEGF [16].
The release of inflammatory cytokines and recruitment of inflammatory cells have been con-
sidered the potential factors for delayed ulcer healing in H. pylori infection [2, 28]. Chronic 
inflammation, including H. pylori infection, is known to cause aberrant DNA methylation 
[37, 38]. Here, we focused on COX-2 methylation in H. pylori-infected gastric mucosa. Human 
COX-2 has CGIs in the promoter region, and methylation levels in this region are increased in 
Figure 8. DNA methylation levels at COX-2 in the MG gastric mucosa in the presence or absences of H. pylori infection. 
Methylation levels at COX-2 in the MG gastric mucosa were analyzed by quantitative bisulfite pyrosequencing.
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H. pylori-infected gastric mucosa. In addition, COX-2 promoter methylation levels in patients 
with successfully eradicated H. pylori infection are lower than the levels in H. pylori-positive 
cases. As mentioned above, experiments using rodents have shown that COX-2 mRNA 
expression is enhanced during ulcer healing. Thus, we investigated the influence of H. pylori 
infection on COX-2 expression during stomach ulcer healing in MGs. Acetic acid-induced 
ulcer healing was delayed in H. pylori-infected MG stomachs when compared to the healing of 
ulcers without H. pylori infection [29]. The COX-2 promoter region of MGs also has abundant 
CGIs, comparable to human COX-2. Thus, MGs are good models for investigating the role of 
COX-2 methylation in gastric mucosal healing. While COX-2 mRNA expression at the ulcer 
edge was increased 5 days after acetic acid injection in MG stomachs without H. pylori infec-
tion, as was observed in the mouse and rat models, such increases in COX-2 mRNA expres-
sion were not observed in H. pylori-infected MG gastric mucosa. However, a demethylating 
agent restored COX-2 mRNA expression in both human and MG gastric carcinoma cell lines 
in which COX-2 is densely methylated. Accordingly, we demonstrated in vitro and in vivo that 
COX-2 mRNA expression is regulated through an epigenetic mechanism in human and MG 
gastric mucosa. Aberrant DNA methylation has been extensively investigated in the context 
of the pathogenesis of various cancers, including stomach cancer. In addition, the involve-
ment of epigenetic modifications has been reported in the pathogenesis of various chronic 
diseases, such as essential hypertension and cardiovascular disease [39]. Taken together, the 
epigenetic inhibition of COX-2 expression due to chronic inflammation induced by H. pylori 
infection seems to interfere with ulcer healing and increase the vulnerability of the gastric 
mucosa. The decrease in COX-2 methylation levels after H. pylori eradication may restore 
gastric mucosal defense.
8. Conclusions
H. pylori infection, the leading cause of peptic ulcer disease, induces sustained inflammation 
in the gastric mucosa. This chronic inflammation causes aberrant DNA methylation in various 
genes. The COX-2 promoter regions in both MGs and humans contain abundant CGIs. COX 
plays critical roles in peptic ulcer development and healing, and both COX-1 and COX-2 
are necessary for the gastric mucosal defense system. COX-1 is a housekeeping enzyme, 
which maintains microcirculation and mucous production. During ulcer healing, COX-2 is 
expressed at the margin of an ulcer, and COX-2-derived PGs induce various growth factors to 
promote mucosal healing and angiogenesis. Ulcer healing is delayed in H. pylori infected-MG 
stomachs, which is the best model of H. pylori infection in humans. We showed that  COX-2 
mRNA induction during ulcer healing was impaired in H. pylori-infected-MG stomachs. 
The  COX-2 promoter region is methylated in both H. pylori-infected human and MG gastric 
mucosa. These CGIs are also methylated in human Kato III cells and MGC2 gastric carcinoma 
cells. COX-2 mRNA expression in these cells is restored by treatment with a demethylat-
ing agent. In H. pylori-infected gastric mucosa, COX-2 promoter methylation appears to be 
involved in the impaired COX-2 mRNA induction typically observed during ulcer healing, 
which leads to delayed ulcer healing.
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Abstract
Hepatitis B virus (HBV) is the most important cause of chronic viral hepatitis worldwide. 
The genome of HBV is 3.2 kb partially double-stranded DNA, which is translocated to 
the nuclei of infected hepatocytes and converted to complete double-stranded DNA, aka 
covalently closed circular DNA (cccDNA). Typical course of chronic HBV infection results 
in inactive carrier state with clearance of viral particles in the bloodstream. However, the 
cccDNA can be detected in the hepatocytes from inactive carriers by sensitive methods. 
It has been increasingly known that epigenetic mechanisms contribute to the control of 
HBV replication in the inactive stage of HBV infection. Histone modification and DNA 
methylation have been identified in the HBV cccDNA, leading to modification of tran-
scriptional activity. The understanding of epigenetic control of transcription will shed 
light on the development of new therapeutic strategy against HBV cccDNA.
Keywords: hepatitis B virus, covalently closed circular DNA, histone modification, 
inactive carrier
1. Introduction
Hepatitis B virus (HBV) is the most important cause of chronic viral hepatitis worldwide. 
About 240–350 million people are infected with HBV globally [1]. Development of potent 
nucleos(t)ide analogs (Nas) has revolutionized the treatment of HBV, but current treatment 
cannot eradicate the DNA genome of HBV, i.e., covalently closed circular DNA (cccDNA) 
from the nuclei of infected hepatocytes. Since there have been no innate clearing mechanisms 
identified for foreign double-stranded DNA in mammalian cells, theoretically HBV cccDNA 
in the liver stem cells will dilute out but persist indefinitely in some portion of the hepatocytes 
[2]. Therefore, prolonged use of current NA therapy is recommended without interruption, 
which is very costly.
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It has been known that transcriptional activity of HBV cccDNA varies according to the stage 
of natural history of chronic hepatitis B (CHB) [3, 4]. Interestingly, many patients with chronic 
hepatitis B are free from circulating HBV during the natural course despite the presence of 
HBV cccDNA in the infected nuclei [5]. These findings raise the possibility that replication 
of HBV is regulated at the transcriptional level. Genetic changes, i.e., DNA mutation, are 
an attractive explanation for the variable transcriptional activity since the reverse transcrip-
tase activity of HBV is error-prone. However, no universal mutations have been identified 
associated with transcriptional suppression [6]. Consequently, epigenetic control has been 
proposed as the mechanism of these variable transcriptional activities in CHB patients [7], 
and this article covers the current knowledge of epigenetic mechanisms contributing to the 
transcriptional control of HBV replication.
2. Organization of HBV cccDNA and its transcriptional control
Hepatitis B virus (HBV) is a partially double-stranded circular DNA virus [8]. The viral DNA 
goes into nuclei of infected hepatocytes where it is converted to cccDNA [8]. The cccDNA 
is a viral minichromosome, which takes the form of “beads-on-a-string” conformation of 
nucleosomal packaging [9], analogous to DNA packaging by mammalian nucleosome. HBV 
core protein and X protein along with histone H3 and H4 are components of HBV minichro-
mosome [9–11]. A variety of cellular transcription factors bind HBV cccDNA, which in turn 
control transcriptional activity of HBV promoters: the preC/pregenomic, S1, S2, and X promoters 
[12]. The core promoter initiates transcription of preC and pregenomic RNA, the template for 
the viral genome by reverse transcription. Ubiquitous transcription factors such as specificity 
protein 1 (SP1), nuclear factor kappa B (NF-κβ), activator protein 1 (AP-1), and liver-enriched 
transcription factors such as hepatocyte nuclear factor 3 (HNF3), CAAT enhancer-binding 
protein (C/EBP), and several nuclear receptors such as hepatocyte nuclear factor 4 (HNF4), 
peroxisome proliferator-activated receptors (PPAR) and retinoid X receptors (RXRα), farne-
soid acid receptor (FXR), small heterodimer partner (SHP), and testicular orphan receptor 4 
(TR4) can bind core promoter [13, 14].
3. Epigenetic control of HBV transcription: histone modification
As described above, ultrastructure of HBV cccDNA simulates that of mammalian nucleosome, 
suggesting the possibility of histone molecules as a main factor for transcriptional control [9]. 
Indeed, Pollicino et al. demonstrated the feasibility of HBV-associated histone modification as 
a major transcriptional regulator of HBV [11]. Genome-wise search for posttranslational mod-
ification (PTM) of HBV-infected liver cell lines has revealed that active marks of transcription 
such as H3K4me3, H3K27ac, and H3K122ac are abundant in active chromatin, especially in 
the core promoter region [19]. Interestingly, however, the repressive marks of transcription, 
i.e., H3K27me3 and H3K9me2, are depleted in the HBV cccDNA, suggesting that modified 
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histones regulate HBV transcription mainly in favor of active replication. Pol2 enrichment is 
co-localized at the H3K27me-enriched transcription start site of precore/pregenomic area, and 
treatment with interferon alpha reduces the active PTMs, also suggesting that active marks of 
histone modification contribute to the transcriptional activity of HBV.
Much is unknown regarding the effects of histone modification on the binding of these 
transcription factors. Hepatitis X protein (HBx) is the most studied modulator of HBV-
bound histone [20, 21]. HBx is bound to the cccDNA and enhance transcription by increas-
ing histone acetylation and recruiting cellular coactivators p300, CBP, and PCAF [22], 
by inhibiting protein arginine methyltransferase 1 and reducing H4 methylation [23]. 
HBx also increases histone acetylation and H3K4me3 and decreases HP1 binding and 
Histone change Modifier HBV response and mechanisms References
H3K4me3 MLL3 Activation (H3K4me modification of the NTCP promoter 
by MLL3 may facilitate HBV infection in vivo.)
[19, 30]
Zinc finger and 
homeoboxes (ZHX2)
Repression (ZHX2 inhibited trimethylation of H3K4. 
Overexpression of ZHX2 also decreases the acetylation 
levels of H3K27 and H3K122.)
[26]
H3K27ac EZH2 Activation (Knockdown of EZH2 resulted in upregulation 
of HBeAg and ABsAg, indicating a repressive function of 
EZH2 on HBV gene expression.)
[28, 31]
H3K122ac P300/CBP Activation [19, 32, 33]
AcH3/AcH4 
H3K4me3
HBx Activation [20–22, 24]
H4R3me2s PRMT5 Repression (PRMT5-mediated histone H4 dimethyl Arg3 
symmetric (H4R3me2s) represses cccDNA transcription.)
[28]
H3K9me3 SETDB1 Repression (upon HBV infection, cellular mechanisms 
involving SETDB1-mediated H3K9me3 and HP1 
induce silencing of HBV cccDNA transcription through 
modulation of chromatin structure.)
[24]
SIRT3 Repression (SIRT3 is a novel host factor epigenetically 
restricting HBV cccDNA transcription by acting 
cooperatively with histone methyltransferase.)
[25]
H3K27me3 Suz12 Repression (downregulation of Suz12 and Znf198 enhances 
HBV replication.)
[34]
H3K79me KDM2B Repression (KDM2B as an H3K79 demethylase and link its 
function to transcriptional repression via SIRT1-mediated 
chromatin silencing.)
[27]
etc BCP mutation Repression (BCP mutations decrease viral replication 
capacity possibly by modulating the acetylation and 
deacetylation of cccDNA-bound histones.)
[29]
IFNα Repression [19, 35, 36]
Table 1. Histone modification affecting HBV transcription.
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Table 1. Histone modification affecting HBV transcription.
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H3K9me3 on the cccDNA [24]. Other host transcription factors, mainly suppressors, that 
act via epigenetic control of HBV include SIRT3 [25], zinc finger and homeoboxes 2 (ZHX2) 
[26], KDM2B [27], protein arginine methyltransferase 5 (PRMT5) [28], and SETDB1 [24]. 
Interestingly, mutations in the basal core promoter are also reported to be associated with 
histone modification [29]. The effect of histone modification on HBV replication is sum-
marized in Table 1.
4. Epigenetic control of HBV transcription: cccDNA methylation
Isolation and testing of HBV cccDNA shows methylation not only of HBV DNA integrated in 
host chromosome [39, 40] but also of HBV cccDNA. Methylation is speculated to affect repli-
cative activity of HBV [38], and this hypothesis was confirmed in the hepatoma cell lines [41] 
and human liver tissue [15, 16]. HBV cccDNA has three CpG islands which harbor methyla-
tion in human liver and hepatoma cell lines [37, 38]. Methylation of HBV in the CpG islands 
of cccDNA is associated with suppressed transcriptional activity of HBV [15, 16] (for recent 
reviews, see [17, 18]). Especially, methylation of CpG island II is associated with reduced HBV 
replicability [42].
Although DNA methyltransferases, i.e., DNMT1, DNMT3a, and DNMT3b, are expressed in 
normal tissues [45], the level of expression is higher in HCC [46], which may explain the 
increased levels of methylation in hepatocellular carcinoma (HCC) compared to noncancer-
ous tissues [43, 44]. In addition, since the hepatic expression of DNMT3a and DNMT3b, the 
de novo methylators, increases with age [47], methylation of HBV may also increase with 
age [42], which might explain suppressed replicative activity of HBV in the later stage of 
natural history. Degree of methylation also depends on HBeAg positivity [15, 42] and degree 
of hepatic fibrosis [42].
The mechanism of HBV DNA methylation is still unknown (Table 2). From the specific pat-
terns of methylation in the HBV genome [42], it can be speculated that some kind of molecular 
chaperon (s) may guide the de novo methylation enzymes to the specific target sequence. HBx 
may play a role, because it recruits DNMT3A to the regulatory promoters [48]. Small RNAs 
may be a plausible candidate, as suggested by our in vitro study in which short hairpin RNA 
induced methylation of the target site in HBV [49].
HBV 
area
Modifier HBV replication References
CpG2 HBc Increased (The relative abundances of HBc binding to CpG island 2 were 
associated with the binding of CREB binding protein (CBP) and with 
hypomethylation in CpG island 2 of HBV cccDNA minichromosomes.)
[50]
CpG3 PEG-IFN Decreased (PEG-IFN treatment significantly increased methylation of HBV 
cccDNA in CpG island III.)
[51]
Table 2. Mechanisms of methylation in HBV cccDNA.
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5. Therapeutic implications and future perspectives of epigenetics in 
chronic hepatitis B
NAs, the most commonly used modality of CHB therapy, is costly without definite duration. 
Interferon induces sustained virologic response with finite duration, but the response rate is 
suboptimal. The realistic goal of CHB therapy is to render the patients to the clinical situation 
similar to inactive carrier stage, i.e., normal alanine aminotransferase levels with low or nega-
tive serum HBV DNA levels. Since epigenetic silencing may contribute to the suppressive 
HBV replication status of inactive carrier stage, it would be theoretically feasible and clini-
cally useful to induce epigenetic suppression of HBV replication simulating natural inactive 
stage of disease. Further studies will be needed to elucidate the mechanisms and long-term 
consequences of epigenetic suppression of HBV replication.
6. Conclusions
Epigenetic modification is an important mechanism of host-viral interaction in the transcrip-
tional control of HBV. Current treatment strategy focuses on the inactivation/elimination of 
HBV cccDNA [17, 52], and knowledge on the epigenetic control is prerequisite for the novel 
development of HBV cure in the foreseeable future.
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Abstract
PiRNAs [P-element-induced wimpy testis (PIWI)-interacting RNAs] represent the most 
frequent but the least well-investigated subtype of small ncRNAs and are characterized 
by their interaction with PIWI proteins, a subclass of the Argonaute family. PiRNAs and 
PIWI proteins maintain integrity of the genomic structure and regulate gene expres-
sion in germline and somatic cells. The PIWI-piRNA pathway primarily constitutes a 
conserved immune-like surveillance process that recognizes self and nonself. This axis 
controls genome integrity of germline cells and nonaging somatic cells by silencing and 
suppressing propagation of transposable elements through epigenetic and posttranscrip-
tional mechanisms. However, mounting evidences indicate that the PIWI-piRNA path-
way has broader implications in both germinal and somatic cells in various physiological 
and pathological processes. It modulates mRNAs levels of expression, stability, turnover, 
and translation and interacts directly with many transcription factors and signaling 
pathways molecules. PIWI proteins and piRNAs play pivotal roles in germline stem cell 
maintenance and self-renewal, fertilization and development, genes and proteins expres-
sion, genome rearrangement, and homeostasis.
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stem cells (CSCs) and progenies. These cells harbor chromosomal abnormalities, alterations 
of suppressor genes (TSG) and oncogenes, and aberrant transcriptomic profiles generated 
by genetic and epigenetic alterations [1, 2]. These cancer cells are in close relationship with 
a tumor microenvironment (TME), composed of immune and nonimmune stromal cells and 
modified extracellular matrix. Reciprocal interactions between tumor cells and TME are 
pivotal in cancer progression, allowing remodeling of TME and reprogramming of cancer 
cells that develop adaptive strategies to adjust their phenotype to unfavorable environmen-
tal conditions. Recently, CSCs were implicated in a new paradigm accounting for tumor 
heterogeneity [3]. CSCs have the property of self-renewal, lack senescence, maintain an 
undifferentiated state, and proliferate rapidly. These properties are controlled by epigenetic 
mechanisms that induce changes in gene expression profiling of tumor cells. Opposite to 
aging cells that increase genomic and chromosomal instability during adulthood, nonaging 
immortal cells, such as germline, somatic, and cancer stem cells, harbor a genomic instabil-
ity triggered by unrepaired mutations with either no or only limited number of genomic 
alterations [4]. Epigenetic abnormalities are early events in cancer progression, resulting from 
various environmental injuries, and associate heterogeneity of DNA methylation, posttran-
scriptional modifications of histones, and deregulation of noncoding RNAs (ncRNAs). Global 
DNA hypomethylation results in chromosomal instability, overexpression of oncogenes, and 
reactivation of transposable elements (TEs) [5]. Localized (genes promoters) or wide (>1 Mb) 
DNA hypermethylation initiates repression of TSGs and modification of epigenetic marks 
through histone alterations, resulting in occurrence of an aberrantly stemlike state of CSCs. 
These alterations of the genomic methylation during carcinogenesis allow reprogramming of 
atypical proliferative cells into highly malignant cells characterized by unlimited prolifera-
tion, epithelial-mesenchymal transition (EMT), invasion, and prometastatic properties [6].
Until recently, RNAs were considered as epigenetic regulators and mediators of gene expres-
sion, functioning as intermediates of translation in the flow of genetic information from DNA 
to proteins [7]. Large-scale genomic technologies have provided an astonishing insight into 
human genome and transcriptome. Next-generation sequencing techniques combined with 
bioinformatics have revealed that more than 50% of mammalian genomes were composed 
of TEs and that more than 98% of the human genome was actively transcribed [8]. However, 
only 1.1% of the genome encodes proteins, and a majority of genes are noncoding RNAs 
(ncRNAs) [9]. NcRNAs play pivotal roles in developmental and homeostatic processes, and 
their alterations are implicated in the pathogenesis of many diseases, by modulating expres-
sion of numerous genes at epigenetic, transcriptional, and posttranscriptional levels [10]. Most 
importantly, ncRNAs are frequently deregulated in cancer and have crucial roles in tumor ini-
tiation, progression, and metastatic spread. NcRNAs are classified into housekeeper ncRNAs 
(rRNAs, tRNAs, and snoRNAs) and regulatory ncRNAs. Regulatory ncRNAs are divided 
into several subfamilies, depending on their size, biogenesis, and biological functions. Small 
ncRNAs are composed of transcripts shorter than 200 nucleotides (nt), whereas long noncod-
ing RNAs (lncRNAs) comprise transcripts longer than 200 nt [11]. Small ncRNAs also differ 
by their precursor structure and their mechanisms of biogenesis. They comprise microRNAs 
(miRNAs), small interfering RNAs (siRNAs), and PIWI-interacting RNA (piRNAs) [12–15].
MiRNAs and siRNAs are generated from double-stranded precursors, whereas piRNAs are 
processed from long single-stranded precursors. The endoribonuclease Dicer is pivotal in 
the maturation of miRNAs and siRNAs, but not in the piRNAs processing [16]. Regulatory 
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functions of small ncRNAs are insured by Argonaute (AGO) protein family, which is a very 
well-conserved master component of RNA silencing complexes in all organisms [17]. The least 
well-investigated small ncRNAs are the piRNAs, which were first identified in 2006 in mouse 
and rat germ cells as ncRNAs interacting with PIWI proteins, a subclass of the Argonaute 
proteins [18–21]. PiRNAs actually constitute the largest and most diverse class of ncRNAs 
[16]. PiRNAs and PIWI proteins were initially implicated in epigenetic regulation of germline 
cells and their overexpressions have been more recently observed in various cancers through 
aberrant DNA methylation.
This review will provide an overview of the PIWI-piRNA pathway, focusing mainly on ori-
gin, biochemical properties, biogenesis, functions, and mechanisms of action in germline and 
somatic tissues. Furthermore, we will discuss emerging implications of piRNAs in carcino-
genesis and highlight their potential clinical utilities as diagnostic/prognostic biomarkers and 
therapeutic tools.
2. The PIWI-piRNA pathway
RNA interference (RNAi) is a widely conserved small-RNA-mediated gene-silencing mecha-
nism involved in crucial homeostatic events of most eukaryotes [22–24]. Small regulatory 
RNAs of 20–32 nt, such as endogenous siRNAs, miRNAs, and piRNAs, modulate transcrip-
tional and posttranscriptional repression through complementary RNA or DNA recognition 
by interacting with well-conserved proteins of 95 kDa belonging to the Argonaute family that 
cleave their targets [25, 27]. AGO proteins include a PAZ domain [P-element-induced wimpy 
testis (PIWI)-AGO-Zwille] located in the N terminal region, which binds small ncRNAs 
and a PIWI domain in the C-terminal region that functions as double-strand-specific RNA 
endonuclease [28]. Based on sequence homology and functional domains in different species, 
the AGO family of proteins is divided into three subfamilies: AGO proteins (homologous to 
Arabidopsis thaliana AGO1), PIWI proteins (homologous to Drosophila melanogaster Piwi), and 
WAGO (worm-specific Argonaute clade). The number of AGO family proteins varies consid-
erably between species. Eight different proteins were present in humans, whereas 27 proteins 
were identified in C. elegans and only one protein was observed in fission yeast [29]. AGO 
proteins interact functionally with siRNAs and miRNAs, which are small single-stranded 
RNAs of 20–22 nt in length processed in a Dicer-dependent manner from double-stranded 
precursors, to induce posttranscriptional gene silencing in the cytoplasm [30–32]. Conversely, 
PIWI proteins are implicated in biogenesis of piRNAs and in their main function through 
transcriptionally and posttranscriptionally repressing TEs in the nucleus and the cytoplasm 
[33]. PIWI proteins and piRNAs edify ribonucleoproteins named PiRNA-induced silenc-
ing complexes (pi-RISCs). Pi-RISCs specificity is determined by piRNA sequence, whereas 
Argonaute PIWI protein mediates its effector function. PiRNAs associate with PIWI proteins 
and guide piRISCs to recognize complementary targets and achieve RNA silencing at tran-
scriptional and posttranscriptional levels (Figure 1). Cytoplasmic PIWI-piRNA complexes 
silence their targets posttranscriptionally via piRNA-directed cleavage and the “ping-pong” 
amplification cycle, whereas nuclear PIWI proteins and piRNAs silence gene transcription-
ally through epigenetic changes, including DNA methylation, implementation of H3K9me3 
repressive marks, interactions with Mael and HP1 proteins, and repression of Pol II.
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ity triggered by unrepaired mutations with either no or only limited number of genomic 
alterations [4]. Epigenetic abnormalities are early events in cancer progression, resulting from 
various environmental injuries, and associate heterogeneity of DNA methylation, posttran-
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DNA hypermethylation initiates repression of TSGs and modification of epigenetic marks 
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tion, epithelial-mesenchymal transition (EMT), invasion, and prometastatic properties [6].
Until recently, RNAs were considered as epigenetic regulators and mediators of gene expres-
sion, functioning as intermediates of translation in the flow of genetic information from DNA 
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of TEs and that more than 98% of the human genome was actively transcribed [8]. However, 
only 1.1% of the genome encodes proteins, and a majority of genes are noncoding RNAs 
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(rRNAs, tRNAs, and snoRNAs) and regulatory ncRNAs. Regulatory ncRNAs are divided 
into several subfamilies, depending on their size, biogenesis, and biological functions. Small 
ncRNAs are composed of transcripts shorter than 200 nucleotides (nt), whereas long noncod-
ing RNAs (lncRNAs) comprise transcripts longer than 200 nt [11]. Small ncRNAs also differ 
by their precursor structure and their mechanisms of biogenesis. They comprise microRNAs 
(miRNAs), small interfering RNAs (siRNAs), and PIWI-interacting RNA (piRNAs) [12–15].
MiRNAs and siRNAs are generated from double-stranded precursors, whereas piRNAs are 
processed from long single-stranded precursors. The endoribonuclease Dicer is pivotal in 
the maturation of miRNAs and siRNAs, but not in the piRNAs processing [16]. Regulatory 
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functions of small ncRNAs are insured by Argonaute (AGO) protein family, which is a very 
well-conserved master component of RNA silencing complexes in all organisms [17]. The least 
well-investigated small ncRNAs are the piRNAs, which were first identified in 2006 in mouse 
and rat germ cells as ncRNAs interacting with PIWI proteins, a subclass of the Argonaute 
proteins [18–21]. PiRNAs actually constitute the largest and most diverse class of ncRNAs 
[16]. PiRNAs and PIWI proteins were initially implicated in epigenetic regulation of germline 
cells and their overexpressions have been more recently observed in various cancers through 
aberrant DNA methylation.
This review will provide an overview of the PIWI-piRNA pathway, focusing mainly on ori-
gin, biochemical properties, biogenesis, functions, and mechanisms of action in germline and 
somatic tissues. Furthermore, we will discuss emerging implications of piRNAs in carcino-
genesis and highlight their potential clinical utilities as diagnostic/prognostic biomarkers and 
therapeutic tools.
2. The PIWI-piRNA pathway
RNA interference (RNAi) is a widely conserved small-RNA-mediated gene-silencing mecha-
nism involved in crucial homeostatic events of most eukaryotes [22–24]. Small regulatory 
RNAs of 20–32 nt, such as endogenous siRNAs, miRNAs, and piRNAs, modulate transcrip-
tional and posttranscriptional repression through complementary RNA or DNA recognition 
by interacting with well-conserved proteins of 95 kDa belonging to the Argonaute family that 
cleave their targets [25, 27]. AGO proteins include a PAZ domain [P-element-induced wimpy 
testis (PIWI)-AGO-Zwille] located in the N terminal region, which binds small ncRNAs 
and a PIWI domain in the C-terminal region that functions as double-strand-specific RNA 
endonuclease [28]. Based on sequence homology and functional domains in different species, 
the AGO family of proteins is divided into three subfamilies: AGO proteins (homologous to 
Arabidopsis thaliana AGO1), PIWI proteins (homologous to Drosophila melanogaster Piwi), and 
WAGO (worm-specific Argonaute clade). The number of AGO family proteins varies consid-
erably between species. Eight different proteins were present in humans, whereas 27 proteins 
were identified in C. elegans and only one protein was observed in fission yeast [29]. AGO 
proteins interact functionally with siRNAs and miRNAs, which are small single-stranded 
RNAs of 20–22 nt in length processed in a Dicer-dependent manner from double-stranded 
precursors, to induce posttranscriptional gene silencing in the cytoplasm [30–32]. Conversely, 
PIWI proteins are implicated in biogenesis of piRNAs and in their main function through 
transcriptionally and posttranscriptionally repressing TEs in the nucleus and the cytoplasm 
[33]. PIWI proteins and piRNAs edify ribonucleoproteins named PiRNA-induced silenc-
ing complexes (pi-RISCs). Pi-RISCs specificity is determined by piRNA sequence, whereas 
Argonaute PIWI protein mediates its effector function. PiRNAs associate with PIWI proteins 
and guide piRISCs to recognize complementary targets and achieve RNA silencing at tran-
scriptional and posttranscriptional levels (Figure 1). Cytoplasmic PIWI-piRNA complexes 
silence their targets posttranscriptionally via piRNA-directed cleavage and the “ping-pong” 
amplification cycle, whereas nuclear PIWI proteins and piRNAs silence gene transcription-
ally through epigenetic changes, including DNA methylation, implementation of H3K9me3 
repressive marks, interactions with Mael and HP1 proteins, and repression of Pol II.
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PiRNAs are small single-stranded ncRNAs of 25–33 nt identified in various organisms rang-
ing from sponges to higher vertebrates [34]. Experimental and bioinformatics studies have 
shown that piRNAs are the most abundant small ncRNAs expressed in mammalian species 
[35]. They are derived from long single-strand RNA precursors in a Dicer-independent 
manner. The human genome comprises more than 30,000 piRNAs in which 80% originate 
from intergenic sequences and 20% from introns and exons of pre-mRNAs [36]. Unlike 
miRNAs and endosiRNAs, production of piRNAs is not carried out in a precise manner 
and single strands of long primary precursor transcripts generate numerous piRNAs 
without a conserved sequence [37]. They comprise Uracil at their 5′ end and methylated 
2′-O group at their 3′ end [38, 39]. PiRNAs were first identified in Drosophila melanogaster 
and were named repeat-associated small-interfering RNAs (rasiRNAs) because of their 
repetitive elements and TEs suppressing activity. RasiRNAs were later found to interact 
with Argonaute PIWI proteins and ultimately renamed piRNAs in 2006 [40–42]. PiRNAs 
were further investigated in Caenorhabditis elegans, zebrafish, mice, and more recently in 
humans. Their vast number present in numerous locations of the genome suggests that 
piRNAs may have potential crucial implications in the control of major biological pro-
cesses. Indeed, PIWI-piRNA complexes silence TEs and control expression and activity 
of genes and proteins. They are also instrumental in genome rearrangement, germ stem 
cell maintenance, reproduction and fertility regulation, embryogenesis, and homeostasis 
[26, 43–48]. At the opposite of miRNAs and endosiRNAs, piRNAs function only through 
binding with PIWI proteins and harbor tissue-specific expression in various organs such as 
prostate and thyroid [49].
PIWI proteins were also initially identified in Drosophila melanogaster in which they play cru-
cial roles in germline stem cell maintenance and self-renewal [50]. These proteins contain 
Figure 1. Biogenesis of piRNA and PIWI-piRNA pathways and their function in maintaining genome integrity through 
transposable element (TE) in germline cells at transcriptional and posttranscriptional level. In Drosophila ovaries, the 
primary pathway (in the nucleus) operates in both germline and surrounding somatic cells, whereas the “ping-pong” 
cycle (in the cytoplasm) operates only in germline cells. In the nucleus, PIWI-piRNA complex can regulate HP1, H3K9 
methylation, and DNA methylation to influence transposons.
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three functional domains: the PIWI-Argonaute-Zwille (PAZ) domain recognizing the 3′ end 
of the RNA, the middle domain (MID) providing a binding pocket for the 5′ end of guide 
strand RNA, and the PIWI domain containing catalytic residues that cleave target transcripts 
[47]. Unlike proteins of the AGO subclass, PIWI proteins comprise posttranslationally dimeth-
ylated arginine-rich motifs that allow interactions with Tudor proteins. These last proteins 
have pivotal role in functional activities of PIWI proteins by providing a scaffold for edifica-
tion of higher-order molecular complexes located in Drosophila germ cells and mouse testis 
perinuclear granules named “nuage,” similar to P-bodies [51–53]. The PIWI protein family 
is conserved in numerous organisms, including jellyfish, sponge, planaria, zebrafish (Ziwi, 
Zili), Caenorhabditis elegans (Prg1, Prg 2), Drosophila melanogaster (Piwi, Aub, Ago3), mouse 
(MIWI, MILI, MIWI2), and human (PIWIL1, PIWIL2, PIWIL3, PIWIL4) [51] (Table 1). PIWIL3 
is observed only in human, and its functions are actually largely unknown. PIWI proteins 
expression is identified in a majority of organs such as liver, lung, heart, brain, pancreas, 
and kidney [54, 55]. PIWI proteins and piRNAs were first implicated in development, dif-
ferentiation, and maintenance of germline cells [18, 56, 57]. However, mounting evidence has 
revealed that the PIWI-piRNA pathway is also instrumental in controlling gene expression 
both in germinal and somatic cells [58].
This pathway has pivotal roles at all steps of oogenesis and spermatogenesis, but also in 
somatic cells such as ovary and testis of Drosophila [15]. This axis also controls, although at 
lower levels of expression, numerous biological processes implicated in homeostasis, includ-
ing brain maturation [59] pancreatic function [55], fat metabolism [60], and regeneration [61]. 
Indeed, this pathway was initially studied in gonads and implicated in gene silencing of ger-
minal cells [43]. Loss of function studies performed in zebrafish, Drosophila, Caenorhabditis, 
and mice have confirmed that the PIWI-piRNA pathway is involved in germline develop-
ment, spermatogenesis, and maintenance of germline stem cells. Mutations in this pathway 
resulted in expansive TEs mobility, genomic instability, and sterility [44]. PIWI proteins 
have nonredundant functions in cell compartments. Drosophila PIWI proteins Aub and Ago3 
cleaved TEs in the cytoplasm, whereas Piwi inactivated TEs in the nucleus [62, 63]. All mouse 
PIWI proteins MIWI, MILI, and MIWI2 were expressed during spermatogenesis, whereas 
only MILI was weakly expressed in female germinal cells [64, 65]. These mouse PIWI proteins 
not only silenced TEs posttranscriptionally but also inactivated TEs genes transcriptionally 
through CpG DNA methylation on TEs loci. Homozygous MIWI, MILI, and MIWI2 knockout 
male mice models were associated with propagation of LINE1 sequences, depleted spermato-
genesis, and apoptosis of germinal cells [66]. Particularly, Drosophila PIWI mutants were cor-
related with derepression of TEs, absence of germline stem cell renewal, and depletion of 
gametes [67–69]. Actually, the main function of this pathway is maintaining germline and 
somatic genome integrity by silencing TEs at transcriptional and posttranscriptional levels 
[70]. However, only 20% of piRNAs are localized in TEs and other repeat genomic regions, 
suggesting that this pathway may have additional biological functions. In germinal cells, the 
PIWI-piRNA pathway prevents genomic instability of the next generation and sterility. In 
somatic nonaging cells, this pathway is pivotal in self-renewal, differentiation and maturation 
of stem cell, embryonic development, and whole body regeneration. In somatic tissues, the 
PIWI-piRNA pathway is implicated in chromosomal conformation, memory-related synaptic 
plasticity, transcriptional regulation of mRNAs with deadenylation, and transgenerational 
inheritance to preserve the memory of self and nonself [71–73].
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and single strands of long primary precursor transcripts generate numerous piRNAs 
without a conserved sequence [37]. They comprise Uracil at their 5′ end and methylated 
2′-O group at their 3′ end [38, 39]. PiRNAs were first identified in Drosophila melanogaster 
and were named repeat-associated small-interfering RNAs (rasiRNAs) because of their 
repetitive elements and TEs suppressing activity. RasiRNAs were later found to interact 
with Argonaute PIWI proteins and ultimately renamed piRNAs in 2006 [40–42]. PiRNAs 
were further investigated in Caenorhabditis elegans, zebrafish, mice, and more recently in 
humans. Their vast number present in numerous locations of the genome suggests that 
piRNAs may have potential crucial implications in the control of major biological pro-
cesses. Indeed, PIWI-piRNA complexes silence TEs and control expression and activity 
of genes and proteins. They are also instrumental in genome rearrangement, germ stem 
cell maintenance, reproduction and fertility regulation, embryogenesis, and homeostasis 
[26, 43–48]. At the opposite of miRNAs and endosiRNAs, piRNAs function only through 
binding with PIWI proteins and harbor tissue-specific expression in various organs such as 
prostate and thyroid [49].
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cial roles in germline stem cell maintenance and self-renewal [50]. These proteins contain 
Figure 1. Biogenesis of piRNA and PIWI-piRNA pathways and their function in maintaining genome integrity through 
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three functional domains: the PIWI-Argonaute-Zwille (PAZ) domain recognizing the 3′ end 
of the RNA, the middle domain (MID) providing a binding pocket for the 5′ end of guide 
strand RNA, and the PIWI domain containing catalytic residues that cleave target transcripts 
[47]. Unlike proteins of the AGO subclass, PIWI proteins comprise posttranslationally dimeth-
ylated arginine-rich motifs that allow interactions with Tudor proteins. These last proteins 
have pivotal role in functional activities of PIWI proteins by providing a scaffold for edifica-
tion of higher-order molecular complexes located in Drosophila germ cells and mouse testis 
perinuclear granules named “nuage,” similar to P-bodies [51–53]. The PIWI protein family 
is conserved in numerous organisms, including jellyfish, sponge, planaria, zebrafish (Ziwi, 
Zili), Caenorhabditis elegans (Prg1, Prg 2), Drosophila melanogaster (Piwi, Aub, Ago3), mouse 
(MIWI, MILI, MIWI2), and human (PIWIL1, PIWIL2, PIWIL3, PIWIL4) [51] (Table 1). PIWIL3 
is observed only in human, and its functions are actually largely unknown. PIWI proteins 
expression is identified in a majority of organs such as liver, lung, heart, brain, pancreas, 
and kidney [54, 55]. PIWI proteins and piRNAs were first implicated in development, dif-
ferentiation, and maintenance of germline cells [18, 56, 57]. However, mounting evidence has 
revealed that the PIWI-piRNA pathway is also instrumental in controlling gene expression 
both in germinal and somatic cells [58].
This pathway has pivotal roles at all steps of oogenesis and spermatogenesis, but also in 
somatic cells such as ovary and testis of Drosophila [15]. This axis also controls, although at 
lower levels of expression, numerous biological processes implicated in homeostasis, includ-
ing brain maturation [59] pancreatic function [55], fat metabolism [60], and regeneration [61]. 
Indeed, this pathway was initially studied in gonads and implicated in gene silencing of ger-
minal cells [43]. Loss of function studies performed in zebrafish, Drosophila, Caenorhabditis, 
and mice have confirmed that the PIWI-piRNA pathway is involved in germline develop-
ment, spermatogenesis, and maintenance of germline stem cells. Mutations in this pathway 
resulted in expansive TEs mobility, genomic instability, and sterility [44]. PIWI proteins 
have nonredundant functions in cell compartments. Drosophila PIWI proteins Aub and Ago3 
cleaved TEs in the cytoplasm, whereas Piwi inactivated TEs in the nucleus [62, 63]. All mouse 
PIWI proteins MIWI, MILI, and MIWI2 were expressed during spermatogenesis, whereas 
only MILI was weakly expressed in female germinal cells [64, 65]. These mouse PIWI proteins 
not only silenced TEs posttranscriptionally but also inactivated TEs genes transcriptionally 
through CpG DNA methylation on TEs loci. Homozygous MIWI, MILI, and MIWI2 knockout 
male mice models were associated with propagation of LINE1 sequences, depleted spermato-
genesis, and apoptosis of germinal cells [66]. Particularly, Drosophila PIWI mutants were cor-
related with derepression of TEs, absence of germline stem cell renewal, and depletion of 
gametes [67–69]. Actually, the main function of this pathway is maintaining germline and 
somatic genome integrity by silencing TEs at transcriptional and posttranscriptional levels 
[70]. However, only 20% of piRNAs are localized in TEs and other repeat genomic regions, 
suggesting that this pathway may have additional biological functions. In germinal cells, the 
PIWI-piRNA pathway prevents genomic instability of the next generation and sterility. In 
somatic nonaging cells, this pathway is pivotal in self-renewal, differentiation and maturation 
of stem cell, embryonic development, and whole body regeneration. In somatic tissues, the 
PIWI-piRNA pathway is implicated in chromosomal conformation, memory-related synaptic 
plasticity, transcriptional regulation of mRNAs with deadenylation, and transgenerational 
inheritance to preserve the memory of self and nonself [71–73].
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3. Origin and biogenesis
Understanding of piRNA origin and biogenesis results principally from studies in Drosophila 
and mice [75]. PiRNAs can be classified according to their origin in three subgroups: transpo-
son-derived piRNAs, mRNA-derived piRNAs, and lncRNAs-derived piRNAs. Transposon-
derived piRNAs are produced from both genomic strands and generate sense and antisense 
piRNAs, whereas RNA-derived piRNAs are transcribed from 3′ untranslated regions (UTRs) 
of mRNAs and lncRNAs-derived piRNAs originate from the entire transcript [76]. Unlike 
miRNAs and siRNAs, which are derived from stem-loop and double-stranded precursors 
that are processed by the RNAse III Dicer, piRNAs are predominantly transcribed as large up 
to 200 kb single-stranded precursors independently from Dicer [43]. Furthermore, piRNAs do 
not possess secondary structures [77, 78].
The piRNA pathway is composed of PIWI proteins that interact with piRNAs, whose precur-
sors are transcribed from piRNA clusters, cleaved by PIWI proteins, and secondary amplified 
in the cytoplasm through a sequence-complementary-dependent “ping-pong” cycle. Mature 
piRNAs are thus derived from two major pathways, the primary pathway and the “ping-
pong” cycle that amplifies secondary piRNAs. In germline cells, molecules implicated in bio-
genesis of the PIWI-piRNA pathway are located at a perinuclear organelle called the “nuage” 
[79, 80]. Various components of the “nuage” colocalize with mitochondria [81]. In Drosophila, 
the primary pathway was observed in both germline and somatic cells, whereas the “ping-
pong” cycle was identified only in germline cells.
3.1. Primary piRNA biogenesis
Deep sequencing of piRNAs recently revealed millions of distinct piRNAs [29]. However, they 
were usually located to discrete genomic loci, called piRNA clusters [31]. In the primary piRNA 
biogenesis, piRNAs provide from long single-strand RNA precursors originating from these 
clusters. These transcriptional units are highly enriched in dysfunctional remnants of TEs and 
other repetitive elements and are mainly located in pericentromeric and subtelomeric hetero-
chromatin [41, 70, 82]. PiRNA clusters constitute the basis of immunity against TEs dissemina-
tion. Primary piRNAs derived from these clusters include uridine (U) at their 5′ nucleic acid 
and are mostly antisense to TEs mRNA sequences, functioning as guides for PIWI proteins to 
inactivate TE transcripts through complementary base pairing [40–42]. In the female Drosophila 
germline, these loci are either unidirectionally transcribed (unistrand clusters generating 
antisense piRNAs) or bidirectionally transcribed (dual-strand clusters generating both sense 
and antisense piRNAs), producing piRNAs that map to one genomic strand and both strands, 
respectively [41]. Transcription of unistrand clusters is performed through the canonical poly-
merase II, whereas dual-strand clusters transcription is generated via the noncanonical rhino-
deadlock-cutoff (RDC) complexes that are also recruited by PIWI proteins and piRNAs through 
an intricate feedback loop [34, 83–86]. In female flies, piRNA clusters are expressed in germline 
cells (oocytes and nurse cells) and somatic cells (follicular cells). Interestingly, germline clusters 
are transcribed bidirectionally, whereas somatic clusters are transcribed unidirectionally, pro-
ducing piRNAs antisense to TE coding regions in flies. In mouse spermatogenic cells, one class 
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of piRNA clusters is transcribed during embryonic development and defends the germline 
against TEs, whereas a second class of clusters is expressed in adolescent mice during the first 
division of meiosis. The transcription factor A-MYB regulates expression of pachytene piRNA 
clusters and regulates their transcription through the PIWI-piRNA pathway in mouse [88–97].
In Drosophila, nuclear primary transcripts are processed into cytoplasmic mature primary 
piRNAs (Figure 1). These transcripts are resolved of secondary structures by the RNA heli-
case Armitage and then cleaved by the mitochondria-associated endonuclease Zucchini to 
generate pre-piRNAs with a characteristic 5′ monophosphate [93–97]. Pre-piRNAs are then 
loaded on PIWI proteins and their 3′ ends trimmed to a final length by the 3′–5′ exonuclease 
Nibbler [98, 99]. The 2′ hydroxy group at the 3′ end is then methylated by the small-RNA 
2′-O-methyltransferase Hen1 that increases PIWI binding affinity and piRNA stability, while 
the 5′ end residue of the piRNA incorporated in PIWI shows a strong bias for uridine residues 
[100–103]. After processed into final length, piRNAs bind PIWI proteins and edify piRNA/
PIWI ribonucleoprotein effector complexes (piRISCs) located into the cytoplasmic perinuclear 
“nuage” [104–106]. PiRISCs migrate back to the nucleus and reach their target genes to epi-
genetically repress their transcription. Through complementary base pairing of piRNAs and 
DNA, piRISCs induce transcriptionally heterochromatin formation by establishing a repressive 
H3K9me3 chromatin state mark on chromatin at target TEs loci and adjacent genes, in order 
to induce their silencing [107, 108]. H3K9me3 repressive marks are deposited by SETDB1 and 
Su(var)3–9 methyltransferases and heterochromatin protein 1 (HP1) [109, 110]. In Drosophila, 
the nuclear protein Panoramix is an adaptor allowing interactions between the PIWI-piRNA 
pathway and the general silencing machinery. Panoramix is implicated with its nuclear partner 
Asterix, in amplification of the piRNA-dependent TEs silencing [111]. In this way, piRNAs con-
stitute transcriptional regulators that act mainly on TE sequences by recruiting histone methyl-
transferases, which will lead to establishment of transcriptionally silent heterochromatin [26].
In Drosophila, primary piRNAs accumulating in the cytoplasm are amplified by the “ping-
pong” cycle [19]. They interact with Ago3 or Aub proteins to form piRNA/Ago or piRNA/Aub 
complexes, which contain complementary sequences to each other. PiRNA/Ago complexes 
generate sequences of RNA functioning as substrates for the generation of new piRNAs, which 
can load Aub proteins. Resulting piRNA/Aub complexes will generate additional RNA sub-
strates to edify new piRNA/Ago3 complexes. The “ping-pong” amplification cycle is mainly 
observed in early evolutionary species, including sponges, zebrafish, and D. melanogaster [34].
3.2. Secondary piRNA biogenesis
Secondary piRNAs are generated from mRNA transcripts of active TEs [79]. They are primed 
in the cytoplasmic “nuage” by primary piRNAs (Figure 1) that guide their associated PIWI 
proteins to cleave target TE transcripts based on sequence complementarity [112]. Cleaved TEs 
are loaded on another PIWI protein and modified to give rise to multiplied secondary piRNAs 
in an amplification loop, called the “ping-pong” cycle. This posttranscriptional mechanism 
associates TEs silencing with piRNAs biogenesis by modifying TEs transcripts to give rise 
to secondary piRNAs [52]. Cleavage of TEs transcripts by PIWI proteins leads to destruction 
of TEs message, generation of secondary piRNAs, and concomitant amplification of these 
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defensive sequences targeting active TEs [44]. This process is highly conserved through spe-
cies and characterized by 5′ U bias of primary piRNAs, 10th adenosine bias of secondary piR-
NAs, and 10-nt overlap between the 5′ ends of primary and secondary piRNAs [113–115]. The 
secondary piRNA biogenesis cycle may constitute an adaptive system to TEs propagation by 
increasing piRNAs production after incorporation of new TEs into piRNA clusters [116, 117].
3.3. Cellular localization and mechanisms of action
PIWI proteins and piRNAs are located in the nucleus and the cytoplasm of cells expressing 
this pathway. Loading of piRNAs onto PIWI proteins is localized into the cytoplasm, and 
PIWI-piRNA complexes generated are required for trafficking of PIWI proteins to the nucleus 
[90]. Several cytoplasmic organelles, including mitochondria and the “nuage,” are instrumen-
tal in functional activity of the PIWI-piRNA axis by controlling piRNA precursor processing 
[118]. PIWI-piRNA complexes control gene expression through two different mechanisms of 
action functioning at transcriptional and posttranscriptional levels.
At transcriptional level, nuclear PIWI-piRNA complexes control TEs and gene expression by 
promoting epigenetic modifications of the chromatin structure and histone proteins through 
combining DNA and histone methylation. PIWI proteins and piRNAs regulate expression and 
activity of three active DNA methyltransferases (DNMT1, DNMT3A, and DNMT3B), which 
normally repress initiation of transcription through methylation of CpG islands in promoter 
sites of target genes. When PIWI-piRNA complexes recognize TEs and target transcripts, they 
directly upregulate expression of these DNA methyltransferases and prevent binding of tran-
scription factors through methylation of promoter regions. PIWIL1 induces overexpression of 
DNMT1 and DNMT3a [119], and piR-823 upregulates DNMT3A and DNMT3B [120]. PIWIL2 
and PIWIL4 promote overexpression of DNMT1, DNMT3A, and DNMT3B, which silence TEs 
and target genes. Experimental loss of PIWIL2 and PIWIL4 induces downregulation in DNA 
methylation of promoter regions [121]. The PIWI-piRNA complexes also control methyla-
tion of histone lysine residues H3K and H4K through recruiting and interacting with histone 
methyltransferases (HMTs) such as Suv39H1 and SETDB1, which upregulate the histone H3 
lysine 9 methylation (H3K9me). Furthermore, these complexes bind with different isoforms 
of HP1 and guide them to interact with H3K9me in target regions, which is a gene repressive 
mark. Accumulated methylation of H3K9 induces a heterochromatin state that allows seg-
regation of chromosomes during cell division and prevents accessibility of TEs and genes to 
transcription factors [122]. Thus, PIWI-piRNAs complexes promote gene repression by using 
epigenetic mechanisms that allow HP1α recruitment to TEs loci, heterochromatin edification, 
and transcription silencing state [123]. PIWIL2 and PIWIL4 increase H3K9 methylation [124]. 
PIWIL4 recruits SUV39H1 or SETDB1 and promotes H3K9 methylation in promoter region 
of CD1A in monocytes, resulting in recruitment of HP1α and repression of gene transcrip-
tion [125]. In leukemias, cell cycle-related piRNAs hsa-piR_014637 and hsa_piR_011186 are 
implicated in edification of molecular complexes combining DNMT1 and HMTs Suv39H1 
and EZH2 that induce H3K9 and H3K27 methylation in the CDKN2B gene and inhibition 
of its transcription by DNMT1-induced CpG methylation in promoter region. In Drosophila, 
PIWI proteins also interact with subunits of the polycomb repressive complex 2 (PRC2). They 
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maintain integrity of the ovary germline stem cells genome through preventing binding of 
PRC2 to HP1α at target gene sites and inhibition of H3K27 di- and trimethylation, a repres-
sive mark upregulated on facultative heterochromatin [126]. Reduction of HP1α interactions 
with H3K27me3 promotes maintenance of constitutive heterochromatin, which is pivotal for 
accurate chromatin segregation and repression of developmentally regulated genes [127].
At posttranscriptional level, cytoplasmic PIWI-piRNA complexes principally govern degrada-
tion of TEs transcripts through the “ping-pong” amplification cycle. Apart from their impli-
cation in repression of TEs transcripts, the cytoplasmic functions of the PIWI proteins are 
mostly independent of their partner piRNAs. PIWI proteins modulate functions of many 
intracellular signaling proteins and receptors through degradation of mRNAs, inhibition 
of translation, and posttranslational modifications. PIWI proteins inhibit gene expression 
through mRNAs degradation by interacting with deadenylation complexes (Trf4-Air2-Mtr4 
polyadenylation complex or CCR4 complex), resulting in shortening of poly-A tails. The 
PIWIL4-piR30840-Ago4 complex induces degradation of pre-mRNAs through binding to 
the Trf4-Air2-Mtr4 polyadenylation complex in human T lymphocytes [128]. They repress 
translation by interacting with translation initiation factors (eIF3a, eIF4E, eIF4F), prevent-
ing ribosomal subunits binding to 5′ cap of mRNAs. In mouse, Miwi interacts with eIF4E, 
while Mili binds to eIF3a, eIF4E, and eIF4F [129]. These proteins also regulate activity and 
stability of numerous molecules belonging to major signaling pathways by controlling 
posttranslational modifications such as phosphorylation and ubiquitination. PIWIL2 and 
PIWIL4 interact with the transcription factor STAT3 and upregulate its phosphorylation 
and activity. At the opposite, PIWIL4 binds to p53 and prevents serine 15 phosphorylation, 
inhibiting its functions [130]. PIWI proteins can also upregulate stability of target mol-
ecules by preventing their ubiquitination-dependent degradation. Interaction of PIWIL1 
with Stathmin 1 inhibits its phosphorylation, resulting in prevention of PIWIL1 degrada-
tion by the ubiquitin ligase RLIM. Likewise, PIWIL2 binding to cytokeratin 8 promotes 
its phosphorylation and upregulates its stability by preventing its ubiquitination-derived 
degradation [131].
3.4. Biological functions
Up to now, biological functions of piRNAs have been only partially identified, due to the 
wide variation in piRNA sequences and mechanisms of action over species. However, a 
great majority of piRNAs are not complementary to mRNAs of target genes and are mainly 
implicated in epigenetic regulation rather than posttranscriptional modulation of biologic 
processes. PiRNAs have been implicated in TEs silencing, epigenetic, genes and proteins 
regulation, genome rearrangement, fertilization, germline and somatic stem cell self-renewal, 
embryogenesis, and maintenance of homeostasis.
3.4.1. Maintenance of genome stability and integrity
The PIWI-piRNA pathway maintains integrity and stability of the general organization of the 
genome, including regulation of genes, through recognition of self and nonself and prevention 
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tal in functional activity of the PIWI-piRNA axis by controlling piRNA precursor processing 
[118]. PIWI-piRNA complexes control gene expression through two different mechanisms of 
action functioning at transcriptional and posttranscriptional levels.
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promoting epigenetic modifications of the chromatin structure and histone proteins through 
combining DNA and histone methylation. PIWI proteins and piRNAs regulate expression and 
activity of three active DNA methyltransferases (DNMT1, DNMT3A, and DNMT3B), which 
normally repress initiation of transcription through methylation of CpG islands in promoter 
sites of target genes. When PIWI-piRNA complexes recognize TEs and target transcripts, they 
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scription factors through methylation of promoter regions. PIWIL1 induces overexpression of 
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and PIWIL4 promote overexpression of DNMT1, DNMT3A, and DNMT3B, which silence TEs 
and target genes. Experimental loss of PIWIL2 and PIWIL4 induces downregulation in DNA 
methylation of promoter regions [121]. The PIWI-piRNA complexes also control methyla-
tion of histone lysine residues H3K and H4K through recruiting and interacting with histone 
methyltransferases (HMTs) such as Suv39H1 and SETDB1, which upregulate the histone H3 
lysine 9 methylation (H3K9me). Furthermore, these complexes bind with different isoforms 
of HP1 and guide them to interact with H3K9me in target regions, which is a gene repressive 
mark. Accumulated methylation of H3K9 induces a heterochromatin state that allows seg-
regation of chromosomes during cell division and prevents accessibility of TEs and genes to 
transcription factors [122]. Thus, PIWI-piRNAs complexes promote gene repression by using 
epigenetic mechanisms that allow HP1α recruitment to TEs loci, heterochromatin edification, 
and transcription silencing state [123]. PIWIL2 and PIWIL4 increase H3K9 methylation [124]. 
PIWIL4 recruits SUV39H1 or SETDB1 and promotes H3K9 methylation in promoter region 
of CD1A in monocytes, resulting in recruitment of HP1α and repression of gene transcrip-
tion [125]. In leukemias, cell cycle-related piRNAs hsa-piR_014637 and hsa_piR_011186 are 
implicated in edification of molecular complexes combining DNMT1 and HMTs Suv39H1 
and EZH2 that induce H3K9 and H3K27 methylation in the CDKN2B gene and inhibition 
of its transcription by DNMT1-induced CpG methylation in promoter region. In Drosophila, 
PIWI proteins also interact with subunits of the polycomb repressive complex 2 (PRC2). They 
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while Mili binds to eIF3a, eIF4E, and eIF4F [129]. These proteins also regulate activity and 
stability of numerous molecules belonging to major signaling pathways by controlling 
posttranslational modifications such as phosphorylation and ubiquitination. PIWIL2 and 
PIWIL4 interact with the transcription factor STAT3 and upregulate its phosphorylation 
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inhibiting its functions [130]. PIWI proteins can also upregulate stability of target mol-
ecules by preventing their ubiquitination-dependent degradation. Interaction of PIWIL1 
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its phosphorylation and upregulates its stability by preventing its ubiquitination-derived 
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3.4. Biological functions
Up to now, biological functions of piRNAs have been only partially identified, due to the 
wide variation in piRNA sequences and mechanisms of action over species. However, a 
great majority of piRNAs are not complementary to mRNAs of target genes and are mainly 
implicated in epigenetic regulation rather than posttranscriptional modulation of biologic 
processes. PiRNAs have been implicated in TEs silencing, epigenetic, genes and proteins 
regulation, genome rearrangement, fertilization, germline and somatic stem cell self-renewal, 
embryogenesis, and maintenance of homeostasis.
3.4.1. Maintenance of genome stability and integrity
The PIWI-piRNA pathway maintains integrity and stability of the general organization of the 
genome, including regulation of genes, through recognition of self and nonself and prevention 
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of TEs propagation. During interphase, the genome of eukaryotic cells is organized into vari-
ous spatial three-dimensional topologically associating domains (TADs) edifying functional 
subcompartments implicated in pivotal cellular activities [132]. It has been recently observed 
in somatic cells of Drosophila ovaries PIWI-interacting chromosomal domains overlapping 
with genomic regions bound by nuclear pore complexes (NPCs). Furthermore, a third of 
protein-coding genes have been identified in the PIWI-interacting domains. PIWI proteins 
stochastically interact with nascent transcripts of genes and TEs and scan them through 
complementarity with piRNAs. Although perfect complementarity allows transcriptional 
silencing of TEs, imperfect complementarity leads to maintenance of PIWI proteins interac-
tions with transcripts in the mRNPs after their detachment from the sites of transcription until 
dissociation from mRNPs in the nucleoplasm [133].
3.4.2. Retrotransposons silencing
TEs, first identified in maize by Barbara McClintock in the 1940s, constitute genetic units that 
can move and propagate within the genome [70]. More recently, genome-sequencing tech-
niques have revealed that TEs occupy 15–22% of the genome of Drosophila melanogaster and 
55% of the human genome. TEs of the human genome are divided into two major classes. Class 
II comprises DNA transposons that are generally inactive genetic elements representing less 
than 2% of the human genome and depending on transposases for their mobilization. They do 
not need transcription to propagate and use a “cut and paste” mechanism to excise and insert 
into new genomic sites without increasing their copy number. Conversely, class I retrotranspo-
sons are usually active genetic elements propagating through a “copy and paste” mechanism 
that allows retrotranscription into cDNA by a reverse transcriptase encoded by the retrotrans-
poson and insertion into new genomic sites via these RNA transposition intermediates [134]. 
Retrotransposons are composed of three subclasses: (1) the long interspersed elements 1 and 
2 (LINE-1/L1 and LINE-2/L2) are about 6 kb long and encode the two proteins ORF1p and 
ORF2p. ORF1p is implicated in edification of the retrotransposon particle, and ORF2p allows 
the enzymatic activities required for retrotransposition such as reverse transcriptase and endo-
nuclease. Analysis of transgenic mice has demonstrated presence of L1 transcripts in gametes, 
but rare genomic insertion, suggesting posttranscriptional mechanisms allowing preservation 
of genomic integrity in germline. Conversely, genomic insertions of L1 sequences were mostly 
identified in somatic tissues during the early phases of embryogenesis [135]; (2) the short 
interspersed elements (SINEs) belong to the SINE-Alu and SVA classes. Whereas LINEs are 
autonomous sequences encoding a reverse transcriptase, SINEs are dependent on two proteins 
encoded by LINEs for their replication and integration [136]. Non-LTR families L1, SVA, and 
Alu were found to be upregulated in breast, ovarian, colon, and hematological cancers [137]; (3) 
the third subclass is composed of inactive LTR retrotransposons resulting from ancient germline 
retroviral infections. Within the human genome, only 80–100 TEs among LINE sequences are 
competent for the entire retrotransposition activity [8]. In the germline, TEs represent pivotal 
actors implicated in the shaping of genomes during evolution, and presence of retrotransposi-
tion in numerous somatic cells indicates that TEs contribute to edification of mosaicism. TEs 
have important role in edifying genetic diversity but are also a major source of genetic instability 
through mutations, chromosomes rearrangements, and epigenetic/genetic deregulations [138]. 
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Although mobilization of class I retrotransposons may be considered as beneficial by promot-
ing biological variability within the genome, existence of an active insertional mutagenesis 
can induce genomic instability in aging cells, leading to human genetic diseases, degenerative 
pathologies, and cancer [39]. Class I retrotransposons propagating through their “copy and 
paste” mechanism result in an increased copy of TEs number, which may become a source of 
endogenous mutagenesis by producing insertion-mediated deletions with cell cycle arrest and 
nonhomologous recombination [139]. Gradual release of TEs induces molecular alterations in 
DNA repair processes, autophagy, chaperones, and ubiquitin-proteasome system [140, 141].
During evolution, organisms have adopted molecular systems to contain expansion of TEs 
activity. Among them, PIWI proteins and piRNAs constitute a small-RNA-based innate 
immune-like system mainly expressed in gonads. Upon new expansion, TEs propagate into 
different regions in the genome, can be trapped into piRNA clusters, and leave traces of their 
sequences in these TEs traps. By falling into these clusters, novel piRNAs targeting TEs are 
generated and amplified through the two biogenesis pathways [87]. These pathways are highly 
conserved in eukaryotes and mainly implicated in protection of the genome integrity and nor-
mal gametogenesis by silencing TEs [62]. Within the germline, TEs inactivation is performed 
by both PIWI-piRNA and siRNA pathways. Propagation of TEs is controlled by the PIWI-
piRNA pathway, of which the PIWI proteins are the executive components. The nuclear PIWI 
proteins allow transcriptional silencing of TEs by recognizing nascent transcripts through 
perfect complementarity with loaded piRNAs and are assisted by the RNA-binding protein 
Asterix. Recognition of multiple complementary sites in nascent TE transcripts by Asterix-
PIWI-piRNA complexes favors interaction with the adaptor protein Panoramix, resulting in 
recruitment of the cell silencing machinery that represses TEs transcription. Moreover, introns 
containing remnants of TEs or genes located in proximity of TEs can be repressed by the PIWI-
piRNA axis. Current studies indicated that the high mobility group protein Maelstrom (Mael) 
may act downstream of Piwi and histone methylation. In mouse, both Mili and Miwi2 promote 
TEs silencing and a heterochromatin state in mice through DNA and histones methylation. 
Decreased expression of PIWI proteins and piRNAs is associated with upregulation and prop-
agation of active TEs. However, unlike siRNAs, which are active in both gonadal and somatic 
aging cells, the PIWI-piRNA pathway predominantly operates in nonaging cells of gonads 
[142, 143]. This pathway could be part of a mammalian recognition system of coding and non-
coding self-genes and non-self-TEs and repeat sequences by using characteristic TEs mobility.
3.4.3. Epigenetic activation
Mounting evidence suggests that PIWI proteins and piRNAs can function as epigenetic acti-
vators. In Drosophila, Piwi protein increases chromosome 3R telomere-associated sequence 
(3R-TAS) expression [144].
3.4.4. Genes and proteins regulation
PiRNAs control levels of expression of genes where they are localized. PiR_015520, located 
in intron 1 of the human melatonin receptor 1A gene (MTNR1A), is upregulated in prostate 
Part 1: The PIWI-piRNA Pathway Is an Immune-Like Surveillance Process That Controls...
http://dx.doi.org/10.5772/intechopen.79974
245
of TEs propagation. During interphase, the genome of eukaryotic cells is organized into vari-
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tions with transcripts in the mRNPs after their detachment from the sites of transcription until 
dissociation from mRNPs in the nucleoplasm [133].
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niques have revealed that TEs occupy 15–22% of the genome of Drosophila melanogaster and 
55% of the human genome. TEs of the human genome are divided into two major classes. Class 
II comprises DNA transposons that are generally inactive genetic elements representing less 
than 2% of the human genome and depending on transposases for their mobilization. They do 
not need transcription to propagate and use a “cut and paste” mechanism to excise and insert 
into new genomic sites without increasing their copy number. Conversely, class I retrotranspo-
sons are usually active genetic elements propagating through a “copy and paste” mechanism 
that allows retrotranscription into cDNA by a reverse transcriptase encoded by the retrotrans-
poson and insertion into new genomic sites via these RNA transposition intermediates [134]. 
Retrotransposons are composed of three subclasses: (1) the long interspersed elements 1 and 
2 (LINE-1/L1 and LINE-2/L2) are about 6 kb long and encode the two proteins ORF1p and 
ORF2p. ORF1p is implicated in edification of the retrotransposon particle, and ORF2p allows 
the enzymatic activities required for retrotransposition such as reverse transcriptase and endo-
nuclease. Analysis of transgenic mice has demonstrated presence of L1 transcripts in gametes, 
but rare genomic insertion, suggesting posttranscriptional mechanisms allowing preservation 
of genomic integrity in germline. Conversely, genomic insertions of L1 sequences were mostly 
identified in somatic tissues during the early phases of embryogenesis [135]; (2) the short 
interspersed elements (SINEs) belong to the SINE-Alu and SVA classes. Whereas LINEs are 
autonomous sequences encoding a reverse transcriptase, SINEs are dependent on two proteins 
encoded by LINEs for their replication and integration [136]. Non-LTR families L1, SVA, and 
Alu were found to be upregulated in breast, ovarian, colon, and hematological cancers [137]; (3) 
the third subclass is composed of inactive LTR retrotransposons resulting from ancient germline 
retroviral infections. Within the human genome, only 80–100 TEs among LINE sequences are 
competent for the entire retrotransposition activity [8]. In the germline, TEs represent pivotal 
actors implicated in the shaping of genomes during evolution, and presence of retrotransposi-
tion in numerous somatic cells indicates that TEs contribute to edification of mosaicism. TEs 
have important role in edifying genetic diversity but are also a major source of genetic instability 
through mutations, chromosomes rearrangements, and epigenetic/genetic deregulations [138]. 
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(3R-TAS) expression [144].
3.4.4. Genes and proteins regulation
PiRNAs control levels of expression of genes where they are localized. PiR_015520, located 
in intron 1 of the human melatonin receptor 1A gene (MTNR1A), is upregulated in prostate 
Part 1: The PIWI-piRNA Pathway Is an Immune-Like Surveillance Process That Controls...
http://dx.doi.org/10.5772/intechopen.79974
245
cancer and represses MTNR1A gene by directly interacting with its genomic site [145]. 
PiRNAs also modulate stability of their PIWI partners by promoting direct molecular inter-
actions with specific proteins. During late mouse spermatogenesis, piRNAs regulate ubiq-
uitination of Miwi through its binding to APC/C complex [146]. Furthermore, piRNAs can 
modify activity and expression of many distant genes. PiRNA-36026 interacts with suppres-
sor proteins Serpin peptidase inhibitor, clade A, member 1 (SERPINA1), and lecithin retinol 
acyltransferase (LRAT). However, the PIWI-piRNA pathway is also present at lower levels 
in somatic pluripotent stem cells to differentiated cells [147, 148]. In adult somatic cells of 
Drosophila melanogaster, this pathway is active in ovarian follicle cells, in salivary glands, and 
in the brain [149]. The pathway is principally observed in stem cells with pluripotent capaci-
ties, including mesenchymal and hematopoietic stem cells, but rarely in adult stem cells with 
limited differentiation capacity [150]. Furthermore, the PIWI-piRNA pathway seems also to 
regulate protein-coding genes. The first piRNAs identified in Drosophila melanogaster were 
transcribed from the Suppressor of Stellate locus located on the Y chromosome and targeted 
the protein-coding gene Stellate on the X chromosome [151]. More recently, genome-wide 
mapping techniques have demonstrated that genic piRNAs derive from TEs and 3′ UTRs 
of coding genes [56]. Mounting evidence suggests that germline genes could have ancestral 
implication in regulating stemness. The “nuage” is located in lower metazoan stem cells but 
restricted to germline cells in upper metazoans [152]. The PIWI-piRNA pathway is expressed 
in stem cells of metazoans with partial or whole-body regeneration capabilities [153].
3.4.5. Differentiation
PIWI proteins play pivotal roles in cell differentiation during early embryogenesis. In Drosophila 
ovary, self-renewal of differentiated germline stem cells is located in niches composed of dif-
ferent types of cells, including escort cells (ECs). Experimental deregulation of PIWI proteins 
expression in EC cells was associated with reduction of EC cell population and predominance 
of undifferentiated germline stem cells. PIWI proteins induced germline cell differentiation by 
promoting direct interaction between germline stem cells and escort cells through repression 
of the TGFβ signaling and bone morphogenetic protein (BMP) pathway by preventing edifica-
tion of Smad complexes. PIWIL2 is the major PIWI protein implicated in cell differentiation 
through inhibition of the TGFβ signaling pathway. PIWIL2 directly interacts with Smad4 and 
HSP90 and prevents HSP90-TβR complex formation, resulting in inhibition of the TGFβ signal-
ing pathway. Furthermore, PIWIL2 promotes degradation of TGFβ receptor (TβR) and Smad 
by upregulating ubiquitination and degradation of TβR by the ubiquitin E3 ligase Smurf2. 
PIWI proteins contribute to germline stem cells differentiation by repressing c-Fos at post-
transcriptional. These proteins promote piRNAs synthesis from 3′ UTR region of c-Fos mRNA, 
resulting in c-Fos mRNA instability and repression of its translation [151–154].
3.4.6. Cell survival
The PIWI-piRNA axis promotes activation of numerous prosurvival molecules. PIWIL1-
induced cell survival by upregulating expression of antiapoptotic molecule FGF8 and down-
regulating expression of proapoptotic Bax and p21. In blastema cells of Mexican axolotl, 
Chromatin and Epigenetics246
experimental defect of PIWIL1 and PIWIL2 promoted apoptosis by suppressing FGF8 expres-
sion at transcriptional level and prevented limb regeneration and development. PIWIL2 prin-
cipally controlled p53 through direct interaction with STAT3 and c-Src by edifying a PIWIL2/
STAT3/c-Src complex, resulting in repression of p53 phosphorylation and expression and 
inhibition of Fas-mediated apoptosis. PIWIL2 - induced activation of STAT3 also upregulated 
expression of the antiapoptotic Bcl-XL [125].
3.4.7. Fertilization and development
Although most attention has been given to the pivotal role of the PIWI-piRNA pathway in 
germline TEs silencing, mounting evidence has revealed their implication in germline and 
somatic epigenetic and posttranscriptional regulation of gene expression [151]. This path-
way is mainly implicated in the germline biology, including maintenance, differentiation, 
and function of Drosophila and murine GSCs. Furthermore, piRNAs epigenetically activate 
gene expression with transgenerational epigenetic effects by inducing euchromatin through 
activation of H3K4me3 and inhibition of H3K27me3 in subtelomeric heterochromatin [56, 73, 
152–155]. The PIWI-piRNA axis is implicated in embryonic development, including cell cycle 
progression, nuclear division, chromatin organization, chromosome integrity during mito-
sis, control of mRNA translation, and embryonic sex determination [144, 156–158]. Spatial-
temporal activation and regulation of PIWI proteins and piRNAs are of pivotal importance 
during mammalian oogenesis and spermatogenesis, early embryogenesis, organogenesis, 
and postbirth [159]. PIWIL2 is upregulated in germline cells and appears instrumental in 
maintaining genome stability, an open state of chromatin and DNA repair via silencing TEs 
and histones modifications, thus preventing TEs propagation, chromosome rearrangements, 
oncogenic mutations, and gene dysregulation [160].
3.4.7.1. Oogenesis
In Drosophila, PIWI-piRNA complexes promote TEs silencing at embryonic germ cell stage, 
mediate cellular memory of TEs repression, and thus maintain this mechanism in ovaries at 
the adult stage. In mouse ovary, Miwi upregulation is observed during neonatal stage and 
its expression is lower in adult ovaries [161]. Human PIWI proteins expression profiling 
is also variable, depending on the stage of development. PIWIL1 and PIWIL2 are highly 
upregulated in oocytes of human adult ovary that present a strong activity of TEs, whereas 
fetal oocytes, whose TEs propagation is lower, overexpress PIWIL2 but not other PIWI 
proteins [162].
3.4.7.2. Spermatogenesis
In mouse, Miwi inactivation occurs during late spermatogenesis and is induced by the ana-
phase promoting complex (APC)/C-26S proteasomal pathway [159]. Functional destruction 
box (D-box) is required for Miwi ubiquitination and degradation by (APC)/C system. A 
genetic analysis in mouse azoospermia showed that mutations in D-box favor Hiwi stabi-
lization in late spermatogenesis. Stabilized mutant Hiwi interacts with RNF8 implicated in 
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cancer and represses MTNR1A gene by directly interacting with its genomic site [145]. 
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actions with specific proteins. During late mouse spermatogenesis, piRNAs regulate ubiq-
uitination of Miwi through its binding to APC/C complex [146]. Furthermore, piRNAs can 
modify activity and expression of many distant genes. PiRNA-36026 interacts with suppres-
sor proteins Serpin peptidase inhibitor, clade A, member 1 (SERPINA1), and lecithin retinol 
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experimental defect of PIWIL1 and PIWIL2 promoted apoptosis by suppressing FGF8 expres-
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histone ubiquitination and prevents its nuclear translocation and ubiquitin ligase activity 
[163]. Human PIWIL4 function is crucial in accurate spermatogenesis, and genetic polymor-
phisms of PIWIL4 gene are significantly correlated with defective spermatogenesis associated 
with spermatogenesis defect and male infertility [164].
3.4.7.3. Organogenesis
In Drosophila, PIWI proteins induce ovary tissue morphogenesis through c-Fos inactivation at 
posttranscriptional level [165]. They are implicated in development of eye color [144]. In silk-
worm, fempiRNA, a piRNA located on female W-chromosome, is pivotal in sex determina-
tion by repressing masculinization mRNA at posttranscriptional level [167]. At early stages of 
human embryonic lungs development, PIWIL1, PIWIL2, and PIWIL4 levels of expression are 
strongly upregulated from 6th week to 9th week and then decline [168]. In human, PIWIL1 
and PIWIL2 have crucial role in neural polarization and radial migration during maturation 
of the cerebral cortex region of the brain [59].
3.4.8. Physiological processes
The PIWI-piRNA pathway has pivotal role in numerous physiological processes.
3.4.8.1. Brain plasticity
PIWI proteins and piRNAs are instrumental in synaptic plasticity and stabilization of long-
term memory through serotonin-dependent suppression of CREB2 at transcription level that 
is induced by methylation of CpG islands in the promoter region of the CREB2 gene [59]. In 
rodents, several piRNAs are upregulated in hippocampal neurons and Miwi associated with 
piRNAs control dentritic spine development and morphogenesis [149]. Mili expression is 
associated with anxiety and locomotory drive [54]. In humans, PIWIL1 controls cortical neu-
ron activity through modulation of microtubule-associated proteins (MAPs) expression [169]. 
Furthermore, mutations of PIWIL2 and PIWIL4 are significantly correlated with autism [170].
3.4.8.2. Regeneration
PIWI proteins and piRNAs have crucial role in self-renewal, regeneration, and homeo-
stasis. In planarian Schmidtea mediterranea, SMEDWI-2 and SMEDWI-3 increase division 
of adult stem cells to induce regeneration in injured tissues [113]. In jellyfish, Cniwi is 
upregulated during transdifferentiation of striated muscle into smooth muscle [171]. In 
humans, PIWI proteins promote hepatocyte regeneration [61] and maintain integrity of 
retinal cells [130].
3.4.8.3. Metabolism
The PIWI-piRNA pathway controls fat metabolism through repression of TEs, and fat metab-
olism inactivation is associated with depletion of lipid synthesis and storage [60]. PIWIL2 and 
PIWIL4 modulate pancreatic β-cells function and insulin secretion. Alterations of their levels 
of expression were observed in diabetic conditions [55].
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4. Deregulation of the PIWI/piRNA pathway in pathological 
nonneoplastic disorders
Mounting evidence has revealed that many transcription factors and signaling molecules inter-
act with the PIWI-piRNA pathway and represent downstream targets of these complexes under 
pathological conditions. PIWI proteins and piRNAs are deregulated, and their levels of expres-
sion are highly altered in various pathological processes. The PIWI-piRNA pathway is pivotal 
for regeneration after amputation in Botrylloides leachi [172]. In Mexican axolotl, PIWIL1 and 
PIWIL2 transient upregulation in limb blastemal cells induces regeneration of wounded limb 
[173]. In rat, PIWIL2 expression increases after 24 h of partial hepatectomy, and a set of 72 piR-
NAs is deregulated during 48 h of posthepatectomy [58]. In rodents, expression of more than 
100 piRNAs is deregulated in brain during ischemic condition [174]. In rat, PIWIL2 enhances 
activity of the autophagic process in diabetic nephropathy by regulating expression of beclin 
1 and LC3A study in diabetic rat kidney [175]. Pro-inflammatory cytokines IL1β and TNFα 
promote PIWIL2 and PIWIL4 upregulation in synovial fibroblasts of rheumatoid arthritis [176].
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Epigenetic abnormalities are early events in carcinogenesis and associate heterogeneity 
of DNA methylation, modifications of histones, and deregulation of noncoding RNAs. 
Aberrant expressions of PIWI proteins and piRNAs were recently observed in numer-
ous subtypes of malignant tumors and were implicated in occurrence of most cancer 
hallmarks such as cell proliferation, genomic stability, apoptosis inhibition, invasion, and 
metastatic spread. However, this pathway is a new emerging research field, and further 
investigations are necessary to elucidate their oncogenic or tumor-suppressing status. 
Since the aberrant expression of this pathway may induce stemness, analysis of rela-
tionship between PIWI proteins, piRNAs, and cancer stem cells may open new avenues 
in cancer research. The objective of this review is to provide a broad overview of the 
emerging implication of PIWI proteins and piRNAs in carcinogenesis and their potential 
clinical interest as diagnostic and prognostic biomarkers and therapeutic tools.
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1. Deregulation of the PIWI-piRNA pathway in cancer
Recent evidences have suggested that activation of the PIWI-piRNA pathway has impor-
tant implications in carcinogenesis (Table 1). PIWI proteins and piRNAs are deregulated in 
numerous human cancers such as breast cancer, prostate cancer, hepatic cancer, gastric can-
cer, malignant melanoma, and lung cancer. Experimental analyses have demonstrated that 
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PIWI proteins and piRNAs altered levels of expression are associated with major hallmarks 
of cancer, including genomic chronic proliferation, differentiation, and survival [1]. Emerging 
roles of PIWI-piRNA-mediated epigenetic alterations in cancer seem related to promotion of 
a stem-like state of tumor cells through aberrant DNA methylation. Experimental studies in 
Drosophila have confirmed that PIWI proteins and piRNAs functions are upstream modula-
tors of cell cycle progression and proliferation through control of DNA synthesis, maintain of 
chromatin structure, and assembly of mitotic spindle. In Drosophila, maternal alterations of the 
three PIWI proteins, Piwi, Aub, and Ago3, were associated with chromatin disorganization, 
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Table 1. Role of PIWI and/or piRNA in carcinogenesis. This table shows recent evidences that deregulation (overexpression 
and/ or underexpression) of the PIWI-piRNA and PIWI proteins pathway in different cancer types has important 
implications in cancer hallmarks.
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of this pathway in cancer is still in its infancy, and investigation is currently underway to 
determine whether ectopic expression of piRNAs and PIWI proteins could have a driver role. 
Expression status and roles of the PIWI proteins and piRNAs remain poorly understood in 
cancer, and most of the current data about association of this pathway with carcinogenesis 
result from clinic-pathological reports. Aberrant expressions of these genes have been associ-
ated with various hallmarks of cancer and prognostic/predictive factors [2, 3].
1.1. Deregulation of PIWI proteins in cancer
Based mainly on both in vivo and in vitro functional studies combined with clinico-pathologic 
analysis, mounting evidence has identified all four human PIWI proteins as new molecular 
players in carcinogenesis [4]. Alterations of their expression levels are actually better inves-
tigated than piRNAs, with PIWI proteins overexpressed in germline and somatic malignant 
tumors. Deregulated PIWI proteins observed in somatic malignant tumors can be included in 
the cancer/testis antigens (CTAs) class and could thus be pertinent targets of immunotherapy 
[5]. They are linked to most of cancer hallmarks, suggesting an oncogenic role [6]. The four 
PIWI proteins PIWIL1/HIWI, PIWIL2/HILI, PIWIL3, and PIWIL4/HIWI2 were thus found to 
be involved in cancer cell proliferation, apoptosis, invasion, and metastasis and could repre-
sent diagnostic and prognostic biomarkers.
1.1.1. Proliferation, apoptosis, and stemness
PIWIL1: PIWIL1-induced DNA hypermethylation generates genetic and epigenetic changes 
promoting carcinogenesis [7]. PIWIL1 was upregulated in seminoma. In gastric cancer, 
PIWIL1 progressive increased expression was observed from preneoplastic lesions to inva-
sive cancer, whereas inhibition of PIWIL1 suppressed growth of tumor epithelial cells and 
induced cell-cycle arrest at the G2/M phase. PIWIL1 induced cyclin B1 overexpression and 
promoted cell cycle progression from G2 to M phase [8]. In sarcomas, PIWIL1 upregula-
tion was associated with repression of tumor differentiation and indefinite proliferation and 
inversely correlated with TSGs expression, including p15, p21, and p27. Lung cancer stem 
cells overexpressed PIWIL1 whose knockdown was associated with inhibition of sphere for-
mation ability and colony forming capacity in nude mice [9]. The promoting role of PIWIL1 in 
cell proliferation was also demonstrated in breast cancer [10]. In glioma, PIWIL1 repression 
was associated with inhibition of cell proliferation by promoting apoptosis and increasing 
cell cycle arrest. PIWIL1 induced cell cycle progression through increasing cyclin D1 and 
cyclin B levels of expression and repressed expression of p21, an inhibitor of cyclin D1 and 
CDK4, whereas its suppression through siRNAs blocked S phase entry via p21 upregula-
tion and cyclin D1 downregulation [11]. In hepatocellular carcinoma, PIWIL1 was underex-
pressed leading to reduction of proliferation and migration of cancer cells [12].
PIWIL2: PIWIL2-induced Stat3/Bcl-XL pathway activation promoted oncogenesis [13]. 
In breast cancer, PIWIL2 played an anti-apoptotic role and increased cancer stem cells 
proliferation by promoting the STAT3/Bcl-xL pathway [14]. PIWIL2 activated the STAT3/
cyclin D1 pathway. The splice isoform PL2L60 of PIWIL2 was overexpressed in tumors 
and was implicated in G0/1 to S phase transition and cancer cells proliferation through 
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activation of NF-κB and upregulation of STAT3 and Bcl-2 [15, 16]. In this way, PIWIL2 can 
directly bind to STAT3 protein via its PAZ domain and edify a PIWIL2/STAT3/c-Src triple 
protein-protein complex. Then, c-Src-induced phosphorylated STAT3 is translocated to the 
nucleus and binds to p53 promoter, inhibiting its transcription and reducing apoptosis in 
cancer cells. PIWIL2 silencing could reduce tumor proliferation and colony formation but 
increase apoptosis in vitro. PIWIL2 inactivation in colon cancer cells reduced proliferation 
and colony formation [14]. A significant positive correlation at mRNA level was observed 
between PIWIL1 and OCT4, as well as PIWIL2 and SOX2 in colon cancer cells [17]. In gastric 
cancer, PIWIL2 upregulated the expression of CDK2, CDK4, cyclin A, and c-Myc-dependent 
cyclin D1. In lung carcinoma, PIWIL2 enhanced CDK2 and cyclin A expression and initi-
ated mitotic phase [22]. In hepatocellular and cervical carcinoma, PIWIL2 promoted c-Myc 
expression through interaction of NME2 kinase to c-Myc promoter region [41]. PIWIL1 
and PIWIL2 modulated microtubules activity to increase malignant cell proliferation and 
invasion. PIWIL1 upregulated Stathmin1 expression, a pivotal cytosolic phosphoprotein 
implicated in edification of the mitotic spindle and segregation of chromosomes [43]. Direct 
interaction between Stathmin1 and PIWIL1 prevented its inhibition by CaMKII and its deg-
radation by E3 ubiquitin ligase RLIM. PIWIL2 promoted interaction of the tubulin folding 
cofactor B (TBCB) with HSP90 and repressed binding of TBCB to the E3 ubiquitin ligase 
adaptor protein gigaxonin, resulting in tubulin polymerization and microtubule edification 
during cell division [31].
PIWIL4: PIWIL4 also plays an oncogenic role in cervical cancer by inhibiting apoptosis 
through H3K9 methylation at the p14-ARF locus [18]. In glioma, PIWIL4 upregulated cyclin 
D1 expression and repressed the inhibitor of cyclin D1/CDK4 p16. PIWIL4 also promoted 
cyclin D1 expression through activation of STAT3, Bcl2, and Bcl-xL, and its expression was 
modulated by miR384 [46]. In cervical cancer, PIWIL4 promoted survival of cancer cells by 
inhibiting expression of p14-ARF and p53 and prevented apoptosis by inactivating the p14-
ARF/p53 axis. Furthermore, PIWIL4 downregulated PTEN expression and activity at the tran-
scriptional level, through DNMT1-induced hypermethylation of the PTEN gene promoter. 
PTEN inhibits numerous survival factors such as STAT3 and Akt/PI3K and through dephos-
phorylation induced by its phosphatase activity [1].
Furthermore, overexpression of PIWI proteins contributes to carcinogenesis by decreasing 
differentiation and promoting cancer stemness. PIWIL1 and PIWIL2 are implicated in main-
tenance and proliferation of lung and breast cancer stem cells, respectively [15].
1.1.2. Genomic integrity
Cancer cells overexpressing PIWI proteins often have genomic alterations partially resulting 
from reactivation of TEs. In sarcomas, PIWIL1, and p15, p21 and p27 expression levels are 
inversely correlated [7]. PIWI proteins maintain genome integrity in tumor cells by using 
epigenetic mechanisms. PIWIL1-induced carcinomas were characterized by global DNA 
hypermethylation at nonpromoter CpG regions. In mouse embryonic fibroblasts, PIWIL2 was 
implicated in DNA repair by promoting histone acetylation, chromatin relaxation, and DNA 
damage response [1].
Part 2: Deregulated Expressions of PIWI Proteins and piRNAs as New Candidate Biomarkers…
http://dx.doi.org/10.5772/intechopen.81738
267
of this pathway in cancer is still in its infancy, and investigation is currently underway to 
determine whether ectopic expression of piRNAs and PIWI proteins could have a driver role. 
Expression status and roles of the PIWI proteins and piRNAs remain poorly understood in 
cancer, and most of the current data about association of this pathway with carcinogenesis 
result from clinic-pathological reports. Aberrant expressions of these genes have been associ-
ated with various hallmarks of cancer and prognostic/predictive factors [2, 3].
1.1. Deregulation of PIWI proteins in cancer
Based mainly on both in vivo and in vitro functional studies combined with clinico-pathologic 
analysis, mounting evidence has identified all four human PIWI proteins as new molecular 
players in carcinogenesis [4]. Alterations of their expression levels are actually better inves-
tigated than piRNAs, with PIWI proteins overexpressed in germline and somatic malignant 
tumors. Deregulated PIWI proteins observed in somatic malignant tumors can be included in 
the cancer/testis antigens (CTAs) class and could thus be pertinent targets of immunotherapy 
[5]. They are linked to most of cancer hallmarks, suggesting an oncogenic role [6]. The four 
PIWI proteins PIWIL1/HIWI, PIWIL2/HILI, PIWIL3, and PIWIL4/HIWI2 were thus found to 
be involved in cancer cell proliferation, apoptosis, invasion, and metastasis and could repre-
sent diagnostic and prognostic biomarkers.
1.1.1. Proliferation, apoptosis, and stemness
PIWIL1: PIWIL1-induced DNA hypermethylation generates genetic and epigenetic changes 
promoting carcinogenesis [7]. PIWIL1 was upregulated in seminoma. In gastric cancer, 
PIWIL1 progressive increased expression was observed from preneoplastic lesions to inva-
sive cancer, whereas inhibition of PIWIL1 suppressed growth of tumor epithelial cells and 
induced cell-cycle arrest at the G2/M phase. PIWIL1 induced cyclin B1 overexpression and 
promoted cell cycle progression from G2 to M phase [8]. In sarcomas, PIWIL1 upregula-
tion was associated with repression of tumor differentiation and indefinite proliferation and 
inversely correlated with TSGs expression, including p15, p21, and p27. Lung cancer stem 
cells overexpressed PIWIL1 whose knockdown was associated with inhibition of sphere for-
mation ability and colony forming capacity in nude mice [9]. The promoting role of PIWIL1 in 
cell proliferation was also demonstrated in breast cancer [10]. In glioma, PIWIL1 repression 
was associated with inhibition of cell proliferation by promoting apoptosis and increasing 
cell cycle arrest. PIWIL1 induced cell cycle progression through increasing cyclin D1 and 
cyclin B levels of expression and repressed expression of p21, an inhibitor of cyclin D1 and 
CDK4, whereas its suppression through siRNAs blocked S phase entry via p21 upregula-
tion and cyclin D1 downregulation [11]. In hepatocellular carcinoma, PIWIL1 was underex-
pressed leading to reduction of proliferation and migration of cancer cells [12].
PIWIL2: PIWIL2-induced Stat3/Bcl-XL pathway activation promoted oncogenesis [13]. 
In breast cancer, PIWIL2 played an anti-apoptotic role and increased cancer stem cells 
proliferation by promoting the STAT3/Bcl-xL pathway [14]. PIWIL2 activated the STAT3/
cyclin D1 pathway. The splice isoform PL2L60 of PIWIL2 was overexpressed in tumors 
and was implicated in G0/1 to S phase transition and cancer cells proliferation through 
Chromatin and Epigenetics266
activation of NF-κB and upregulation of STAT3 and Bcl-2 [15, 16]. In this way, PIWIL2 can 
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1.1.3. EMT, invasion, and metastasis
Reciprocal interactions between PIWI proteins and transcription factors involved in EMT 
have been identified [19]. In colon carcinomas, PIWI proteins and piRNA 34736 activate genes 
implicated in EMT [20].
The four PIWI proteins identified in humans are variably overexpressed in numerous can-
cers and implicated in invasion and metastatic spread. The first example of PIWI protein 
deregulated in carcinogenesis was that of PIWIL1 overexpression in seminomas [21]. Since 
then, increased levels of PIWIL1 have been detected in lung, breast, gastrointestinal tract, 
pancreas, liver, cervical, ovarian, and endometrial carcinomas. In most of these malignant 
tumors, PIWIL1 overexpression is associated with large tumor size, high histologic grade, 
advanced stage, and poorer prognosis [22–24]. Compared with PIWIL1 and PIWIL2, PIWIL3 
and PIWIL4 have been studied in few cancers.
PIWIL1 upregulation was implicated in carcinogenesis by promoting expression of CSC 
transcription factors OCT4, NANOG, and BMI1 with increased self-renewal properties and 
resistance to chemotherapies [25]. In breast cancer, PIWIL1 modified cell cycle progression 
through regulating levels of TGF-β receptors, CDK4, CDK6, and CDK8 [26]. During gastric 
carcinogenesis, PIWIL1 levels of expression were gradually increased in normal tissues, 
atrophic gastritis, intestinal metaplasia, and invasive carcinoma [25]. In colon cancer, PIWIL1 
overexpression induced global DNA methylation and proliferation. In hepatocellular carci-
nomas, PIWIL1 overexpression promoted invasion and metastatic spread, whereas PIWIL1 
inactivation decreased metastatic evolution [27]. In glioblastomas, PIWIL1 inactivation 
reduced migration by inactivating expression of MMP2 and MMP9 [1]. Conversely, PIWIL1 
had an inhibiting effect on invasion in ovarian cancer [28].
PIWIL2 upregulation was identified in various stages of cervical low-grade and high-grade 
squamous, intraepithelial lesions, and invasive cervical carcinomas and had the potential to 
be used as a complementary biomarker for p16 [29]. In colon cancer, PIWIL2 overexpres-
sion was significantly correlated with more aggressive clinical and pathological parameters, 
including lymph node and distant metastasis and poor prognosis [30]. PIWIL2 overexpres-
sion induced invasion through activation of MMP9, whereas PIWIL2 inhibition decreased 
migration via E-cadherin upregulation and TWIST, vimentin, and N-cadherin downregula-
tion [30]. Experimental PIWIL2 knockdown was associated with inhibition of colon cancer 
cells invasion through MMP9 downregulation. In breast cancer, PIWIL2 upregulation in can-
cer stem cells was correlated with large tumor size, high histological grade, estrogen receptor 
expression, proliferation marker Ki67, advanced tumor stage, and lymph node metastasis 
[26]. In prostate cancer, PIWIL2 overexpression was associated with deregulation of EMT 
factors. In breast cancer, PIWIL2 and piRNA 932 overexpression promoted EMT in CD44+/
CD24− CSCs [31].
PIWIL4 was upregulated in breast and renal cell cancers, as compared with normal tissue [32, 33]. 
PIWIL4 can also induce cervical cancer cell invasion through inhibiting p14/ARF and p53 
expression [34].
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1.2. Deregulation of piRNAs in cancer
Compared to PIWI proteins, few literatures are available about piRNAs in carcinogenesis. 
Despite numerous piRNAs are generated in the human genome, only a small number is 
consistently expressed in normal and tumor tissues [1]. With the previously established evi-
dence on PIWI proteins deregulation in cancer, the hypothesis that piRNAs are also aber-
rantly expressed in various cancers is very likely because piRNAs are pivotal part of the 
pi-RISC effector complexes that allow recognition of TEs. Deregulation of piRNAs that target 
mRNA transcripts containing TE-derived sequences could induce alterations of TSGs and 
oncogenes [15]. Deregulation of both PIWI proteins and molecules implicated in biogenesis 
of the PIWI-piRNA are also in favor of a driver role for piRNAs in cancer. Recent evidence 
suggests that piRNAs control transcriptional and post-transcriptional genes regulation in 
cancer cells through epigenetic mechanisms associating global DNA hypomethylation, gene-
specific DNA hypermethylation, and histones hypoacetylation, which result in oncogenes 
activation, TSG repression, genomic silencing, and induction of a stem-like state [35, 36]. 
Furthermore, piRNAs drive carcinogenesis by using nonepigenetic mechanisms such as 
cell cycle deregulation, proliferation, and invasion [37, 38]. Differential expressions of few 
piRNAs were reported between malignant tumors and normal tissues. Transcriptomic analy-
sis of 6260 human piRNAs from 11 types of tumors and normal tissues has revealed that 
among the 20,831 known piRNAs, only 522 piRNAs were expressed in tumor tissues in a 
cancer-type specific manner, whereas 273 piRNAs were expressed in normal tissues [39].
The first examples of piRNAs deregulated in cancer were piR-651, piR-823, and piR-932. PiR-651 
was aberrantly overexpressed in numerous tumors, such as breast, gastric, colon, and lung can-
cers, compared to normal tissues. By using small RNA sequencing techniques in breast cancer, 
over 100 deregulated piRNAs were identified in tumors compared to normal tissues, including 
piR-34736, piR-36249, piR-35407, piR-36318, piR-34377, piR-36743, piR-36026, and piR-31106. 
Among them, piR-36743, piR-36026, and piR-31106 were overexpressed, whereas piR-34736, 
piR-36249, piR-35407, piR-36318, and piR-34377 were underexpressed [33]. Furthermore, estro-
gen deficiency and the estrogen receptor ERβ controlled metastatic spread of breast cancer 
cells by directly modulating piRNA expression. Eight piRNAs were significantly differentially 
expressed between breast tumors and normal tissue, with overexpression of piR-4987, piR-
20365, piR-20485, and piR-20582 correlated with lymph node metastasis [33]. In lung cancer, 
555 piRNAs were differentially expressed between lung adenocarcinomas and squamous cell 
carcinomas and normal bronchial tissue. The most frequently underexpressed piRNA in lung 
cancer was piR-L-163, localized in intron 10 of the LAMC2 gene. PiR-651 promoted cyclin D1 
and CDK4 overexpression, resulting in G1 phase entry [38]. In gastric cancer, piR-823 underex-
pression and piR-651 overexpression were initially identified by using piRNA microarray and 
PCR compared to matched nonmalignant tissues. PiR-651 overexpression induced transition 
from G2 to M phase [40]. A total of 156 piRNAs, including piR-32105, piR-58099, and piR-59056, 
were significantly differentially expressed by using small RNA sequencing from a series of 
320 carcinomas and 38 nonmalignant tissues [1]. In liver cancer, piR-Hep1 was overexpressed 
compared to normal liver tissues. PiR-Hep1 levels of expression positively correlated with 
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PIWIL2, suggesting that piR-Hep1 may interact with PIWIL2 to induce carcinogenesis [41]. In 
pancreatic cancer, piR-017061, localized within HBII-296A snoRNA, was shown to be under-
expressed compared to normal pancreatic tissues [42]. In leukemias, piR-823 inhibited p16 
expression through activation of DNMT3A and DNMT3B, resulting in upregulation of cyclin 
D1 and CDK4. PiR_011186A downregulated p15 expression and thus promoted cyclin D1 and 
CDK4 upregulation through edification of a molecular complex combining DNMT1, EZH2, and 
Suv39H1 [44]. In kidney cancer, study of 24 tumors revealed that 19 piRNAs were differentially 
expressed between clear cell renal cell carcinomas and benign tissues. Furthermore, 46 piRNAs 
were differentially expressed between primary and metastatic carcinomas. Among piRNAs 
deregulated in renal cell metastatic carcinomas, three overexpressed piRNAs (piR-32051, piR-
39894, and piR-43607) were localized on the same piRNA cluster on chromosome 17 [43]. In 
multiple myeloma, piR-823 was significantly underexpressed in tumors, compared to normal 
tissues [44]. Furthermore, numerous PiRNAs, including piR-Hep1, piR-651, piR-823, piR-932, 
piR-L-163, piR-4987, piR-20365, piR-20485, piR-20582 and piR-ABC, were associated with hall-
marks of cancer and could be pertinent diagnostic and prognostic biomarkers [40, 41, 45].
1.2.1. Proliferation, survival, and apoptosis
In bladder cancer, piRNAs microarray study identified 106 overexpressed piRNAs and 91 
underexpressed piRNAs, including piRNA DQ594040. PiRABC repressed cancer cells pro-
liferation and increased cell apoptosis through TNFSF4 protein overexpression. In multiple 
myeloma, PiR-823 was upregulated and implicated in proliferation, apoptosis, cell-cycle regu-
lation, and angiogenesis related to DNMT3A and p16-INK4A repression and associated with 
advanced clinical stage [44]. PiRNA-823 repression promoted deregulation of cell cycle regula-
tors and apoptosis-related proteins and inhibited pro-angiogenic activity [44]. In glioblastoma, 
piR-598 promoted cancer cells survival and proliferation [46]. In lung carcinoma, piR-55490 
underexpression was associated with increased proliferation through reduction of piRNA-
induced 3’UTR mTOR mRNA binding and degradation. Furthermore, inhibition of piR-L-163 
enhanced DNA synthesis and promoted tumor cells survival and proliferation [38, 47].
1.2.2. Invasion and metastatic spread
In breast cancer, piR-4987 upregulation was significantly associated with lymph node metas-
tasis and PIWIL2-piR-932 complex enhanced EMT through Latexin methylation of its pro-
moter region [31, 48, 49]. In clear cell renal cell carcinoma, 19 piRNAs were differentially 
expressed between tumor and normal tissues and 46 piRNAs were associated with metastasis 
and poor survival [43]. PiRNA microarray analysis revealed 235 piRNAs upregulated and 
369 piRNAs downregulated in malignant tissue from 106 patient samples. RT-qPCR analysis 
confirmed that piR-57125 was downregulated in metastatic tumors, whereas piR-30924 and 
piR-38756 were upregulated [50]. In gastric cancer, downregulated blood levels of piR-823 
were correlated with stage, lymph node, and distant metastasis, suggesting that piRNAs 
may be pertinent blood biomarkers [51]. Furthermore, PiR-651 inhibition promoted growth 
suppression and cell cycle arrest at the G2/M stage [40]. In hepatocellular carcinoma (HCC), 
deep sequencing analysis identified oncogenic piR-Hep1 upregulation associated with 
PIWIL2 overexpression. Inhibition of piR-Hep1 repressed Akt phosphorylation, motility, and 
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invasion [41]. In pancreatic ductal adenocarcinoma, piR-017061 located within HBII-296A 
snoRNA was found to be downregulated in tumors compared to normal tissues [42]. In lung 
cancer, PiR-651 overexpression promoted survival, invasion, and metastatic progression 
through cyclin D1 and CDK4 overexpression [70]. In colon cancer, PiR-823 upregulation was 
correlated with lymph node and distant metastasis, whereas in gastric cancer, piR-823 over-
expression suppressed tumor cell growth [1, 69].
1.3. Mechanisms of the PIWI-piRNA pathway deregulation in cancer
Few studies have identified molecular mechanisms implicating PIWI proteins and piR-
NAs reactivation in carcinogenesis [52, 53]. The first hypothesis concerning deregulation 
of the PIWI-piRNA pathway in cancer results from its control of TEs propagation. In nor-
mal germline stem cells, piRNAs cooperate with abundant PIWI proteins to regulate TEs 
inactivation via DNA methylation. During embryonic development, these cells containing 
high levels of PIWI proteins develop into various somatic tissues in which PIWI proteins 
are not normally expressed. In cancer, recent studies have demonstrated that methylation 
of TEs was decreased, whereas TEs transcripts and proteins were upregulated and cor-
related with higher metastasis frequency [54, 55]. Prolonged exposure to detrimental envi-
ronmental factors may promote TEs mobilization with disruption of various TSGs via TEs 
Figure 1. The PIWI-piRNA pathway in germline and somatic cells, and mechanisms of the PIWI-piRNA pathway 
deregulation in cancer cells.
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integration [56]. A widespread hypomethylation of the genome during progression could 
induce both aberrant reactivation and propagation of TEs with reactive ectopic overex-
pression of the PIWI-piRNA pathway. High levels of piRNAs and PIWI proteins observed 
in somatic cancers could promote abnormal extensive DNA methylation, resulting in 
silencing of TSGs and acquisition of an aberrant stem-like state [57, 58]. The hypothesis 
that piRNAs guide PIWIL1 and PIWIL2 to transcriptionally silence TSGs is consolidated 
by analysis of their orthologs in mice, in which MILI and MIWI2 mutants fail to establish 
DNA methylation of TEs [59]. Furthermore, by suppressing expression of particular TEs, 
aberrant reactivation of the PIWI-piRNA axis in cancer may induce genomic and chro-
mosomal instability. Thus, this pathway could be implicated in cancer not only in repres-
sion of TEs but also in inactivation of various mRNAs not exposed to germline cells. The 
second hypothesis is the participation of this pathway in a putative biological system that 
can differentiate self from nonself RNA [60]. The third hypothesis is the ectopic and coor-
dinated reactivation and overexpression in cancer of cancer/testis antigens (CTA) normally 
restricted to the germline and including molecules of the PIWI-piRNA axis. As observed in 
normal gametogenesis, CTAs promote immortalization, implantation, and migration that 
could correspond in carcinogenesis to transformation, invasion, and metastasis, respec-
tively (Figure 1). In this ectopic context, reactivation of the PIWI-piRNA pathway could 
confer properties of proliferative germline stem cells to cancer cells [61–68].
2. PIWIs and piRNAs as potential biomarkers and therapeutic tools
2.1. PIWI proteins as biomarkers
PIWIL1 overexpression was correlated with poor 5-year survival in malignant glioma, hepa-
tocellular, gastric cancer, colon cancer, pancreatic ductal adenocarcinoma, and ovarian cancer 
[1]. In hepatocarcinoma, PIWIL1 high levels of expression were correlated with larger tumor 
size, intrahepatic metastasis, overall survival, and recurrence-free survival [41]. PIWIL2 
upregulation was observed in breast cancer, colon cancer, gastrointestinal stromal tumors, 
renal cell carcinoma, and endometrial carcinoma. In colorectal cancer, PIWIL2 overexpression 
was associated with aggressive clinico-pathological characteristics and poorer prognostic [30]. 
In esophageal cancer, PIWIL2 was significantly correlated to high histological grade, advanced 
clinical stage, and poorer clinical outcomes. Furthermore, PIWIL2 upregulation was identified 
in a cancer cell subpopulation expressing OCT4 and NANOG stemness factors, suggesting a 
role in stem-cell maintenance and self-renewal. In breast cancer, PIWIL2 was mainly located in 
cancer stem cells and showed different expression patterns, with slight nuclear localization in 
preneoplastic lesions and cytoplasmic/nucleus topography in invasive and metastatic cancers. 
Its upregulation was correlated with poorer survival [33]. PIWIL2 can promote invasion and 
metastasis among various cancers by increasing c-Myc expression through binding of NM/
NM23 nucleoside diphosphate kinase 2 (NME2) to G4-motif region within c-Myc. In hepa-
tocellular carcinoma, nuclear co-expression of PIWIL2 and PIWIL4 had a worse prognostic 
phenotype [71]. In ovarian cancer, PIWIL2 overexpression was associated with cisplatin resis-
tance and poorer prognostic [28]. PIWIL3 and PIWIL4 overexpression were associated with 
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worse prognosis in breast cancer. In gastric cancer, PIWIL1-4 upregulation was significantly 
associated with TNM stage histological grade and lymph node metastasis [15, 40, 62].
2.2. PiRNAS as biomarkers
PiRNAs are increasingly investigated as diagnostic and prognostic biomarkers [69]. PiRNAs 
are small RNAs of only 24–32 nt in length which can pass through cell membrane. Like miR-
NAs, piRNAs are not degraded in circulation and possess the capability to resist incubation 
and storage conditions used in laboratories. They are thus detectable in patient samples like 
blood plasma and serum, saliva, sputum, and urine. Furthermore, piRNAs possess higher 
sensitivity and specificity compared to an existing lncRNA and miRNA-based biomarkers. 
They are highly expressed in germinal tissues, but also although at lower levels in various 
somatic normal tissues, saliva, and plasma-derived exosomes. Furthermore, piRNAs present 
higher specificity and sensitivity, when compared to miRNAs. In breast cancer, 8 piRNAs 
were identified as independent prognostic markers and associated with overall survival [63]. 
Moreover, piR-4987 upregulation in peripheral blood was correlated with lymph node metas-
tasis [48]. In gastric cancer, piR-651 high level of expression in peripheral blood was associated 
with poor differentiation, advanced TNM stage, and metastasis. A three-piRNA signature, 
including piR-59056, piR-54878, and piR-62701, could separate patients by risk of recurrence 
[5]. PiR-651 was also upregulated in other cancers, including lung, colon, and breast tumors. 
In clear cell renal cell carcinoma, piR-30924 and piR-57125 were shown to be independent 
prognostic predictors in nonmetastatic patients. In colon cancer, piR59056, piR-54878, and 
piR-62701 were associated with recurrence-free survival. Few studies have investigated on 
interactions between piRNAs and PIWI proteins in cancer [70, 72–75]. Actually, it remains 
unclear whether PIWI proteins independently possess cytoplasmic pro-oncogenic properties 
that promote cancer cell proliferation, invasion, and metastasis or PIWI proteins located in the 
nucleus epigenetically modulate numerous biological processes by edifying ribonucleoproteic 
complexes with piRNAs.
2.3. PIWI proteins and piRNAs as therapeutic tools
Recent studies have revealed the potential for piRNAs as therapeutic tools that target 
PIWI proteins and oncoproteins [71]. Mounting evidence has revealed that upregulation 
of PIWI proteins was negatively correlated with patient survival, and that downregula-
tion of PIWI proteins could reduce the number of G2/M phase cells and enhance expres-
sion of p53 protein, thus inhibiting proliferation and promoting apoptosis. In addition, 
PIWI proteins could increase resistance to chemotherapy drugs such as cisplatin, and 
their downregulation could increase sensitivity of cancer cells to cisplatin. In this way, 
synthetic piRNAs targeting PIWI genes are potential pertinent tools in transcriptional 
silencing during cancer progression, and PIWI antibodies targeting PIWI proteins con-
stitute another approach to antagonize cancer cells proliferation at post-transcriptional 
level. Synthetic piRNAs could also block synthesis of cancer-related proteins by bind-
ing to mRNAs. Compared to miRNAs, piRNAs do not require enzymes processing and 
have better specificity to targets. In a mouse model, artificial piRNAs could be obtained 
Part 2: Deregulated Expressions of PIWI Proteins and piRNAs as New Candidate Biomarkers…
http://dx.doi.org/10.5772/intechopen.81738
273
integration [56]. A widespread hypomethylation of the genome during progression could 
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DNA methylation of TEs [59]. Furthermore, by suppressing expression of particular TEs, 
aberrant reactivation of the PIWI-piRNA axis in cancer may induce genomic and chro-
mosomal instability. Thus, this pathway could be implicated in cancer not only in repres-
sion of TEs but also in inactivation of various mRNAs not exposed to germline cells. The 
second hypothesis is the participation of this pathway in a putative biological system that 
can differentiate self from nonself RNA [60]. The third hypothesis is the ectopic and coor-
dinated reactivation and overexpression in cancer of cancer/testis antigens (CTA) normally 
restricted to the germline and including molecules of the PIWI-piRNA axis. As observed in 
normal gametogenesis, CTAs promote immortalization, implantation, and migration that 
could correspond in carcinogenesis to transformation, invasion, and metastasis, respec-
tively (Figure 1). In this ectopic context, reactivation of the PIWI-piRNA pathway could 
confer properties of proliferative germline stem cells to cancer cells [61–68].
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renal cell carcinoma, and endometrial carcinoma. In colorectal cancer, PIWIL2 overexpression 
was associated with aggressive clinico-pathological characteristics and poorer prognostic [30]. 
In esophageal cancer, PIWIL2 was significantly correlated to high histological grade, advanced 
clinical stage, and poorer clinical outcomes. Furthermore, PIWIL2 upregulation was identified 
in a cancer cell subpopulation expressing OCT4 and NANOG stemness factors, suggesting a 
role in stem-cell maintenance and self-renewal. In breast cancer, PIWIL2 was mainly located in 
cancer stem cells and showed different expression patterns, with slight nuclear localization in 
preneoplastic lesions and cytoplasmic/nucleus topography in invasive and metastatic cancers. 
Its upregulation was correlated with poorer survival [33]. PIWIL2 can promote invasion and 
metastasis among various cancers by increasing c-Myc expression through binding of NM/
NM23 nucleoside diphosphate kinase 2 (NME2) to G4-motif region within c-Myc. In hepa-
tocellular carcinoma, nuclear co-expression of PIWIL2 and PIWIL4 had a worse prognostic 
phenotype [71]. In ovarian cancer, PIWIL2 overexpression was associated with cisplatin resis-
tance and poorer prognostic [28]. PIWIL3 and PIWIL4 overexpression were associated with 
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They are highly expressed in germinal tissues, but also although at lower levels in various 
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higher specificity and sensitivity, when compared to miRNAs. In breast cancer, 8 piRNAs 
were identified as independent prognostic markers and associated with overall survival [63]. 
Moreover, piR-4987 upregulation in peripheral blood was correlated with lymph node metas-
tasis [48]. In gastric cancer, piR-651 high level of expression in peripheral blood was associated 
with poor differentiation, advanced TNM stage, and metastasis. A three-piRNA signature, 
including piR-59056, piR-54878, and piR-62701, could separate patients by risk of recurrence 
[5]. PiR-651 was also upregulated in other cancers, including lung, colon, and breast tumors. 
In clear cell renal cell carcinoma, piR-30924 and piR-57125 were shown to be independent 
prognostic predictors in nonmetastatic patients. In colon cancer, piR59056, piR-54878, and 
piR-62701 were associated with recurrence-free survival. Few studies have investigated on 
interactions between piRNAs and PIWI proteins in cancer [70, 72–75]. Actually, it remains 
unclear whether PIWI proteins independently possess cytoplasmic pro-oncogenic properties 
that promote cancer cell proliferation, invasion, and metastasis or PIWI proteins located in the 
nucleus epigenetically modulate numerous biological processes by edifying ribonucleoproteic 
complexes with piRNAs.
2.3. PIWI proteins and piRNAs as therapeutic tools
Recent studies have revealed the potential for piRNAs as therapeutic tools that target 
PIWI proteins and oncoproteins [71]. Mounting evidence has revealed that upregulation 
of PIWI proteins was negatively correlated with patient survival, and that downregula-
tion of PIWI proteins could reduce the number of G2/M phase cells and enhance expres-
sion of p53 protein, thus inhibiting proliferation and promoting apoptosis. In addition, 
PIWI proteins could increase resistance to chemotherapy drugs such as cisplatin, and 
their downregulation could increase sensitivity of cancer cells to cisplatin. In this way, 
synthetic piRNAs targeting PIWI genes are potential pertinent tools in transcriptional 
silencing during cancer progression, and PIWI antibodies targeting PIWI proteins con-
stitute another approach to antagonize cancer cells proliferation at post-transcriptional 
level. Synthetic piRNAs could also block synthesis of cancer-related proteins by bind-
ing to mRNAs. Compared to miRNAs, piRNAs do not require enzymes processing and 
have better specificity to targets. In a mouse model, artificial piRNAs could be obtained 
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through expression of sense and antisense transcripts, resulting in epigenetic silencing of 
target genes [1, 72]. Furthermore, piRNAs could be considered as tools to regulate expres-
sion levels of TSGs. A lncRNA (GAS5)/SnoRNA-derived piRNA enhanced activation of 
TRAIL gene by site-specifically recruiting MLL/COMPASS-like complexes with induction 
of H3K4 methylation and H3K27 demethylation, resulting in transcriptional activation of 
TRAIL and inhibition of tumor growth [64].
3. Conclusion and perspectives
PiRNAs and PIWI proteins were first recognized more than a decade ago and are coming into 
attention with development of high-throughput sequencing technologies and bioinformat-
ics methods. This pathway is considered as a conserved immune-like surveillance process to 
suppress propagation of TEs in germline cells and various types of somatic mostly nonaging 
cells. Furthermore, the PIWI-piRNA pathway seems to be implicated in maintain of the genome 
organization, epigenetic modifications of genes expression, and identification of self and non-
self genes that are trans-generationally inherited. Moreover, this axis could be implicated in 
dual DNA/RNA-level regulation of genes expression. Nevertheless, there is still lack of com-
plete understanding of the functions and interactions of piRNAs and PIWI proteins. Therefore, 
the complicated biogenesis and functions of piRNAs need further elucidation to improve our 
understanding of the implication of these molecules in cancer. Since discovery of the unexpected 
role of this pathway in seminoma, aberrant levels of expression of these molecules have been 
observed across numerous malignant tumors, though further research is needed to elucidate 
their oncogenic or tumor-suppressing status. Growing evidence suggests that the PIWI-piRNA 
pathway modulates occurrence of most of cancer hallmarks. PIWI proteins and piRNAs could be 
pertinent diagnostic/prognostic biomarkers in cancer and therapeutic tools in targeted therapies. 
However, the potential driver role of a deregulated PIWI-piRNA pathway in cancer needs to 
be further evaluated. Furthermore, it remains unclear whether PIWI proteins regulate cancer 
cell proliferation, apoptosis, metastasis, and invasion in the cytoplasm independently or PIWI 
proteins perform epigenetic control of homeostasis by taken to the nucleus with piRNAs. Most 
importantly, since the aberrant expression of this pathway may induce stemness, analysis of 
relationship between PIWI proteins, piRNAs, and cancer stem cells may open new avenues in 
future investigations.
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